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Synaptic vesicle (SV) recycling in the presynapse is essential for the maintenance of 
neurotransmission. During mild stimulation clathrin-mediated endocytosis (CME) 
dominates, however during intense stimulation activity-dependent bulk endocytosis 
(ADBE) is the dominant form of membrane retrieval.  
The aim of this thesis was to determine how the signalling molecule GSK3 
controlled ADBE, with the hypothesis that this enzyme was required at multiple 
stages of this endocytosis mode. I also hoped to identify a specific cargo for ADBE. 
I found that during intense action potential stimulation, a localised calcium increase 
is necessary for the activation of Akt, which inhibited GSK3. This activation was 
mediated via a phosphatidylinositol 3-kinase (PI3K)-dependent mechanism. 
Furthermore, I found that phosphatidylinositol 4-kinaseIIα (PI4KIIα), a molecule 
whose abundance is regulated by GSK3, had a key role in ADBE. Specifically, I 
found that the absence of PI4KIIα accelerated CME but inhibited ADBE and that 
PI4KIIα controls CME and ADBE via distinct mechanisms.  
The PI4KIIα study revealed potential cross-talk between CME and ADBE. To 
determine whether modulation of either endocytosis mode impacts on the other, the 
retrieval of genetically-encoded reporters of SV cargo was monitored during intense 
stimulation during inhibition of either CME or ADBE. The recovery of almost all SV 
cargo was unaffected by ADBE inhibition but was arrested by abolishing CME. In 
contrast, VAMP4-pHluorin retrieval was perturbed by inhibiting ADBE and not by 
blocking CME. Knockdown of VAMP4 also arrested ADBE, indicating that in 
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addition to being the first identified ADBE cargo, it is also essential for this 
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Neurons are electrically excitable cells which are responsible for the transmission of 
information through electrical and chemical signals. Neurons are connected to form a 
neural network and vary in structure and function depending on their roles. Examples 
include sensory neurons which can respond to physical stimulus such as sound, touch 
or light via the sensory organs they innervate; interneurons which form connections 
between neurons within the central nervous system (CNS) or between the CNS and 
peripheral nervous system (PNS), enabling communication between different 
neuronal types; and motor neurons which receive signals from the brain or spinal 
cord to affect a muscular or glandular response. 
Typically, a neuron consists of a soma or cell body which houses the nucleus of the 
cell, a number of dendrites through which an electrical input is conducted into the 
cell and an axon through which a collated electrical input from the dendrites 
progresses on to the next neurite.  
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1.1 Synapse Structure and Function 
A synapse is the junction of two neurons. Through this junction an electrical impulse 
(action potential) is transmitted from one neuron to the other via a chemical 
intermediate, termed a neurotransmitter. The synapse consists of a presynaptic 
terminal (in which quanta of neurotransmitter are contained in synaptic vesicles 
(SVs)); a synaptic cleft (an extracellular space separating the two cells); and the post- 
synaptic terminal (on which resides membrane-bound receptors for neurotransmitter 
detection) (see Figure 1.1). The post-synaptic membrane is a component of a 
dendrite of the next neuronal cell. 
Action potentials are transmitted down axons of presynaptic neurons via the 
controlled exchange of charged ions, creating a difference in membrane potential 
which travels extremely quickly toward the presynapse. The arrival of an action 
potential in the presynaptic terminal depolarises the cell membrane and causes an 
influx of extracellular calcium (Ca2+) (Figure 1.1 A). This influx mainly occurs at a 
site called the active zone, an area enriched with voltage-gated Ca2+ channels 
(VGCCs). A population of neurotransmitter-containing SVs are tethered to the 
plasma membrane (PM) in close proximity to these Ca2+ channels, allowing Ca2+-
sensitive machinery to respond rapidly to stimulation of the cell and causing fusion 
of the SV (Südhof 2013). This fusion allows the neurotransmitter to be released into 
the synaptic cleft (Figure 1.1 B), diffusing across to the post-synaptic membrane and 
binding to receptors. Depending on the type of neurotransmitter released this has one 
of two effects: 1) For excitatory presynaptic cells, postsynaptic binding of 
neurotransmitter increases the probability of an action potential being transmitted 
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down the axon of the post-synaptic cell by changing its cross-membrane potential. 
For example, the postsynaptic binding glutamate or acetylcholine causes the opening 
of channels, allowing influx of positively charged ions and causing depolarisation of 
the postsynaptic cell and the procession of the action potential down the dendrite. 2) 
For inhibitory presynaptic cells, the binding of neurotransmitter decreases the 
possibility of an action potential progression. For example, postsynaptic GABA 
causes the opening of chloride channels allowing influx of negatively charged ions 
and causing hyperpolarisation of the postsynaptic cell. This has the effect of making 
it less likely that input from an excitatory presynaptic cell will depolarise the 
postsynaptic cell sufficiently to transmit the action potential onwards. 
To enable the release of vesicles for a subsequent stimulus, and to avoid inflation of 
the cell due to insertion of membrane, SVs are formed directly or via an endosomal 
intermediate from the edge of the active zone or the peri-active zone (Figure 1.1 C, D 




1.2 Synaptic Vesicle Pools 
Within the presynapse, SVs have been proposed to reside within functionally discrete 
groupings referred to as “pools”. The hypothesis of distinct vesicle pools was first 
developed when observing acetylcholine release from feline sympathetic ganglia 
(Birks & MacIntosh 1961). Upon stimulation, a small “readily releasable” fraction of 
acetylcholine was observed which depleted rapidly during stimulation at high 
frequencies as well as a larger, “non-readily releasable” fraction (Birks & MacIntosh 
1961). These observations led to the idea of SVs with different release probabilities 
residing within a synapse which were undergoing fusion only when their specific 
release criteria had been met.  
A universally agreed model on the identity and function of different SV pools has not 
yet been developed, and terminology differs between laboratories. Most groups 
concur that there is a pool of vesicles from which SVs are rapidly released on 
stimulation: the readily-releasable pool (RRP). However, during prolonged activity 
the number of vesicles which fuse with the PM can greatly exceed the number of 
vesicles docked at the active zone (Betz 1970). It is agreed that there is another pool 
of vesicles which are mobilised only during prolonged stimulation: the reserve pool 
(RP). Together, these two pools can be termed as the recycling pool i.e. the 
collection of all SVs which are available for release (Südhof 2000). SVs outwith 
these populations of releasable vesicles are therefore classified as belonging to the 
“resting pool” of SVs. 
A typical hippocampal synapse contains somewhere in the vicinity of 200 SVs 
(Schikorski & Stevens 1997). Using SV proteins which have been lumenally-tagged 
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Figure 1.1 Synaptic Vesicle Recycling in the Presynaptic Terminal 
An action potential arriving via an axon of the presynaptic terminal depolarises the synaptic 
membrane and causes the opening of calcium channels, leading to an influx of Ca2+ 
molecules (a). This Ca2+ interacts with fusion machinery and causes the exocytosis of docked 
and primed SVs (b). Coupled tightly to this is the endocytosis of SVs via CME. SVs or formed 
via a clathrin coat (c) and scissioned from the membrane via dynamin (d). Newly formed SVs 
are then uncoated, acidified and filled with neurotransmitter (e). During intense activity, larger 
sections of membrane are invaginated via ADBE (f). 
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with a pH-sensitive GFP molecule (pHluorin), one can track the relative amount of a 
certain protein to be exposed to the exterior of the cell compared to its total 
population. Using pHluorins it has been demonstrated that within a given population, 
the number of SVs available for release (recycling pool) during a prolonged 
stimulation is around 50% in neurons (Kim & Ryan 2010). 
It is worth noting that other models propose that nearly all SVs are available for 
release in the synapse with sustained activity. With regards to these models the three 
pools are classified as such: the readily releasable pool (1%) – SVs docked and 
primed at the  active zone and primed for release; the recycling pool (5-20%) – the 
pool of vesicles that maintain release during moderate stimulation; and the reserve 
pool – the remaining 80-90% of vesicles which are only released during intense 
stimulation (Rizzoli & Betz 2005). This model was, however, developed around data 
acquired from goldfish retinal bipolar cells as well as frog neuromuscular junction 
(NMJ) cells which are much larger and have a greatly increased number of SVs: 
around 700,000 and 500,000 per synapse respectively. It was also noted in these 
studies that the frequencies needed to stimulate the exocytosis of these SVs was most 
likely not representative of physiological stimulation (Rizzoli & Betz 2005). 
The RRP is tethered in close proximity to the active zone, allowing for rapid fusion 
upon arrival of an action potential to the synapse. The reserve pool however is 
immobilised and away from the active zone membrane. Actin has been implicated in 
the clustering of these SVs  (Doussau & Augustine 2000) and several studies have 
shown a dynamic modification of actin filaments in the presynapse in response to 
activity (Morales et al. 2000; Colicos et al. 2001; Sankaranarayanan et al. 2003). 
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Depolymerisation of actin via lantrunculin A increases neurotransmitter release 
without affecting the size of the RRP (Morales et al. 2000) showing a role for actin in 
the restraint of SVs separate from the RRP during stimulation.  
Further interference with actin function has shown a role for actin filaments in the 
recycling of SVs after endocytosis back to this vesicle cluster (Shupliakov et al. 
2002). Other work has shown an active recruitment of actin from the axon to 
presynaptic vesicle clusters during stimulation in hippocampal neurons 
(Sankaranarayanan et al. 2003). However, despite disrupting this recruitment, 
interference with actin dynamics using lantrunculin A does not inhibit SV formation 
as measured by uptake of styryl dyes (Sankaranarayanan et al. 2003). As such it 
would seem that actin recruitment is not essential for SV formation and it is likely it 
plays a role as a scaffolding protein for regulatory molecules involved in SV 
formation. 
Actin does not interact with SV membrane directly (Doussau & Augustine 2000) and 
as such the regulation of the mobilisation and release of SVs held within this actin 
filament structure is mediated via an intermediate: synapsin (Hilfiker et al. 1999). 
Synapsins are a family of peripheral SV phospho-proteins which are capable of 
binding both actin and SVs simultaneously (Benfenati et al. 1992).  
The necessity for synapsin in the assembly and/or maintenance of a reserve pool has 
been demonstrated in synapsin knockout mice; mouse models deficient in all 
isoforms of synapsin (I a and b, II a and b and III a and b) have shown a decrease in 
the number of SVs clustered away from the PM, with no effect on the number of SVs 
docked at the PM (Gitler et al. 2004), showing a role for synapsin in the maintenance 
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of a pool of vesicles distinct from the RRP, similar to if not overlapping with the role 
performed by actin. Similar studies in mouse models devoid of only one or two 
synapsin isoforms have shown similar effects on the clustering of SVs (L. Li et al. 
1995; Takei et al. 1995). On an ultrastructural level, synapsins have been shown to 
localise specifically to SVs distal to the active zone (De Camilli et al. 1983; 
Hirokawa et al. 1989; Torri-Tarelli et al. 1990; Pieribone et al. 1995; Bloom et al. 
2003), possibly indicating a specificity for reserve pool SVs.  
The release of SVs from this synapsin-actin matrix is dependent on phosphorylation. 
The affinity of synapsin for SVs is dramatically decreased when synapsin is 
phosphorylated by cAMP-dependent protein kinase (PKA), Ca2+ /calmodulin-
dependent kinase I (CaM kinase I) or Ca2+ /calmodulin-dependent kinase II (CaM 
kinase II) (Schiebler et al. 1986; Hosaka et al. 1999; Menegon et al. 2006); whereas 
phosphorylation of synapsin by mitogen-activated protein kinase (MAP kinase) 
decreases its affinity for actin (Jovanovic et al. 1996).  
During periods of prolonged activity an increase in internal calcium concentration 
([Ca2+]i) causes an activation of Ca2+-dependent kinases such as CaM kinase I/II and 
those forms of PKA which are Ca2+-sensitive. This causes a decrease in the affinity 
of synapsin for SVs and mobilisation of those vesicles held within the matrix (Chi et 
al. 2001; Chi et al. 2003; Menegon et al. 2006). Increased [Ca2+]i during periods of 
high activity also causes the activation of calcineurin which dephosphorylates those 
sites phosphorylated by MAP kinase and increases the affinity of synapsin for actin. 
This adaptable interaction may be responsible for modulating actin dynamics during 
high synaptic activity (Jovanovic et al. 1996; Jovanovic et al. 2001). Together this 
10 
shows that the reserve pool of vesicles is held within an actin-synapsin matrix 
designed to change shape during periods of intense activity, freeing these SVs and 




1.3 Synaptic Vesicle Life Cycle 
The cycle of fusion (exocytosis) and formation (endocytosis) of SVs in the 
presynapse is essential for efficient neuronal signalling and therefore function of the 
nervous system. Mutations or abnormal expression of proteins integral to this process 
have been linked to a variety of neurological conditions. Examples include: a single 
point mutation in synaptic protein synapsin I and familial epilepsy (Garcia et al. 
2004); decreased expressions of essential endocytic proteins synaptotagmin, AP-2, 
AP180 and dynamin I in Alzheimer’s disease (Yao 2004); and mutations of the 
presynaptic phosphatase synaptojanin 1 in certain cases of mania or depression (Saito 
et al. 2001; Stopkova et al. 2004).   
1.3.1 Synaptic Vesicle Exocytosis 
Exocytosis of a vesicle is not as simple as two membranes colliding and fusing. It 
occurs via a series of tightly regulated processes. All of which; docking, priming and 
fusion and require a multitude of proteins to facilitate each stage.  
 Docking and Priming of Synaptic Vesicles 
The current model for the docking and priming of SVs hypothesises that SVs connect 
(“dock”) to the active zone within the presynapse. Subsequent to this the SVs 
undergo a process allowing them to become capable of fusion (“primed”). These SVs 
form the RRP, the docking and priming of these SVs in such close vicinity to the 
calcium channels of the active zone allows them to be rapidly fused with the PM 
upon an increase in [Ca2+]i (Südhof 2013).  
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Although the necessity for each of these processes is accepted, the conclusions drawn 
from studies into the molecular processes belying them remains relatively 
inconclusive. For example, one theory derived from work in chromaffin cells stated 
that the SV protein synaptotagmin-1 functions as calcium-sensitive machinery during 
docking through its interactions with membrane-bound synaptosomal-associated 
protein 25 (SNAP-25)/syntaxin complexes (de Wit et al. 2009). This model is 
popular and yet contentious as other work in synaptotagmin-1 KO mice showed that 
though a phenotype was observed in the docking of large dense-core vesicles in 
chromaffin cells, this defect was not recapitulated in the fusion of secretory vesicles 
(Schonn et al. 2008). Work in synapses utilising synaptotagmin KO or mutant mice 
have shown deficits in the release of neurotransmitter with little to no corresponding 
defects in the size or location of the RRP (Geppert et al. 1994; Liu et al. 2009). These 
results would disagree with the model of synaptotagmin as a component for docking 
but instead imply more of a role in the fusion of a SV.   
The variety of models, cell types, methods of fixation, definitions and terminology 
used in the study of the docking and priming of vesicles across the field of study 
make a consensus difficult to gauge. The accurate identification of docked vesicles 
has been argued to require the measurement of intermembrane differences in the 
order of nanometres (Verhage & Sørensen 2008), resulting in a morphological rather 
than functional definition of docked vesicles which can only be studied reliably via 
electron microscopy. 
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The docking of a SV at the active zone requires an interaction of both vesicular and 
membrane proteins. The process of priming organises these proteins in such a way to 
facilitate a rapid fusion upon Ca2+ entry to the active zone. 
The initial recruitment of SVs to an available space at the active zone is likely driven 
by the binding of SV proteins (e.g. Rab3/27) to Rab-interacting molecules (RIMs) 
(Haucke et al. 2011) and RIM-binding proteins (Liu et al. 2011). RIMs directly 
associate with a large portion of active zone and SV proteins including calcium 
channels themselves (Mittelstaedt et al. 2010) and have been shown to be essential 
for SV docking and priming (Koushika et al. 2001; Schoch et al. 2002; Schoch et al. 
2006; Gracheva et al. 2008), though their exact mechanism of action is unknown.  
The docking and priming of SVs to the active zone after their recruitment is 
facilitated through the association of membrane proteins. The collective name for the 
proteins which assemble between SV and PM during docking and priming is SNARE 
proteins (for Soluble N-ethylmaleimide-sensitive factor {NSF}-Attachment protein 
REceptors). The SNARE complex, formed upon docking, consists of proteins both 
on the vesicle (v-SNARES) and on the PM (t-SNARE) (Söllner et al. 1993). 
t-SNAREs consist of syntaxin-1 and SNAP-25 and the v-SNARE is synaptobrevin II. 
Although SNARE proteins are varied in size and structure each protein shares a 
SNARE motif in their cytosolic domain. This is a 60-70 amino acid region that 
contains heptad repeats which are able to form coiled-coil structures. SNAP-25 is 
unique in that it has two SNARE motifs. Once assembled the SNARE proteins form 
a complex consisting of four α-helix domains, with one each of synaptobrevin and 
syntaxin and both SNAP-25 motifs contributed (Sutton et al. 1998; Stein et al. 2009). 
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The incorporation of syntaxin into this SNARE complex is the rate limiting step of 
this interaction. Syntaxin is held in a “closed” state by Munc-18 in which it is 
incapable of interacting with other SNARE proteins (Burkhardt et al. 2008); t-
SNAREs syntaxin and SNAP-25 must first form a dimer before v- and t-SNARE 
binding can successfully occur to form a trans-SNARE complex (Fasshauer et al. 
2002; Rickman et al. 2004). 
Munc-18 is one of the family of Sec1/Munc18-like (SM) proteins. Munc18 was first 
linked to membrane fusion through the discovery of its association with syntaxin 
(Hata et al. 1993) and is essential for exocytosis of SVs (Verhage et al. 2000) though 
its exact function is not exactly understood. Its arch-shaped structure contains a 
central cavity with a high-affinity for the t-SNARE syntaxin (Misura et al. 2000; 
Burkhardt et al. 2008). However, it is thought that Munc-18 has a role in the 
initiation of the fusion machinery assembly (Jahn & Fasshauer 2012) and it remains 
associated with a SNARE complex throughout assembly and disassembly 
(Khvotchev et al. 2007).  
However, the binding of Munc-18 to the individual t-SNARE syntaxin occludes part 
of the SNARE motif and therefore inhibits SNARE -complex formation; this is 
referred to as a “closed” conformation of syntaxin (Dulubova et al. 1999; Misura et 
al. 2000). The consequences of this interaction would suggest a contradictory 
suppressive action of Munc-18 on SNARE complex formation. It has been 
hypothesised therefore that Munc-18 firstly acts as a chaperone for syntaxin-1 to a 
prospective fusion site (Jahn & Fasshauer 2012) and the closed formation of syntaxin 
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is necessary to prevent the formation of ectopic SNARE complexes before its arrival 
at the active zone (Medine et al. 2007).  
Another hypothesis for the purpose of Munc18 observes the similarities between a 
closed syntaxin structure and a complete SNARE complex. In addition to its coiled 
SNARE motif, syntaxin also contains a three-helix bundle comprising its globular, 
N-terminal “Habc” domain. This domain folds back and binds the helical SNARE 
motif to form the closed syntaxin conformation (Dulubova et al. 1999; Misura et al. 
2000). In this closed configuration, syntaxin forms a four helix bundle which is 
clasped by Munc-18. The Habc domain of Munc-18 is also able to bind to a fully 
formed four helix SNARE complex (Dulubova et al. 2007). It has been proposed that 
Munc-18 releases syntaxin during SNARE-complex assembly allowing the opening 
of its structure and subsequent incorporation into the SNARE complex, it then forms 
an association with the four helix bundle of the SNARE complex, possibly helping to 
form this transmembrane SNARE complex when the three SNARE proteins are 
brought into proximity. 
The SNARE/Munc-18 complex, is not the only release machinery involved in 
priming a SV for exocytosis. Complexin (also known as synaphin) is a highly 
charged, hydrophilic protein (Ishizuka et al. 1995) which binds with high affinity 
only to partly or fully formed SNARE complexes. It is possible that the binding of 
complexin to a SNARE complex allows its associated SV to become what is termed 
as “superprimed”; and that it is in this formation that a SNARE complex becomes a 
substrate for the Ca2+-sensitive component of SV release machinery synaptotagmin I 
– all synaptotagmin-controlled fusion reactions examined to date appear to require 
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complexin (Südhof 2013). It is also possible that the integration of complexin into 
this complex allows the stabilisation of the correctly orientated syntaxin-
synaptobrevin allowing more efficient fusion (Tang et al. 2006; Jahn & Fasshauer 
2012) and that complexin binding has no effect on synaptotagmin as it is independent 
from the SNARE complex. 
The role of complexin in the priming of SVs is somewhat confused by the presence 
of both an N-terminal head, which is directed towards the PM and is required to 
facilitate fusion (Maximov et al. 2009) but also a central helix which plays an 
inhibitory role in fusion (Giraudo et al. 2009). This has led to two main theories of 
the molecular mechanism of complexin and its seemingly dual stimulatory and 
inhibitory roles (Brose 2008; Stein & Jahn 2009; Sudhof & Rothman 2009; Sørensen 
2009; Neher 2010a). Firstly, the addition of complexin to an assembling SNARE 
complex may promote the “zippering” of the separate helices and sensitise them to 
the action of synaptotagmin in the presence of calcium. Secondly, the addition of 
complexin to a zippering complex may act as a clamp and block further progression 
and spontaneous fusion. A block which is relieved by the calcium-triggered action of 
synaptotagmin.  
These two functions are not necessarily mutually exclusive; if SVs are not held in a 
stable configuration the potential for spontaneous firing and depletion of the RRP is 
greatly increased and complexin has been shown to inhibit spontaneous exocytosis 
(Wragg et al. 2013). With this in mind, a SV must be capable of rapid fusion when a 
synaptic stimulus arrives. As such complexin serves the dual purposes of facilitating 
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the action of Ca2+-sensitive machinery whilst maintaining the stability of the SNARE 
complex.  
Complexin is not essential for exocytosis to proceed, however complexin knockout 
mice show a greatly reduced release of RRP SVs demonstrating a facilitative role of 
the protein in the maintenance of a population of primed SVs (Reim et al. 2001).  
 Fusion 
After the docking and priming of a SV, the SNARE proteins embedded in each 
membrane form a trans-complex which undergo a zippering together of the four 
helical SNARE motifs which progresses from N- to C-terminal on each motif 
(Hanson et al. 1997).  
This zippering action is triggered by entry of Ca2+ to the active zone. This Ca2+ -
dependent response is mediated via a protein complex consisting of RIM, RIM-BP 
and Munc-13. This complex binds SVs via Rab proteins Rab3 and Rab 27 whilst 
simultaneously binding VGCCs (Südhof 2013), effectively tethering one to the other. 
The close proximity of the SV and its SNARE complex to this entering Ca2+ allows a 
rapid fusion of membrane after stimulation. The calcium-sensitive element of SV 
release machinery has been identified as synaptotagmin 1 (Fernández-Chacón et al. 
2001; Sørensen et al. 2003; Pang et al. 2006). There are 16 different synaptotagmins 
expressed in the brain and eight of these bind Ca2+. Synaptotagmin 1, 2 and 9 all 
have roles in some form of synchronous SV exocytosis and all with slightly different 
kinetics which are suited for the particular cell type in which they are expressed (Xu 
et al. 2007).  
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Synaptotagmin is a transmembrane protein with two cytoplasmic C2 domains (Perin 
et al. 1990) which contain Ca2+ binding sites (Brose et al. 1992): C2A- which can 
bind three Ca2+ ions and C2B which can bind two (Südhof 2004). These C2 domains 
are connected to each other and the membrane by flexible linkers (Jahn & Fasshauer 
2012) and have the ability to bind Ca2+ in a manner which increases their affinity for 
phospholipids (Brose et al. 1992; C. Li et al. 1995). These C2 domains also facilitate 
folding of synaptotagmin (Perin et al. 1990; Davletov & Sudhof 1993; Sutton et al. 
1995; Südhof 2004) as well as binding to syntaxin and SNARE complexes (Bennett 
et al. 1992; Söllner et al. 1993; C. Li et al. 1995) in a manner which is increased in 
the presence of Ca2+. These facts together create a model for Ca2+-mediated fusion 
being facilitated by synaptotagmin bound to a trans-SNARE complex, and 
undergoing a conformational shift implemented by Ca2+ binding to its C2 domains 
and completing the zippering of the SNARE complex helices. This zippering action 
forces the vesicular and PM into close proximity and consequently destabilises their 
hydrophilic surfaces, opening a fusion pore. 
This is not the only current model as to the role of synaptotagmin in SV fusion. 
There is evidence that synaptotagmin does not bind to SNARE complexes in vivo 
due to the presence of polyvalent ions such as ATP and Mg2+ and that it is actually 
synaptotagmins association with the phospholipid PIP2 which mediates the fusion of 
SVs upon Ca2+ entry (Park et al. 2015). In this model, the addition of Ca2+ ions to the 
C2 domains of synaptotagmin causes their insertion into the lipid bilayer of the PM, 
bringing it and the SV membrane into closer proximity and causing fusion. 
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Despite the general acknowledgement of synaptogamin’s role as the calcium 
sensitive effector for SV release, it is still controversial as to how the influx of 
calcium implements the rapid, synchronous exocytosis of SVs. It is widely agreed 
that a primed SV is tethered by a SNARE complex in a partially zipped state which 
is somehow prevented from full co-ordination. This could be either by an energy 
barrier or by an interfering protein (such as complexin or possibly synaptotagmin). It 
is also possible that Munc-18 is still bound to the SNARE complex at this stage. 
Some believe that this complex is strained, storing energy that could be released 
during exocytosis. Others believe that this complex is relaxed allowing a flexibility 
of the linkers connecting the zippered section of the complex and the membrane 
(Jahn & Fasshauer 2012). 
The model of synaptotagmin-mediated fusion therefore would differ depending on 
which conformation SNARE complex is perceived. The reaction of synaptotagmin 
after Ca2+ binding could progress in any of the following ways: 
1. Ca2+ binding allows synaptotagmin to disengage from SNAREs, thereby 
removing itself as an inhibitory device (fusion clamp model – synaptotagmin) 
(Chicka et al. 2008). 
2. Ca2+ binding allows synaptotagmin to bind the SNARE complex, thereby 
displacing the inhibitory complexin (fusion clamp model – complexin) (Yang 
et al. 2010) and/or… 
3. …Ca2+ binding allows synaptotagmin to bind the SNARE complex, thereby 
promoting the completion of SNARE motif zippering (energy barrier model) 
(Yang et al. 2010). 
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4. Ca2+ binding allows synaptotagmin to bind to PM adjacent to partially zipped 
SNARE complex, causing destabilisation at the fusion site (energy barrier 
model) (Stein et al. 2007; Xue et al. 2008; Lee et al. 2010). 
5. Ca2+ binding allows synaptotagmin to increase curvature stress by displacing 
lipids in the PM (energy barrier model) (Martens et al. 2007; Hui et al. 2009). 
6. Ca2+ binding allows synaptotagmin to bind to PM, therefore accelerating 
fusion by charge compensation due to the positive electrostatic potential of its 
C2 domains (energy barrier model) (Araç et al. 2006). 
Currently none of these models uniformly fit the wealth of gathered evidence (Jahn 
& Fasshauer 2012) and hence the method of Ca2+-activated synaptotagmin-mediated 
fusion remains elusive. 
 SNARE Complex Disassembly and Retrieval  
Upon fusion, the SV collapses into the PM, hence the SNARE complex formed of v-
SNAREs and t-SNAREs is no longer a trans-SNARE complex residing on two 
distinct membranes but a cis-SNARE complex – tightly bound via the SNARE 
motifs and residing entirely on the PM. To ensure a sustainable pool of t-SNARE 
proteins on the PM, and to allow the uptake of v-SNAREs onto newly forming SVs, 
these cis-SNARE complexes must be broken apart into their constituent parts. 
The process of “unzipping” the assembled SNARE motifs requires energy. This is 
supplied via the ATPase N-ethylmaleimide-sensitive fusion (NSF) protein which 
binds to SNARE complexes via adaptors called soluble NSF-attachment proteins 
(SNAPs). NSF is a member of a AAA+ family of ATPases (Erzberger & Berger 
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2006) and forms homomeric hexamers with each protomer containing two ATPase 
domains and one amino-terminal domain which is responsible for SNAP and 
possibly SNARE binding (Whiteheart et al. 2001). Together the NSF hexamer, 
SNAPs and SNARE complex bind to form a “20S” complex prior to ATP hydrolysis 
(Söllner et al. 1993). 
It has been hypothesised that in any given 20S structure there contains up to four 
molecules of SNAP, one hexameric ring of NSF and one SNARE complex (Zhao et 
al. 2015). This hypothesis has given rise to the following model: firstly, a barrel of 
SNAP molecules surrounds the SNARE helices. After this NSF attaches to form a 
complete 20S structure, and its ATPase rings tighten like a loaded spring (Zhao et al. 
2015). This model suggests that the 20S complex utilises ATP hydrolysis to twist 
and exert a torque force to unwind the SNARE helices (Zhao et al. 2015). 
After this disassembly, all components of this SNARE complex become available for 
future rounds of exocytosis. t-SNAREs remain on the PM and v-SNARES are 
retrieved via endocytosis onto new SVs along with all other SV cargo. Failure to 
clear the active zone of these proteins leads to an inhibition of neurotransmitter 







Figure 1.2 Fusion of Synaptic Vesicles – Exocytosis 
Schematic showing the docking, priming and fusion of synaptic vesicles. Beginning from the top panel and going clockwise: Box 1: a SV is brought 
into the vicinity of the active zone. On the plasma membrane, the t-SNARE syntaxin (orange) is held in its closed formation by Munc18 (blue). Box 2: 
Priming I – Syntaxin opens and a SNARE complex is formed via the SNARE motif of syntaxin, the two of SNAP-25 (green) (t-SNAREs) and 
synaptobrevin II (red) (v-SNARE). Munc18 then binds this four helix bundle. Box 3: Priming II – after this formation complexin (pink) inserts itself into 
the complex, facilitating the future fusion of the two membranes, possibly by association with synaptotagmin (purple). Box 4: Fusion-pore opening – 
during stimulation, Ca2+ binds synaptotagmin and causes an alteration in its association with the SNARE complex, bringing the two membranes into 
contact and forcing fusion. Box 5: Fusion completion -  The SV collapses into the plasma membrane and neurotransmitter is released into the 
extracellular space. The SNARE complex is now residing bound on one membrane. NSF (cream) and SNAPs (brown) bind the complex and utilise 




1.3.2 Synaptic Vesicle Endocytosis 
 Clathrin Mediated Endocytosis 
Clathrin mediated endocytosis (CME) is required for the uptake of not only SNAREs 
but all SV cargo from the presynaptic PM. This endocytic route is the best 
characterised method of synaptic membrane retrieval and utilises a host of accessory 
proteins, allowing the uptake of a variety of cargo proteins into each internalised SV. 
CME can be separated into several stages: nucleation, cargo selection, invagination, 
fission and uncoating. The process of endocytosis of a single SV after stimulation 
has been measured using fluorescent-tagged SV proteins such as synaptophysin-
pHluorin and estimated to take a time of  around 15 seconds (Granseth et al. 2007) 
for a SV to become entirely separated from the PM. 
However, this model of initiation has recently been called into question. Several 
studies have shown a role for the formation of a nucleation module, which appear to 
label those sites on the PM to which clathrin and its adaptor proteins will be recruited 
(Henne et al. 2010; Stimpson et al. 2010).  
This nucleation module consists of FCH domain only (FCHO) proteins, EGFR 
pathway substrate 15 (eps15) and intersectins  (Henne et al. 2010; Stimpson et al. 
2010; Reider et al. 2009) and its assembly at the PM is thought to be facilitated by an 
affinity for PIP2 (McMahon & Boucrot 2011). Depletion of either FCHO, eps15 or 
intersectins inhibits clathrin coat recruitment in yeast (Henne et al. 2010; Stimpson et 
al. 2010; Reider et al. 2009). 
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FCHO proteins contain curvature-sensing F-BAR domains which act to create very 
low curvatures. Deletion of this F-BAR domain inhibits the formation of clathrin-
coated pits (Henne et al. 2010) showing a necessity for membrane curvature even 
before the recruitment of adaptor proteins and clathrin molecules. However, it has 
been suggested that the role played by FCHO proteins is not essential in all CME as 
and at least partially redundant with that played by Eps15 (Wang et al. 2016). 
1.3.2.1.1 Cargo Selection 
Once the nucleation module is formed, generating a slight membrane curvature, it is 
now thought to be responsible for the recruitment of AP-2 (Henne et al. 2010; 
McMahon & Boucrot 2011) via its interactions with module component eps15 
(Benmerah et al. 1998). AP-2 is a tetramer and consists of two large subunits (α2 and 
β2), an intermediate size subunit (µ2) and a small subunit (σ2). AP-2 anchors itself to 
the PM through a direct interaction with PIP2 via the α2 subunit (Gaidarov & Keen 
1999). The β2 subunit of AP-2 binds directly to the SV scaffold protein clathrin, 
recruiting it to an invaginating SV (Shih et al. 1995).  
AP-2 also binds to epsin (Chen et al. 1998), an ENTH-domain protein which binds to 
PIP2 and inserts an amphipathic helix into the PM, inducing further membrane 
curvature (Ford et al. 2002). It is possible that both ENTH-domain proteins epsin and 
eps15 work in concert. Epsin and eps15 interact via their carboxy-terminal and EH 
domains respectively (Chen et al. 1998) both are capable of binding multiple copies 
of AP-2 and both are displaced from AP-2 upon clathrin binding (Morgan et al. 
2003; Praefcke et al. 2004) and move to the rim of growing coated pits.   
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AP-2 acts as the major hub for protein interactions in the growing clathrin-coated pit, 
the μ- and σ-subunits are capable of interacting directly with the cytoplasmic tails of 
transmembrane receptors as well as indirectly with other SV cargo using appendage 
domains to bind accessory adaptor proteins (Collins et al. 2002; Kelly et al. 2008). A 
variety of accessory adaptor proteins are responsible for the retrieval of different 
cargo (see Table 1.1). For example, human immunodeficiency virus Rev-binding 
protein (HRB) retrieves vesicle-associated membrane protein 7 (VAMP7) (Pryor et 
al. 2008). Importantly though, these cargo-specific adaptors all bind AP-2 
(McMahon & Boucrot 2011) ensuring a targeted and co-ordinated accumulation of 
cargo and adaptor proteins.  
One example of these accessory adaptor proteins is AP180 which contains both an 
ANTH domain, which is responsible for the association of this protein with the PM, 
and a “membrane-bending” ENTH domain (Ford et al. 2001). AP180 binds to 
clathrin and has a role as a chaperone of the SV cargo protein synaptobrevin. 
Synapses expressing mutant AP180 show a wider dispersal of synaptobrevin with 
less concentration at active zones (Dittman & Kaplan 2006). AP180 is also important 
in its role as an assembler of clathrin molecules (Hao et al. 1999). 
Stonin 2 is another adaptor protein which is known to retrieve synaptotagmin 
(Haucke & De Camilli 1999). However, more recent work has implied a larger role 
for this adaptor in the retrieval of vesicles and their cargo. The knockdown of stonin 
2 in hippocampal cells lead to a much larger effect on pHluorin retrieval than any 
AP-2 subunit knockdown with these results recapitulated using an acute method of 
protein removal (Willox & Royle 2012). 
27 
The plethora of interactions of AP-2 with necessary SV cargo proteins would imply 
that the recruitment of AP-2 is the step of cargo selection in CME. Though, as its 
removal via rerouting does not cause a severe effect on the retrieval of SV proteins in 
comparison to clathrin or Stonin 2 (Willox & Royle 2012) it is possible that its role is 
complementary in nature. Also, FCHO proteins contain a possible ligand-binding 
domain (Stimpson et al. 2010; Reider et al. 2009) and as such it is possible that some 
cargo sorting occurs as early as nucleation.  
1.3.2.1.2 Clathrin Coat Assembly 
Clathrin is a triskelion shaped scaffolding protein consisting of three heavy and three 
light chains. Clathrin cannot directly bind to the PM and as such is only tethered to 
the SV via its interactions with adaptor proteins such as AP180, epsin and AP-2 
(McMahon & Boucrot 2011). AP180 interacts with the heavy chains in clathrin 
triskelion (Prasad & Lippoldt 1988; Lindner & Ungewickell 1991), clathrin triskelia 
are therefore directed to sites of adaptor protein concentration. When clustered, 
individual triskelia aggregate to form a polyhedral lattice and form coats of 60-70 nm 
diameter around the invaginating vesicle (Ahle & Ungewickell 1986; Prasad & 
Lippoldt 1988; Morris et al. 1993). The formation of this coat stabilises the curvature 
of the invaginating SV, it also displaces some curvature effectors such as eps15 and 
epsin (Tebar et al. 1996; Saffarian et al. 2009) allowing them to perform their 
membrane-bending function most effectively at the neck of the vesicle. 
In a clathrin-depleted cell, AP-2 remains in puncta co-localised with the nucleation 
complex but this site does not mature into an invagination (Henne et al. 2010). 
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Whereas the disruption of AP-2 recruitment to the active zone via the knockdown of 
the AP-2 μ2 subunit results in the successful assembly of a nucleation complex but 
no recruitment of clathrin, resulting in a lack of vesicle formation (Motley et al. 
2003; Boucrot et al. 2010; Henne et al. 2010). These results would appear to reveal 
the sequence of events in which cargo selection and clathrin recruitment occur at the 
active zone. A nucleation complex on the PM binds AP-2 which then recruits 
clathrin along with other essential proteins to allow successful endocytosis of a 
clathrin-coated vesicle. 
1.3.2.1.3 Fission 
The scission of a clathrin-coated vesicle is dependent on the GTPase dynamin 
(Kosaka & Ikeda 1983). Dynamin must be recruited to the neck of invaginating 
structures to perform its function. This is performed via a number of membrane-
sensing (BAR-domain) proteins which recognise the curvature of the vesicle neck 
(Wigge et al. 1997; Ferguson et al. 2009; Sundborger et al. 2011). These include 
amphiphysin, endophilin and sorting nexin 9 (SNX9). All of these proteins contain 
SRC homology 3 (SH3) domains which bind to the proline rich domain of dynamin 
(McMahon & Boucrot 2011).  
The mechanistic action responsible for the fission of SV from the PM occurs after 
polymerisation of dynamin around the neck of the invaginating vesicle. This 
arrangement causes activation of GTPase activity of dynamin (Hinshaw & Schmid 
1995; Sweitzer & Hinshaw 1998). The exact mechanism of dynamin-mediated 
scission is unclear. However it is known that the dynamin ring undergoes a GTP 
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hydrolysis-dependent conformational change causing subsequent fission of the 
vesicle (Sweitzer & Hinshaw 1998; Stowell et al. 1999; Roux et al. 2006; Bashkirov 
et al. 2008). Several models for dynamin function in scission have been proposed 
since it was first discovered as an essential fission protein. The higher-order structure 
and its construction into a helical collar around the neck of an invaginating vesicle 
suggested a mechanism of constriction of the neck until it fused (Roux 2014). Other 
mechanisms such as a lengthening of the dynamin collar to “pop” off the SV have 
also been proposed. Though the constriction model remains the one with the most 
experimental support to date (Roux 2014). 
Numerous dynamin disruptions have been utilised to demonstrate the necessity for 
dynamin in vesicle scission. For example, the expression of mutant forms of 
dynamin I unable to hydrolyse GTP causes an arrest of endocytosis at a stage after 
clathrin-coat recruitment (Van Der Bliek et al. 1993). Dynasore is a small molecule 
which interferes with the GTPase activity of dynamin. Pharmacological inhibition of 
dynamin GTPase activity by dynasore also rapidly arrested endocytosis of SVs 
(Macia et al. 2006) resulting in half- or fully-formed SVs remaining attached to the 
membrane. Though, as this drug was shown to block other, dynamin-independent 
forms of endocytosis in triple dynamin knockout fibroblasts (Park et al. 2013) these 
results should be treated with caution. 
1.3.2.1.4 Uncoating 
After scission from the PM the clathrin coat must be converted from its polymerised 
lattice configuration into its individual triskelia to “uncoat” the SV. This is achieved 
30 
through the action of the ATPase heat shock cognate 70 (HSC70) and auxilin 
(Schlossman et al. 1984; Ungewickell et al. 1995). Auxilin initially binds to a 
clathrin coated vesicle after  scission and then recruits HSC70 (Barouch et al. 1997; 
McMahon & Boucrot 2011). The uncoating of a vesicle is known to be ATPase 
dependent as the addition of ATP greatly increases the complex of HSC70 and 
clathrin whereas the addition ADP decreases this interaction (Prasad et al. 1994). 
Auxilin also functions as a potentiator of the ATPase activity of HSC70 (Jiang et al. 
1997). 
The binding of Auxilin to a clathrin cage weakens the structure of the lattice by 
disturbing the contacts between the heavy chains in each triskelion. This weakening 
facilitates the disassembly of the clathrin cage via the action of HSC70 (Fotin et al. 
2004). It is likely that auxilin is only recruited to a clathrin coated vesicle after 
fission as the area of the SV which was previously occupied by the connective neck 
will now exhibit a gap in its clathrin coat. This may allow for easier access of these 
molecules and therefore more effective destruction of the lattice (McMahon & 
Boucrot 2011). In vitro experiments have shown that per clathrin triskelion one 
auxilin and up to three HSC70 molecules are required for optimum disassembly of a 
clathrin lattice (Böcking et al. 2011; Rothnie et al. 2011). 
Clathrin is not the only protein which requires removal from a budded vesicle. After 
scission, the SV has a coat of both clathrin scaffold and the host of adaptor proteins 
responsible for retrieving cargo during endocytosis. These proteins are removed via 
changes in phosphoinositide composition. Synaptojanin is a lipid phosphatase which 
converts PI(4,5)P2 into PI(4)P. The activity of this phosphatase works in a curvature 
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sensitive manner and as such has a much a higher level of activity on an internalised 
SV than on the PM (Chang-Ileto et al. 2011).  
After endocytosis synaptojanin works to deplete levels of PI(4,5)P2 on the SV 
membrane, disrupting the binding of epsin, AP180 as well as the cargo hub AP-2 
which are all bound to the vesicular membrane in a PI(4,5)P2-dependent manner. 
This will cause a dissociation of adaptor molecules from the SV, allowing them to be 
recycled for further use. A further method of action of synaptojanin may be to create 
a lipid environment suitable to increase the binding of auxilin (Massol et al. 2006), 
therefore initiating the assembly of uncoating machinery. The uncoating of a 
clathrin-coated vesicle releases individual triskelia back into the cytoplasm to be 
reused for further rounds of CME. 
The refilling of an SV with neurotransmitter for use in further rounds of transmission 
requires the acidification of its lumen. Acidification is the result of the Vacuolar-type 
H+ (V-type) ATPase proton pump which uses the energy from converting ATP to 
transport protons (H+) across the SV membrane (creating a vesicle membrane 
potential – Δψ). The membrane potential gradient caused by this pump is responsible 
for the accumulation and neurotransmitters (Maycox et al. 1990). All types of 
neurotransmitter are loaded into an SV via pumps which exchange protons for 
molecules of neurotransmitter (Gasnier 2000). Inhibition of the ATPase function of 
the proton pump via bafilomycin A1, has been demonstrated to inhibit the vesicular 
accumulation of neurotransmitter (Haigh et al. 1994; Roseth et al. 1995) showing the 
essential role played by V-type ATPase. 
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This stage is not necessary for the fusion competence of an SV: vesicles which have 
not been acidified/refilled can still be released via exocytosis (Cousin & Nicholls 
1997), however this should not occur naturally as acidification occurs within seconds 
after scission (Atluri & Ryan 2006). The exact sequence of uncoating and 
acidification is ill-defined.  There is evidence that the two occur simultaneously as 
coated SVs have been seen to be filled with neurotransmitter (Prior & Clague 1997). 
If this is true it would allow for rapid re-entry of SVs into the recycling pool after 
uncoating. 
 Ultrafast Endocytosis 
Ultrafast endocytosis is clathrin-independent mode of membrane retrieval and is 
named for its rapid onset after stimulation. Using a novel “flash-and-freeze” protocol 
(Watanabe et al. 2013) it was possible to compare different forms of membrane 
retrieval over very small incremental time points after an optogenetic stimulation 
leading to the relatively recent discovery of a possible new form of endocytosis.  
Endosomes formed via ultrafast endocytosis were seen to be formed within 50-100 
ms of a single, short light stimulus (eliciting one action potential) in hippocampal 
cell synapses (Watanabe et al. 2013b) whereas smaller SVs and other endocytic 
structures were not yet formed. The formation of SVs via CME is widely agreed to 
take between 15-20 seconds (Balaji & Ryan 2007; Granseth et al. 2006; Wienisch & 
Klingauf 2006; Miller & Heuser 1984; Jockusch et al. 2005), a timescale around 200-
fold longer than ultrafast endocytosis. This would suggest that ultrafast endocytosis 
is specialised to rapidly restore cell surface area during initial exocytosis of docked 
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vesicles which occurs as quickly as 30 ms after the beginning of stimulation 




Figure 1.3 Key Stages of Clathrin-Mediated Endocytosis 
Left to right: Box 1: Site of endocytosis is saturated with PIP2 and SV cargo molecules such as synaptotagmin. Nucleation modules formed of FCHO 
molecules, Eps15 and intersectins recognise saturated sites. Box 2: Membrane curvature is initiated via Epsin molecule insertions which cause a larger 
disturbance on the cytoplasmic side of the phospholipid bilayer of the plasma membrane causing curvature. AP-2 and AP180 bind to both cargo 
molecules (such as synaptotagmin via stonin-2) and PIP2. Box 3: Clathrin molecules bind to AP2 and form a scaffold around the invaginating SV and 
displacing epsin to the neck of the vesicle. Box 4: Amphiphysin senses membrane curvature and recruits dynamin I to the neck of the vesicle. Box 5: 




Core Components  
Protein Function 
Clathrin Three light chains and three heavy chains form clathrin 
triskelion. Self-polymerisation forms lattices which serve 
as a scaffolding cage around an invaginating vesicle. 
FCHO F-BAR domain-containing proteins that generate the initial 
membrane curvature for endocytosis and nucleate clathrin-
coated pits. 
AP2 Heterotetrameric adaptor complex made up of α2, β2, µ2 
and σ2 subunits. Responsible for linking membrane cargo 
to clathrin and accessory proteins. 
Eps15 Part of the nucleation complex which binds AP-2. 




ANTH domaining-containing PIP2-binding protein that 
binds AP-2 and clathrin. 
Epsin ENTH domain-containing membrane-bending protein.  
Amphiphysin N-BAR domain-containing protein that bends plasma 
membrane and recruits dynamin to clathrin-coated pits. 
SNX9 BAR domain-containing protein that binds AP-2 and 
dynamin. 
Dynamin Self-polymerising mechanoenzyme that triggers vesicle 
scission upon GTP-hydrolysis 
Auxillin (brain) 
GAK (ubiquitous) 
J domain-containing protein that recruits HSC70 to 
clathrin cages for uncoating. 
HSC70 ATPase which triggers uncoating of clathrin cages. 
Stonin-2 Recruits synaptotagmin to AP-2. Also possibly acts as a 
hub for SV protein retrieval. 




Synaptojanin Lipid phosphatase recruited to clathrin-coated pits by AP-2 and 
endophilin. 
SHIP2 Lipid phosphatase recruited to clathrin-coated pits by intersectins. 
OCRL Lipid phosphatase recruited to mature clathrin-coated pits by AP-
2 and clathrin. 
Protein Kinases 
Protein Function 
AAK1 Phosphorylates the μ-chain of AP-2. 
CVAK104 Phosphorylates the β2 subunit of AP-2. 
DYRK1A Phosphorylates several proteins involved in CME. 
Actin-nucleation at clathrin-coated vesicles 
Protein Function 
HIP1/HIP1R ANTH domain-containing proteins that bind clathrin, actin, AP-2 
(HIP1 only) and cortactin (HIP1R only) 
Cortactin Recruits actin polymerisation machinery to budding clathrin-
coated vesicle through dynamin and HIP1R 
Other proteins potentially involved in clathrin-mediated endocytosis 
Protein Function 
Endophilin N-BAR domain-containing protein that bends the membrane and 
recruits dynamin and synaptojanin 
Table 1.1 CME Machinery 
A list of proteins making up the machinery of CME. Adapted from (McMahon & Boucrot 
2011). Abbreviations: AAK1, AP2-associated kinase 1; ANTH, AP180 amino-terminal 
homology domain; AP-2, adaptor protein 2; CALM, clathrin assembly lymphoid myeloid 
leukaemia; CVAK104, coated vesicle associated kinase of 104 kDa; DYRK1A, dual-
specificity Tyr phosphorylation-regulated kinase; ENTH, epsin N-terminal homology domain; 
EPS15, EGFR pathway substrate 15; FCHO, FCH domain only; GAK, cyclin G-associated 
kinase; HIP1, huntingtin-interacting protein 1; HIP1R, HIP1-related; HSC70, heat shock 
cognate 70; OCRL, oculocerebrorenal syndrome of Lowe; SHIP2, SH2 domain-containing 
inositol phosphatase 2; SNX9, sorting nexin 9; VAMP7, vesicle-associated membrane 
protein 7.  
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Ultrafast endocytosis only occurs in synapses at physiological temperatures (34-37 
oC), in these conditions ultrafast endocytosis appears to take the dominant role in 
membrane retrieval with little evidence of the clathrin-coated pits which denote 
active CME (Watanabe et al. 2014). However, at room temperature (22oC) there is 
no evidence of ultrafast endocytosis (Watanabe et al. 2014) this is possibly due to the 
effect of lower (non-physiological) temperatures on the kinetics of actin 
polymerisation in mammalian cells (Kane 1976; Hartmann-Petersen et al. 2000; 
Gisselsson et al. 2005; Jensen et al. 2007) which would inhibit the advantageous 
rapidity of ultrafast endocytosis as an instantaneous corrector of the increase in 
surface area caused by exocytosis. In these conditions the slower endocytic mode of 
CME becomes dominant (Watanabe et al. 2014).  
The formation of ultrafast endosomes from the plasma membrane does not appear to 
rely on clathrin, however clathrin is essential for the formation of individual SVs 
from ultrafast endosomes. Use of a clathrin heavy chain shRNA resulted in identical 
numbers of ultrafast endosomes after a stimulus, however these endosomes remained 
whole and were not broken down into SVs over time as was observed in the 
scrambled control (Watanabe et al. 2014). This suggests a role for clathrin in the 
budding of ultrafast endosomes but not in invagination. 
Ultrafast endocytosis is actin-dependent. The role of actin was discovered with 
application of latrunculin-A, a disrupter of actin polymerisation (Spector et al. 1983). 
Actin polymerisation was shown to be an essential step in the formation of these 
structures using the same methods of optogenetic stimulation and immediate freezing 
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with or without this agent, with no ultrafast endosomes or endocytic pits observed in 
synapses with interrupted actin polymerisation (Watanabe, Rost, et al. 2013).  
To probe the role of the GTPase dynamin in ultrafast endocytosis, dynasore was 
used. In the presence of dynasore, ultrafast endosomes were still observed after 
stimulation however they appeared to be still anchored to the PM, showing an 
inhibition of membrane scission (Watanabe, Rost, et al. 2013). This demonstrates 
that dynamin is essential for the cleavage, but not the formation of, ultrafast 
endosomes from the PM. 
 Activity Dependent Bulk Endocytosis 
During high frequency stimulation, CME lacks the capacity to compensate for the 
large addition of membrane being inserted via exocytosis during these conditions. 
Activity-dependent bulk endocytosis (ADBE) was theorised after the observations 
that a “bulk” section of membrane was internalised from the PM in neuronal cells 
during intense stimulation (Heuser & Reese 1973; Gad et al. 1998; Takei et al. 1998; 
Richards et al. 2000; Holt et al. 2003). Large areas of membrane are internalised 
direct from the PM and scissioned forming an endosome which is later “budded” to 
form SVs to replenish the reserve pool (Clayton & Cousin 2009; Cousin 2009). 
ADBE is the dominant form of endocytosis during high frequency stimulation (HFS) 
and is a rarer event at low frequencies (Clayton et al. 2008; Wenzel et al. 2012). 
Without the initiation of ADBE, a presynaptic cell would be delayed in its recovery 
from intense stimulation conditions and unable to sustain high frequency 
communication. 
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This implies that ADBE could play an important role in neuronal events in which 
high frequency stimuli are integral such the physiological mechanisms long-term 
potentiation or injurious events such as epileptic seizures. 
1.3.2.3.1 Methods of Monitoring ADBE 
There are many different assays which can be used to specifically monitor ADBE 
and its roles in the refilling of SV pools. Initiation, scission and budding can all be 
monitored via electron microscopy. If stimulated in the presence of the electron-
dense HRP at high frequencies, distinct endocytic structures (both vesicular and 
endosomal) can be viewed which have taken up HRP from the extracellular medium 
and their number and progression can be examined. For example, one can determine 
if a manipulation results in more bulk endosomes, if the endosomes are still attached 
to the membrane or if they have begun to bud. The same can be done for 
investigating any process which internalises extracellular medium such as CME. This 
form of investigation is of most use for pharmacological intervention or for mutant or 
knockout mouse lines. It is less useful for transfected cell conditions which have a 
low efficiency within a culture if using non-viral delivery methods. Though immuno-
EM, which utilises antibodies tagged with electron-dense gold particles, can be used 
to identify transfected cells in electron microscopy investigations.  
Tetramethylrhodamine-dextran (dextran) is 40kDa and large enough that it is very 
unlikely to be internalised via CME, it therefore selectively labels bulk endosomes in 
a non-releasable fashion (Clayton et al. 2008; Clayton & Cousin 2009). 
Unfortunately, dextran uptake assays provide insight only as to how many nerve 
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terminals are undergoing ADBE. It does not provide information as to whether bulk 
endosomes formed but were not severed from the membrane, allowing dextran 
molecules to be washed out. It also does not provide information as to how many 
endosomes have been formed per nerve terminal. However, this assay gives a clear 
indication of ADBE disruption and can be used in transfected neurons which make it 
a very useful and simple tool. 
Another tool for investigating ADBE are the styryl dyes FM1-43 and FM2-10 which 
exhibit differential labelling of CME and ADBE (Richards et al. 2000; Evans & 
Cousin 2007; Clayton & Cousin 2008). FM2-10 preferentially labels SVs formed via 
CME whereas FM1-43 labels both SVs and bulk endosomes. This disparity allows 
the observer to distinguish between effects on endocytosis and effects on ADBE 
specifically. The uptake of FM dyes is often monitored, as is the unloading of dye as 
SVs which internalised the dye are recycled and released. This method can be used 
for transfected or culture-wide conditions and can be used to investigate an array of 
parameters such as vesicle pool replenishment as discussed below. 
1.3.2.3.2 Initiation 
During periods of high activity, when ADBE is initiated, CME reaches a saturation 
point (Sankaranarayanan & Ryan 2000) and can no longer compensate for the 
additional surface area of the cell caused by SV exocytosis. Saturation of CME is 
possibly caused due to a limited number of clathrin molecules in a presynapse 
(López-Murcia et al. 2014), meaning only a set number of clathrin cages can be 
formed at any one time.  
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Increased SV fusion during intense stimuli is thought to be one of the factors which 
triggers ADBE. There are two main sets of evidence for this: firstly, the inhibition of 
SV fusion using tetanus toxin during HFS results in an inhibition of ADBE as 
viewed via EM and dextran uptake (Morton et al. 2015). However, ablating 
exocytosis will have an equal effect of ablating endocytosis via CME as well as 
ADBE and as such this evidence could also argue a role for CME saturation as an 
ADBE trigger. The exposure to tetanus toxin however does not inhibit Ca2+ influx, 
and as such this shows that increased [Ca2+]i alone is not sufficient to initiate ADBE. 
Secondly, ADBE does not continue after stimulation terminates (Clayton & Cousin 
2009b). If ADBE was triggered due to an increased surface area of the cell or a 
saturation in the rate of CME, one would expect it to continue after stimulus 
termination until either of these variables was corrected. The fact that this is not the 
case could indicate a more important role for SV fusion, which ceases after 
stimulation, than CME in ADBE initiation. The model of CME saturation as a trigger 
for ADBE is also flawed due to the immediate onset of ADBE upon HFS (Clayton & 
Cousin 2009b). 
As discussed above, the interference of SV fusion in isolation from Ca2+ influx 
inhibits ADBE. It is also true that inhibiting an increase in cytosolic Ca2+ (i.e. outside 
the active zone) with the calcium chelator EGTA-AM does not affect SV fusion but 
does inhibit ADBE as viewed by EM (Morton et al. 2015). Both SV fusion and 
cytosolic calcium increase are therefore essential but not individually sufficient for 
the process of ADBE. 
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The initiation of ADBE, like CME, appears to have a reliance on lipid composition 
of the PM. Phosphatidylinositol (4,5) biphosphate (PI(4,5)P2) is enriched at the site 
of ADBE (Gormal et al. 2015). Several enzymes known to control the levels of this 
specific phospholipid have also been implicated in ADBE such as synaptojanin 
(Clayton & Cousin 2009b), the primary lipid phosphatase in nerve terminals.  
The main protein interaction partner of synaptojanin is endophilin. (Micheva et al. 
1997; Ringstad et al. 1997), a BAR domain-containing protein. Mutant synaptojanins 
incapable of binding endophilin expressed in synaptojanin KO mice were capable of 
rescuing SV endocytosis only during a brief stimulus (Mani et al. 2007). This implies 
a role for synaptojanin-endophilin binding in ADBE. What is interesting about the 
necessity for both the 5-phosphatase activity of synaptojanin and its interaction with 
endophilin is that they are both controlled by its phosphorylation status i.e. 
dephosphorylation enhances both phosphatase activity and binding (Lee et al. 2004). 
Not only this, but said dephosphorylation occurs via the activation of calcineurin 
during prolonged stimulation (McPherson et al. 1994; Marks & McMahon 1998). 
Together these observations convey a potential mechanism for endophilin-mediated 
recruitment of synaptojanin and subsequent modification of membrane phospholipids 
all facilitated via the activity-dependent dephosphorylation of synaptojanin by 
calcineurin. 
Another key player in the maintenance of PI(4,5)P2 levels in neurons is 
phosphatidylinositol (4) phosphate 5 kinase type I γ (PIPKIγ), the major PIP kinase 
at the synapse (Di Paolo et al. 2004). PIPKIγ is dephosphorylated by activated 
calcineurin during prolonged stimulation (Lee et al. 2005) culminating in the 
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activation of the kinase via interaction with talin (Lee et al. 2005). HFS and 
calcineurin activation therefore causes both the synthesis and the metabolism of 
PI(4,5)P2 at the synapse. 
The importance of PI(4,5)P2 metabolism in endocytosis is exemplified in the 
temperature-sensitive Rolling Blackout mutant in Drosophila (Huang et al. 2004). 
Rolling blackout is a membrane lipase integral in the conversion of PI(4,5)P2 into 
inositol triphosphate (IP3) and diacylglycerol (DAG) (Huang et al. 2004). Drosophila 
expressing this mutant form of Rolling Blackout displayed paralysis within minutes 
of being exposed to the restrictive temperature (37 oC) (Huang et al. 2006) and an 
activity-dependent accumulation of PI(4,5)P2 and concurrent depletion of DAG. This 
indicates a role in the regulation of PI(4,5)P2 levels as well as its metabolites in SV 
endocytosis.  It would seem however that this lipase activity of Rolling Blackout is 
only essential for endocytosis in non-neuronal cells as an inactivated form of the 
lipase was sufficient to restore endocytosis in neuromuscular junction cells 
(Vijayakrishnan et al. 2010). This indicates another function of Rolling Blackout is 
necessary for neuronal endocytosis.  
There is strong evidence for a specific role of Rolling Blackout in ADBE. In 
neuromuscular synapses expressing temperature-sensitive mutant Rolling Blackout 
display a pronounced inhibition in FM1-43 uptake (Vijayakrishnan et al. 2009). 
Using neuronal cultures and Garland cells this inhibition was seen to be facilitated 
via a significantly decreased endosome formation upon stimulation (Vijayakrishnan 
et al. 2009) implying a specific role of Rolling Blackout in ADBE. A concomitant 
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increase in the number of newly-formed SVs over control (Vijayakrishnan et al. 
2009) also indicated an attempt in compensation through single vesicle endocytosis.  
As it has been shown that the lipase function of Rolling Blackout is not essential for 
synaptic endocytosis other aspects of the protein were examined. EFR3 is a homolog 
of Rolling Blackout found in yeast and has integral function as a scaffolding protein 
as well as a recruiter of PI4P kinase, therefore regulating PM phosphoinositide 
signalling (Baird et al. 2008). It is therefore possible that the role played by Rolling 
Blackout in ADBE is facilitated by its scaffolding, rather than lipase, ability. This is 
not unheard of for a synaptic enzyme, for example calmodulin-dependent protein 
kinase II has dual functions as a Ca2+-dependent kinase as well as independent roles 
as a membrane scaffold (Hojjati et al. 2007). 
1.3.2.3.3 Scission 
After the initiation of ADBE, an infolded structure has been formed and is attached 
to the membrane. This structure must undergo scission to become an endosome. This 
process is facilitated via the GTPase action of dynamin I much like the scission of 
SVs via CME. The necessity for dynamin in ADBE has been demonstrated via EM 
images in neuronal cells utilising the GTPase inhibitor dynasore during HFS. Under 
these conditions both CME and ADBE were almost completely ablated (Clayton et 
al. 2009). However, as previously stated dynasore is known to be a rather non-
specific inhibitor of dynamin. 
Further experiments have been performed utilising the more potent and specific 
Dyngo4aTM (Mccluskey et al. 2013) in NMJs in which a complete block in bulk  
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Figure 1.4 - Schematic of Key Events in Activity Dependent Bulk Endocytosis 
a) Neuronal activity causes large influx of calcium ions (Ca2+) into the synapse. During high 
frequency stimulation, the [Ca2+]i increases above the threshold required to activate the 
phosphatase calcineurin. b) Activated calcineurin de-phosphorylates dynamin I on two serine 
residues (774 and 778). c) This dephosphorylation facilitates the interaction of dynamin I with 
syndapin. d) The shallow membrane-sensing F-BAR domain of syndapin allows it to 
recognise and recruit dynamin I to the invaginating endosome. Dynamin polymerises in 
around the neck of the endosome and its GTPase function causes a conformational change 
forcing scission of the endosome from the plasma membrane. e) After the endosome 
acidifies SVs are budded via a clathrin and dynamin-dependent mechanism. f) Budded SVs 
uncoat and are filled with neurotransmitter to rejoin the recycling vesicle pool. g) During 
periods of mild stimulation, the [Ca2+]i does not increase sufficiently to activate calcineurin, 
dynamin is not dephosphorylated and therefore will not bind with syndapin. Phosphorylated 
dynamin I binds the BAR domain-containing amphiphysin (as does dephosphorylated 
dynamin I). h) Amphiphysin recruits dynamin I to the neck of a SV undergoing CME. Dynamin 
I polymerises around the neck of the vesicle and the GTPase function of dynamin causes a 
conformational change leading to vesicle scission. These SVs then uncoat, are filled with 
neurotransmitter (f) and rejoin the recycling pool. 
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endosome formation was observed (Nguyen et al. 2012). It should be noted though 
that treatment with these drugs creates greater endocytic phenotypes than those seen 
in mouse synapses lacking all three isoforms of synaptic dynamin (Park et al. 2013). 
Normal bulk endocytosis was seen to continue in these conditions (Park et al. 2013). 
As such the results of these specific studies should be treated with caution and the 
role of dynamin in ADBE is still slightly contentious. 
Calcineurin is activated during high frequencies due to a high cytoplasmic Ca2+ 
concentration (Morton et al. 2015). The function of calcineurin in ADBE was 
investigated using the styryl dyes FM1-43 and FM2-10. Inhibition of calcineurin by 
cyclosporine A decreases loading of FM1-43 but not FM2-10, showing an essential 
role for calcineurin activation in ADBE (Evans & Cousin 2007). Activated 
calcineurin dephosphorylates the GTPase responsible for SV scission dynamin I on 
two serine sites (serine 774 and serine 778). Dephosphorylation of these sites only 
occurs at stimulation frequencies at which ADBE is triggered (Clayton et al. 2009). 
Dynamin I binds to the ADBE-essential protein syndapin I only after 
dephosphorylation on these two residues (Anggono et al. 2006).  Inhibition of this 
interaction by competitive peptides or by expressing dominant negative dynamin I 
mutants incapable of syndapin binding effectively inhibits ADBE as demonstrated by 
EM, dextran uptake and FM1-43 analysis (Clayton et al. 2009), showing this 
interaction is essential for the progression of a bulk endosome.  
Syndapin is a member of a family of dynamin I-binding proteins which contain an N-
terminal bin-amphiphysin-RVS (BAR) domain along with endophilin and 
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amphiphysin. BAR domains sense membrane curvature and also have roles in the 
tubulation of membrane (Gallop & McMahon 2005; Dawson et al. 2006). Other 
binding partners of dynamin I such as amphiphysin and endophilin contain an N-
BAR domain which are sensitive to a tight curvature in membrane (Peter et al. 2004) 
allowing them to fulfil their role in the invagination of single SVs. Syndapin contains 
an F-BAR domain which is sensitive to a more shallow membrane curvature (Henne 
et al. 2007; Shimada et al. 2007) such as that exhibited by an invaginating endosome. 
It is unknown if syndapin is purely an escort for dynamin I or if it plays a more 
active role in ADBE scission as may be implied by the presence of a BAR domain.  
The de- and re-phosphorylation cycle of dynamin I has been shown to be of critical 
importance for the continuation of ADBE, expression of both phospho-mimetic and 
phospho-null forms of the proteins resulted in an inhibition of ADBE as measured by 
dextran uptake (Clayton et al. 2010) showing that in order for dynamin to perform its 
function it must be able to be modified at these sites.   
After cessation of a high frequency stimulus, dynamin I is rephosphorylated by 
cyclin-dependent kinase 5 (Cdk5) on serine 778 and then by glycogen synthase 
kinase 3 (GSK3) on serine 774 (Clayton et al. 2010). Cdk5 is constitutively active 
and performs its action first on the dynamin I protein (Clayton et al. 2010) whereas 
GSK3 is inhibited via phosphorylation on Ser 9 (β isoform) or 21 (α isoform) (Frame 
& Cohen 2001). This activity-dependent phosphorylation occurs via the activity-
dependent kinase Akt during HFS.  
Akt activity is also modulated by its phosphorylation but in the opposite direction. 
Phosphorylation on Ser 473 and Thr 308 cause activation of Akt (Alessi et al. 1997; 
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Sarbassov et al. 2005). Both GSK3 and Akt show phosphorylation on two serine sites 
in response to high frequency stimulation and in correlation with dynamin 
dephosphorylation (Smillie & Cousin 2012). This system ensures maximal 
dephosphorylation of dynamin I via the inhibition of GSK3 and therefore maximal 
ADBE (Smillie & Cousin 2012).  
If GSK3 or cdk5 are inhibited via application of CT99021 (CT) or roscovitine 
respectively, there is no effect on ADBE during a single HFS as dynamin I is 
dephosphorylated normally under these conditions. However, if inhibition is 
continued throughout a second high frequency stimulus there is a significant 
inhibition of ADBE (Clayton et al. 2010). This suggests that dynamin I must be 
rephosphorylated after stimulation by GSK3 and cdk5 to be used in further rounds of 
ADBE. 
This signalling cascade was determined to have no role in CME during HFS. The 
unloading of CME-specific styryl dye, FM2-10 (Clayton et al. 2009), an indicator of 
the number of SVs formed during stimulation, was not affected by the expression of 
constitutively active from of Akt in CGNs (Smillie & Cousin 2012) whereas the 
same overexpression caused a significant reduction in ADBE as seen by dextran 
uptake (Smillie & Cousin 2012). As these cells would experience a consistent 
phosphorylation of GSK3 due to heightened Akt activity, this showed a requirement 
for the modulation, but not chronic inhibition, of GSK3 activity specifically in 
ADBE.  
Although it would appear that Akt activation and GSK3 inhibition ensures an 
efficient and maximal dephosphorylation of dynamin during HFS, an acute inhibition 
49 
of Akt did not cause an inhibition of dextran uptake in the same cells (Smillie & 
Cousin 2012). This shows that the less efficient dephosphorylation of dynamin that 
would be seen with a higher level of GSK3 activity is still sufficient to allow ADBE.  
Monitoring the uptake of fluorescent markers in conjunction with the disruption of 
actin filaments with cytochalasin D or latrunculin A shows a need for actin dynamics 
in the process of bulk endosome formation (Kuromi & Kidokoro 1998; Holt et al. 
2003; Richards et al. 2004; Nguyen et al. 2012). However, it is unknown at which 
point actin may play its role. Only one such study has implied a role for actin 
filaments in the initiation of ADBE prior to a role in the scission of an endosome 
(Nguyen et al. 2012). 
As discussed above dynamin I has an essential role in the scission of both SVs and 
bulk endosomes, it has also been shown to play an essential role in actin 
polymerisation in endocytosis (Kessels et al. 2001; Gu et al. 2010). Syndapin I can 
form homo-oligomers via it F-BAR domain and as such can simultaneously bind 
dynamin I and a protein known to initiate actin polymerisation via the recruitment 
the arp2/3 complex, neuronal Wiskott-Aldrich syndrome protein (N-WASP)  
(Kessels & Qualmann 2006; Halbach et al. 2007). It is possible that this association 
allows syndapin to form a complex with both dynamin and actin to recruit and even 
co-ordinate actin dynamics via N-WASP interactions at the sites of ADBE (Kessels 
& Qualmann 2002). In support of this theory, the perturbation of syndapin binding in 
lamprey reticulospinal synapses caused a reduction in actin accumulation at 
endocytic sites (Andersson et al. 2008). 
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Recent work in neurosecretory cells has indicated a role for actin-myosin rings in the 
scission of endosomes after secretagogue stimulation. Rings of GFP-labelled actin 
were observed around the necks of invaginating endosomal structures which then 
contracted before scission (Gormal et al. 2015). Inhibitors of myosin II were used to 
demonstrate a necessity for myosin as well as actin for the formation of these 
contracting rings around endosomal necks.  
1.3.2.3.4 Budding 
After a bulk endosome has been severed from the PM it undergoes “budding”. This 
is a process in which smaller vesicles are generated from the larger endosome to re-
enter the recycling pool of SVs, possibly after shuttling through other endosomal 
structures. SVs formed via bulk endosomes have been shown to preferentially refill a 
pool of vesicles termed the “reserve pool” which are only mobilised during periods 
of intense activity which correlate to the activation of ADBE. 
During mild stimulation, newly formed SVs are preferentially recruited to the RRP in 
a process termed “reuse” (Pyle et al. 2000; Kavalali 2006). This process of reusing 
newly formed SVs to refill the RRP is conserved during HFS (Sara et al. 2002). 
However, in amphibian neuromuscular junctions it was observed that those SVs 
formed via ADBE were not immediately available for release unlike these reused 
SVs (Richards et al. 2000; Richards et al. 2004). This observation along with the 
preferential use of the reserve pool during high intensity stimulation (Südhof 2000) 
led to the hypothesis that SVs formed via ADBE are directed to replenish the reserve 
pool after intense stimulation. 
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Work using the styryl dyes FM1-43 and FM2-10 in primary neuron cultures, showed 
an increase in labelling of the reserve pool by FM1-43 over FM2-10 after identical 
HFS (as seen by monitoring the unloading of dye during stimulation protocols 
tailored to unload the RRP or RP separately – the “FM unloading protocol”) in a 
manner not observed after mild stimulation (Cheung et al. 2010). As both of these 
dyes label CME, but only FM1-43 labels bulk endosomes. The increase in labelling 
of the reserve pool by FM1-43 during intense stimulation therefore suggests a 
significant contribution of SVs formed via ADBE into the reserve pool.  
Further work utilising EM allowed observations as to the time taken for a bulk 
endosome to bud into vesicles after scission. Neurons were stimulated at high 
frequencies in the presence of HRP so that any SVs and bulk endosomes formed 
during this stimulation were distinct. These cells were then washed of HRP and 
depleted of both the readily-releasable and reserve pool, leaving only bulk 
endosomes which were formed during the first stimulation as visible structures. The 
cells were then left to rest for 30 minutes - this will hereafter be referred to as the 
“HRP budding protocol”. After this 30-minute period, HRP-labelled SVs were 
visible. As all labelled SVs formed via CME had been depleted, the only possible 
provenance of these SVs is from bulk endosomes meaning that bulk endosomes have 
begun to or have completed budding SVs within 30 minutes of their formation 
(Cheung et al. 2010). 
Calcium plays an essential role in the budding of SVs from bulk endosomes. This is 
perhaps not surprising as the Ca2+-dependent phosphatase calcineurin has been 
shown to perform essential roles in both the initiation and the budding of endosomes. 
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Interestingly, it is the efflux of intra-endosomal calcium which dictates normal 
budding. This was manipulated via the addition of calcium chelators during the HRP 
budding assay. BAPTA-AM was used to chelate Ca2+ which had escaped the 
endosome after HRP loading and caused an inhibition in SV budding (Cheung & 
Cousin 2013). To deplete intra-endosomal Ca2+ a chelator was conjugated onto a 
dextran molecule which were not internalised by single SVs  (Holt et al. 2003; 
Clayton et al. 2008) and utilised in the HRP budding assay. Depletion of endosomal 
Ca2+ inhibited the formation of SVs from bulk endosomes (Cheung & Cousin 2013) 
demonstrating the necessity of internal Ca2+ and the logical extension that the 
internalisation of extracellular Ca2+ via ADBE is also essential for SV budding. 
It has been shown that endosome acidification via vacuolar-type H+-ATPase (V-type 
ATPase) is essential for budding to occur (Cheung & Cousin 2013). Inhibition of this 
proton transporter via bafilomycin A1 (Gerasimenko et al. 1998) causes a depletion 
in SVs formed by the budding of bulk endosomes as viewed by the HRP budding 
protocol and a consequential depletion of the reserve pool of vesicles as denoted by 
FM unloading protocol (Cheung & Cousin 2013). It is unknown if the presence of V-
type ATPases on bulk endosomes is a result of cargo retrieval in ADBE or of a 
fusion even between a bulk endosome and another structure containing V-type 
ATPases such as a SV and as such one cannot speculate as to the ability of 
endosomes to retrieve cargo from these results alone. However, it does offer an 
insight into the directionality of events preceding budding. These results in 
conjunction with those indicating that endosomal Ca2+ efflux is necessary for SV 
budding also indicates that endosomal acidification by V-type ATPases is the trigger 
for Ca2+ efflux.  
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Several other components have been found to be essential for bulk endosome 
budding. Calcineurin was first observed as a component of ADBE initiation. 
However, if the calcineurin inhibitor cyclosporine A is present in the HRP budding 
protocol after the formation of bulk endosomes but throughout the rest period, there 
is a significant reduction in the number of HRP-labelled, budded SVs (Cheung & 
Cousin 2013). This shows a necessity for calcineurin activity in the budding of SVs 
from bulk endosomes in a role totally separate from that which it plays in the 
initiation or scission of bulk endosomes. This result was recapitulated using the FM 
unloading assay (Cheung & Cousin 2013), reinforcing the hypothesis that SVs 
budded from bulk endosomes go on to refill the RP. 
Budding requires the formation of SVs from bulk endosome membrane, a process 
which must require the efficient sorting of any membrane cargo present in bulk 
endosomes. During CME protein sorting is largely facilitated through the adaptor 
protein AP-2 (Royle & Lagnado 2003). Rapid inactivation of clathrin light or heavy 
chains using fluorescein-assisted light inactivation (FALI) has shown a potential role 
for clathrin coat assembly in the budding of bulk endosomes (Heerssen et al. 2008; 
Kasprowicz et al. 2008). As clathrin depends on its interactions with adaptor proteins 
to co-ordinate itself and any cargo this would imply a necessity for AP complexes in 
bulk endosome budding. 
Of the five known adaptor protein complexes, AP-1 and AP-3 were of interest when 
trying to identify the adaptor proteins responsible for SV budding from bulk 
endosomes for several reasons: Both AP-1 and AP-3 are enriched in nerve terminals 
(Glyvuk et al. 2010; Newell-Litwa et al. 2010) and are found on SVs (Takamori et al. 
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2006) which implies a role in SV formation which cannot be attributed to CME. 
Mice lacking an essential subunit of AP1-B display decreased endosome numbers as 
well as a delay in recycling pool recovery after strong stimulation (Glyvuk et al. 
2010). Also, endosomal vesicle budding in other cell types has been shown to be 
inhibited by brefeldin A (BFA) (Drake et al. 2000) though in neuronal cultures SV 
endocytosis was only inhibited during intense stimulation (Voglmaier et al. 2006; 
Kim & Ryan 2009). This is of significance as BFA inhibits the GTPase ADP-
ribosylation factor 1 (ARF1) which is essential in the recruitment of both AP-1 and 
AP-3 to membrane (Faúndez et al. 1998; Pagano et al. 2004; Newell-Litwa et al. 
2007)  
The budding of SVs from bulk endosomes has also been shown, via HRP budding 
assays, to be inhibited by exposure to BFA in CGNs (Cheung & Cousin 2012). This 
block in SV budding also translated into a deficit in the refilling of the reserve pool 
as observed via the FM unloading protocol (Cheung & Cousin 2012). These results 
imply a role for AP-1 and/or AP-3 in SV budding.  
Knockdowns of subunits of either AP-1 or AP-3 showed an equal inhibition on the 
budding of SVs, however this could not be observed via HRP budding assay due to 
the nature of transfection and as such this was only observed via the effects on FM 
labelling of the RRP (Cheung & Cousin 2012).  Neither knockdown resulted in a 
reduction of bulk endosome formation as measured by dextran (Cheung & Cousin 
2012) and as such the defect in RP refilling was due to an inhibition of budding and 
not initiation of ADBE.  
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It is possible that the process of ADBE requires little to no sorting of SV cargo at the 
PM and that cargo sorting occurs at later stage. The individual impact of each of 
these knockdowns implied a lack functional redundancy between with adaptor 
complexes i.e. they would seem to be performing separate, possibly sequential roles. 
It was theorised that the budding of SVs from bulk endosomes is not a single 
process. Instead, “immature” SVs bud from the bulk endosome in a process 
dependent on one adaptor protein and go on to fuse with another endosomal 
intermediate such as an early endosome. “Mature” SVs with a full complement of 
SV cargo are then budded from the early endosome via a mechanism dependent on 
the second adaptor protein (Cheung & Cousin 2012).  
Further work is required to identify any specific cargo which interacts with these 
adaptors during bulk endosome budding. An example of a protein of interest would 
include phosphatidylinositol 4-kinase II α (PI4KIIα) which is shuttled from the cell 
body to the synapse via AP-3 or BLOC-1. Another would be VAMP7 which is 
involved in the fusion of late endocytic compartments with other membranes 




Lipids are small, hydrophobic molecules with the ability to assemble autonomously 
into complex structures in an aqueous environment. The nervous system has an 
especially enriched and diverse lipid composition compared to other tissues (Sastry 
1985; Bozek et al. 2015) and variation in the neural lipodome has been associated 
with a variety of diseases such as Alzheimer’s, Parkinson’s and Huntington’s 
(Lauwers et al. 2016).  
Phosphoinositides (PIs) belong to a subset of membrane lipids which are amphiphilic 
and due to their negatively charged head groups (which reside on the cytosolic 
membrane surface) and a non-polar backbone and tails (Lauwers et al. 2016). Other 
members of this family include phosphatidylserine, sphingomyelin and 
phosphatidylcholine. PIs can be phosphorylated to make seven different lipids. 
Phosphatidylinositol (PtdIns) is the unphosphorylated form of a PI and contains an 
inositol ring containing six, phosphorylatable -OH groups. The nomenclature to 
distinguish these groups was originally designed to allow a simple visualisation of a 
body of a turtle, with its six -OH groups (D1-D6) forming its head, four legs and tail 
(Agranoff 1978). Only three of these OH- sites (D3, D4, and D5) are phosphorylated 
in naturally occurring PIs, allowing for seven known combinations of PtdIns 
phosphorylation comprising of all known PIs (Figure 1.5 ). The different 
phosphorylation states of a population of PIs is regulated by a host of kinases and 
phosphatases with specificity to each -OH group (see Figure 1.5)
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Figure 1.5 Phosphorylation Cycle of Phosphoinositides 
Schematic showing common kinases, phosphatases and actions involved in the production of phosphoinositides (PtdIns). PtdIns have an inositol 
ring with 6 hydroxyl groups (D1-6). D1 alone is phosphorylated in PtdIns (left). Kinases add phosphate groups to groups D2-D5. E.g. Actions of any 
of the 4 mammalian phosphatidylinositol 4-kinases (PI4Ks) can phosphorylate PtdIns on D4 creating PtdIns(4)P. Further phosphorylation on either 
D3 or D5 will create PtdIns(3,4)P2 or PtdIns(4,5)P2 respectively. PtdIns(3,4,5)P3 can be created from either of these via phosphorylation of the 
remaining position. The addition of any of these phosphate groups is reversible by the actions of phosphatases. D2 and D6 are not typically 
phosphorylated due to steric hindrance. Adapted from data in (Shisheva 2008) 
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1.4.1 Importance of PI Levels in SV Recycling 
The transmission of information via synapses requires extensive remodelling of 
membrane, although this process is largely driven by protein machinery the lipids of 
the membrane play key roles (Davletov & Montecucco 2010; Puchkov & Haucke 
2013). Phosphoinositides have essential roles in multiple stages of the SV cycle, in 
exo- and endocytosis as well as the coupling of the two processes (Koch & Holt 
2012) with their electrostatic charge being of central importance to its functions 
(Lauwers et al. 2016).  
As well as its membranes being enriched with lipid components, the synapse 
contains a host of lipid metabolising enzymes which are capable of locally altering 
lipid structures.  Although PIs are low-abundance membrane lipids (only making 10-
20% of total cellular phospholipids (Balla 2013)) they are of crucial importance for 
the localisation of certain proteins to different membrane compartments.  
 Exocytosis 
Of particular importance at the presynaptic terminal is the PI phosphorylated at the 
D4 and D5 positions; PI(4,5)P2. The necessity for PI(4,5)P2 in SV fusion has been 
demonstrated via many different methods. For example, via the application of high-
affinity pleckstrin homology (PH) domain probes which effectively shield sites on 
specific PIs, inhibiting their interaction with binding partners. Use of these PH 
domain probes to specifically block PI(4,5)P2 interactions resulted in a block of 
exocytosis as measured by both electrochemical and electrophysiological techniques 
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in chromaffin cells (Holz et al. 2000). Another, specific, method of interfering with 
PI(4,5)P2 binding is via the HIV-1Tat protein which has a 20 fold higher affinity for 
PI(4,5)P2 than PH domain probes (Debaisieux, S. 2012). The use of these proteins in 
PC12 cells also demonstrated a block in exocytosis due to inhibited PI(4,5)P2 
interactions (Tryoen-Toth et al. 2013).   
PI levels can also be manipulated by altering the expression or location of the 
metabolising kinases or phosphatases. PI(4)P5-kinase Iγ (PIPK1γ) is a major 
regulator of PI(4,5)P2, converting PI4P via the addition of a phosphate group to the 
OH group at the D5 position (see Figure 1.5). In a PIPK1γ knockout mouse the 
abundance of PI(4,5)P2 is significantly decreased but PI4P levels are unaffected (Di 
Paolo et al. 2004). In this model a host of synaptic transmission deficits were 
detected in cortical neurons, amongst them a smaller RRP and a reduced rate of 
exocytosis (Di Paolo et al. 2004). Conversely, the increased synthesis of PI(4,5)P2 
via overexpression of PIPK1γ caused an increase in sustained rates of evoked 
exocytosis in PC12 cells (Aikawa & Martin 2003; Milosevic et al. 2005).  
There are different theories as to the mechanism by which PI(4,5)P2 is essential for 
SV fusion. At the PM of neuroendocrine cells there are distinct microdomains of 
PI(4,5)P2 at fusion sites (Martin et al. 2012) which may suggest a role for the 
membrane curvature qualities of this PI provided by its conical structure. However, 
other cellular processes performed by PI(4,5)P2 are achieved via the recruitment and 
activation of PI(4,5)P2-binding proteins so it is also possible that PI(4,5)P2 exerts its 
main function in SV fusion in the same manner.  
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Active zones contain the many proteins which form the machinery for exocytosis. 
These include Q-SNARES Syntaxin 1 and SNAP-25 as well as proteins such as RIM 
and unc-13 which mediate SV docking and priming as well as VGCC recruitment 
(Südhof 2012). The interaction of these proteins with PIs are mediated mostly by 
organised, positively charged motifs such as C2 domains which allow Ca2+-
dependent and -independent binding to PI(4,5)P2 and are found in cytosolic proteins 
such as unc-13 and RIM (Südhof 2012). 
PI(4,5)P2 binds directly with syntaxin 1A and is found to be concentrated within the 
active zone in subdomains corresponding with syntaxin 1A clusters and docked 
dense core vesicles (Aoyagi et al. 2005). Overexpression of the PI(4,5)P2- and 
PI(3,4,5)P3-metabolising enzyme synaptojanin causes a dispersion of syntaxin 1A 
across the PM (Murray & Tamm 2009) and shows that this association is specific to 
lipid composition of the active zone. These results do not specifically link PI(4,5)P2 
to syntaxin 1A clustering however and it is possible that PI(3,4,5)P3, which has a 
greater negative charge, could be playing a similar role in syntaxin clustering. 
Indeed, studies have shown that lowering the availability of PI(3,4,5)P3 causes a 
similar effect on syntaxin 1A clustering as well as a reduction in neurotransmitter 
release (Khuong et al. 2013). 
PI(4,5)P2 microdomains only co-localise with a subset of docked SVs and are known 
to cluster and activate several proteins involved in the docking and priming of SVs. 
Studies in neuroendocrine cells have shown roles for PI(4,5)P2 in the activation or 
recruitment of SNARE-binding proteins such as calcium-dependent activator protein 
for secretion (CAPS), a Ca2+-dependent regulator for the exocytosis of large dense 
61 
core vesicles (LDCVs) (Loyet et al. 1998), Munc-13, and synaptotagmin (Martin 
2014).  
Synaptotagmin, the Ca2+-sensitive activator of SV fusion, undergoes an altered 
affinity for PIs in the presence or absence of Ca2+. In the absence of Ca2+, 
synaptotagmin binds preferentially to PI(3,4,5)P3. In the presence of Ca2+ however, 
synaptotagmin binds PI(3,4)P2 or PI(4,5)P2 (Schiavo et al. 1996). It is possible that 
PI(4,5)P2-binding is of primary importance however, as inhibition of PI(3,4)P2 
synthesis does not affect the priming of large core dense vesicles (LCDVs) in PC12 
cells (Martin et al. 1997).  
Synaptotagmin and Doc2-β (a modulator of spontaneous release of SVs (Groffen et 
al. 2010)) both contain a C2 domain and are responsible for bridging the SV 
membrane with the PM (Davletov & Sudhof 1993; Wen et al. 2011). These protein-
bridge membrane interactions may be regulated by other negatively charged lipid 
molecules such as phosphatidylserine (PtdSer) which compete with PIs for protein 
interactions. PtdSer is actually much more abundant in synaptic membranes 
(Takamori et al. 2006) than PIs and has known roles in facilitating vesicle fusion in 
PC12 cells. In vitro studies suggest that PIs and PtdSer compete for binding and the 
successful lipid determines whether synaptotagmin binds to SV membrane in a cis 
formation, or to PM in a trans formation (Chapman 2002; Vennekate et al. 2012) 
The issue of PI(3,4,5)P3 involvement is confused by conflicting results of the effects 
of interfering with the function or availability of the lipid. The inhibition of Ca2+ 
activated exocytosis by phospholipase C (Hay et al. 1995) (a phospholipid enzyme 
which specifically cleaves PI(4,5)P2 and not PI(3,4,5)P3) implies a lack of role for 
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PI(3,4,5)P3 in PC12 cells. This finding is further strengthened by the lack of effect of 
PI3K inhibition by LY294002 in PC12 cells on ATP-dependent priming (Martin et 
al. 1997). However, LY294002 has been reported to cause an inhibition of evoked 
exocytosis in other studies (Chasserot-Golaz et al. 1998). This finding should be 
treated with caution though as LY294002 also has an inhibitory effect on type III 
PI4-kinases (Balla 2013). Furthermore, work using PH domains specific to 
PI(3,4,5)P3 have also resulted in a decrease in neurotransmitter release (Khuong et al. 
2013). 
1.4.1.1.1 Ion Channel Activity 
Ion channel activity is tightly regulated by PIs. The conformation of ion channels is 
so strongly controlled by PI(4,5)P2-binding that in many cases only a proteo-lipid 
(PI(4,5)P2-bound) form of the complex will conduct ions (Gamper & Shapiro 2007). 
The mechanism responsible for this regulation in the inward rectifying potassium 
channels (Kir2.2) (responsible for the maintenance of a neuronal resting potential 
(Lauwers et al. 2016)) has been revealed via visualisation of the crystal structure of 
both the PI(4,5)P2-bound and unbound forms of the channel. This investigation 
showed a shift in the whole carboxy-terminal domain toward the membrane as well 
as a rotation of its helices following PI(4,5)P2-binding (Hansen et al. 2011; Li et al. 
2015). This modified confirmation is then capable of conducting potassium ions. In 
accordance with this, the ability of the family of Kir2 channels to conduct ions is 
inhibited by increases in lipid phosphatases or by exposure to anti-PI(4,5)P2 
antibodies which inhibit their interaction (Lauwers et al. 2016). 
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It is unknown if this regulatory conformational change is universal across ion 
channels. However, a similar change is seen in Kir7.1 channels (Zaydman et al. 
2013) suggesting a broadly relevant mechanism. It has been proposed that this 
reliance on PI(4,5)P2-binding ensures a channel is only active once it has been 
trafficked to the PI(4,5)P2-rich environment of the active zone (Lauwers et al. 2016). 
For calcium channels this would mean their ability to conduct ions is only activated 
once in the vicinity of the Ca2+-dependent membrane-remodelling machinery. 
Further work in T-cells has also raised the theory that Ca2+ serves to neutralise the 
negative charge of PIs to release protein-PI interactions (Shi et al. 2013). If this is 
true, PI(4,5)P2-binding of ion channels may function not only to activate them 
specifically at the active zone but also to provide a Ca2+-sensitivity. 
This collective data supports a model of enriched domains of lipids such as PI(4,5)P2 
defining the function and/or localisation of exocytic proteins to presynaptic active 
zones. PI(4,5)P2 organises SV fusion sites and clusters with the SNARE molecule 
syntaxin. The same lipid is also responsible for regulating interactions leading to SV 
docking and priming as well as ion channel activity and, by extension, neuronal 
excitability and presynaptic release efficacy. 
 Endocytosis 
Subsequent to exocytosis, membrane-essential lipids and proteins are retrieved via 
endocytosis. This occurs within milliseconds of exocytosis via ultrafast endocytosis 
in the area directly surrounding the active zone or within seconds via CME or ADBE 
in the peri-active zone (L. Zhou et al. 2014; Kononenko & Haucke 2015). 
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PI(4,5)P2 is known to play an important role in CME due to its affinity for many 
endocytic factors including the clathrin adaptors AP2, AP180, CALM, and Epsins 
(Lauwers et al. 2016). Inhibiting the interactions between PI(4,5)P2 and these binding 
partners results in a disrupted localisation of these endocytic adaptors on the PM 
(Lauwers et al. 2016). The specific interactions of PI(4,5)P2 in CME-mediated cargo 
retrieval has been discussed more fully previously (see 1.3.2.1). 
Using PH domain probes to disrupt PI(4,5)P2-binding in perforated A431 cells (a 
model system used to reconstitute receptor-mediated endocytosis) resulted in the 
inhibition of clathrin-coated vesicle (CCV) formation after stimulation (Jost et al. 
1998), implying a role for PI(4,5)P2-binding in CME.  
Levels of PIs at specific areas of the cell such as the active zone can be manipulated 
using rapamycin-mediated redirection of specific phosphatases or kinases to 
particular membranes. Redirecting inositol 5-phosphatase to the PM using this 
method results in a dephosphorylation of both PI(4,5)P2 and PI(3,4,5)P3 on the PM at 
the D5 position. Reducing levels of these PIs resulted in a reduction in clathrin-
coated pit formation and a concurrent block in transferrin uptake in COS-7 cells 
(Zoncu et al. 2007), these results indicate a role for PIs in the early stages of CME.  
The role of PIs in CME is not only limited to the early stages of nucleation and 
invagination.  PI(4,5)P2 also binds a host of CME accessory proteins, including the 
GTPase dynamin via its PH domain. Upon binding the GTPase activity of dynamin 
is dramatically increased (around 1000 fold) and this binding may also serve to direct 
dynamin to the PM (Lin & Gilman 1996; Barylko et al. 1998; Klein et al. 1998; 
Achiriloaie et al. 1999). In addition to this PI(4,5)P2 binds many actin regulatory 
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proteins such as Arp2/3 (Zoncu et al. 2007). Redirection of inositol 5-phosphatases 
to the PM also results in a disruption of dynamin and Arp2/3 localisation (Zoncu et 
al. 2007) showing a necessity for a specific PI enrichment to guarantee proper 
organisation of the machinery responsible for scission of a vesicle as well as a 
variety of other endocytic proteins. 
Little is known about essential molecules in the process of ultrafast endocytosis 
(discussed in 1.3.2.2). However, as it is known that clathrin is responsible for the 
formation of SVs from these ultrafast endosomes (Watanabe et al. 2014). Since 
clathrin requires adaptor proteins to facilitate in the formation of vesicles and these 
adaptor proteins require the presence of PI(4,5)P2 on the membrane for their 
recruitment, it can be assumed that PI(4,5)P2 plays a role in this process. The same 
may be true of SV budding from endosomes formed either directly via ADBE or 
from other endosomal structures with which bulk endosomes have fused. More is 
known about the contribution of PIs in ADBE and has been discussed earlier in this 
thesis (see 1.3.2.3.2). 
1.4.2 Phosphoinositide 3-Kinase 
Phosphatidylinositol 3-kinases (PI3Ks) are responsible for the phosphorylation of 
PtdIns at the D3 position to create PI3P as well as the modification of other forms of 
PI in the same location. PI3Ks are activated in response to cell stimulation by growth 
factors, hormones and insulin (Cantley 2002; Smillie & Cousin 2011). This 
activation sets a co-ordinated series of events in motion leading to a variety of 
functions in cells including cell cycle initiation, growth, migration and survival 
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(Cantley 2002). This is mediated via a host of signalling proteins including protein 
tyrosine kinases, serine-threonine kinases and exchange factors which contain 
domains which specifically recognise and bind to D3 phosphorylated 
phosphoinositides (Cantley 2002). During resting conditions, these signalling 
proteins are located in the cytosol of a cell. However, in response to PI3K 
stimulation and subsequent D3 phosphorylation they accumulate at the PM. The 
active, membrane-bound proteins then initiate various localised responses via the 
regulation of heterotrimeric guanosine triphosphate (GTP)-binding proteins. The 
results of these regulatory roles include the polymerisation of actin, assembly of 
signalling complexes and the priming of protein kinase cascades (Cantley 2002).  
Upon stimulation by growth factors, activation of PI3K leads to the conversion of 
PI(4,5)P2 into PI(3,4,5)P3. Those signalling proteins containing a PH domain will 
accumulate at sites of PI(3,4,5)P3 synthesis via direct binding. Of these proteins the 
serine-threonine kinases Akt and phosphoinositide-dependent kinase I (PDK1) are of 
particular interest. Akt and PDK1 both bind PI(3,4,5)P3 directly and as such, growth 
factor stimulation brings the two into close proximity allowing the phosphorylation 
and therefore activation of Akt by PDK1 (Lawlor & Alessi 2001). 
Akt activation leads to the phosphorylation (and usually inhibition) of a variety of 
proteins involved in cell cycle entry, growth and survival. An important target of Akt 
enzyme activity is GSK3. GSK3 is constitutively active during basal conditions but 
is inhibited by phosphorylation (Frame & Cohen 2001). GSK3 activity in SV 
recycling is discussed more thoroughly elsewhere in this thesis (see 1.3.2.3.3 and 
3.1) but this protein has roles in many other signalling cascades usually in an 
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inhibitory capacity until its phosphorylation. One example of its function outside of 
SV turnover is in the establishment of axonal polarity in immature nerve terminals. 
Active GSK3 phosphorylates collapsing response mediator protein 2 (CRMP-2) and 
adenomatous polyposis coli (APC), inhibiting their interaction with actin 
microtubules. The phosphorylation and inhibition of GSK3 via PI3K-mediated 
activation of Akt (during growth factor stimulation) prevents the phosphorylation of 
CRMP2 and APC and allows microtubule polymerisation (Zumbrunn et al. 2001; 
Yoshimura et al. 2005). This results in the prevention of axonal polarisation and the 
promotion of axonal growth. 
1.4.3 Phosphoinositide 4-Kinase 
Phosphatidylinositol 4-kinases (PI4Ks) are responsible for the phosphorylation of 
PtdIns at the D4 position to create PI4P, it also phosphorylates other PIs at the same 
region to create lipids such as PI(3,4)P2. PI4P is the predominant lipid determinant of 
the Golgi and trans-Golgi network (McCrea & De Camilli 2009) it also contributes to 
the acidic nature of the PM (Hammond et al. 2012).  
PI4P was originally believed to hold no specific function of its own, and only serve 
as a precursor for PI(4,5P)2 and PI(3,4,5)P3 (Boura & Nencka 2015). However, 
studies with yeast revealed many essential functions of PI4P in signalling and 
cellular trafficking which are conserved in human physiology (Boura & Nencka 
2015). 
Eukaryotes express two families of PI4K; type II and type III (Balla & Balla 2006) 
and each possesses a unique domain organisation. PI4K type II (PI4KII) is known as 
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“atypical” as it is dissimilar from other known lipid kinases whereas PI4K type III is 
known as “typical” as it is very similar in structure to PI3Ks. 
Humans, unlike yeast, express two isoforms of type II PI4Ks: PI4KIIα and PI4KIIβ. 
The kinase domain of both isoforms contain a CCPCC motif. Palmitoylation of this 
region causes a stable association with a membrane along with activation of kinase 
activity and is therefore the main method of regulation of the enzyme (Boura & 
Nencka 2015). 
PI4KIIα is the more active of the two isoforms and is responsible for the synthesis of 
around 50% PI4P in humans (Boura & Nencka 2015). It is predominantly located on 
the Golgi and plays a role in vesicle trafficking. It is also enriched on endosomes 
where both the AP-3 sorting motif on PI4KIIα and its kinase domain are required for 
its function in endosome trafficking (Craige et al. 2008). PI4KIIα-mediated synthesis 
of PI4P is needed for the recruitment of clathrin adaptors to endosomes (Salazar et al. 
2005) as well as the trans-Golgi network (Wang et al. 2007). PI4KIIα also has 
specific functions in the endosomal sorting of the R-SNARE VAMP3 (Jović et al. 
2014).  
PI4KIIα is involved in the regulation of Wnt signalling via its production of PI4P  
(Boura & Nencka 2015). The trans-Golgi network/endosomally localised E3 
ubiquitin ligase Itch has been identified as a direct binding partner as well as 
regulator of PI4KIIα enzyme activity (Mössinger et al. 2012).  It appears that 
ubiquitination of PI4KIIα by Itch inhibits its production of PI4P which limits the 
Wnt signalling response (Mössinger et al. 2012). As well as this, ubiquitination by 
Itch enhances the interaction of PI4KIIα with endosomal sorting proteins such as 
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Tom1 and myoferlin while inhibiting interactions with endocytic proteins such as 
endophilin, SNX9, SNX18 and SGIP1 (Mössinger et al. 2012). This implies an Itch-
mediated switch that redirects PI4KIIα from the PM to a degradative endosomal 
pathway. 
PI4KIIα is not only involved in the trafficking of endosomal and Golgi-derived 
vesicles. As previously mentioned, PI(4,5)P2 is an essential component of SV 
retrieval at the PM. PI4KIIα has been identified as the isoform responsible for PI4K 
activity on SVs (Guo et al. 2003), creating the PI4P substrate for the synthesis of 
PI(4,5)P2. This makes PI4KIIα an important component of the SV cycle as well as 
endosomal and Golgi trafficking. The phosphorylation of this PI4P at the D5 position 
most likely only occurs once SVs have fused with the PM, possibly explaining the 
lack of clathrin-coat formation on SVs prior to exocytosis. 
It is well known that proteins are capable of modifying the physical properties as 
well as the shape of biological membranes (Boura & Nencka 2015). Interestingly 
though, analysis of PI4KIIα structure and function has revealed a reversal of this 
role. It appears that the current state of membrane regulates the enzyme activity of 
PI4KIIα and this regulation is possibly determined by the fluidity (i.e. the cholesterol 
content) of the membrane (Zhou et al. 2014; Sun et al. 2014).  
Less is currently known about the isoform PI4KIIβ. It is mostly localised to an 
inactive cytoplasmic pool which is stabilised by heat shock protein 90 (Jung et al. 
2011) and is known to be activated by platelet-derived growth factor (Wei et al. 
2002). This isoform has also been noted as an integral signalling component of early 
T-cell activation (Sinha et al. 2013).   
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1.5 Hypothesis of the Project 
The activity-dependent regulation of GSK3 makes it an interesting candidate for 
research in the field of ADBE. Increased levels of synaptic activity result in an 
inhibition of its high basal activity and it has many substrates in the presynapse. The 
hypothesis of this project is that GSK3 has another essential role in ADBE other than 
dynamin I phosphorylation via the regulation of certain key substrates such as 
PI4KIIα. 
1.6 Aims and Objectives 
1.6.1 To determine how neuronal activity is translated into GSK3 
inactivation 
I aimed to determine which effects of HFS on the presynapse culminates in the 
phosphorylation and inactivation of GSK3. As it is known that GSK3 activity is 
essential for continued rounds of ADBE, a knowledge of those factors which 
modulate its activity could be of great use in future work into the modulation of 
ADBE. 
1.6.2 To determine whether PI4KIIα regulation has any relevance to 
ADBE 
GSK3 activity is responsible for the downregulation of PI4KIIα. As this activity is so 
intrinsically linked with the activity of a neuron and the continuation of ADBE it was 
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my aim to determine if PI4KIIα had any role in the process of ADBE. This could 
also indicate another distinct role for GSK3 in the process of ADBE. 
1.6.3 To determine whether CME and ADBE are bi-directionally 
coupled 
It is known that exo- and endocytosis are coupled to ensure optimal recycling of PM 
as well as SV proteins. As CME and ADBE work together during HFS it is possible 
that these two modes also possess a degree of coupling. It is possible that, if such a 
relationship exists, that it could be used to manipulate the speed or incidence of 
either mode by facilitating or inhibiting the other. This would be a convenient way of 




















2. Materials and Methods 
2.1 Materials 
Foetal bovine serum was from Biosera (Sussex, UK). Neurobasal media, B-27 
supplement, Penicillin /streptomycin and Minimum Essential Medium and 
lipofectamine 2000 were from Invitrogen (part of ThermoFisher, Massachusetts, 
USA).  
The primary antibodies phospho-Akt Ser473, GSK3α/β Ser21/9 and clathrin heavy 
chain (CHC) were from Cell Signalling (Massachusetts, USA).  Bovine serum 
albumin was from Roche (West Sussex, UK). BAPTA-AM, CNQX and AP-5 were 
from Tocris. EGTA-AM was from Cambridge Bioscience (Cambridge, UK). 
Fluorsave reagent, Roscovitine and ionomycin were from Merck Chemicals 
(Nottingham, UK). CT92001 was from R&D Systems (Minnesota, USA).  
Pitstop2-AM and antibodies for Synaptotagmin 1 and Synaptobrevin-II were from 
AbCam (Cambridge, UK).  40kDa tetramethylrhodamine dextran, was from Life 
technologies (part of ThermoFisher). FM1-43 and advasep-7 were from Biotium Inc. 
(California, USA). The VAMP-4 antibody was from Synaptic Systems (Göttingen, 
Germany).  
Secondary antibodies, β-Actin antibody, LY294002, Wortmannin, acrylamide and all 
other chemicals were bought from Sigma (Missouri, USA). 
Nitrocellulose was from Bio-Rad Laboratories Ltd (California, USA).  
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The pHluorin expression vectors were obtained from the following sources - 
Synaptophysin-pHluorin - Prof. L. Lagnado (University of Sussex, UK), 
Synaptotagmin1-pHluorin - Prof. V. Haucke (Leibniz Institute of Molecular 
Pharmacology, Berlin, Germany); vGLUT1-pHluorin - Prof. R. Edwards (University 
of California, San Francisco, USA); synaptobrevinII-pHluorin - Prof. G. Miesenbock 
(Oxford University, UK); VAMP4-pHluorin - Prof. Ege Kavalali (UT South-western 
Medical Centre, Texas, USA).  
The sequence encoding VAMP4-pHluorin was cloned into a Clontech EGFP-N1 
mammalian expression vector by first removing EGFP and then inserting VAMP4-
pHluorin using AgeI and NotI enzymes. The VAMP4-pHluorin L25A vector was 
created by Alexandros Kokotos of Edinburgh University via site-directed 
mutagenesis. The pSuper neo vector was engineered to express mCerulean (Rizzo et 
al. 2004) (mCer) by removing GFP with the enzymes AgeI and BsrGI and replacing 
with pre-digested mCerulean (Cheung et al. 2010). mCer N1 empty vector was made 
using a Clontech EGFP-N1 backbone in which the sequence encoding EGFP was 
replaced by mCer using AgeI and BsrGI enzymes (Anggono et al. 2006). For species 
and vector information see Table 2.1. 
shRNA against syndapin I was designed using the pSUPER vector system (pSUPER 
neo-GFP, OligoEngine) (Cheung et al. 2010). shRNAs and their scrambled controls 
against VAMP4 and Clathrin Heavy Chain (CHC)  were made using previously 
validated oligos (Bal et al. 2013; Royle et al. 2005) inserted into a pSuper neo 
backbone, the shRNA sequences were inserted using AgeI and Not I or BglII and 
XhoI enzymes respectively. PI4KIIα shRNA and its scrambled control as well as all 
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PI4KIIα rescue vectors were provided by Dr. Adam Cole (Garvan Institute of 
Medical Research, Sydney, Australia). For vector backbones and nucleotide 
sequences see Table 2.2 shRNA Plasmids. 
.
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Table 2.1 Protein Expression Plasmids 
Expressed Protein Species Vector Reference 
Synaptophysin-pHluorin Rat pEGFP-C1 (Granseth et al. 2006) 
Synaptotagmin-pHluorin Rat pcDNA3 (Kononenko et al. 2014) 
vGlut-pHluorin Rat PCAGGS (Voglmaier et al. 2006) 
Superecliptic SynaptobrevinII-pHluorin Mouse pC1-neo (Miesenbock et al. 1998) 
VAMP-4-pHluorin WT Human Clontech EGFP-N1 (Nicholson-Fish et al. 2015) 
VAMP-4-pHluorin L25A Human Clontech EGFP-N1 (Nicholson-Fish et al. 2015) 
GFP- N1 N/A Clontech EGFP-N1 (Andres et al. 2004) 
mCer N1 empty vector N/A Clontech EGFP-N1 (Anggono et al. 2006) 
mCer pSuper neo N/A pSuper neo (Cheung et al. 2010) 
PI4KIIα Wild-Type Human pRK5 - FLAG-tagged (Robinson et al. 2014) 
PI4KIIα QUAD-D Human pRK5 - FLAG-tagged (Robinson et al. 2014) 
PI4KIIα S9/51A Human pRK5 - FLAG-tagged (Robinson et al. 2014) 
PI4KIIα L60/61A Human pRK5 - FLAG-tagged (Robinson et al. 2014) 
PI4KIIα K152A Human pRK5 - FLAG-tagged  
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Table 2.2 shRNA Plasmids 
Target Species Vector shRNA Sequence Reference 
PI4KIIα Mouse/Rat pSuper 5’-GATTTGATTC TTCCAAAGA-3’ (Robinson et al. 2014) 
PI4KIIα Scrambled N/A pSuper  (Robinson et al. 2014) 
Syndapin I Mouse/Rat pSuper 5’-AGAAGAAAC TTGTGGATAA-3’ (Cheung et al. 2010) 
Clathrin Heavy 
Chain 
Mouse pSuper neo 5’-TCCAATTCGAAGACCAAT-3’ (Royle et al. 2005) 
Clathrin Heavy 
Chain Scrambled 
N/A pSuper neo 5’-GACCTCGAATCATAACTA-3’ (Royle et al. 2005) 
VAMP4 Rat pSuper neo 5’-AGATAATATTACCAAGGTAAT-3’ (Bal et al. 2013) 
VAMP4 Scrambled N/A pSuper neo 5’-GATATGATACGATAATAAGCA-3’ (Raingo et al. 2012) 
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Table 2.3 Drugs and Small Molecules 
Name Concentration Pre-Incubation Exposure Source Catalogue 
Ionomycin 2.5 µM N/A 1 min Calbiochem 407950 
LY294002 10 µM 10 min During Stimulation Sigma Aldrich L9908 
Wortmannin 200 nM 10 min During Stimulation Sigma Aldrich W1628 
BAPTA-AM 100 µM 30 min N/A Calbiochem 196419 
EGTA-AM 100 µM 30 min N/A Calbiochem 324628 
CT99021 2 µM 10 min During Stimulation Tocris 4423/10 
Roscovitine 10 µM 10 min During Stimulation Calbiochem 557360 
Pitstop2 15 µM ≤ 8 seconds During Stimulation Abcam ab120687 
AP5 50 µM 10 min (Lysis only) During Stimulation Abcam ab120271 
CNQX 10 µM 10 min (Lysis only) During Stimulation Abcam ab120044 
Tetrodotoxin 100 nM 48 hr N/A   
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(Yuan et al. 2011) 
(Andres et al. 2013) 
Phospho-GSK3 
α/β Ser 21/9 
Rabbit 1:1000 2 hours WB Cell Signalling 9331S 




Mouse 1:50000 30 min WB Sigma A3854 (Gao et al. 2008) 
Clathrin Heavy 
Chain 
Rabbit 1:50 30 min IF Cell Signalling P1663 (Popova et al. 2011) 
PI4KIIα Mouse 1:4 30 min IF 
Dr. Shane 
Minogue, UCL 






Dilution Incubation Use Manufacturer Catalogue # Reference 
VAMP-4 Rabbit 1:100 30 min IF 
Synaptic 
Systems 
136 002 (Wilhelm et al. 2014) 








Incubation Dilution Use Manufacturer Catalogue # 
Alexa Fluor 568 Chicken Goat 30 min 1:500 IF Invitrogen A11041 
Alexa Fluor 568 Rabbit Goat 30 min 1:500 IF Invitrogen A21069 
Alexa Fluor 568 Mouse Goat 30 min 1:500 IF Invitrogen A11004 
Alexa Fluor 488 Chicken Goat 30 min 1:500 IF Invitrogen A11039 
HRP Rabbit Goat 1 hour 1:5000 WB Sigma Aldrich A6154 
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2.2 Methods 
2.2.1 Cell Culture 
 Rat Cerebellar Granule Neurons 
Autoclaved coverslips were pre-coated by immersion and constant agitation in a 
poly-D-lysine solution (50 μg/mL in 0.1 M Borate buffer in autoclaved sterile H2O 
{from a MilliQ Academic Ultrapure Water System, Millipore} pH 8.5) for at least 3 
hours. Coverslips were then washed three times with sterile H2O before drying on 
sterilised paper. 
Cerebella were removed from P7 Sprague-Dawley rat pups (killed by euthatal 
injection – Schedule 1) and run twice through a McIlwain tissue chopper (Mickle 
Laboratory Eng. Co. Ltd. Surrey, UK) using 375μM intervals at 90˚ angles. The 
tissue was then placed Solution B (14 mM glucose, 50 μM bovine serum albumin 
{fatty acid free} (BSA), 3 mM MgSO4, 153 mM Na+, 4 mM K+, 139 mM Cl-, 10 
mM PO42-) supplemented with 0.25 mg/mL trypsin and kept at 37 ºC for 20 minutes. 
After trypsinisation 20 mL of solution W (3.2:16.8 Solution C (defined below): 
Solution B) containing 8 μg/mL soybean trypsin inhibitor and 8 U/mL DNase was 
added and the sample was centrifuged at 1000g for 60 seconds. The supernatant was 
removed and ~1 mL solution C (50 U/mL DNase, 50 μg/mL soybean trypsin 
inhibitor, 3 mM MgSO4 in solution B) was added and flame-polished Pasteur 
pipettes with bore sizes of decreasing diameters were then used to disaggregate the 
cells. The cell suspension was then layered onto an Earle’s Balanced Salt Solution + 
4% BSA solution and centrifuged at 1500g for 5 minutes. The pellet was 
84 
resuspended in culture medium (Minimal Essential Medium, 10% foetal bovine 
serum, 100 U/mL penicillin 100 μg/mL, 25 mM KCl, 33 mM glucose and 2 mM L-
glutamine) and a cell density calculation performed using a haemocytometer: 10 µL 
of cell suspension was diluted in 90 µL culture medium and pipetted into the 
haemocytometer. A cell count of a 1 mm2 area (containing 100 nL of 1:10 cell 
suspension) is repeated 4 times and an average taken. This cell count is then inserted 
into the following equation: 
   
, ,




This cell suspension was then diluted in culture medium to a density of 7.5x106 
cells/100 μL. A droplet of 50 or 75 µL (lysis experiments: action potential or 
ionomycin respectively) at this density was then plated or diluted to a density of 
1.406 x 105 cells/ 75 µL (imaging experiments) and a droplet of 75 µL pipetted onto 
the centre of a pre-coated 25 mm coverslip each. After 1 hour each coverslip was 
covered in 2 mL of culture medium. After 24 hours this medium was removed and 
replaced with culture medium supplemented with 10 μM cytosine-β-D-
arabinofuranoside (Ara-C), this inhibits cell proliferation and thereby prevents 
astrocyte growth. Cells were kept in an incubator at 5% CO2, 37 ºC and used 
between 8-14 days in vitro (DIV). 
 Mouse Hippocampal Neurons 
Hippocampal cells were prepared by the Cousin Laboratory. Coverslips were 
prepared as described for Rat CGNs. Dissociated primary hippocampal enriched 
neuronal cultures were prepared from both male and female E17.5 C56BL/6J mouse 
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embryos taken from mothers culled by cervical dislocation- Schedule 1. Isolated 
hippocampi were kept in ice-cold phosphate buffered saline supplemented with 1 % 
v/v penicillin/streptomycin before being transferred to 10 U/mL papain and 
incubated at 37 ºC for 20 minutes. Excess papain was removed and replaced with 
Supplemented DMEM/F12 (Dulbecco’s Modified Eagle Medium: Nutrient Mixture 
F-12) supplemented with 1% v/v penicillin/streptomycin solution and 10% w/v foetal 
bovine serum and triturated to obtain a single-cell suspension. The suspension was 
centrifuged (1500rpm, room temp, 5 min). Any insoluble material was carefully 
removed. The supernatant was discarded and the pellet resuspended in Neurobasal 
supplemented with 2% B-27, 0.5 mM L-glutamine, and 1% v/v 
penicillin/streptomycin. A cell density calculation was then performed using a 
haemocytometer to assess initial concentration (ConcentrationA) and the suspension 
was then diluted to a density 0.5 x 107 cells/mL (ConcentrationB) using the equation: 
   =     
10 µL of this solution was then seeded onto previously prepared 25 mm coverslips 
into a pre-placed 50 µL spot of supplemented Neurobasal enriched with laminin (0.1 
µg/mL). The cells were allowed to attach to the coverslip substrate in a 37 ºC / 5% 
CO2 incubator for 1 hour before a further 1.5 mL of supplemented Neurobasal media 
was added. After 72 hours, cultures were further supplemented with 1 µM Ara-C to 
inhibit glial proliferation.  
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2.2.2 Transfection 
 Rat Cerebellar Granule Neurons 
Rat cerebellar granule neurons (CGNs) were transfected after 5-8 days in culture 
with Lipofectamine 2000: conditioned culture medium was removed and replaced 
with MEM (single or co-transfections) or opti-MEM (triple transfections) for 2 hours 
with 2 µL of lipofectamine and 1/0.7µg DNA per construct (single or double/ triple 
respectively) per coverslip. Cells were subsequently washed with MEM before 
replacement of conditioned culture medium. Cells were imaged at 8-11 days in 
culture (3 days after transfection). 
 Mouse Hippocampal Neurons 
Cells were transfected after 6-8 days in culture with Lipofectamine 2000 just as 
CGNs with the following alterations: conditioned neurobasal medium was removed 
and replaced with MEM for 2 hours with 2 µL of lipofectamine and 1 µg DNA 
construct per coverslip. Cells were subsequently washed with MEM before 
replacement of conditioned Neurobasal. Cells were imaged at 13-15 days in culture 
(7 days after transfection). 
2.2.3 CGN Lysis 
CGNs were removed from culture medium and repolarised in “imaging buffer” (170 
mM NaCl, 3.5 mM KCl, 400 µM KH2PO4, 20 mM TES [N-tris[hydroxy-methyl]-
methyl-2-aminoethane-sulfonic acid], 5 mM NaHCO3, 5 mM glucose, 1.2 mM 
Na2SO4, 1.2 mM MgCl2, 1.3 mM CaCl2 at pH 7.4) for 10 minutes. This medium was 
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then replaced by imaging buffer supplemented with (2R)-amino-5-phosphonovaleric 
acid (AP-5, 50 µM), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM) and the 
relevant drug of interest if preincubation was required (Table 2.3). For electrical field 
stimulation experiments coverslips were placed in a Warner imaging chamber with 
embedded parallel platinum wires (RC-21BRFS, Warner Instruments, Connecticut, 
USA) and either challenged with a train of 800 action potentials delivered at 80 hertz 
(Hz) (100 mA at 1 msec pulses) or no stimulus (basal).  In experiments using 
ionomycin, cells were treated in an identical manner, with the exception that the 
challenge with 2.5 µM ionomycin or a vehicle control (DMSO) was for 1 min.   
In all experiments drugs were present during stimulation with the exception of those 
using either BAPTA-AM or EGTA-AM (see Table 2.3 for incubation times and 
concentrations).  Low calcium imaging buffer had the following alterations, CaCl2 
was reduced to 100 µM, MgCl2 was increased to 10 mM and EGTA was added at 50 
µM. After stimulation with either action potentials or ionomycin, CGNs were 
immediately lysed in 25 µL of SDS sample buffer (67 mM Tris, 9.3% glycerol, 2 
mM EGTA, 67 mM SDS, bromophenol blue, 12% β-mercaptoethanol) and boiled at 
95˚C for at least 5 min.  
2.2.4 Western Blotting 
CGN lysates were separated using a 10 % polyacrylamide gel using a Bio-Rad 
Protean 3 system and transferred onto nitrocellulose using a Wet Western blot 
transfer apparatus from Bio-Rad Laboratories and transfer buffer (25 mM Tris, 192 
mM Glycine in 1:4 methanol to H2O solution) the membrane was exposed to 
Ponceau stain to confirm a successful transfer. The membrane was then blocked for 1 
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hour using tris-buffered saline (20mM Tris, 137 mM NaCl, pH 7.6) with 0.1% 
Tween (TBST) supplemented with 5% semi-skimmed milk powder.  Membranes 
were then washed with TBST for 3 washes of 5 minutes with constant agitation 
before being placed in primary antibody (see Table 2.4). After primary antibody 
incubation membranes were washed with TBST for 3 washes of 5 minutes with 
constant agitation and then exposed to secondary antibodies (see Table 2.5) where 
required.  Following a further 3 washes of 5 minutes with TBST membranes were 
covered with a 1:1 mixture of luminol solution (0.1M Tris pH 8.5,2.5 mM luminol, 
396 nM P-coumaric acid) and peroxide solution (0.1M Tris pH 8.5, 0.06% hydrogen 
peroxide) for enhanced chemiluminescence (ECL). Kodak BioMax X-ray film was 
used to determine chemiluminescence on the membrane for each blot. 
 Western Blotting Analysis 
The intensity of the detected chemiluminescence signal was determined using Image 
J (NIH):  boxes were superimposed over the images to encompass all bands (Figure 
2.1 B), and a histogram of greyscale intensity was created (Figure 2.1 C). Sections of 
the histogram corresponding to each band were then separated and measured giving 
raw densitometry values. Raw densitometry values were normalised firstly to the 
highest value within an individual blot and then to individual corresponding loading 
controls (β-Actin) (which was also normalised to the highest value). All Western blot 
data was displayed after normalisation to basal signal from each drug condition 
within a blot. All data was analysed using Microsoft Excel with statistical analysis 
performed using GraphPad Prism. Student’s t-tests were performed comparing all 
data sets to their corresponding basal condition unless otherwise stated. 
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2.2.5 Fluorescence Microscopy 
Fluorescence microscopy is of use in cell imaging as it allows defined spatial 
resolution in fixed cells as well as temporal resolution in live cells as it allows the 
visualisation of trafficking and recycling of fluorescent markers in real time. Live 
cell imaging experiments were all conducted with hippocampal or CGN cultures. 
CGN cultures were repolarised for 10 minutes in imaging buffer before being loaded 
onto a Warner chamber and placed onto the stage of a microscope. Fixed cells to be 
imaged were mounted on slides and cured (see 2.2.5.2) before being loaded onto the 
stage of an inverted epifluorescence microscope. 
All experiments except for those utilising fura2-AM (see 2.2.5.1.1) were imaged on a 
Zeiss Axio Observer A1 epifluorescence microscope. Cultures were visualised with a 
Zeiss Plan Apochromat x40 oil immersion objective (NA 1.3). Single images or 
time-lapse images at 4 second intervals were captured using a Zeiss AxioCam MRm 
Rev.3 digital camera. All images were processed offline using Image J 1.43 software. 
Timelapse videos were processed using the ImageJ plugin Time Series Analyser 
(http://rsb.info.nih.gov/ij/plugins/time-series.html). Identically sized regions of 
interest (ROIs) were placed over boutons and the total fluorescence recorded over 





Figure 2.1 Example of Western Blot Analysis:  
Levels of chemiluminescence were detected using X-ray film (A). Densitometry was then 
performed using ImageJ: a box was drawn around the relevant bands as closely as possible 
(B) and a histogram of greyscale intensity was created (C). The bands were separated (black 
lines, C) and the background intensity removed when needed (red lines, C). The area of each 
band was then measured. 
91 
 Calcium Imaging 
2.2.5.1.1 FURA 2-AM Assay 
Fura-2 is a ratiometric fluorescent dye that is excited by different wavelengths of 
light depending whether or not it has bound a calcium ion. In its bound state it is 
maximally excited by a 340 nM wavelength but in its unbound state it is maximally 
excited by 380 nM (Tsien et al. 1985). The ratio of emissions between these 
wavelengths can give a comparative representation of calcium concentration within a 
cell ([Ca2+]i) with the added advantage of any value being independent of amount of 
dye loaded into the cell. The acetoxymethyl (AM) region makes the Fura dye cell 
permeable, this region is then cleaved by esterases within the cell, trapping the Fura 
intracellularly. 
After repolarisation, imaging buffer was removed and then replaced with imaging 
buffer supplemented with 10 μM Fura2-AM for 30 minutes. After this the cultures 
were washed twice in imaging buffer. The coverslips were then mounted onto a 
Warner imaging chamber, covered with 200 μL of imaging buffer and viewed on a 
Nikon Diaphot TMD inverted epifluorescence microscope fitted with a 20x NA 0.75 
air objective lens. Cells were excited with light of wavelengths 340 nm and 380 nm 
in sequential 6 second cycles with emissions captured for 0.5 seconds at 505 nm 
using a Hamamatsu ORCA-ER CCD (Hamamatsu City, Japan) camera and the 
software C- imaging PCI (HC image, Pennsylvania, USA). A baseline fluorescence 
was acquired for 30 seconds before addition of 50 μL imaging buffer alone (control) 
or supplemented with either 1 μM, 2.5 μM, or 5 μM ionomycin (final) and imaged 
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continuously for 90 seconds. Imaging was then paused for 10 minutes to allow 
maximal calcium influx and resumed for a further 5 minutes. 
2.2.5.1.1.1 Fura 2-AM Assay Analysis 
Time-series stacks were acquired as a composite of emissions at 505 nm from 
excitation in both 340 and 380 nm (Figure 2.2 C, F). The stack was split into two 
channels – emissions when excited by 340 nm or by 380 nm light (Figure 2.2 A, B, 
D, E). One hundred identically sized (5 x 5 pixel) regions of interest (ROIs) were 
placed on the neurites of the image and superimposed onto each channel. The total 
pixel intensity was calculated within each ROI for each frame and the ratios between 
the individual readings for each frame on either channel was then calculated using 
ImageJ with the Time Series analyser plugin. The values were then expressed as a 
ratio of 340/380 i.e. the higher the ratio value, the more calcium-bound Fura (Figure 
2.2 G). For these experiments n refers to the number of coverslips examined.  
2.2.5.1.2 Fluo3-AM Imaging 
Fluo-3 has an affinity for calcium (Kd{Ca2+}) of 335 nM. When internalised within 
the cell its fluorescence can be used as a measure of [Ca2+]i. Fluo-3 has a low 
fluorescence when unbound which sharply increases (typically > 100-fold) upon 
binding a calcium ion. Its structure was based upon that of conventional rhodamines 
and fluoresceins (Minta et al. 1989). It is a preferable calcium indicator to Fura-2 for  
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Figure 2.2 Example of Fura2-AM Analysis:  
Fura loaded cultures were imaged using 340 nm (A and D) and 380 nm (B and E) UV 
filters, after baseline acquisition ionomycin was added to the imaging buffer (red arrow, G). 
Stacks were aligned and identically sized ROIs were placed over neurites in the composite 
images (yellow circles, C and F). Fluorescence within these ROIs in each wavelength was 
measured throughout the stack and screened for responsive synapses. For each frame a 
ratio of fluorescence intensity between 340 and 380 nm was calculated and plotted against 
time. Traces were then averaged together (G). 
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Figure 2.3 Example of Fluo3-AM Analysis:  
Neurons loaded were Fluo3 were imaged using CFP filter set. Cultures were stimulated twice (red bars, F) while imaging.  Timelapse stacks were 
aligned (A-E) and identically sized ROIs were place over neurites responsive to the first stimulation (yellow circles, B). Fluorescence within these ROIs 
was measured throughout the stack and normalised to baseline and maximum fluorescence (1 and 4). Remaining traces were then averaged together 
(F) and peak heights compared as S1/S2. 
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our purposes due to its excitation wavelength. Fura-2 requires excitation at 340 and 
380 nm wavelengths which are in the ultraviolet (UV) spectrum and nearing the limit 
for transmission through glass, UV excitation of living cells is also potentially 
injurious. Fluo-3 is maximally excited at 506 nm which is in the visible spectrum and 
more compatible with common filter sets.  
CGN cultures were removed from culture medium and placed into imaging buffer 
supplemented with 10 µM fluo3-AM for 30 minutes. Cultures were then washed 
twice in imaging buffer before being placed into a Warner imaging chamber, covered 
with 200 µL of imaging buffer and placed on the stage of the Zeiss Axio Observer 
A1 epifluorescence microscope. A dichroic 455 nm and a band-pass emission filter, 
535 nm (Zeiss filter set 46 YFP) were used. A baseline of 30 seconds was acquired 
before a stimulation train of 400 action potential at 40 Hz. Cells were imaged for a 
further minute before imaging was paused. 5 minutes after initiation of imaging, 50 
µL of imaging buffer supplemented with 5 times concentration of the relevant 
antagonist (see Table 2.3) was added directly to the Warner imaging chamber. After 
10 minutes of drug incubation an identical protocol of imaging and stimulation as 
described above was performed (Figure 2.3).   
2.2.5.1.2.1 Fluo3-AM S1 S2 Assay Analysis 
Only traces from ROIs that increased in fluorescence in response to the first action 
potential stimulation were analysed. The fluorescence change was calculated as: 
Change in fluorescence (FΔ) / Baseline fluorescence (F0) 
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with difference between baseline and stimulation peak fluorescence measured for 
each stimulation (S1 and S2) and compared for each experiment. Values are 
expressed as ΔF S2/ ΔF S1 and n refers to the number of individual coverslips 
examined.   
2.2.5.1.3 pHluorin Imaging 
The genetically encoded reporters called pHluorins allow the investigation of 
synaptic vesicle recycling. A pH-sensitive version of a GFP molecule was made by 
Miesenböck et al. (1998)  via the following mutations: S147D, N149Q, T161I, S202F, 
Q204T and A206T and fused to the luminal domain of a synaptic vesicle protein, 
making a pHluorin.  The lumen of a synaptic vesicle has a pH of around 5.5, 
pHluorins are quenched when in an acidic (<6) pH and therefore have minimal 
fluorescence when encapsulated inside a vesicle. When the GFP molecule is exposed 
to the neutral pH of the extracellular environment (i.e. via exocytosis) it dramatically 
increases in fluorescence (20-fold) and when the pHluorin is re-acidified inside a 
vesicle (after endocytosis) this fluorescence is re-quenched (Figure 2.4).  
A method of normalisation utilised with pHluorins is exposure to an (alkaline) 
“ammonium imaging buffer” (imaging buffer with 50 mM NH4Cl substituted for 50 
mM NaCl), this allows visualisation of all pHluorin molecules present in a given cell. 
This is possible by NH+ diffusing across the SV membrane and neutralising the 
lumen, causing the pHluorin molecules to fluoresce despite their internalisation. The 
proportion of surface-bound pHluorin molecules can also be determined by pulsing 
an impermeant acidic imaging buffer (imaging buffer with 20 mM MES substituted 
for 20 mM TES, pH 5.5) over the cell, quenching any accessible pHluorin molecules. 
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All pHluorins with the exception of synaptobrevin II- and synaptophysin-pHluorin 
constructs were co-transfected with an empty mCer-tagged vector to allow 
identification of transfected cells for pHluorins with a low baseline fluorescence. 
Transfected neurons were visualised at 436 nm excitation (to illuminate mCer where 
present) using a dichroic 455 nm and a band-pass emission filter, 480 nm (Zeiss filter 
set CFP), whereas pHluorin reporters were visualised at 500 nm using a dichroic 455 
nm and a band-pass emission filter, 535 nm (Zeiss filter set 46 YFP). This allowed 
separation of mCer fluorescence from pHluorin fluorescence. During all experiments 
cells were subject to continuous perfusion with imaging buffer. A baseline of one 
minute was acquired prior to each stimulation with action potentials (300 AP at 10 
Hz or 400 AP at 40 Hz) and imaged for at least 3 minutes after. At the end of each 
experiment cultures were challenged with alkaline imaging buffer to reveal total 
pHluorin fluorescence (Figure 2.4). 
Imaging of hippocampal cultures was performed in essentially the same manner 
except for the absence of a 10 min repolarisation period and the use of an altered 
“hippocampal imaging buffer” (136 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1.3 mM 
MgCl2, 10 mM glucose, 10 mM HEPES, pH 7.4 supplemented with 10 µM CNQX 
and 50 µM AP-5) and alkaline imaging buffer (50 mM NH4Cl substituted for 50 mM 
NaCl).  
Only regions that showed an increase of fluorescence in response to action potential 
stimulation and exhibited an alkaline buffer fluorescence greater than stimulation 
intensity were selected for analysis. The average trace from each experiment was 
normalised to baseline and alkaline wash maximum fluorescence to 0 and 1  
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Figure 2.4 Example of pHluorin Analysis:  
Images of pHluorin transfected neuron were acquired with YFP filter set. Timelapse images 
were aligned (A-D) and identically sized ROIs were placed over boutons on transfected cells 
(yellow circles, A). Fluorescence within these ROIs was measured throughout the stack and 
screened for responsive synapses and normalised to baseline and maximum fluorescence 
(E). Remaining traces were then averaged together (F) and any measurements of τ or peak 
height were made from this average. Red bar represents time of stimulation. Error bars 
represent SEM. 
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respectively (Figure 2.4 E). The pHluorin fluorescence change was calculated as 
FΔ/F0. A non-linear regression curve-fit was fitted to the endocytic decay of the 
pHluorin trace using GraphPad Prism and the tau (τ) value calculated for each 
stimulation. Peak height was measured using Microsoft Excel and calculated as 
FΔ/F0 in comparison to alkaline maximum fluorescence.  In all cases n refers to the 
number of individual coverslips examined. 
VAMP4-pHluorin analysis differs from the above protocol in the following ways: a 3 
x 3 pixel binning was implemented in either Axiovision or Zen Pro software during 
acquisition. This was due to the low basal fluorescence of a VAMP4-pHluorin 
transfected neuron. VAMP4-pHluorin undergoes significant photo bleaching over 
time; in GraphPad Prism a non-linear regression curve was fitted to the first 19 
frames of baseline acquisition for each trace, the equation of these curves were then 
subtracted from the original data to compensate for fluorescence lost through decay 
(see Figure 2.5 A and B). Trace acquisition, decay correction and screening for 
responsive synapses occurred in an identical manner to that described above however 
VAMP4-pHluorin data also requires an additional step of analysis. Screened traces 
(Figure 2.5 C) were inserted into a Microsoft Excel spreadsheet which firstly 
normalised each trace to the maximum fluorescence given with alkaline imaging 
buffer and secondly separated those traces which increased in fluorescence upon 
stimulation from those which decreased (Figure 2.5 D) using the following 
calculation: 
 “IF('Normalised Traces'!BH5<AVERAGE('Normalised Traces'!B5:O5),,))” 
Meaning: 
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If, after 2 minutes of recovery, fluorescence intensity is lower than the average value 
of its baseline, classify as Down () if not classify as Up (). 
When an experiment required two stimulations this spreadsheet was modified to 
separate out traces based on both stimulations, creating four subsets: 
1) S1 Up, S2 Up 
2) S1 Up, S2 Down 
3) S1 Down, S1 Down 
4) S1 Down, S2 Up 
These subsets were then averaged. The proportion of each subset within each 
experiment was also calculated and compared. 
2.2.5.1.3.1 Single Stimulation pHluorin Assay 
Cultures were subjected to stimulation with a train of either 400 action potentials 
delivered at 40 Hz or 300 action potentials delivered at 10 Hz (100 mA, 1 ms pulse 
width) where indicated. Where the drug pitstop2 was utilised the cell was exposed to 
the drug 4-8 seconds before stimulation.  
Comparisons between traces were performed using a 2-way ANOVA in GraphPad 
Prism. Peak Heights and Tau values were compared using t-tests or one-way 
ANOVAs where stated using GraphPad Prism. 
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Figure 2.5 Example of VAMP4-pHluorin Analysis 
Raw data from timelapse images (A - average) were fit with non-linear regression curves and decay corrected (B - average). Individual 
decay corrected traces (C) were then separated into two subsets: those which had a relative decrease in fluorescence 2 minutes after 
stimulation and those which had a relative increase (D). Red bar represents point of stimulation, error bars represent SEM. 
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2.2.5.1.4 S1 S2 pHluorin Assay 
For experiments blocking ADBE, cells were incubated with the relevant drug or 
imaging buffer alone (control) for 10 minutes after initial repolarisation. Cultures 
were subjected to continuous perfusion with imaging buffer plus/minus the relevant 
drug. A baseline of 1 minute was acquired before cells were stimulated with a train 
of 400 action potentials delivered at 40 Hz (100 mA, 1 ms pulse width) “S1”. 
Cultures were allowed to recover for 10 minutes in total with images acquired for 3 
minutes after S1 before a second identical stimulus train and imaging protocol “S2”. 
In experiments using pitstop-2 (to block CME) the first stimulation serves as an 
internal control with the drug only being applied 4-8 seconds before the second 
stimulation.  
2.2.5.1.4.1 S1 S2 Assay pHluorin Analysis 
Peak height and τ values were noted for each stimulation within the experiment and a 
ratio of S1/S2 calculated per value. Ratios between conditions were compared using 
Microsoft Excel and GraphPad Prism. 
2.2.5.1.5 Acid Wash pHluorin Assay 
Perfusion of an impermeant acidic imaging buffer over a cell expressing pHluorins 
allows one to isolate the fraction of pHluorin molecules residing on the cell surface 
in relation to the total pool as revealed by alkaline imaging buffer. It can also be used 
to reveal any pHluorin which has been internalised into a neutral-pH environment 
after stimulation via comparison to a control acid wash. 
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Cells transfected with syp-pH were imaged for 40 seconds with constant perfusion of 
imaging buffer before perfusion of acidic imaging buffer for a further 40 seconds. 
This is the control acid wash, which provides a baseline of minimum fluorescence. 
Acidic buffer was replaced with imaging buffer via perfusion before a stimulus train 
of 400 action potentials delivered at 40 Hz (100 mA, 1 ms pulse width). Thirty 
seconds after stimulation, during the recovery period, acidic buffer was pulsed over 
the culture for 30 seconds and then replaced with imaging buffer. This is the first 
post-stimulation acid wash. After 90 seconds, acidic buffer was again pulsed over the 
culture and again replaced with imaging buffer, this is the second post-stimulation 
acid wash. 
2.2.5.1.6 Acid Wash pHluorin Assay Analysis 
The difference in fluorescence between control acid wash to stimulation intensity 
was determined (FΔ0) and compared to difference in fluorescence between first (FΔ1) 
or second (FΔ2) post-stimulation acid wash and stimulation intensity. Values are 
expressed as percentage of control acid wash difference e.g.: 
            (FΔ1)   x 100                                                                                                                   
(FΔ0) 
This experiment was repeated using VAMP4-pHluorin using an identical protocol as 
described above with the following alterations. After stimulation only one post-
stimulation acid wash was performed immediately after stimulation had ceased. The 
experiment was performed with stimulus trains of either 400 AP at 40 Hz or 300 AP 
at 10 Hz. 
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Figure 2.6 Example of Acid Wash Analysis 
Neurons transfected with pHluorin were exposed to acidic imaging buffer (light grey bands) to reveal surface fraction. The cell was then stimulated 
with 40 HZ 10 sec and exposed to acidic buffer twice more at set time points to reveal any sequestered pHluorin. Raw data from timelapse images 
was screened for responsive synapses (A) and normalised to its baseline and alkaline pulse (dark grey bands) fluorescence (B) and averaged 
together (C). This averaged trace was then normalised to the stimulation peak height and the differences between the peak height and the control 
acid wash (black arrow, D), first post-stimulation wash (green arrow, D) and second post-stimulation wash (blue arrow, D) was calculated and 
compared. Red line indicates stimulation time point, error bars represent SEM. 
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2.2.5.1.7 Vesicle Acidification Assay 
Cultures were perfused with imaging buffer for 1 minute and then exposed to 
alkaline imaging buffer. The alkaline buffer was then replaced with either imaging 
buffer alone (control) or supplemented with 15 µM Pitstop-2. This solution was then 
perfused for the length of a typical one stimulation experiment (4 minutes) and 
challenged with another exposure to alkaline imaging buffer alone (control) or with 
Pitstop-2. The culture was then left for 5 minutes in either imaging buffer alone 
(control) or with Pitstop-2 before renewing acquisition. A third alkaline buffer wash 
was then executed (control) with Pitstop-2. 
2.2.5.1.8 Vesicle Acidification Assay Analysis 
Only regions that responded to all alkaline imaging buffer challenges were selected 
for analysis. The differences between baseline and total fluorescence was calculated 
for all 3 exposures and compared between control and Pitstop-2 conditions. Values 
were normalised to the greatest difference in fluorescence and all FΔ/F0 values were 
expressed as a percentage of the largest. 
 Immunofluorescent Antibody Assay 
CGN or hippocampal cultures were removed from culture medium and washed twice 
in PBS solution (0.1 M phosphate buffer, 2.7 mM KCl, 137 mM NaCl, pH 7.4) 
before fixing in 4% PFA in PBS for 20 minutes. The PFA was then quenched with 
two 5 minute washes in PBS solution supplemented with 50 mM NH4Cl. Cells were 
permeabilised to allow labelling of intracellular structures via 2 washes of 4 minutes 
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in PBS solution supplemented with 0.1% Triton X-100. Cells were then placed in 
blocking solution (PBS solution with 2% BSA) for ≥10 minutes. 
Primary antibodies were made up in blocking solution to the correct concentration 
(see Table 2.4). Fixed, permeabilised and blocked cultures were exposed to the 
primary antibody solution in a humidifying chamber at room temperature for 30 
minutes. The antibody was then removed with 3 washes of PBS solution. 
Secondary antibodies were made up in blocking solution to the correct concentration 
(see Table 2.5) and antibody exposure was conducted in an identical manner to that 
of the primary antibody. For every primary antibody investigated 2 controls were 
performed (primary or secondary antibody alone). 
After secondary antibody exposure coverslips were submerged in sterile H2O in 3 
separate containers to remove any unbound antibody, dried and placed on slides with 
Fluorsave reagent mountant and left to cure in the dark overnight. Slides were left in 
a 4 
o
C environment until imaged. 
CGN cultures were placed on the stage of Zeiss Axio Observer A1 epifluorescence 
microscope. Transfected neurons were located with a Zeiss Plan Apochromat x40 oil 
immersion objective (NA 1.3) at 436 nm excitation to illuminate mCerulean using a 
dichroic 455 nm and a band-pass emission filter, 480 nm (Zeiss filter set 47 CFP) or 
at 500 nm where Alexa Fluor 488-bound GFP antibody was present using a dichroic 
455 nm and a band-pass emission filter, 535 nm (Zeiss filter set 46 YFP). Antibodies 
labelled with an Alexa Fluor 568 secondary were visualised at 546 nm using a 
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dichroic 560 nm and a band-pass emission filter, 608 nm (Zeiss filter set 20 
Rhodamine). A least 8 fields were imaged per coverslip. 
2.2.5.2.1.1 Immunofluorescence Assay Analysis 
Images from each region were overlaid and ROIs of identical sizes were placed over 
transfected synaptic boutons and the fluorescence in the rhodamine channel of each 
ROI was taken using ImageJ with the Time Series analyser plugin. Equal-sized ROIs 
were then placed over non-transfected synaptic boutons as visualised in the 
rhodamine channel and the fluorescence of each ROI taken. ROIs of equal size were 
also placed over synaptic bouton-adjacent areas devoid of neurons to acquire an 
accurate representation of average background fluorescence intensity. This 
background intensity was then subtracted from each value for both transfected and 
non-transfected ROI set and the remainders averaged for each image. These averages 
were then expressed normalised to the non-transfected value, giving the transfected 
values as a percentage of the non-transfected. n represents number of transfected 
cells imaged. 
   Dextran Imaging 
CGN cultures were repolarised in imaging buffer and then placed into a Warner 
imaging chamber. Imaging buffer (200 µL) supplemented with 50 µM 40kDa 
tetramethylrhodamine-Dextran (dextran) was then added to the chamber and cultures 
were challenged with a stimulus train of 400 action potentials at 40 Hz, dextran was 
removed and replaced with imaging buffer. Hippocampal cultures were treated in the 
same manner with previously stated alterations (see 0). The Warner chamber was 
108 
then mounted onto the stage of a Zeiss Axio Observer A1 epifluorescence 
microscope and any non-internalised dextran was washed off with imaging buffer via 
perfusion for at least 1 minute. dextran was imaged at 546 nm using a 560 nm 
dichroic and a 608 nm band-pass emission filter (Zeiss filter set 20 Rhodamine). At 
least 8 fields were imaged per coverslip. 
2.2.5.3.1 Field Dextran Assays 
For a single stimulation CGN cultures were repolarised for 10 minutes in imaging 
buffer before being placed in in a Warner imaging chamber and covered with 200 µL 
of 50 µM dextran in imaging buffer alone (control) or supplemented with the 
relevant drug and subjected to a stimulus train of 400 action potentials at 40 Hz and 
treated as stated above. 
For S1 S2 experiments, repolarised CGN cultures were incubated for 10 minutes 
with imaging buffer alone (control) or supplemented with 2 µM CT92001 or 10 µM 
roscovitine. Coverslips were then placed in a Warner imaging chamber and 
stimulated with 400 AP at 40 Hz (S1) and left to recover for 10 minutes before an 
identical dextran loading protocol as that stated above (S2). 
2.2.5.3.1.1 Field Dextran Assay Analysis 
The number of dextran puncta per image were assessed using a macro: a threshold of 
fluorescence was set using the plugin Auto Threshold 
(https://github.com/fiji/Auto_Threshold/) to eliminate lowly fluorescing or 
overexposed bodies. It then counted bodies of circular shapes (puncta) within the 
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defined fluorescence range with a diameter of between 4 and 14 pixels in each image 
using the command “Analyze Particles”. The number of valid puncta in each image 
were averaged within coverslips and then within conditions. Values are expressed as 
a percentage of control (n represents number of coverslips imaged). 
2.2.5.3.2 Dextran with Transfected Cell Assay  
After an identical dextran loading and washing protocol as described in 2.2.5.3, 
transfected cells were located at 436 nm excitation to illuminate mCerulean using a 
dichroic 455 nm and a band-pass emission filter, 480 nm (Zeiss filter set 47 CFP). 
Images were acquired in both CFP and Rhodamine.  
2.2.5.3.2.1 Dextran with Transfected Cell Assay Analysis 
Lengths of transfected neurites were measured in pixels using the Fiji (ImageJ 
analogue) plugin Simple Neurite Tracer (http://fiji.sc/Simple_Neurite_Tracer) 
(Figure 2.7 C). Images of transfected neurons and dextran were overlaid and any 
dextran puncta which overlaid entirely with a transfected neurite were counted 
(Figure 2.7). Puncta per pixel were calculated and normalised to the control 
condition. Data is expressed as puncta/pixel as a percentage of control (n represents 
transfected cell number). 
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Figure 2.7 Example of Transfected Dextran Analysis:   
Images were captured with both CFP (mCer) and Rhodamine (Dextran) filter sets (A and B 
respectively). Neurite length was measured in pixels using “Simple Neurite tracer” (C). 
Images were then overlaid (D) and puncta co-localising with transfected neurites were 
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3. PI3K couples localised calcium influx to Akt activation in central 
nerve terminals  
3.1 Introduction 
During intense stimulation an additional form of endocytosis is initiated alongside 
single SV retrieval via CME, activity-dependent bulk endocytosis (ADBE). ADBE is 
triggered immediately during high frequency stimulation and is a rare event during 
low frequencies. This mode permits dramatically increased retrieval capacity via the 
formation of large endosomes direct from the PM. These bulk endosomes then 
undergo “budding”, a clathrin-dependent process which forms SVs from the larger 
endosome. These SVs are capable of repopulating the recycling pool (Clayton & 
Cousin 2009; Kokotos & Cousin 2015). 
Initiation of ADBE is dependent on the dephosphorylation of the large GTPase 
dynamin I at two serine residues (Ser774 and Ser778) (Clayton et al. 2009). This 
event is mediated by the calcium-dependent protein phosphatase calcineurin and only 
occurs during intense activity (Clayton et al. 2009). In order to maintain ADBE 
across multiple trains of stimuli the two serine residues of dynamin I must be 
rephosphorylated by cyclin-dependent kinase 5 (cdk5) on Ser778 and then 
subsequently by glycogen synthase kinase 3 (GSK3) on Ser774 (Clayton et al. 2010). 
Expression of both phospho-null and phospho-mimetic Ser774 mutant versions cause 
an inhibition of ADBE (Clayton et al. 2010). This demonstrates the need for both de- 
and rephosphorylation in the initiation of this process. 
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Although Cdk5 is constitutively active, the high basal activity of GSK3 is modulated 
via its phosphorylation status (Frame & Cohen 2001). Phosphorylation of Ser 21/9 of 
GSK3β/α by upstream cascades inhibit its protein kinase activity. GSK3 
phosphorylation can occur as a consequence of many different signalling cascades 
(Eldar-Finkelman 2002). GSK3 is phosphorylated in central nerve terminals in 
response to stimulation only during high levels of neuronal activity, coincident with 
dynamin I dephosphorylation (Smillie & Cousin 2012). This activity-dependent 
phosphorylation of GSK3 is performed by Akt (also known as protein kinase B 
{PKB}). During periods of intense neuronal activity Akt is activated via 
phosphorylation on Ser473 and Thr308. This activity-dependent inhibitory signalling 
cascade of Akt activation leading to GSK3 de-activation ensures efficient and 
maximal dephosphorylation of Ser-774 on dynamin I during periods of intense 
activity (Smillie & Cousin 2012). Importantly, either expression of constitutively 
active Akt or addition of signalling molecules capable of activating Akt, such as 
brain-derived neurotrophic factor (BDNF), reduces incidence of ADBE as measured 
by dextran uptake in cultured neurons (Smillie & Cousin 2012; Smillie et al. 2013). 
Together, this suggests that this activity-dependent signalling cascade is essential for 
efficient presynaptic endocytosis during intense neuronal activity. 
It is unknown what specific factors of HFS are responsible for the phosphorylation of 
Akt and GSK3, and which specific upstream components are responsible for the 
procession of the cascade. To address this, the phosphorylation status of both Akt 
and GSK3 was monitored utilising phospho-specific antibodies with Western 
blotting whilst manipulating elements such as intracellular free calcium ([Ca2+]i)  as 
well as inhibiting potential contributors.   
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3.2 Results 
3.2.1 An Intracellular Free Calcium Increase is Essential for 
Phosphorylation of Akt/GSK3 
It is currently unclear how action potential stimulation is transduced into activation 
of Akt. The pronounced activity-dependence of Akt and GSK3 phosphorylation 
could suggest an essential requirement for increased [Ca2+]i, an event which is also 
essential for the initial dephosphorylation of dynamin I.  
To assess the importance of increased [Ca2+]i on both Akt and GSK3 phosphorylation 
the calcium ionophore ionomycin was employed to uniformly increase [Ca2+]i 
throughout the presynaptic bouton independent of depolarisation. To assess the 
duration for which neurons should be exposed to this ionophore in order to elicit a 
significant [Ca2+]i increase, a preliminary experiment was performed using the 
ratiometric calcium reporter Fura-2.  
Independent cultures which had been loaded with Fura-2 and then washed to remove 
any un-internalised reporter were incubated with different concentrations of 
ionomycin (1, 2.5 and 5 µM) and the rate of [Ca2+]i increase was monitored and 
assessed using timelapse imaging. The time taken to reach 75% of maximum [Ca2+]i 
was determined to be consistently between 30 and 60 seconds for ionomycin 
concentrations of both 2.5 and 5 µM (Figure 3.1). Based on these data it was decided 
that these concentrations would be utilised for further experiments and an appropriate 
exposure time was determined to be 1 minute.  
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To test the effect of an artificially increased [Ca2+]i  on Akt and GSK3 
phosphorylation, cultures were exposed to 5 µM ionomycin for 1 minute in the 
presence and absence of extracellular Ca2+ and immediately lysed. These lysed cell 
samples were then Western blotted using phospho-specific antibodies for those 
activity-dependent phosphorylation states of Akt and GSK3.  
Significant phosphorylation of both Akt and GSK3 was observed when CGNs were 
exposed to ionomycin in the presence of extracellular calcium in comparable 
amounts to that seen during intense stimulation. However, no evoked increase was 
observed when this experiment was repeated in low calcium buffer (Figure 3.2). This 
indicates that increased [Ca2+]i in the absence of membrane depolarization is 
sufficient to cause activation of this signalling cascade. The absence of the same 
phosphorylation in the presence of ionomycin but with no increase in [Ca2+]i shows 
that this is not an ionomycin-specific effect. Controls were conducted in the absence 
of inonomycin and no effect was observed with differing concentrations of 
extracellular calcium alone. 
Increased presynaptic [Ca2+]i during action potential stimulation is usually a result of 
activation of VGCCs. To assess if these channels are responsible for the increased 
[Ca2+]i  leading to Akt/GSK phosphorylation during HFS the nonselective calcium 
channel inhibitor flunarizine was employed (Cousin et al. 1993).   
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Figure 3.1[Ca2+]i reaches high levels within 1 minute of ionomycin exposure 
CGN cultures were loaded with Fura2-AM and excited at both 340 (to illuminate Ca2+ 
bound Fura) and 380 nm (to illuminate unbound Fura). A baseline was acquired before the 
addition of 1, 2.5 or 5 µM ionomycin (arrow, A). Cultures were imaged for a further 2 
minutes, imaging was paused for 10 minutes and resumed for a further 5 minutes. A) 
Average traces of ratio of illumination from both 340 and 380 nm excitation + SEM against 
time is displayed. B) The average time taken for the ratio to increase by 75% of total 




Figure 3.2 [Ca2+]i increases are essential for Akt/GSK3 phosphorylation. 
CGN cultures were either rested (Basal) or stimulated with 5 µM ionomycin for 1 minute in 
imaging buffer containing either 1.3 mM (+Ca2+) or low (-Ca2+) calcium. A) Representative 
blots are displayed showing either Akt Ser473 phosphorylation (P-Akt), GSK3 α/β Ser21/9 
phosphorylation (P-GSK3) or β-Actin levels (β-Actin). B,C) The fold increase in 
phosphorylation of either Akt Ser473 (B, open bars) or GSK3 α/β Ser21/9 (C, closed bars) is 
displayed after corrected for protein levels using β-Actin and normalisation to the low calcium 
control. All error bars represent ± SEM; n=5 for P-Akt and n=4 for P-GSK3 (Student’s t test. 
*p<0.05, -Ca2+ to +Ca2+ per condition) 
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To confirm that flunarizine was effectively blocking calcium entry during intense 
stimulation in CGNs, a fluorescent calcium indicator was employed. To avoid any 
injury to cells from UV illumination (such as is required with Fura-2) the reporter 
Fluo3-AM was used, which requires excitation by light in the visible spectrum. CGN 
cultures were loaded with Fluo-3 for 30 minutes. After this the cultures were washed 
to remove any un-internalised Fluo-3 and then subjected to a stimulation train of 800 
AP at 80 Hz whilst taking timelapse images. After 5 minutes of recovery, cultures 
cells were incubated with or without flunarizine for 10 minutes and stimulated again 
(Figure 3.3 A). Flunarizine was successful in blocking calcium entry during intense 
stimulation (Figure 3.3 B and C).   
After confirming that flunarizine was effective in ablating [Ca2+]i   increase via 
VGCC during HFS, I next sort to determine if [Ca2+]i   increase leading to Akt and 
GSK3 phosphorylation upon intense stimulation was dependent on entry through 
VGCCs. CGN cultures were incubated for 10 minutes with or without flunarizine 
and then stimulated with a train of 800 action potentials (80 Hz), a stimulus protocol 
that ensures maximal Akt and GSK3 phosphorylation (Smillie & Cousin 2012). As 
expected, a large activity-dependent phosphorylation of both Akt and GSK3 was 
observed in the absence of flunarizine. In contrast, incubation with flunarizine (10 
µM) resulted in a complete block of activity-dependent Akt and GSK3 
phosphorylation (Figure 3.4 A-C).  
To ensure that this inhibition was due to blockade of calcium channels, these 
experiments were repeated with ionomycin exposure, causing increased [Ca2+]i 
independently of calcium channel activation. Flunarizine had no effect on 
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ionomycin-evoked Akt/GSK3 phosphorylation (Figure 3.4 D-F), illustrating that its 
inhibition of activity-dependent phosphorylation was not due to off-target effects. 
Therefore, influx of extracellular calcium via VGCCs is essential for activation of the 
Akt/GSK3 phosphorylation cascade during intense neuronal activity. 
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Figure 3.3 Flunarizine Effectively Blocks [Ca2+]i Increase on Stimulation 
A) Protocol of experiment: CGN cultures were loaded with Fluo3-AM before a stimulus train 
of 800 AP at 80 Hz (S1), cells were left to recover for 5 minutes before being incubated for 
10 minutes with imaging buffer (control) supplemented with flunarizine, calmidazolium or 
LY294002 (10 µM each) and stimulated again (S2). B) Average time traces + SEM of Fluo-
3 fluorescence for all conditions. C) Peak heights were measured, Average value of S2 
measured as a percentage of S1 is displayed + SEM. In all cases, fluorescence was 
normalised to a baseline acquired before S1 and the highest peak fluorescence. n = 4 for 
all conditions. One-way ANOVA to control, ****=p<.0001 
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Figure 3.4 Ca2+ influx via voltage-gated calcium channels is essential for Akt/GSK3 
phosphorylation. 
CGNs cultures were incubated in imaging buffer (control) supplemented with 10 µM 
flunarizine for 10 min. After this point CGNs were left to rest (0 Hz/-) or challenged with 
either 800 action potentials (80 Hz) or ionomycin (IONO, 2.5 µM for 1 minute). A,D) 
Representative blots showing either Akt Ser473 phosphorylation (P-Akt), GSK3 α/β 
Ser21/9 phosphorylation (P-GSK3) or β-Actin levels (β-Actin) after either action potential 
(A) or ionomycin (D) stimulation. B, E) The average fold increase in phosphorylation of Akt 
Ser473 (open bars) in response to either action potentials (B) or ionomycin (E) is displayed 
+ SEM. C, F). The average fold increase in phosphorylation of GSK3 α/β Ser21/9 (closed 
bars) in response to either action potentials (B) or ionomycin (E) + SEM. In all cases 
phosphorylation levels were corrected for protein levels using β-Actin and normalisation to 
the basal controls. n=5 for both P-Akt and P-GSK3 with 80 Hz, n=6 for P-Akt IONO and 
n=7 for P-GSK3 IONO. Student’s t test. *=p<0.05, **=p<0.01 either basal to 80 Hz or basal 
to ionomycin per condition. 
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3.2.2 A Localised Intracellular Calcium Concentration Increase is 
Essential for Akt/GSK3 Phosphorylation 
In central nerve terminals VGCCs are clustered at the active zone. During action 
potential stimulation the opening of these channels generates a localised 
microdomain of high [Ca2+]i which is required for neurotransmitter release (Adler et 
al. 1991). I next sought to determine whether this localised microdomain and not 
cytoplasmic increase in [Ca2+]i is required for Akt and GSK3 phosphorylation during 
intense neuronal activity.  
To assess this, CGNs were challenged with a train of 800 action potentials at 80 Hz 
and then immediately lysed after prior treatment with the calcium chelators BAPTA-
AM and EGTA-AM for 30 minutes (both 100 μM, cells were washed of any un-
internalised chelator before stimulation). Both chelators have the same affinity for 
calcium but each has a different on-rate for its binding. This means that BAPTA-AM 
effectively buffers [Ca2+]i increases at the active zone, whereas EGTA-AM does not 
(Adler et al. 1991). Both chelators, however, efficiently buffer activity dependent 
[Ca2+]i increases outside of the active zone.  
Interestingly, CGNs treated with EGTA-AM displayed a robust activity-dependent 
phosphorylation of both Akt and GSK3 after stimulation (Figure 3.5 A-C). CGNs 
treated with the active zone-buffering BAPTA-AM however displayed an 
abolishment of action potential-evoked increase in both Akt and GSK3 
phosphorylation (Figure 3.5 A-C). This confirms a requirement for an increased  
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Figure 3.5 Localised Ca2+ influx is essential for Akt/GSK3 phosphorylation.   
CGN cultures were incubated in imaging buffer (control) supplemented with either 100 µM 
BAPTA-AM or EGTA-AM for 30 min. After this point CGNs were left to rest (0 Hz/-) or 
challenged with either 800 action potentials (80 Hz) or ionomycin (IONO, 2.5 µM for 1 
minute). A,D) Representative blots showing either Akt Ser473 phosphorylation (P-Akt), GSK3 
α/β Ser21/9 phosphorylation (P-GSK3) or β-Actin levels (β-Actin) after either action potential 
(A) or ionomycin (D) stimulation. B, E). The average fold increase in phosphorylation of Akt 
Ser473 (open bars) in response to either action potentials (B) or ionomycin (E) + SEM. C, F). 
The fold increase in phosphorylation of GSK3 α/β Ser21/9 (closed bars) in response to either 
action potentials (B) or ionomycin (E) + SEM. In all cases phosphorylation levels were 
corrected for protein levels using β-Actin and normalisation to the basal controls. n=4 for P-
Akt 80 Hz, n=5 for P-GSK3 80 Hz, n=7 for P-Akt IONO and n=6 for P-GSK3 IONO. Student’s 
t test. *=p<0.05, **=p<0.01, ***=p<0.001 basal to 80 Hz or basal to ionomycin per condition. 
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[Ca2+]i specifically in the active zone for Akt/GSK3 phosphorylation during action 
potential stimulation.  
Importantly, both BAPTA-AM and EGTA-AM arrested phosphorylation of Akt and 
GSK3 when [Ca2+]i increase in CGNs was evoked by ionomycin exposure (Figure 
3.5 D-F). This was expected, ionomycin increases [Ca2+]i globally across the nerve 
terminal with no predilection for the active zone meaning this microdomain is not 
formed. This also provides proof that EGTA is functioning as a calcium chelator. 
Thus during intense neuronal activity, a localised increase in [Ca2+]i at the active 
zone is essential for triggering both Akt and GSK3 phosphorylation. 
3.2.3 PI3K Activity is Required for Activity-Dependent Akt and GSK3 
Phosphorylation 
To understand how activity-dependent calcium influx is coupled to downstream Akt 
and GSK3 phosphorylation, the role of PI3K was examined. PI3K activity plays a 
key role in phosphorylation of Akt and subsequently GSK3 in the presence of the 
signalling molecule BDNF in CGNs (Smillie & Cousin 2012). However, it is not 
known whether action potentials activate the same signalling pathway.  
To determine the role for PI3K in activity-dependent Akt and GSK3 
phosphorylation, the PI3K inhibitor LY294002 (10 µM) was used. CGNs were 
incubated in basic imaging buffer with or without a supplement of LY294002 for 10 
minutes before a stimulation of 800 action potentials at 80 Hz. Inhibition of PI3K 
resulted in an arrest of activity-dependent Akt phosphorylation. LY294002 also 
significantly reduced GSK3 phosphorylation (Figure 3.6 A-C). This block in Akt and 
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GSK3 phosphorylation did not appear to be caused by an inhibition of [Ca2+]i 
increase, which was measured during an identical stimulation protocol whilst 
monitored using the reporter Fluo-3 (Figure 3.3 B and C). Thus intense neuronal 
activity results in activation of PI3K, which triggers activity-dependent Akt and 
GSK3 phosphorylation. 
To ensure the effect on Akt and GSK3 phosphorylation via LY294002 was in fact 
caused by its inhibition of PI3K and not due to an off-target effect of the drug 
another PI3K inhibitor, Wortmannin (200 nM), was utilised using an identical 
protocol as with LY294002. Inhibiting PI3K function with Wortmannin resulted in 
an identical block in phosphorylation of both Akt and GSK3 during HFS (Figure 3.6 
D-F). This means the outcomes observed using both drugs are most likely due to 
their PI3K inhibition and not due to off-target effects of the drugs 
In order to transduce activity-dependent calcium influx into activation of PI3K, a 
calcium sensor must be present in nerve terminals, most probably at the active zone 
as this is the location of the essential increase in [Ca2+]i. One potential candidate for 
this role is the calcium binding protein calmodulin (Chin & Means 2000). 
Calmodulin can directly activate PI3K on elevation of [Ca2+]i (Joyal et al. 1997) and 
is required for calcineurin activation during intense neuronal activity (Wu et al. 
2009) resulting in dynamin I dephosphorylation.  
To determine whether calmodulin can transduce increased [Ca2+]i into PI3K 
activation (and downstream Akt/GSK3 phosphorylation) the calmodulin antagonist 
calmidazolium was used. An identical protocol was used to that of PI3K inhibition 
with the substitution of calmidazolium (10 µM). Inhibition of calmodulin however 
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had no significant effect on the activity-dependent phosphorylation of either Akt or 
GSK3 after 800 action potentials at 80 Hz (Figure 3.7 A-C) and no significant effect 
on [Ca2+]i as reported by Fluo-3 (Figure 3.3).  Interestingly when [Ca2+]i was raised 
globally with ionomycin (using an identical protocol as previously with flunarizine), 
calmidazolium abolished both Akt and GSK3 phosphorylation (Figure 3.7 D-F). 
Thus the activity-dependent calcium sensor for activation of the PI3K/Akt/GSK3 
cascade is not calmodulin, however this cascade can be activated via calmodulin via 
global [Ca2+]i increases.  
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Figure 3.6 PI3K activity is essential for activity-dependent Akt/GSK3 phosphorylation. 
CGN cultures were incubated in imaging buffer (control) supplemented with 10 µM 
LY294002 for 10 min. After this point CGNs were left to rest (0 Hz) or challenged with either 
800 action potentials (80 Hz). A) Representative blots are displayed showing either Akt 
Ser473 phosphorylation (P-Akt), GSK3 α/β Ser21/9 phosphorylation (P-GSK3) or β-Actin 
levels (β-Actin) after either action potential stimulation. B, C). The average fold increase in 
phosphorylation of Akt Ser473 (B, open bars) or GSK3 α/β Ser21/9 (C, closed bars) in 
response to action potential stimulation + SEM. In all cases phosphorylation levels were 
corrected for protein levels using β-Actin and normalisation to the basal controls. n=6 for P-
Akt, n=16 for P-GSK3. Student’s t test. *=p<0.05, **p=<0.01, ****p<0.0001 0 to 80 Hz per 
condition and between 80 Hz data. 
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Figure 3.7 Calmodulin is not the calcium sensor for activity-dependent Akt/GSK3 
phosphorylation.  
CGN cultures were incubated in imaging buffer (control) supplemented with 10 µM 
calmidazolium for 10 min. After this point CGNs were left to rest (0 Hz/-) or challenged with 
either 800 action potentials (80 Hz) or ionomycin (IONO, 2.5 µM for 1 minute). A,D) 
Representative blots showing either Akt Ser473 phosphorylation (P-Akt), GSK3 α/β Ser21/9 
phosphorylation (P-GSK3) or β-Actin levels (β-Actin) after either action potential (A) or 
ionomycin (D) stimulation. B, E). The average fold increase in phosphorylation of Akt 
Ser473 (open bars) in response to either action potentials (B) or ionomycin (E) + SEM. C, 
F). The average fold increase in phosphorylation of GSK3 α/β Ser21/9 (closed bars) in 
response to either action potentials (B) or ionomycin (E) + SEM. In all cases 
phosphorylation levels were corrected for protein levels using β-Actin and normalisation to 
the basal controls. n=6 for P-Akt 80 Hz, n=9 for P-GSK3 80 Hz, n=8 for P-Akt IONO and 
n=9 for P-GSK3 IONO. Student’s t test. *=p<0.05, **=p<0.01 basal to 80 Hz or basal to 
ionomycin per condition. 
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3.3 Discussion 
The maintenance of neurotransmission during intense neuronal activity is reliant on 
the integration of activity-dependent calcium influx, multiple signalling cascades and 
several SV endocytosis modes (Kononenko & Haucke 2015; Clayton & Cousin 
2009). One such cascade is the activity-dependent inhibition of GSK3 via Akt, which 
is essential for the efficient dephosphorylation of dynamin I, a key event in the 
triggering of ADBE (Smillie & Cousin 2012; Smillie et al. 2013). It is shown here 
that localised calcium influx via VGCCs is essential for this event to occur. 
Furthermore, a key role for PI3K, but not calmodulin, has been demonstrated in the 
transduction of activity-dependent calcium influx into activation of Akt. 
PI3K is implicated in the regulation of secretion and membrane trafficking in a 
variety of systems (Balla 2013; Chasserot-Golaz et al. 2010; Osborne et al. 2006; 
Mazza & Maffucci 2011). One member of this family, PI3K-Class 2 α (PI3K-C2α), 
regulates exocytosis either indirectly via modulation of signalling pathways (Leibiger 
et al. 2010) or directly via control of the molecular fusion machinery (Meunier et al. 
2005; Dominguez et al. 2011). The enzymatic activity of PI3K-C2α is stimulated by 
calcium (Wen et al. 2008), suggesting that PI3K-C2α is a good candidate for 
participation in transduction of activity-dependent calcium influx to the Akt 
signalling cascade. However, PI3K-C2α is insensitive to LY294002 and wortmannin 
at the concentrations used in this study (Domin et al. 1997), making it unlikely that 
PI3K-C2α is involved in the activity-dependent activation of Akt.  
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LY294002 and wortmannin sensitive Class I PI3Ks have been implicated at several 
stages of SV recycling in central nerve terminals, including replenishment of the 
RRP from the reserve pool (Cousin et al. 2003), generation of bulk endosomes (Holt 
et al. 2003) and SV generation from bulk endosomes (Richards et al. 2004). PI3K is 
also required for the negative regulation of ADBE via BDNF (Smillie et al. 2013). 
Therefore, it would be of interest to determine the specific activity-dependent role of 
PI3K in both dynamin I dephosphorylation and ADBE. 
3.3.1 Activity-dependent Akt phosphorylation at nerve terminals 
The inhibition of GSK3 and activation of Akt respectively was assessed by 
monitoring their phosphorylation status. Inhibition of GSK3 occurs via 
phosphorylation of either Ser9 of GSK3β or Ser21 of GSK3β (Frame & Cohen 
2001). In this study it was found that GSK3α and GSK3β behaved in an identical 
manner across all stimulation conditions and pharmacological manipulations. The 
activation of Akt was assessed by determining the phosphorylation status of Ser473. 
Phosphorylation of both Ser473 and Thr308 are required for maximal Akt activity 
(Alessi et al. 1997; Sarbassov et al. 2005) and it has previously been shown that the 
phosphorylation status of both sites respond in a similar manner to action potential 
stimulation in CGNs (Smillie & Cousin 2012).  
Interestingly, these sites are proposed to be phosphorylated by different protein 
kinases. Thr308 is a PDK1 substrate, which is activated by PI3K (Alessi et al. 1997; 
Brazil & Hemmings 2001), whereas Ser473 can be phosphorylated by either the 
mTORC2 complex (Sarbassov et al. 2005) or DNA-PK (Bozulic & Hemmings 
133 
2009). However, here it is shown that the PI3K antagonist LY294002 inhibits the 
activity-dependent phosphorylation of Ser473.  
There are several explanations as to how these findings can be reconciled; one 
explanation is that LY294002 inhibits a distinct protein kinase that phosphorylates 
Ser473. In agreement, LY294002 inhibits mTORC2 in cellular systems within the 
same concentration range for PI3K antagonism (Brunn et al. 1996). This is unlikely 
however, since mTORC2 it is currently only known to be activated via either 
ribosomes (which are absent in nerve terminals) or growth factors (Oh & Jacinto 
2011). Similarly DNA-PK is activated during DNA damage (Bozulic & Hemmings 
2009) making it unlikely that it is the Akt kinase in central nerve terminals. This 
suggests that the LY294002- dependent inhibition of Akt phosphorylation is 
mediated via PI3K and studies that attempt to model this process should take this 
into account. 
Akt and GSK3 have a wide cellular distribution, suggesting that the increased 
phosphorylation observed during action potential stimulation may not be occurring at 
nerve terminals. However, the modulation of both Akt and GSK3 activity-dependent 
phosphorylation directly impact on the phosphorylation status of dynamin I and 
ADBE (Smillie & Cousin 2012; Smillie et al. 2013) and both dynamin I expression 
and ADBE are restricted to nerve terminals (Clayton & Cousin 2009; Ferguson & De 
Camilli 2012). With this in mind, the activity-dependent changes in Akt and GSK3 
phosphorylation can be reasonably attributed to be presynaptic signalling. This 
statement is almost certainly not true for ionomycin-evoked changes, since this 
ionophore will raise [Ca2+]i uniformly throughout the neuron. Ionomycin is used 
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throughout this study as a positive control to confirm the specificity of both 
flunarizine and EGTA-AM in inhibiting calcium channels and global [Ca2+]i 
increases respectively. The inhibition of ionomycin-evoked Akt and GSK3 
phosphorylation by calmidazolium is intriguing however, this may reflect an altered 
activity of these enzymes by postsynaptic calcium as Akt and GSK3 are known to 
have postsynaptic functions (Li et al. 2010; Peineau et al. 2007). 
Many studies have investigated the relationship between both neuronal activity and 
calcium influx in the activation of Akt. Previous work in CGNs showed that chronic 
hyperkalemic stimulation resulted in increased Akt phosphorylation, however this 
was insensitive to PI3K antagonists (Lafon-Cazal et al. 2002). This most likely 
reflects postsynaptic activation of Akt, since permanent depolarisation will reverse 
electrogenic glutamate transporters on the PM (Nicholls 1993) raising extracellular 
glutamate concentrations and thus activating postsynaptic glutamate receptors. In 
agreement, shorter periods of stimulation with elevated KCl resulted in increased Akt 
phosphorylation which was reversed by PI3K antagonists (Vaillant et al. 1999). 
3.3.2 Transduction of calcium influx into Akt phosphorylation 
I have shown that intense neuronal activity causes Akt phosphorylation via localised 
calcium microdomains. This suggests that a sensor must be located within the 
vicinity of this microdomain to couple calcium influx to PI3K/Akt activation. It is 
shown here that calmodulin is unlikely to be the sensor since the antagonist 
calmidazolium was unable to inhibit action potential-evoked Akt phosphorylation. 
Furthermore the ability of calmidazolium to arrest ionomycin-evoked Akt 
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phosphorylation is in agreement with the proposed location of calmodulin in the 
wider cytosol (Chin & Means 2000). 
How could activity-dependent calcium influx be coupled to Akt phosphorylation? 
One potential candidate for the activity-dependent calcium sensor is the family of 
Ras-GRFs (Fernández-Medarde & Santos 2011). Ras-GRF activates the small G-
protein Ras in a calcium-dependent manner (Farnsworth et al. 1995) and 
overexpression of dominant negative Ras inhibits Akt phosphorylation evoked by 
KCl depolarization in peripheral neurons (Vaillant et al. 1999). 
Importantly Ras-GRF2 knockout mice display altered paired pulse facilitation, 
suggesting it is localised in the correct location to be activated by presynaptic 
calcium influx (Li et al. 2006). However the mechanism via which Ras-GRF is 
activated by calcium influx is thought to be via calcium-bound calmodulin binding to 
its IQ domain (Farnsworth et al. 1995; Bähler & Rhoads 2002). Since calmodulin 
inhibition had no effect on activity-dependent Akt phosphorylation, it may be that 
Ras-GRF is not the sensor for this event. 
A second possibility is that there is no calcium a sensor involved in this process. In 
this model the requirement for localised calcium increases is an indirect result of the 
presynaptic release of growth factors such as BDNF. This event only occurs in 
neurons during intense neuronal activity, very similar to that observed in this study 
(Matsuda et al. 2009). This is potentially important for Akt phosphorylation, since 
PI3K can activate either PDK1 or the mTORC2 complex via growth factor receptors 
(Oh & Jacinto 2011). In support, addition of exogenous BDNF initiates the 
phosphorylation of Ser473 in CGNs via a potential PI3K-dependent route (Smillie et 
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al. 2013). Consequently, manipulations resulting in either calcium entry inhibition or 
the buffering of the calcium microdomain should also arrest BDNF release during 
intense activity, stopping it feeding back to increase Akt phosphorylation via PI3K. 
This hypothesis is testable using agents that sequester extracellular BDNF (Chen et 
al. 2012). 
In summary, these results show that during intense neuronal activity phosphorylation 
of Akt (and subsequent inhibition of GSK3) is dependent on localised calcium 
microdomains formed by VGCCs. The identity of the sensor or release mechanism 
which transduces increased [Ca2+]i remains unidentified. This is an important 
question to address, since my hypothesis predicts that modulation of these events 













4. PI4KIIα Controls CME and ADBE via Independent Mechanisms 
4.1 Introduction  
Phosphatidylinositol 4-kinases (PI4Ks) are a family of kinases responsible for 
phosphorylating the four hydroxyl group (D4) on phosphoinositol (PI) creating PI4P 
(Balla & Balla 2006) (see Figure 1.5). There are four mammalian PI4Ks: 
Phosphatidylinositol 4-kinase Type IIα (PI4KIIα), IIβ (PI4K IIβ), Type IIIα (PI4K 
IIIα) and Type IIIβ (PI4K IIIβ). The expression pattern of each of these isoforms 
differs both on an anatomical and intracellular level (reviewed in Clayton et al. 
2013). 
PI4KIIα expression is varied throughout the CNS with particularly high abundance 
in Purkinje cells and Bergman Glia of the cerebellar molecular layer (Simons et al. 
2009) as well as a distinct expression pattern within the hippocampus (Larimore et 
al. 2011). However, despite this anatomical expression pattern, PI4KIIα has a distinct 
intracellular enrichment across the CNS on dendrites, Golgi bodies and SVs 
(reviewed in Clayton et al. 2013) and is the only PI4K located on SVs (Guo et al. 
2003). 
As the only producer of PI4P on SVs, PI4KIIα is of particular interest due to the role 
of PI4P in the recruitment of clathrin adaptor proteins AP-1 (Wang et al. 2003) and 
AP-3 (Craige et al. 2008) during Golgi-endosomal trafficking. As both of these 
adaptors are known to have roles in the formation of SVs from bulk endosomes 
(Cheung & Cousin 2012) it is possible that PI4KIIα could play a role in adaptor 
protein recruitment to facilitate SV budding on bulk endosomes. In support of this 
139 
theory, PI2KIIα is especially enriched on vesicles formed via AP-3 (Salazar et al. 
2005). 
PI4P is an essential precursor for the production of both PI(4,5)P2 and PI(3,4,5)P3 
(Minogue & Waugh 2012). PI(4,5)P2 is known to have an integral role in CME as an 
AP-2 recruiter (Gaidarov & Keen 1999) which could also hint at a supporting role 
for PI4KIIα in the normal function of CME. 
The abundance of PI4KIIα is modulated by the kinase GSK3 (Robinson et al. 2014). 
GSK3 recognises PI4KIIα via previous priming phosphorylation on Ser9 and Ser51 
(Robinson et al. 2014). As is typical with this kinase, GSK3 then phosphorylates 
PI4KIIα on serine sites separated from the priming sites by 4 residues (Ser5 and 
Ser47). When all four residues have been phosphorylated, it is thought that the 
structure of PI4KIIα opens, allowing access to residues 60 and 61 (J. Robinson et al. 
2010), two leucines which together form a di-leucine AP-3 sorting motif (Craige et 
al. 2008). GSK3 enzyme activity is inhibited during periods of high activity in 
synapses (Frame & Cohen 2001). 
AP-3- PI4KIIα binding is essential for both PI4KIIα and AP-3 localisation. Binding 
of AP-3 to PI4KIIα is necessary for the localisation of both proteins to the membrane 
of the early endosome with a PI4KIIα knockdown resulting in an increase in 
cytosolic AP-3 (Craige et al. 2008). The interaction of PI4KIIα and AP-3 has also 
been shown to facilitate the transport of PI4KIIα to the lysosome for degradation 
(Robinson et al. 2014). The kinase activity of PI4KIIα as well as its di-leucine motif 
has been shown to be important for efficient AP-3- PI4KIIα binding and localisation 
(Craige et al. 2008). 
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Phosphorylation of PI4KIIα by GSK3 is essential in its regulatory role in trafficking 
in hippocampal neurons. AMPA receptor subunit GluA1 surface expression was 
shown to be increased with the knockdown of PI4KIIα in a manner that cannot be 
rescued by non-phosphorylatable PI4KIIα (Robinson et al. 2014). This demonstrates 
a necessity for GSK3 phosphorylation of PI4KIIα in AMPA recycling in neurons. 
Due to evidence of GSK3 contributing to abundance and function for PI4KIIα in 
neuronal recycling and the specific action of PI4KIIα on SVs I resolved to 
investigate the effects of manipulation of PI4KIIα abundance, binding and activity on 




Figure 4.1 Phosphorylation and Conformational Change of PI4KIIα 
Membrane-bound PI4KIIα (top) is phosphorylated on residues 9 and 51 (middle). This 
phosphorylation allows recognition of the protein by GSK3. GSK3 then phosphorylates 
PI4KIIα on residues 4 and 47 (bottom). This phosphorylation causes the N-terminal of 
PI4KIIα to open. This structural change allows access to a di-leucine sorting motif by 
adaptor protein 3 (AP-3). This binding facilitates the relocation of the complex either to the 
early endosome or out of the synapse to be degraded in the early endosome 
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4.2 Results 
4.2.1 Silencing PI4KIIα Expression Affects Both CME and ADBE  
 CME is Accelerated During HFS in the Absence of PI4KIIα 
PI4KIIα is the dominant source of PI4K activity on SVs, suggesting that it may 
perform a role in SV recycling. Furthermore, the N-terminus of PI4KIIα is 
phosphorylated on two sites by GSK3 (Robinson et al. 2014), a kinase shown to be 
inactivated during HFS (Smillie & Cousin 2012), and essential for ADBE (Clayton et 
al. 2010). Upon phosphorylation, the N-terminal of PI4KIIα alters conformation 
revealing a di-leucine motif (Robinson et al. 2014). This di-leucine motif is 
recognised by the adaptor protein AP-3 (Craige et al. 2008), which binds to PI4KIIα. 
This recognition is essential for the localisation of AP-3 on the early endosome 
(Craige et al. 2008) as well as facilitating the localisation of PI4KIIα to the lysosome 
for degradation (Robinson et al. 2014). Given that GSK3 is an activity-dependent 
kinase, and PI4KIIα degradation is mediated by said activity, firstly PI4KIIα 
expression was silenced using PI4KIIα shRNA. This protocol may create an 
exaggerated environment of PI4KIIα clearance such as may be caused by its 
phosphorylation by GSK3 phosphorylation during periods of low activity. The 
effects on syp-pH exo- and endocytosis investigated with altered PI4KIIα abundance.  
First, the PI4KIIα knockdown system was validated; CGNs were co-transfected with 
PI4KIIα shRNA (Robinson et al. 2014) or its scrambled control and an empty mCer 
vector. These cells were then fixed and immunostained with a PI4KIIα antibody. 
Transfected CGN nerve terminals were located and the relative abundance of 
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PI4KIIα staining was calculated in comparison to neighbouring, non-transfected 
nerve terminals.  
CGN nerve terminals expressing scrambled shRNA were found to have comparable 
PI4KIIα levels to those non-transfected cells in the same field of view (Figure 4.2 A 
and B). In contrast, CGN nerve terminals expressing PI4KIIα shRNA were found to 
have significantly less PI4KIIα abundance, on average only 25% PI4KIIα when 
compared to non-transfected cells (Figure 4.2 B and C). Thus the PI4KIIα shRNA 
vector induced a large depletion of the enzyme in CGNs. 
After validating the PI4KIIα shRNA, the effects of reducing PI4KIIα levels on SV 
recycling were investigated utilising expression of a pHluorin-tagged synaptophysin: 
synaptophysin-pH (syp-pH).  
The expression of pHluorins in cultured neurons allows an observer to quantify the 
proportion of tagged SV cargo which is deposited in the PM during stimulation in 
relation to the total expression of that cargo within a synapse. This is accomplished 
by measuring the fluorescence increase upon stimulation: as SVs release their 
neurotransmitter content into the synaptic cleft, thereby exposing their lumen to a 
neutral pH, the fluorescence of a pHluorin molecule which resides on the lumenal 
domain of a SV protein is unquenched and becomes fluorescent. The fluorescence 
increase on stimulation is then compared to the fluorescence increase evoked during 
an ammonia imaging buffer pulse. In solution NH4Cl is in equilibrium between NH4+ 
and NH3. NH3 is free to diffuse across membranes within the synapse. Its entry into 
an acidic compartment such as a SV causes NH3 to become protonated and neutralise 
of the acidic pH. This provides an estimate for the total pool of SVs by revealing the 
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maximal fluorescence of all resident pHluorin molecules.  Acidification of SVs 
occurs rapidly after endocytosis (Sankaranarayanan & Ryan 2000; Atluri & Ryan 
2006), therefore by monitoring the rate of decrease of fluorescence after stimulation 
the rate of endocytosis/ acidification can also be measured. 
CGNs co-transfected with syp-pH and either PI4KIIα shRNA or its scrambled 
control were challenged with a two stimulus train protocol. A mild stimulation of 20 
Hz, 10 sec was delivered to the cells, followed by a recovery of four minutes. 
Cultures were then exposed to a second, more intense stimulation of 40 Hz, 10 sec 
(HFS) and again allowed to recover (Figure 4.3 A). After this recovery the culture 
was perfused with ammonia buffer. Alterations in syp-pH fluorescence at CGN nerve 
terminals was monitored throughout this experimental protocol to reveal SV turnover 
during both low and HFS and related to the total SV pool (by normalisation of 
evoked peak height to the fluorescence after ammonium pulse). 
There was no significant difference to the syp-pH fluorescence trace caused by 
silencing PI4KIIα expression during low frequency stimulation (Figure 4.3 B). When 
examined, PI4KIIα shRNA had no effect on either rate of endocytosis (Figure 4.3 D) 
or evoked fluorescence increase (indicative of the extent of SV exocytosis, Figure 
4.3 F). 
However, the syp-pH response observed after HFS showed a significant difference 
between control and PI4KIIα knockdown (Figure 4.3 C). The silencing of PI4KIIα 
expression causes a significant acceleration of syp-pH retrieval after stimulation 
(Figure 4.3 E). The reduction of PI4KIIα levels did not affect the evoked peak height 
on stimulation with HFS (Figure 4.3 G). These results indicate that PI4KIIα only has  
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Figure 4.2 PI4KIIα shRNA Effectively Reduces PI4KIIα Expression in CGNs 
Images of CGNs transfected with A) Scrambled shRNA or B) PI4KIIα shRNA. CGN culture was labelled with PI4KIIα Ab (middle) and transfected cells 
were located by mCer fluorescence (left), when overlaid one can see that the synapses of the transfected cell (white arrows) do not exhibit as much 
PI4KIIα labelling in the presence of PI4KIIα shRNA. Average fluorescence of Scrambled shRNA or PI4KIIα shRNA CGN synapses as a percentage of 








Figure 4.3 Silencing PI4KIIα Expression Accelerates SypHy Retrieval During HFS 
A) CGNs co-transfected with either PI4KIIα shRNA or scrambled control shRNA and 
synaptophysin-pHluorin (syp-pH) were incubated with imaging buffer for 10 minutes prior to 
stimulation and then continuously onwards. Cells were stimulated with a mild stimulation 
train (200 AP, 20 Hz) and recovered for 4 mins followed by stimulation with HFS train (400 
AP, 40 Hz). B and C) Scrambled shRNA (black) Vs. PI4KIIα shRNA (blue) B) Average time 
trace of mild stimulation (200 AP, 20 Hz) + SEM is displayed with stimulation indicated by 
black bar. C) Average time trace of HFS (400 AP, 40 Hz) + SEM is displayed with 
stimulation indicated by black bar D) Average peak heights on mild stimulation (200 AP, 20 
Hz) of each condition (F/F0) + SEM. E) Average peak heights on HFS of each condition 
(F/F0) + SEM. F) Average endocytosis kinetics after mild stimulation (200 AP, 20 Hz) (tau) + 
SEM. G) Average endocytosis kinetics after HFS (400 AP, 40 Hz) (tau) + SEM. Scrambled 
shRNA n=5 (20 Hz) 7 (40 Hz) PI4KIIα shRNA n=8 12. Time traces: ***=p<0.001 Two-way 
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a role in the endocytosis of syp-pH during HFS and may be a negative regulator of 
SV endocytosis. The loss of PI4KIIα does not have any effect on exocytosis at either 
mild or intense stimulation as reported by syp-pH fluorescence. 
 ADBE is Inhibited in the absence of PI4KIIα 
Due to the specificity of the effect on endocytic kinetics of PI4KIIα knockdown to 
HFS and not mild stimulation, ADBE was next investigated for an effect (as this is a 
process which is only activated during HFS). To do this a previously validated 40 
kDa dextran-uptake assay (Clayton et al. 2008) was utilised. Dextran is a fluid phase 
marker of large enough size to make it unlikely to be internalised by single SVs. 
Dextran therefore only reliably labels the larger invaginations of ADBE and gives a 
measurement of how many nerve terminals within a culture or in a cell (when using 
transfected cells) perform ADBE.  
CGNs co-transfected with PI4KIIα or its scrambled control and an empty mCer 
vector were exposed to a HFS in the presence of dextran (50 µM) (Figure 4.4 A). A 
robust uptake of dextran was observed in neurones expressing the scrambled shRNA 
(Figure 4.4 B). In contrast, the silencing of PI4KIIα expression had a significant 
inhibitory effect on the uptake of dextran when compared to the scrambled control 
(Figure 4.4 B). This would imply that the presence or activity of PI4KIIα is required 
for ADBE.  
As it has now been shown that the absence of PI4KIIα inhibits dextran uptake it can 
now be deduced that the acceleration of syp-pH retrieval seen previously cannot be 
attributed to an increase in uptake via ADBE and must therefore represent an 
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increase in the rate of CME. It is possible that the two phenotypes caused by the 
silencing of PI4KIIα expression, acceleration of CME and inhibition of ADBE, are 
functionally related, i.e. the acceleration of CME allows the cell to compensate for 
surface area increase caused by exocytosis via this mode alone and therefore ADBE 
is not triggered. It could also be hypothesised that the inhibition of ADBE is the 
primary effect of PI4KIIα depletion and the rate of CME must be increased to 
compensate for the loss of this high capacity retrieval mechanism. This hypothesis 
seems likely as PI4KIIα depletion only affects the rate of CME during HFS when 
ADBE is activated. 
4.2.2 Rescue with Mutant PI4KIIα Reveals Differential Mechanisms for 
PI4KIIα Influence on Exocytosis, CME and ADBE 
Thus, far it has been shown that knockdown of PI4KIIα both accelerates syp-pH 
retrieval and inhibits ADBE in response to HFS. To determine the molecular basis 
for these effects a series of shRNA-resistant PI4KIIα mutants was utilised to rescue 
function in knockdown neurons. These consisted of: 
WT - Wild-type PI4KIIα. Homologous to the endogenous form of PI4KIIα, there is 
no alteration to either the serine residues which serve as the priming sites for GSK3 
(Ser9 and Ser51) or the GSK3 phosphorylation sites themselves. As such GSK3 can 
phosphorylate residues 4 and 47 to open the structure of the WT protein and allow 





Figure 4.4 Silencing PI4KIIα Expression Inhibits ADBE 
A) CGNs transfected with PI4KIIα shRNA or its scrambled control with an empty mCer 
vector were repolarised in imaging buffer for 10 minutes. Cells were stimulated with a HFS 
train (400 AP, 40 Hz) in the presence of 50 µM dextran. B) Average number of dextran 
puncta per µm of axon expressed as a proportion of scrambled shRNA + SEM. Scrambled 
shRNA n=53, PI4KIIα shRNA n=60.  ****=p<0.0001. Student’s t-test. 
 
151 
QUAD-D – PI4KIIα with serine residues 5, 9, 47 and 51 mutated to aspartic acid 
residues (QUAD-D) this phospho-mimetic mutation causes a conformational change 
of the protein, normally caused via GSK3 phosphorylation. Its structure is innately 
open and therefore allows unimpeded and constant access for AP-3 to the di-leucine 
binding site (Figure 4.5 B).  
S9/51A – PI4KIIα with the GSK3 priming site serines (Ser9 and Ser51) mutated to 
alanine residues. This forms phospho-null versions of GSK3 priming sites meaning 
GSK3 will not recognise and phosphorylate Ser5 and Ser47. Without GSK3 
phosphorylation the protein which will retain its “closed” structure making the di-
leucine motif less accessible to AP-3 (Figure 4.5 C) and inhibits its degradation. 
L60/61A – PI4KIIα in which the di-leucine motif at residues 60 and 61 has been 
mutated to alanine residues causing a disruption in AP-3 binding. This form of the 
protein can be either “open” or closed” as GSK3 phosphorylation is not affected 
(Figure 4.5 D). However, AP-3 will not bind and shuttle PI4KIIα to lysosome for 
degradation. 
K152A – a protein with a lysine residue (Lys152) mutated to an alanine residue. This 
does not cause a change in structure of the protein however it inhibits kinase activity, 
creating a kinase-dead version of PI4KIIα. This form of the protein can be either 
“open” or closed” as GSK3 phosphorylation is not affected (Figure 4.5 E).  
To determine level of rescue of expression achieved by these shRNA-resistant 
PI4KIIα plasmids the following experiment was performed. For a positive control, 
CGNs were triple-transfected with an mCer empty vector, scrambled shRNA vector  
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Figure 4.5 shRNA-Resistant PI4KIIα Mutations and Their Functional Implications 
A) WT: PI4KIIα in its “closed” (above) or “open” (below) structure. GSK3 phosphorylation of 
Ser5/47 causes the structure to open and reveals an AP-3 binding site. B) QUAD-D: PI4KIIα 
mutated at Serines 5,9,47 and 51 to aspartic acid residues. Phospho-mimetic of GSK3 
priming and phosphorylation causes constant “open” structure and access to AP-3 binding 
site. C) S9/51A: PI4KIIα mutated at Serines 9 and 51 to alanine residues. Phospho-null 
mutations of GSK3 priming sites causes constant “closed” structure obscuring AP-3 binding 
site, ablating binding. D) L60/61A: PI4KIIα mutated at Leucines 60 and 61 to alanine 
residues. GSK3 phosphorylation is unaffected and structure can be “open” (above) or 
“closed” (below) but AP-3 binding site is mutated, ablating AP-3 binding. E) K152A: PI4KIIα 
with lysine residue at position 152 mutated to an alanine residue, this causes no effect on 
GSK3 phosphorylation so can be “open” (above) or “closed” (below). AP-3 binding may also 
be affected. This mutation causes PI4KIIα to lose its kinase function. 
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and a PRK5 empty vector. For a negative control (knockdown), CGNs were triple-
transfected with an mCer empty vector, PI4KIIα shRNA and a PRK5 empty vector. 
For all rescue conditions CGNs were triple-transfected with mCer empty vector, 
PI4KIIα shRNA and one of the shRNA-resistant forms of PI4KIIα (WT, QUAD-D, 
S9/51A, L60/61A or K152A). Cultures were then fixed and immunostained with a 
PI4KIIα antibody. 
As seen previously, the scrambled shRNA had no effect on PI4KIIα abundance 
compared to non-transfected nerve terminals (Figure 4.6 A and H). The expression of 
PI4KIIα shRNA resulted in a significant reduction in PI4KIIα abundance in nerve 
terminals when compared to neighbouring non-transfected nerve terminals and 
scrambled controls (Figure 4.6 B and H). All other PI4KIIα shRNA-resistant 
constructs resulted in a significant rescue of PI4KIIα abundance over and above 
scrambled control levels (Figure 4.6 C-H). Expression of all PI4KIIα mutants (bar 
QUAD-D PI4KIIα) in a knockdown background were significantly increased above 
scrambled control PI4KIIα levels (Figure 4.6 H). This shows that all shRNA-
resistant PI4KIIα mutants are able to rescue PI4KIIα expression in CGNs when 






Figure 4.6 PI4KIIα Expression Levels are Effectively Rescued with shRNA-Resistant 
PI4KIIα Constructs 
Images of CGNs triple-transfected with mCer empty vector, and A) Scrambled shRNA 
+PRK5 empty vector. B) PI4KIIα shRNA + PRK5 empty vector. C) PI4KIIα shRNA + WT 
PI4KIIα. D) PI4KIIα shRNA + QUAD-D PI4KIIα. E) PI4KIIα shRNA + S9/51A PI4KIIα. F) 
PI4KIIα shRNA + L60/61A PI4KIIα. G) PI4KIIα shRNA + K152A PI4KIIα. CGN culture was 
labelled with PI4KIIα Ab (middle) and transfected cells were located by mCer fluorescence 
(left), when overlaid one can see that the synapses of the transfected cell (white arrows) do 
not exhibit as much PI4KIIα labelling in the presence of PI4KIIα shRNA but the expression 
of shRNA-resistant PI4KIIα rescues protein levels. H) Average fluorescence of CGN 
synapses transfected with each condition as a percentage of fluorescence nearby non-
transfected synapses of similar size + SEM. Scrambled shRNA +PRK5 n=15, PI4KIIα 
shRNA + PRK5 n=21, PI4KIIα shRNA + WT n=23, PI4KIIα shRNA + QUAD-D n=21, 
PI4KIIα shRNA + S9/51A n=25, PI4KIIα shRNA + L60/61A n=20, PI4KIIα shRNA + K152A 
n=23, ***=p<0.001, ****= p<0.0001. One-way ANOVA to PI4KIIα shRNA + PRK5. 
 
156 
 CME Kinetics can be Rescued with Wild-Type PI4KIIα 
Knockdown of PI4KIIα results in an accelerated rate of CME. To ensure that this 
effect was not caused by an off-target effect of the shRNA vector I attempted to 
rescue the phenotype caused by the knockdown using a shRNA-resistant form of WT 
PI4KIIα. 
CGNs were triple-transfected with PI4KIIα shRNA, syp-pH and either a PRK5 
empty vector (sypHy PI4KIIα KD) or WT PI4KIIα (sypHy WT rescue) (Figure 4.7 
A). As effects on endocytic rate were only seen during intense stimulation, cells were 
now subjected to a single HFS, with no preliminary mild stimulation (Figure 4.7 B).  
Expression of WT PI4KIIα resulted in a significant effect on the retrieval of syp-pH 
after HFS, which can be visualised by normalising the syp-pH traces of each 
condition to their peak height (Figure 4.7 C). When endocytic kinetic values (tau) are 
calculated it is clear that expression of a shRNA-resistant WT PI4KIIα has 
successfully rescued the increased endocytic kinetics of CME as the tau values are 
comparable between neurons in which PI4KIIα has been rescued and those where no 
knockdown has taken place (Figure 4.7 E). This would imply that the effects of 
PI4KIIα shRNA expression are caused by the loss of PI4KIIα expression in the cell 
and are not caused by any side effect of expression of the shRNA.  
Another interesting observation is that the expression WT PI4KIIα causes a 
significant increase in the amount of syp-pH exocytosis during stimulation. This can 
be visualised by normalising the syp-pH fluorescence traces of each condition to 
total syp-pH (the maximum fluorescence value caused by ammonia buffer after 
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stimulation) (Figure 4.7 D). This increased exocytosis results in a significantly 
increased peak height with expression of shRNA-resistant WT PI4KIIα (Figure 4.7 
F). 
 ADBE Inhibition can be Rescued with Wild-Type PI4KIIα 
Next, the ability of the shRNA-resistant WT PI4KIIα to rescue to inhibition of 
ADBE seen with the knockdown of PI4KIIα was investigated. CGNs triple-
transfected with PI4KIIα shRNA, an empty mCer vector and either an empty PRK5 
vector (mCer PI4KIIα KD) or shRNA-resistant WT PI4KIIα (mCer WT Rescue) 
(Figure 4.8 A) were subjected to a HFS in the presence of dextran (50 µM) (Figure 
4.8 B) and the number of puncta per µm of transfected axon was calculated.  
Expression of WT PI4KIIα into a PI4KIIα depleted CGN successfully rescues ADBE 
(Figure 4.8 C). Importantly, the ratio of PI4KIIα shRNA to WT PI4KIIα rescue is 
comparable to that seen between scrambled shRNA and PI4KIIα shRNA seen 
previously (see Figure 4.4). This shows that both endocytic phenotypes seen when 
PI4KIIα expression is silenced by shRNA are due specifically to the loss of PI4KIIα 
and not due to any off-target effects of the shRNA. The lack of increased ADBE with 





Figure 4.7 shRNA-Resistant WT PI4KIIα Successfully Rescues Accelerated CME 
Knockdown Phenotype  
CGNs were triple-transfected with PI4KIIα shRNA, synaptophysin-pHluorin (syp-pH) and 
either a PRK5 empty vector or a shRNA-resistant WT PI4KIIα (A). B) Cells were incubated 
with imaging buffer for 10 minutes prior to stimulation and then continuously onwards. Cells 
were stimulated with a HFS train (400 AP, 40 Hz). C and D) PI4KIIα shRNA + PRK5 (blue) 
or + WT PI4KIIα (red). C) Average time trace + SEM normalised to stimulation peak is 
displayed with stimulation indicated by black bar. D) Average time trace + SEM normalised 
to maximum ammonia pulse fluorescence is displayed with stimulation indicated by black 
bar E) Average endocytic kinetics (tau) + SEM. F) Average peak heights on HFS of each 
condition (F/F0) + SEM. PI4KIIα shRNA + PRK5 n=12, PI4KIIα shRNA + WT PI4KIIα n=5. 
Time traces: **=p<0.01, ***=p<0.001 Two-way ANOVA, Bonferroni post-test. Bar charts: 




Figure 4.8 shRNA-Resistant WT PI4KIIα Successfully Recues Inhibited ADBE Knockdown 
Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, an empty mCer vector and either an 
PRK5 empty vector or shRNA-resistant WT PI4KIIα (A). B) Cells were repolarised in 
imaging buffer for 10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) in 
the presence of 50 µM dextran. C) Average number of dextran puncta per µm of axon 
expressed as a proportion of WT rescue + SEM. PI4KIIα shRNA + PRK5 n=32, PI4KIIα 
shRNA + WT PI4KIIα n=26.  **=p<0.01. Student’s t-test. 
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 Increased Rate of CME is not Rescued with Phospho-Mimetic 
PI4KIIα Mutant 
I next investigated the importance of GSK3 phosphorylation in the function of 
PI4KIIα in both CME and ADBE during HFS. Phosphorylation of PI4KIIα by GSK3 
causes the di-leucine AP-3-binding motif to become accessible and therefore allows 
the protein to be recognised by AP-3 and is subsequently shuttled to the lysosome for 
degradation GSK3 phosphorylates PI4KIIα on serine residues 5 and 47 after being 
primed by a separate kinase on serine residues 9 and 51 (Robinson et al. 2014). To 
mimic a PI4KIIα protein which has been phosphorylated on all four serine residues 
and therefore mimics a GSK3-phosphorylated molecule an shRNA-resistant 
S5/9/47/51D (QUAD-D) PI4KIIα was expressed.  
CGNs triple-transfected with either syp-pH PI4KIIα KD or PI4KIIα shRNA, syp-pH 
and shRNA-resistant QUAD-D PI4KIIα (syp-pH QUAD-D Rescue) (Figure 4.9 A) 
were subjected to a single HFS (Figure 4.9 B). No significant difference between 
PI4KIIα knockdown and QUAD-D rescue was seen on syp-pH retrieval after HFS 
when traces from each condition were normalised to peak height (Figure 4.9 C). This 
was also apparent by a lack of significant effect on endocytic kinetics (tau) (Figure 
4.9 E). This would suggest that the QUAD-D version of PI4KIIα does not support 
normal endocytosis like its WT counterpart. 
Expression of this phospho-mimetic PI4KIIα does not cause an increase in peak 
height (Figure 4.9 D and F) as is seen when WT PI4KIIα is expressed in a PI4KIIα 
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depleted background. Further suggesting that this mutation causes a functional defect 
in relation to the role of PI4KIIα in normal SV recycling. 
 Inhibition of ADBE is not Rescued with Phospho-Mimetic 
PI4KIIα Mutant 
I examined the ability of QUAD-D PI4KIIα to rescue to phenotype of inhibited 
ADBE caused by silencing of PI4KIIα expression. CGNs triple-transfected with 
PI4KIIα shRNA, an mCer empty vector and shRNA-resistant QUAD-D PI4KIIα 
(mCer QUAD-D Rescue) (Figure 4.10 A) were subjected to HFS in the presence of 
dextran (50 µM) (Figure 4.10 B). 
Expression of QUAD-D PI4KIIα did not rescue the ability of the cell to undergo 
ADBE during HFS (Figure 4.10 C). Further suggesting a suppressive activity of 
PI4KIIα phosphorylation by GSK3 in the presynapse.  
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Figure 4.9 shRNA-Resistant QUAD-D PI4KIIα does not Rescue Accelerated CME 
Knockdown Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, synaptophysin-pHluorin (syp-pH) and 
either a PRK5 empty vector or a shRNA-resistant QUAD-D PI4KIIα (A). B) Cells were 
incubated with imaging buffer for 10 minutes prior to stimulation and then continuously 
onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) PI4KIIα shRNA + 
PRK5 (blue) or + QUAD-D PI4KIIα (green). C) Average time trace + SEM normalised to peak 
fluorescence is displayed with stimulation indicated by black bar. D) Average time trace + 
SEM normalised to maximum ammonia pulse fluorescence is displayed with stimulation 
indicated by black bar E) Average endocytic kinetics (tau) + SEM. F) Average peak heights 
on HFS of each condition (F/F0) + SEM. PI4KIIα shRNA + PRK5 n=12, PI4KIIα shRNA + 





Figure 4.10 shRNA-Resistant QUAD-D PI4KIIα does not Rescue Inhibited ADBE Knockdown 
Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, an empty mCer vector and either an PRK5 
empty vector or shRNA-resistant QUAD-D PI4KIIα (A). B) Cells were repolarised in imaging 
buffer for 10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) in the presence 
of 50 µM dextran. C) Average number of dextran puncta per µm of axon expressed as a 
proportion of WT rescue + SEM. PI4KIIα shRNA + PRK5 n=32, PI4KIIα shRNA + QUAD-D 
PI4KIIα n=13. n.s.. Student’s t-test. 
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 Faster Rate of CME is not Rescued But Exacerbated with 
Phospho-Null PI4KIIα Mutants 
I further investigated the importance of GSK3 phosphorylation by employing the 
shRNA-resistant phospho-null mutant S9/51A. PI4KIIα must be phosphorylated on 
two priming sites (Ser9 and Ser51) to allow GSK3 phosphorylation. Mutation of 
these sites to phospho-null alanine residues creates a PI4KIIα protein which will not 
be recognised by GSK3 and will therefore not be phosphorylated on serines 5 and 47. 
This will allow the importance of PI4KIIα phosphorylation by GSK3 for both CME 
and ADBE to be visualised.  
CGNs triple-transfected with either syp-pH PI4KIIα KD or PI4KIIα shRNA, syp-pH 
and shRNA-resistant S9/51A PI4KIIα (syp-pH S9/51A Rescue) (Figure 4.11 A) were 
stimulated with a single HFS (Figure 4.11 B). 
Interestingly, a significant difference in the retrieval of syp-pH after stimulation was 
observed when fluorescence traces from each condition were normalised to their 
peak height (Figure 4.11 C). When endocytic kinetics were calculated, there was also 
a significant difference between the knockdown and rescue with S9/51A. The 
addition of the phospho-null mutant protein did not rescue the increased CME 
kinetics but instead increased the rate further. There was no significant difference in 
evoked peak height (Figure 4.11 D and F) as was seen when rescuing with WT 
PI4KIIα. This would further suggest that this mutation has altered the function of 
PI4KIIα. 
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S9/51A PI4KIIα results in a constitutively “closed” structure of PI4KIIα. This means 
that the AP-3-binding site is perpetually occluded though AP-3 binding is not 
entirely ablated (Robinson et al. 2014). To elucidate if this functional consequence of 
the S9/51A mutation could be causing the further increased rate of CME, another 
mutant PI4KIIα which is incapable of binding AP-3 – L60/61A was utilised. 
AP-3 recognises PI4KIIα via a di-leucine motif (L60 and L61); mutation of these 
leucine residues to alanine residues disrupts AP-3 binding and therefore should result 
in a similar phenotype to that seen with S9/51A expression. 
CGNs triple-transfected with either mCer PI4KIIα KD or PI4KIIα shRNA, syp-pH 
and shRNA-resistant L60/61A PI4KIIα (Figure 4.12 A) were stimulated with a single 
HFS (Figure 4.12 B). 
Expression of AP-3-binding deficient PI4KIIα caused a similar and significant 
difference in syp-pH retrieval after stimulation (Figure 4.12 C) that is clearly seen as 
an increase in rate of CME when endocytic kinetics are calculated (Figure 4.12 E). 
Rescue of PI4KIIα abundance with this mutated form did not cause a significant 
difference in evoked peak height (Figure 4.12 D and F). These results clarify that 
interfering with PI4KIIα -AP-3 binding in a PI4KIIα knockdown background 




Figure 4.11 shRNA-Resistant S9/51A PI4KIIα Exacerbates Accelerated CME Knockdown 
Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, synaptophysin-pHluorin (syp-pH) and 
either a PRK5 empty vector or a shRNA-resistant S9/51A PI4KIIα (A). B) Cels were 
incubated with imaging buffer for 10 minutes prior to stimulation and then continuously 
onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) PI4KIIα shRNA + 
PRK5 (blue) or + S9/51A PI4KIIα (purple). B) Average time trace + SEM normalised to peak 
fluorescence is displayed with stimulation indicated by black bar. D) Average time trace + 
SEM normalised to maximum ammonia pulse fluorescence is displayed with stimulation 
indicated by black bar E) Average endocytic kinetics of each condition (tau) + SEM. F) 
Average peak heights of each condition (F/F0) + SEM. PI4KIIα shRNA + PRK5 n=12, PI4KIIα 
shRNA + S9/51A PI4KIIα n=6. Time traces: *=p<0.05, Two-way ANOVA, Bonferroni post-




Figure 4.12 shRNA-Resistant L60/61A Exacerbates Accelerated CME Knockdown Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, synaptophysin-pHluorin (syp-pH) and 
either a PRK5 empty vector or a shRNA-resistant L60/61A PI4KIIα (A). B) Cells were 
incubated with imaging buffer for 10 minutes prior to stimulation and then continuously 
onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) PI4KIIα shRNA + 
PRK5 (blue) or + L60/61A PI4KIIα (turquoise). C) Average time trace + SEM normalised to 
peak fluorescence is displayed with stimulation indicated by black bar. D) Average time trace 
+ SEM normalised to maximum ammonia pulse fluorescence is displayed with stimulation 
indicated by black bar E) Average endocytic kinetics of each condition (tau) + SEM. F) 
Average peak heights of each condition (F/F0) + SEM. PI4KIIα shRNA + PRK5 n=12, PI4KIIα 
shRNA + S9/51A PI4KIIα n=8. Time traces: *=p<0.05, Two-way ANOVA, Bonferroni post-




Figure 4.13 shRNA Resistant S9/51A PI4KIIα Successfully Rescues Inhibited ADBE 
Knockdown Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, an empty mCer vector and either an 
PRK5 empty vector or shRNA-resistant S9/51A PI4KIIα (A). B) Cells were repolarised in 
imaging buffer for 10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) in 
the presence of 50 µM dextran. C) Average number of dextran puncta per µm of axon 
expressed as a proportion of WT rescue + SEM. PI4KIIα shRNA + PRK5 n=32, PI4KIIα 






Figure 4.14 shRNA-Resistant L60/61A PI4KIIα Successfully Rescues Inhibited ADBE 
Knockdown Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, an empty mCer vector and either an PRK5 
empty vector or shRNA-resistant L60/61A PI4KIIα (A). B) Cells were repolarised in imaging 
buffer for 10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) in the presence 
of 50 µM dextran. C) Average number of dextran puncta per µm of axon expressed as a 
proportion of WT rescue + SEM. PI4KIIα shRNA + PRK5 n=32, PI4KIIα shRNA + L60/61A 
PI4KIIα n=33. **=p<0.01, Student’s t-test. 
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 Inhibition of ADBE is Successfully Rescued with Phospho-Null 
PI4KIIα Mutants  
Both S9/51A and L60/61A caused an exacerbation of the effect seen on CME when 
PI4KIIα expression is silenced. Silencing of PI4KIIα expression also results in an 
inhibition of ADBE and as I have hypothesised that the increased rate of CME may 
be a functionally tied to the reduction of ADBE I next examined what effect these 
mutant PI4KIIα proteins would have on this phenotype. 
CGNs were triple-transfected with either syp-pH PI4KIIα KD or PI4KIIα shRNA, an 
mCer empty vector and shRNA-resistant S9/51A PI4KIIα (mCer S9/51A Rescue) 
(Figure 4.13 A) or L60/61A PI4KIIα (mCer L60/61A Rescue) (Figure 4.14 A). Cells 
were stimulated with a single HFS in the presence of dextran (50 µM) (Figure 4.13. 
B and Figure 4.14 B). 
Interestingly, the expression of both S9/51A and L60/61A did not cause a further 
inhibition of ADBE as one might have expected if the phenotypes of accelerated 
CME and inhibited ADBE were coupled. Both mutated proteins caused a significant 
rescue of inhibited ADBE (Figure 4.13. C and Figure 4.14 C). 
Our original hypothesis for the two endocytic phenotypes seen when PI4KIIα 
expression is silenced (see 4.2.1.2)  posited that the observed acceleration of CME 
was functionally linked to the inhibition of ADBE. This interaction could have been 
in either direction; ablation of ADBE forcing CME to accelerate to compensate for 
the lack of this retrieval mechanism; or a lack of triggering of ADBE due to an 
increased rate of CME, resulting in an increased capacity of the cell to retrieve PM 
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without the aid of ADBE. However, the results seen here would suggest that this 
theory is invalid as these two phenotypes can occur independently. AP-3-binding 
mutants were not able to rescue the accelerated CME caused by PI4KIIα however 
these same mutants rescued the inhibition of ADBE showing that only the increased 
rate of CME is reliant on the interaction of PI4KIIα and AP-3 and not ADBE 
incidence.  
 Faster Rate of CME is not Rescued with Kinase-Dead PI4KIIα 
Mutant 
PI4KIIα activity is especially enriched on SVs and is the only PI4K to synthesis SV 
PI4P (Guo et al. 2003). PI4KIIα phosphorylates PI on the D4 position, allowing 
further phosphorylation on the D3 or D5 position by kinases such as PI3K or PIPKγ 
respectively. The loss of PI4KIIα would therefore presumably have effects in PI 
production which are separate from its relationship with AP-3. To examine the role 
of the kinase activity of PI4KIIα in both CME and ADBE the same rescue 
experiments described above were conducted utilising a kinase-dead mutant form of 
PI4KIIα – K152A. 
CGNs were triple transfected with either syp-pH PI4KIIα KD or syp-pH, PI4KIIα 
shRNA and shRNA-resistant K152A PI4KIIα (syp-pH K152A Rescue) (Figure 4.15 
A). Cells were stimulated with a single HFS and their syp-pH fluorescence was 
monitored over time (Figure 4.15 B).  
When normalised to peak height, CGNs transfected with K152A PI4KIIα did not 
exhibit much evidence of a rescue of CME kinetics (Figure 4.15 C). When tau values 
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are quantified there is no significant effect of K152A PI4KIIα expression on the 
phenotype of accelerated CME caused by PI4KIIα knockdown (Figure 4.15 E). 
This would imply that the action of PI4KIIα on the kinetics of CME is dependent on 
its kinase function, as a kinase-dead PI4KIIα is incapable of rescuing the phenotype 
of an increased CME rate caused by depleting PI4KIIα.  
There was no effect on peak height caused by the expression of PI4KIIα K152A, this 
could indicate that this phenotype, as seen with the expression of WT PI4KIIα, may 
be reliant on the ability of PI4KIIα to perform its kinase function. 
 Inhibition of ADBE is not Rescued by Kinase-Dead PI4KIIα 
I next investigated any role of PI4KIIα kinase function in the function of ADBE. 
CGNs were triple-transfected with either mCer PI4KIIα KD or an mCer empty 
vector, PI4KIIα shRNA and shRNA-resistant PI4KIIα K152A (mCer K152A 
Rescue) (Figure 4.16 A). Cells were then subjected to a HFS in the presence of 
dextran (50 µM) (Figure 4.16 B). 
Interestingly, the expression of kinase-dead K152A PI4KIIα into a knockdown 
background effectively rescues ADBE (Figure 4.16 C). This would indicate that 
though PI4KIIα does play a role in ADBE, this role is not dependent on the ability of 




Figure 4.15 shRNA-Resistant K152A PI4KIIα does not Rescue Accelerated CME Knockdown 
Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, synaptophysin-pHluorin (syp-pH) and 
either a PRK5 empty vector or a shRNA-resistant K152A PI4KIIα (A). B) Cells were incubated 
with imaging buffer for 10 minutes prior to stimulation and then continuously onwards. Cells 
were stimulated with a HFS train (400 AP, 40 Hz). C and D) PI4KIIα shRNA + PRK5 (blue) or 
+ K152A PI4KIIα (pink). C) Average time trace + SEM normalised to peak fluorescence is 
displayed with stimulation indicated by black bar. D) Average time trace + SEM normalised to 
maximum ammonia pulse fluorescence is displayed with stimulation indicated by black bar E) 
Average endocytic kinetics of each condition (tau) + SEM. F) Average peak heights of each 
condition (F/F0) + SEM. PI4KIIα shRNA + PRK5 n=9, PI4KIIα shRNA + K152A PI4KIIα n=12. 





Figure 4.16 shRNA-Resistant K152A PI4KIIα Successfully Rescues Inhibited ADBE 
Knockdown Phenotype 
CGNs were triple-transfected with PI4KIIα shRNA, an empty mCer vector and either an PRK5 
empty vector or shRNA-resistant K152A PI4KIIα (A). B) Cells were repolarised in imaging 
buffer for 10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) in the presence 
of 50 µM dextran. C) Average number of dextran puncta per µm of axon expressed as a 
proportion of WT rescue + SEM. PI4KIIα shRNA + PRK5 n=32, PI4KIIα shRNA + K152A 
PI4KIIα n=30. **=p<0.01, Student’s t-test. 
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4.2.3 Overexpression of Mutant PI4KIIα Reveals Differential 
Mechanisms for PI4KIIα Influence on Exocytosis, CME and 
ADBE 
 Overexpression Wild-Type PI4KIIα Causes Increased 
Exocytosis During HFS 
When examining the ability of the shRNA-resistant wild-type PI4KIIα protein to 
rescue the phenotypes caused by silencing PI4KIIα a new role for PI4KIIα was 
revealed. Expression of WT PI4KIIα into a knockdown background caused an 
increase in peak height when compared to knockdown. This was interesting as no 
effect on peak height was seen with depleted PI4KIIα. The increase in the rate of 
CME means it is unlikely that an inhibitory effect on exocytosis was masked by a 
decrease in concurrent endocytosis and as such it can be stated with confidence that 
there was no effect on exocytosis with PI4KIIα depletion. 
It is possible that this increase in exocytosis was caused by the relative 
overexpression of WT PI4KIIα in this rescue system when compared to endogenous 
PI4KIIα as measured in scrambled shRNA transfected cells (see Figure 4.6). If this is 
the case it would be assumed that this increase in exocytosis on HFS would be 
observable in CGNs overexpressing WT PI4KIIα without a concurrent knockdown 
of endogenous PI4KIIα. 
To test this hypothesis, CGNs triple-transfected with syp-pH PI4KIIα KD, were 
compared to CGNs triple transfected with syp-pH, scrambled shRNA and either 
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PRK5 empty vector (syp-pH Control) or WT PI4KIIα (syp-pH WT Overexpression) 
(Figure 4.17 A). Cells were then subjected to a single HFS (Figure 4.17 B). 
As well as investigating exocytosis, this experiment also allowed the opportunity to 
investigate and impact of PI4KIIα overexpression on endocytic rate. As knockdown 
of PI4KIIα increases the rate of CME it is possible that the overexpression of 
PI4KIIα could cause an opposite effect, slowing CME kinetics. When normalised to 
the peak of syp-pH fluorescence no difference in retrieval of syp-pH after stimulation 
was seen between syp-pH control and overexpression of WT PI4KIIα (Figure 4.17 
C). When the tau values were quantified it was clear that no significant difference 
was seen between control and syp-pH WT overexpression whereas knockdown of 
PI4KIIα resulted in a comparable, reduced tau value as seen in previous HFS 
experiments (Figure 4.17 E). 
To distinguish any change in exocytosis, the amount of syp-pH fluorescence increase 
upon stimulation was studied in relation to the total presence of syp-pH (as revealed 
by an ammonia buffer pulse at the end of each experiment). Using this method, a 
highly significant increase was seen in exocytosis during HFS for syp-pH WT 
overexpression when compared to syp-pH control time trace (Figure 4.17 D). It can 
be stated confidently that this increase in peak height is due to an increase in 
exocytosis as tau analysis shows that WT PI4KIIα does not cause modulation of 
CME.  This reasoning can be further strengthened as the duration of the stimulus in 
the above protocol is sufficiently short that one would not expect to see an effect on 
peak height due purely to an endocytic defect. When peak heights were quantified 
this increase is still pronounced, however the values were not significant when 
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subjected to a one-way ANOVA (Figure 4.17 F).  Despite this, analysis of the time 
trace itself testifies to a significant increase in exocytosis in the presence of WT 
PI4KIIα overexpression. 
 Overexpression of Quadruple Phospho-Mimetic PI4KIIα 
Causes Increased Exocytosis on HFS 
I next examined any effects of overexpressing the quadruple phospho-mimetic 
QUAD-D PI4KIIα mutant which was previously used for rescue experiments. The 
nature of these mutations causes a change in the structure of the protein (see Figure 
4.5) allowing consistent access for AP-3 whereas the wild-type PI4KIIα must 
undergo phosphorylation via GSK3 to gain this structural configuration. QUAD-D 
PI4KIIα was unable to rescue the accelerated CME phenotype caused by knockdown 
of PI4KIIα possibly due to its quick removal from the cytoplasm after expression. 
CGNs were triple-transfected with syp-pH Control, syp-pH PI4KIIα KD or syp-pH, 
scrambled shRNA and QUAD-D PI4KIIα (syp-pH QUAD-D Overexpression) 
(Figure 4.18 A). Cells were subjected to a single HFS (Figure 4.18 B) and syp-pH 
fluorescence was monitored over time. 
No significant difference between syp-pH Control and syp-pH QUAD-D 
Overexpression was seen in the rate of syp-pH retrieval after HFS when visualising 
the fluorescence traces normalised to peak height (Figure 4.18 C). When tau values 
were quantified it was also clear that the overexpression does not affect endocytic 
kinetics compared to control whereas PI4KIIα knockdown resulted in decreased tau 
values consistent with previous HFS experiments (Figure 4.18 E).  
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Figure 4.17 Overexpression of WT PI4KIIα Affects Peak Height But Not Endocytic Rate 
CGNs were triple-transfected synaptophysin-pHluorin (syp-pH), scrambled shRNA with either 
an empty PRK5 vector or WT PI4KIIα (A) or PI4KIIα shRNA with PRK5. B) Cells were 
incubated with imaging buffer for 10 minutes prior to stimulation and then continuously 
onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) Scrambled 
shRNA + PRK5 (black), PI4KIIα shRNA + PRK5 (blue) or Scrambled shRNA + WT PI4KIIα 
(red). C) Average time trace + SEM normalised to peak fluorescence with stimulation 
indicated by black bar. D) Average time trace + SEM normalised to maximum ammonia pulse 
fluorescence with stimulation indicated by black bar E) Average endocytic kinetics of each 
condition (tau) + SEM. F) Average peak heights of each condition (F/F0) + SEM. Scrambled 
shRNA + PRK5 n=8, PI4KIIα shRNA + PRK5 n=5, Scrambled shRNA + WT PI4KIIα n=7. 
Time traces: ***=p<0.001, Two-way ANOVA, Bonferroni post-test. Bar charts: *=p<0.05, One-
way ANOVA to Scrambled PRK5. 
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Figure 4.18 Overexpression of QUAD-D PI4KIIα Has a Mild Effect on Peak Height but not 
on Endocytic Rate 
CGNs triple-transfected synaptophysin-pHluorin (syp-pH), scrambled shRNA with either an 
empty PRK5 vector or QUAD-D PI4KIIα (A) or PI4KIIα shRNA with PRK5. B) Cells were 
incubated with imaging buffer for 10 minutes prior to stimulation and then continuously 
onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) Scrambled 
shRNA + PRK5 (black), PI4KIIα shRNA + PRK5 (blue) or Scrambled shRNA + QUAD-D 
PI4KIIα (green). C) Average time trace + SEM normalised to peak height with stimulation 
indicated by black bar. D) Average time trace + SEM normalised to maximum ammonia 
pulse fluorescence with stimulation indicated by black bar E) Average endocytic kinetics of 
each condition (tau) + SEM. F) Average peak heights of each condition (F/F0) + SEM. 
Scrambled shRNA + PRK5 n=8, PI4KIIα shRNA + PRK5 n=5, Scrambled shRNA (same 
data as seen in 4.17) + QUAD-D PI4KIIα n=9. Time traces: *=p<0.05, Two-way ANOVA, 
Bonferroni post-test. Bar charts: *=p<0.05, One-way ANOVA to Scrambled PRK5. 
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To examine any effect on exocytosis caused by syp-pH QUAD-D Overexpression 
traces were instead normalised to total syp-pH fluorescence elicited by an ammonia 
buffer pulse at the end of each experiment. A significant increase in evoked syp-pH 
fluorescence was seen after HFS in syp-pH QUAD-D Overexpression CGNs (Figure 
4.18 D) in a similar manner to that seen in syp-pH WT Overexpression cells. Again, 
this increase in evoked fluorescence can be attributed to increased exocytosis as the 
rate of CME was unaffected by QUAD-D overexpression. When peak heights were 
analysed separately however this difference in peak height does not retain 
significance although the trend is clear (Figure 4.18 F). This result was unexpected as 
this increase in exocytosis was not observed when expressing QUAD-D in a PI4KIIα 
-depleted background. 
 Overexpression of S9/51A PI4KIIα Does Not Affect Either 
CME or Exocytosis 
I next investigated any effect of overexpressing S9/51A PI4KIIα. This protein is 
constitutively closed in structure and has inhibited binding with AP-3 (Robinson et 
al. 2014). 
When S9/51A PI4KIIα was expressed in a PI4KIIα knockdown background the rate 
of CME was increased to be significantly faster than the increased rate caused by the 
PI4KIIα knockdown. To determine if this phenotype was purely a consequence of 
S9/51A PI4KIIα being the dominant form of PI4KIIα in the cell or if this mutated 
PI4KIIα would exert the same effects on the rate of CME in a cell without PI4KIIα 
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depletion, the same experiment was performed without the knockdown of 
endogenous PI4KIIα.  
CGNs were triple-transfected with syp-pH Control, syp-pH PI4KIIα KD or syp-pH, 
scrambled shRNA and S9/51A PI4KIIα (syp-pH S9/51A Overexpression) (Figure 
4.19 A). Cells were subjected to a single HFS (Figure 4.19 B) and syp-pH 
fluorescence was monitored over time. 
No significant effect was seen in the rate of CME either via observing the individual 
time traces (Figure 4.19 C) or via comparison of calculated tau values (Figure 4.19 
E) between syp-pH Control and syp-pH S9/51A Overexpression. This shows that the 
S9/51A PI4KIIα does not have the ability to affect the kinetics of CME in the 
presence of endogenous PI4KIIα. The lack of effect on endocytic rate when S9/51A 
PI4KIIα is expressed in a cell which also contains endogenous PI4KIIα would 
suggest that this mutation does not lead to a gain-of-function with dominant-negative 
capabilities.  
No effect of S9/51A PI4KIIα overexpression was seen on exocytosis when 
comparing syp-pH fluorescence traces (Figure 4.19 D), this is recapitulated when 
peak heights are calculated (Figure 4.19 F). This shows that the S9/51A mutation 
inhibits the ability of PI4KIIα to increase exocytosis with overexpression.  
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Figure 4.19 Overexpression of S9/51A PI4KIIα Does Not Affect Either Peak Height or Endocytic 
Rate 
CGNs were triple-transfected synaptophysin-pHluorin (syp-pH), scrambled shRNA with 
either an empty PRK5 vector or S9/51A PI4KIIα (A) or PI4KIIα shRNA with PRK5. B) Cells 
were incubated with imaging buffer for 10 minutes prior to stimulation and then 
continuously onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) 
Scrambled shRNA + PRK5 (black), PI4KIIα shRNA + PRK5 (blue) or Scrambled shRNA + 
S9/51A PI4KIIα (purple). C) Average time trace + SEM normalised to peak fluorescence 
with stimulation indicated by black bar. D) Average time trace + SEM normalised to 
maximum ammonia pulse fluorescence with stimulation indicated by black bar E) Average 
endocytic kinetics of each condition (tau) + SEM. F) Average peak heights of each 
condition (F/F0) + SEM. Scrambled shRNA + PRK5 n=8, PI4KIIα shRNA + PRK5 n=5, 
Scrambled shRNA + S9/51A PI4KIIα n=11. Bar charts: *=p<0.05, One-way ANOVA to 
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 Overexpression of L60/61A PI4KIIα Does Not Affect Either 
CME or Exocytosis 
I next investigated the effect of overexpressing the AP-3 binding mutant L60/61A 
PI4KIIα on the exocytosis and retrieval of syp-pH. Similar to S9/51A, L60/61A 
PI4KIIα expression in a PI4KIIα knockdown background increased the rate of CME 
to a rate which was significantly quicker than that observed in the PI4KIIα 
knockdown. As these two affected syp-pH retrieval similarly in the knockdown 
background and as both mutants contain mutations which inhibit AP-3 binding I 
would predict that both S9/51A and L60/61A would exert similar effects (or a lack 
thereof) on syp-pH response when overexpressed. 
CGNs were triple-transfected with syp-pH Control, syp-pH PI4KIIα KD or syp-pH 
scrambled shRNA and L60/61A PI4KIIα (syp-pH L60/61A Overexpression) (Figure 
4.20 A). Cells were subjected to a single HFS (Figure 4.20 B) and syp-pH 
fluorescence was monitored over time. 
No significant effect was seen in the rate of CME either via observing the time traces 
(Figure 4.20 C) or via comparison of calculated tau values (Figure 4.20 E) between 
syp-pH Control and syp-pH L60/61A Overexpression. This is in line with what was 
observed with S9/51A PI4KIIα and shows that the overexpression of L60/61A 
PI4KIIα does not influence the kinetics of CME in the presence of endogenous 
PI4KIIα as might have been expected from additional quickening seen when 
L60/61A PI4KIIα is expressed in a knockdown background.  
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Figure 4.20 Overexpression of L60/61A PI4KIIα Does Not Affect Peak Height or Endocytic 
Rate 
CGNs were triple-transfected synaptophysin-pHluorin (syp-pH), scrambled shRNA with either 
an empty PRK5 vector or L60/61A PI4KIIα (A) or PI4KIIα shRNA with PRK5. B) Cells were 
incubated with imaging buffer for 10 minutes prior to stimulation and then continuously 
onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) Scrambled 
shRNA + PRK5 (black), PI4KIIα shRNA + PRK5 (blue) or Scrambled shRNA + L60/61A 
PI4KIIα (turquoise). C) Average time trace + SEM normalised to peak fluorescence with 
stimulation indicated by black bar. D) Average time trace + SEM normalised to maximum 
ammonia pulse fluorescencewith stimulation indicated by black bar E) Average endocytic 
kinetics of each condition (tau) + SEM. F) Average peak heights of each condition (F/F0) + 
SEM. Scrambled shRNA + PRK5 n=8, PI4KIIα shRNA + PRK5 n=5, Scrambled shRNA + 
L60/61A PI4KIIα n=8. Bar charts: *=p<0.05, One-way ANOVA to Scrambled PRK5. 
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No effect was seen on amount of exocytosis with overexpression of L60/61A 
PI4KIIα in comparison to control (Figure 4.20 D and F). This is in accordance with 
the results seen with the overexpression of S9/51A PI4KIIα, it is possible that AP-3 
binding plays a role in the ability of PI4KIIα to increase exocytosis. 
4.2.4 Overexpression of a Kinase-dead PI4KIIα has Dominant Negative 
Effects on Vesicle Recycling 
The kinase-dead PI4KIIα was one of only two mutant forms of the protein which 
failed to cause any effect on the phenotype of knocking down PI4KIIα. If the effect 
of PI4KIIα knockdown on CME was due to a depletion in phosphorylated products 
of PI4KIIα (as could be assumed by a lack of rescue by a kinase-dead mutant) then 
one would assume overexpression of this kinase-dead mutant would have no effect 
on the endocytic kinetics of syp-pH after HFS.  
CGNs were triple-transfected with syp-pH Control, syp-pH PI4KIIα KD or syp-pH, 
scrambled shRNA and K152A PI4KIIα (syp-pH K152A Overexpression) (Figure 
4.21 A). Cells were subjected to a single HFS (Figure 4.21 B) and syp-pH 
fluorescence was monitored over time. 
When observing the fluorescence time course, syp-pH K152A overexpression cells 
exhibit noticeably faster syp-pH endocytosis than syp-pH Control (Figure 4.21 C) 
resulting in a significant difference between the two traces. When taus were 
calculated, it becomes clear that overexpressing K152A causes a significant increase 
in the rate of CME when compared to syp-pH Control (Figure 4.21 E), resulting in 
similar kinetics to that seen in syp-pH PI4KIIα KD cells. 
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Figure 4.21 Overexpression of K152A, Kinase-dead, PI4KIIα Has Effects on Both Peak 
Height and Endocytic Rate 
CGNs were triple-transfected synaptophysin-pHluorin (syp-pH), scrambled shRNA with either 
an empty PRK5 vector or K152A PI4KIIα (A) or PI4KIIα shRNA with PRK5. B) Cells were 
incubated with imaging buffer for 10 minutes prior to stimulation and then continuously 
onwards. Cells were stimulated with a HFS train (400 AP, 40 Hz). C and D) Scrambled 
shRNA + PRK5 (black), PI4KIIα shRNA + PRK5 (blue) or Scrambled shRNA + K152A 
PI4KIIα (pink). B) Average time trace + SEM normalised to peak height is displayed with 
stimulation indicated by black bar. D) Average time trace + SEM normalised to maximum 
ammonia pulse fluorescence is displayed with stimulation indicated by black bar E) Average 
endocytic kinetics of each condition (tau) + SEM. F) Average peak heights of each condition 
(F/F0) + SEM. Scrambled shRNA + PRK5 n=8, PI4KIIα shRNA + PRK5 n=5, Scrambled 
shRNA + K152A PI4KIIα n=12. Time traces: ***=p<0.001, Two-way ANOVA, Bonferroni post-
test.  Bar charts:**=P<0.01, *=p<0.05, One-way ANOVA to Scrambled PRK5. 
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Another interesting phenotype caused by the overexpression of K152A PI4KIIα is a 
significant increase in evoked syp-pH fluorescence upon stimulation in comparison 
to syp-pH Control (Figure 4.21 D). This significant increase is again lost when peak 
heights of all 3 conditions are compared though the trend remains evident (Figure 
4.21 F). Despite this it is clear from the fluorescence time traces that there is an 
increase syp-pH fluorescence upon stimulation which cannot be attributed to 
decreased endocytosis as it has been ascertained that the rate of CME is increased 
with this overexpression. 
 Overexpression of PI4KIIα Does Not Affect ADBE 
As it is clear that the overexpression of PI4KIIα can have effects on the physiology 
of a nerve terminal, overexpression of each shRNA-resistant PI4KIIα was conducted 
in conjunction with an ADBE assay. 
CGNS were triple-transfected with mCer empty vector, Scrambled shRNA and either 
a PRK5 empty vector (mCer Control) or WT (mCer WT Overexpression), QUAD-D 
(mCer QUAD-D Overexpression), S9/51A (mCer S9/51A Overexpression), L60/61A 
(mCer L60/61A Overexpression) or K152A (mCer K152A Overexpression) PI4KIIα.  
Cells were subjected to a single HFS in the presence of dextran (50 µM) (Figure 4.22 
A).  
Overexpression of different PI4KIIα mutants did not cause an increase in the number 
of synapses undergoing ADBE (Figure 4.22 B). However, I have shown that PI4KIIα 
activity is essential for ADBE. These results may suggest that once PI4KIIα 
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abundance is at a certain level it reaches a threshold and can have no further impact 
on ADBE. 
In conclusion, utilising a series of manipulations including knockdowns, rescues and 
overexpressions I have ascertained roles for PI4KIIα expression and/or activity in 
CME, ADBE and exocytosis. Rescues and overexpression have shown different 
properties of the protein to be relevant to each phenotype, revealing multiple 





Figure 4.22 Overexpression of PI4KIIα Does Not Affect Dextran Uptake 
CGNs were triple-transfected with an empty mCer vector, Scrambled shRNA and either an 
PRK5 empty vector or shRNA-resistant WT, QUAD-D, S9/51A, L60/61A or K125A PI4KIIα. 
(A) Cells were repolarised in imaging buffer for 10 minutes. Cells were stimulated with a HFS 
train (400 AP, 40 Hz) in the presence of 50 µM dextran. B) Average number of dextran 
puncta per µm of axon expressed as a proportion of scrambled shRNA + PRK5 + SEM. 
Scrambled shRNA + PRK5 n=25, Scrambled shRNA + WT PI4KIIα n=20, Scrambled shRNA 
+ QUAD-D PI4KIIα n=20, Scrambled shRNA + S9/51A PI4KIIα n=18, Scrambled shRNA + 
L60/61A PI4KIIα n=19, Scrambled shRNA + L60/61A PI4KIIα n=19 . n.s. , One-way ANOVA 
to scrambled shRNA + PRK5 with Bonferroni post-test. 
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4.3 Discussion 
4.3.1 PI4KIIα Knockdown and its Consequences for SV Recycling 
 PI4KIIα Knockdown Inhibits ADBE 
Above I have shown that ADBE is inhibited with the down-regulation of PI4KIIα 
(see Figure 4.4). PI4KIIα abundance is regulated via phosphorylation by GSK3, 
which is most active during basal conditions (Woodgett 1990). As such, one could 
interpret these results to mean that during extended periods of low activity, when 
GSK3-mediated PI4KIIα degradation is increased, a threshold for ADBE is raised. 
These results could also be interpreted conversely: in a chronically depolarised 
environment in which GSK3 is inhibited, the abundance of PI4KIIα increases due to 
a lack of degradation. This increase in PI4KIIα abundance causes an increased 
potential of the cell to perform ADBE which is needed during intense stimulation. 
This could show a method of chronic regulation of ADBE incidence through GSK3 
activity. 
 PI4KIIα Knockdown Accelerates CME 
As ADBE is decreased with a knockdown of PI4KIIα one might expect any 
inhibition of syp-pH retrieval to be attributable to this inhibition. However, as the 
rate of syp-pH retrieval during HFS is actually increased it is apparent that there is no 
inhibition on syp-pH uptake with inhibition of ADBE. Therefore, the increase in the 
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rate of syp-pH endocytosis must be assumed to be indicative of an increase in the 
rate of CME.  
The effect on CME kinetics is only apparent at stimulation intensities in which 
ADBE would normally be activated. I hypothesised that the increased rate of CME is 
somehow coupled to the inhibition of ADBE. As the data shows the amount of 
exocytosis is unaffected with PI4KIIα knockdown it can be logically assumed that a 
cell in which PI4KIIα expression has been silenced experiences the same amount of 
inserted SV membrane. The most efficient method to compensate for this is to 
increase the rate of the other main form of endocytosis.  
 Protein-Specific Effects of PI4KIIα Knockdown 
To assess the means through which PI4KIIα knockdown causes the phenotypes 
observed in both CME and ADBE one must consider all possible effects on the cell 
with the removal of PI4KIIα.  
4.3.1.3.1 PI4KIIα Substrates and Further Metabolites 
The depletion of PI4KIIα will have several effects. Firstly, as PI4KIIα is the only 
active PI4K isoform found on SVs (Guo et al. 2003) the amount of PI4P produced 
and residing on SVs will be decreased. This may cause an additional effect on the 
levels of other phosphoinositides for which PI4P is a precursor - PI(4,5)P2 and 
PI(3,4,5)P3. If the abundance of these two metabolites is not decreased however, it 
would mean a shift in the ratio of the three phosphoinositides within synapse.  
193 
Previous work has been done showing a necessity for certain phosphoinositides in 
the normal recycling of SVs and bulk endosomes. One study observed both syp-pH 
retrieval and ADBE incidence in PIPKIγ knockout mice. PIPKIγ is the main PI5K 
responsible for PI(4,5)P2 production in synapses (Wenk et al. 2001). Without PIPKIγ 
there was a significant decrease in abundance of PI(4,5)P2 in the brain (Di Paolo et 
al. 2004).  
Cultured neurons from the PIPKIγ knockout mice exhibited a decreased rate of 
syp-pH endocytosis (Di Paolo et al. 2004). This shows that a decrease in PI(4,5)P2 
causes an effect in direct opposition to that caused by decreased PI4P such as would 
occur in PI4KIIα knockdown synapses. However, unlike my findings this slowing of 
endocytic kinetics was seen during mild stimulation. The retrieval of syp-pH during 
HFS was not investigated though the decrease in the rate of syp-pH endocytosis was 
conserved with prolonged stimulation. 
PIPKIγ knockout mice also exhibited an increased number of bulk endosomes after 
stimulation as measured by HRP uptake (Di Paolo et al. 2004). Interestingly, the 
decreased abundance of PI(4,5)P2 again results in an opposite phenotype to that seen 
with a decrease in PI4P as should be caused with knockdown of PI4KIIα.  
These results could lead one to the conclusion that these phenotypes are purely 
caused by PI4P abundance: one might expect PIPKIγ knockout to result in a build-up 
of PI4P due to decreased conversion into PI(4,5)P2. However, PIPKIγ knockout mice 
showed no alteration in PI4P abundance (Di Paolo et al. 2004).  
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It has previously been shown that silencing of PI4KIIα results in a decrease in PI4P 
abundance which was not recapitulated in PI(4,5)P2 as one may expect (Ketel et al. 
2016). These results could indicate that it may not be the overall abundance of these 
molecules but the proportions in which PI4P and PI(4,5)P2 (and possibly PI(3,4,5)P3) 
exist which can affect both CME and ADBE. It is possible that the opposition in 
proportions of these two phosphoinositide forms is what is in fact causing the 
observed phenotypes in both PI4KIIα knockdown (decreased PI4P and unaffected 
PI(4,5)P2) and PIPKIγ knockout (decreased PI(4,5)P2 but unaffected PI4P) systems. 
More work will be needed to investigate the effect of PI4KIIα knockdown on the 
abundance of all of these phosphoinositide forms in the cells used here. 
It should also be noted that levels of PI itself could be the cause of phenotypic 
alterations seen with PI4KIIα knockdown. DGKθ is responsible for converting the 
signalling lipid dicylglycerol (DAG) into phosphotatidic acid (PtdOH) which serves 
as a precursor for PI. Recent work has shown that diacylglycerol kinase θ (DGKθ) 
knockout mice show a large depletion in PtdOH production in the brain. Neurons 
from these knockout mice displayed a dramatic slowing of CME (Goldschmidt et al. 
2015). It is possible that the decrease in PI production caused by the decrease in 
PtdOH is responsible for the slowing in CME kinetics. This could correlate with the 
finding of increased rate in CME kinetics caused by a relative increase in PI on SVs 
caused by the removal of one of its main kinases on SVs: PI4KIIα. 
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4.3.1.3.2 AP-3 Binding and Localisation 
A further effect of PI4KIIα knockdown is on the localisation of the adaptor protein 
AP-3. Previous work has shown a dependence on AP-3- PI4KIIα binding in 
localisation of both PI4KIIα and AP-3 to the early endosome, with a knockdown of 
PI4KIIα resulting in a higher cytosolic presence of AP-3 (Craige et al. 2008). 
Though this study was performed in HEK cells there is sufficient evidence to suggest 
the presence of early endosomes in nerve terminals (de Hoop et al. 1994; 
Wucherpfennig et al. 2003; Hoopmann et al. 2010) and as such this is a relevant 
observation when considering a role PI4KIIα in the presynapse. GSK3-mediated AP-
3- PI4KIIα binding has also been shown to facilitate trafficking of PI4KIIα out of the 
synapse to the lysosome for degradation (Robinson et al. 2014). It is possible that in 
CGN terminals the knockdown of PI4KIIα facilitates an increased AP-3 abundance 
in the cytosol of the presynapse due to a disturbance in AP-3 trafficking to both early 
endosomes within and lysosomes without the nerve terminal.  
Further work could be done to determine any role increased cytosolic AP-3 may play 
in either CME or ADBE. To date, no specific role for AP-3 has been found in CME. 
Investigations of the mocha mouse have shown a varied reliance of SV proteins in 
their recycling (Kantheti et al. 1998) with certain subpopulations of synaptic vesicles 
being depleted in these AP-3 deficient mice (Kantheti et al. 2003). These results have 
been attributed to an AP-3-dependent compensatory endocytosis and separate from 
CME (Voglmaier et al. 2006). However, in depth investigations using overexpression 
of AP-3 have not been conducted to study SV recycling and may elucidate whether 
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the increased cytosolic fraction of AP-3 caused by silencing PI4KIIα expression is 
implementing the observed acceleration of syp-pH retrieval during HFS.  
This experiment would not reveal whether this retrieval is via classic CME or 
through another, AP-3-specific route. However, inhibition of CME-specific 
interactions via pharmacological means such as interrupting clathrin cage formation 
via Pitstop2-AM (Von Kleist et al. 2011) or genetic means such as silencing the 
expression of CME machinery such as clathrin heavy chain may reveal through what 
means any accelerated retrieval of SV proteins was occurring. 
AP-3 has been shown to have a role in the budding of SVs from bulk endosomes but 
knockdown of AP-3 did not show any effect on ADBE as measured by dextran 
uptake (Cheung & Cousin 2012). The data acquired so far however, may suggest an 
effect of the increased abundance of AP-3 on ADBE. As such it may be pertinent to 
perform ADBE measuring assays such as HRP uptake in CGNs overexpressing AP-
3. Equally as important could be the investigation into ADBE budding in PI4KIIα 
KD cells. If the theory of increased AP-3 abundance is correct, it is possible that this 
system will exhibit potentiated ADBE budding. 
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4.3.2 Wild-type and Mutant Versions PI4KIIα and What They Reveal 
About PI4KIIα Function  
As it seems that the effects of PI4KIIα knockdown on CME and ADBE may have 
their roots in different properties of the protein, it is possible that each of these 
phenotypes is in fact being caused via separate mechanisms. Each form of PI4KIIα 
expression revealed varied roles for different functions of the protein (see Table 4.1). 
The effects of PI4KIIα manipulation were considered in context of both major effects 
of PI4KIIα knockdown in an attempt to form explanations of the effects seen with 
both rescue and overexpression of each of the PI4KIIα forms. 
 CME Kinetics Are Only Rescued by expression of WT PI4KIIα 
In CGNs, CME is accelerated with a depletion of PI4KIIα (Figure 4.3). To 
investigate which specific property of PI4KIIα is essential for the role played in 
modulating CME a series of shRNA-resistant PI4KIIα proteins were expressed into 
both a knockdown background (rescue) and a background containing normal levels 
of PI4KIIα (overexpression).  
 Wild-Type PI4KIIα and CME Kinetics 
Wild-type PI4KIIα was successful in rescuing the endocytic kinetics after CME. This 
shows a specificity in the action of PI4KIIα shRNA used. What was also interesting 
was that, despite an absence of PI4KIIα causing an acceleration of CME, an effective 
overexpression (see Figure 4.6) in this knockdown background did not cause an 
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inhibition in CME kinetics. Overexpression of this wild-type PI4KIIα in an 
endogenous PI4KIIα background also resulted in no effect on the retrieval kinetics of 
syp-pH. This could imply that the role of PI4KIIα in CME is not related to the kinase 
activity of the protein. One would assume that if a decrease of PI4P results in an 
acceleration of CME than an increase in PI4P would result in a deceleration, as this 
is not observed it is possible that PI4P is not integral to the role of PI4KIIα in CME. 
However, it is unknown if the overexpression of PI42KA would affect PI4P 
abundance in relation to that of PI(4,5)P2 or PI(3,4,5)P3 and as such the proportions 
of these molecules may be unaffected, resulting in a lack of phenotype. 
These results could allow the explanation of CME being modulated by AP-3 
abundance and localisation. CGNs are cultured in a depolarising medium, in which 
GSK3 is chronically inhibited. As such, it can be assumed that in control conditions 
PI4KIIα abundance is high as a result of an environment without much GSK3-
mediated degradation. It is possible that if there is an upper-threshold of PI4KIIα 
abundance (or lower-threshold for AP-3 cytosolic abundance) to modulate CME that 
it has been reached within the chronically depolarised CGNs and as such 
experiments with overexpression may not result in further effects on the physiology 
of endocytosis. One potential method to explore this possibility would be to remove 
CGNs which have been transfected with overexpression constructs as well as the 
relevant control from their depolarising medium for a 24-hour period prior to 
experiments. This may have a modulating effect on PI4KIIα levels due to increased 
GSK3 activity. Differences observed between CME rates between control and 
overexpression conditions here may reveal the existence of an upper threshold of 
PI4KIIα abundance for the modulation of endocytosis.   
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 Phospho-Mimetic PI4KIIα and CME Kinetics 
Quadruple phospho-mimetic (QUAD-D) PI4KIIα is mutated to mimic PI4KIIα 
which has undergone phosphorylation by GSK3 and is thought to have a 
conformational change allowing access to AP-3 binding sites (Robinson et al. 2014). 
Expression of QUAD-D PI4KIIα into a P PI4KIIα knockdown background did not 
result in a reversal of the acceleration of CME kinetics.  
The explanation as to the inability of QUAD-D PI4KIIα to rescue CME kinetics is 
difficult. This protein is able to bind AP-3 and as such should reverse any cytosolic 
increase caused by PI4KIIα knockdown. As such, this would raise questions as to the 
validity of the AP-3 argument for the function of PI4KIIα in CME.  
However, it should be considered that endogenous PI4KIIα can exist in both GSK-
phosphorylated or non-phosphorylated forms and therefore not all PI4KIIα proteins 
are accessible for AP-3 binding at any one time. However, QUAD-D PI4KIIα is 
innately accessible to AP-3. As AP-3 binding of PI4KIIα causes its relocation it is 
possible that QUAD-D is not located substantially on SVs in order to perform its 
kinase function and/or whatever modulating function it normally provides. 
Unfortunately, it is unknown if the phosphorylation of PI4KIIα by GSK3 (or the 
mutation to mimic its phosphorylation) affects the kinase ability of the enzyme. The 
nature of the experimental medium would make the quantification of different 
phosphoinositide abundance impossible. This could be quantified if lentivirus vectors 
were used to infect whole cultures of CGNs and thin layer chromatography-blotting 
or autoradiography was implemented to measure the amount of incorporation of 
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radioactive phosphate groups. The ability to produce PI4P as well as its metabolites 
of each of the mutant forms of PI4KIIα used here is of vital importance to fully 
understand the implications of their effects on endocytosis and is something that will 
be explored in future. 
Overall these results imply that phosphorylation of PI4KIIα on these sites, normally 
performed by GSK3, inactivates PI4KIIα in relation to its capacity in regulating 
CME. However, the mechanism by which this inactivation occurs is currently 
unclear. 
 Phospho-Null PI4KIIα and CME Kinetics 
Two phospho-null mutants were utilised in rescue experiments – S9/51A and 
L60/61A. Both mutations interrupt the binding of AP-3 via two separate 
mechanisms. S9/51A contains a mutation of the serine priming sites on the N-
terminal domain of PI4KIIα which allow GSK3 to phosphorylate serines 5 and 47. 
This inhibition of GSK3 phosphorylation means the N-terminal will not undergo its 
conformational change, opening its hairpin shape and allowing access to a di-leucine 
AP-3 binding motif. This mutation inhibits AP-3 binding. L60/61A contains 
mutations to the two residues making up this binding motif, preventing AP-3 
binding.  
Expression of both AP-3 binding deficient PI4KIIα versions into a knockdown 
background actually accelerates CME further than the knockdown in isolation 
(Figure 4.11 and Figure 4.12). It is unclear as to why expression of a mutated form of 
PI4KIIα would exacerbate a phenotype caused by its removal. 
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As both mutated forms PI4KIIα do not experience normal AP-3 binding it should be 
considered that this is the primary cause of this exacerbated phenotype rather than 
increased abundance of PI4KIIα itself as this accelerating phenotype is not seen with 
the “over-rescue” of PI4KIIα levels with the other shRNA-resistant forms of PI4KIIα 
when compared to endogenous levels. This is given further credence when one 
considers that overexpression of both of these mutated phenotypes does not cause the 
same acceleration of CME as seen in CGNs overexpressing S9/51A or L60/61A 
behave identically to scrambled controls (Figure 4.19 and Figure 4.20). This would 
not be the case if an increased abundance of these PI4KIIα forms in the nerve 
terminal alone was the cause of the effects seen with rescue. 
It has been noted that when PI4KIIα with ablated AP-3 binding is expressed into a 
PI4KIIα knockdown background the cytosolic presence of AP-3 is increased (Craige 
et al. 2008). This is seemingly due to a necessity for this binding to relocate PI4KIIα 
and AP-3 to early endosomes and lysosomes (Craige et al. 2008; Robinson et al. 
2014). When these AP-3 binding-deficient forms are expressed in the presence of 
endogenous PI4KIIα, normal binding of AP-3 would continue and therefore the 
increase in cytosolic AP-3 would not occur. This could explain the differences seen 
in syp-pH retrieval between rescue and overexpression with these phospho-null 
PI4KIIα mutants. 
To further investigate the role of AP-3 abundance in the modulation of CME 
kinetics, further work could be performed utilising AP-3 overexpression or 
knockdown in conjunction with syp-pH retrieval. High resolution microscopy with 
immunofluorescence could also be performed on transfected cells to see if PI4KIIα 
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knockdown causes an increase in cytosolic versus membrane-bound AP-3 in a 
manner that is then exacerbated by a rescue with these phospho-null mutant forms of 
PI4KIIα.  
Again, it is currently unclear as to whether these mutations hinder the kinase activity 
of PI4KIIα. Clarification of this matter in the future will allow a better understanding 
of the role PI levels may play in CME regulation. 
 Kinase-Dead PI4KIIα and CME Kinetics 
Expression of a kinase-dead PI4KIIα (K152A) was incapable of rescuing the 
accelerated endocytosis phenotype seen in a knockdown background (Figure 4.15). 
This result is in accordance with the hypothesis that the rate of CME is somehow 
effected by the proportions of different phosphoinositides in the presynapse. A 
decrease in PI4P abundance or a shift in the ratio of PI4P to PI(4,5)P2 could be 
causing the observed acceleration of CME in PI4KIIα knockdown cells which 
kinase-dead PI4KIIα is unable to rectify.  
Overexpression of this kinase-dead mutant PI4KIIα also had an effect on the rate of 
CME (Figure 4.21). It is possible that this dominant-negative effect is caused by a 
K152A PI4KIIα competing with endogenous PI4KIIα for PI binding, inhibiting its 
action indirectly and causing a decrease in PI4P. As the acceleration of CME 
observed with overexpression of K152A PI4KIIα was not as dramatic as is observed 
with a knockdown it is apparent that any competitive inhibition caused by 
overexpressing K152A PI4KIIα is not entire and endogenous PI4KIIα is still capable 
of performing at least a portion of its function. 
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The AP-3 explanation could also fit these results. It has been shown that AP-3 
binding is primarily modulated by the sorting motif on the N-terminal domain 
PI4KIIα. However, it is also regulated by its kinase function downstream of this 
domain (Craige et al. 2008). Therefore, it is possible that the lack of rescue observed 
with K152A expression in a knockdown background is actually due to a decreased 
binding probability with AP-3, resulting in an increased cytosolic AP-3 abundance in 
a similar but less dramatic manner than that observed with the other AP-3 binding 
deficient PI4KIIα forms (S9/51A and L60/61A).  
The dominant negative effect of K152A overexpression is more complicated. In the 
same study mentioned above, a kinase-dead mutant form of PI4KIIα was used 
(D308A PI4KIIα) as well as mutant-specific PI4KIIα antibodies. The efficiency of 
cross-linking with AP-3 was analysed in comparison to WT PI4KIIα in rescue or 
wild-type backgrounds. In both backgrounds the D308A mutant lacking kinase 
function formed a cross-linkable complex with AP-3 with half the efficiency 
displayed with WT PI4KIIα (Craige et al. 2008).  This paper did not however 
examine the localisation of AP-3 to early endosomes with this overexpression of 
kinase-dead PI4KIIα. It is possible that the dominant negative effect seen here with 
K152A PI4KIIα is due to a similar AP-3 binding effect. If K152A PI4KIIα binds 
50% of AP-3 but is then not relocated to the endosome, it may mean that AP-3 is 
accumulating in the cytosol as is seen with PI4KIIα knockdowns. 
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 Exocytosis is Increased with overexpression of PI4KIIα Able to 
Bind AP-3  
The rescue of PI4KIIα with a shRNA-resistant form of wild-type PI4KIIα resulted in 
an increase in syp-pH exocytosis (Figure 4.7). The same effect was seen with an 
overexpression of wild-type PI4KIIα (Figure 4.17). It is unclear why overexpression 
of WT PI4KIIα would cause an increased peak height, especially as a knockdown of 
PI4KIIα had no effect on this variable (Figure 4.3). It is possible that this exocytic 
effect is symptomatic of this increase in PI4KIIα abundance and/or the products of 
the kinase activity of PI4KIIα in the nerve terminal in a manner that is not 
bidirectional.  
As mentioned previously, it has been shown that the knockdown of PI4KIIα in one 
cell type causes a decrease in PI4P levels but does not result in a decreased 
abundance of PI(4,5)P2 (Ketel et al. 2016). It is unknown if overexpression of 
PI4KIIα causes an increase in the levels of PI(4,5)P2 though it is a possibility as an 
increased abundance of PI4KIIα would most likely lead to an increased production of 
its precursor PI4P. As it has previously been shown that a reduction in PI(4,5)P2 
production can lead to a smaller RRP (Di Paolo et al. 2004), it is possible that the 
converse is true and that in increasing the production of PI(4,5)P2 somehow increases 
the number of SVs in the RRP, resulting in a larger release of syp-pH upon 
stimulation. It would tally that a decrease in syp-pH exocytosis was not seen within 
the knockdown system if it is the case that removal of PI4KIIα does not affect 
PI(4,5)P2 production. 
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However, overexpression of kinase-dead PI4KIIα also caused an increase in syp-pH 
peak height during stimulation (Figure 4.21) making this explanation unlikely. 
It is possible that this overexpression effect is somehow related to the relationship of 
PI4KIIα with AP-3. However, it is unclear how this effect would cause an exocytic 
effect in only one direction. Knockdown of PI4KIIα causes an increase in cytosolic 
AP-3 and it is possible that overexpression would cause an increase in AP-3 
trafficking to both the endosome and lysosome, decreasing its presence in the 
cytosol. If the effect on exocytosis was in fact due to a relationship with AP-3 one 
would expect that a knockdown would cause a relative decrease in peak height. 
However, it is possible that there is a threshold of AP-3 which is required to 
modulate exocytosis and overexpression of PI4KIIα decreases cytosolic AP-3 to 
surpass this threshold. The fact that only the overexpression of forms of PI4KIIα able 
to bind AP-3, including kinase-dead PI4KIIα which experiences only partially 
ablated AP-3 binding (Craige et al. 2008), cause this phenotype makes this a more 
likely explanation for this increase in syp-pH exocytosis. 
 Inhibition of ADBE Is Successfully Rescued by All But 
Phospho-Mimetic Mutant 
The role for PI4KIIα in the formation of bulk endosomes during HFS is harder to 
theorise. Wild-type, phospho-null and kinase-dead versions of PI4KIIα were all 
capable of rescuing the inhibition of ADBE caused by knockdown of PI4KIIα 
(Figure 4.8,-11,-13,-15 and -17). Only QUAD-D was incapable of restoring normal 
dextran uptake.  
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From these results, it can be inferred that the kinase function of PI4KIIα is not 
essential in the normal function of ADBE. Nor is AP-3 binding/abundance. Together 
with data collected using syp-pH it can also be deduced that the effects of PI4KIIα 
knockdown on both ADBE and CME are not functionally coupled. This is 
demonstrated by phospho-null PI4KIIα rescue causing an exacerbation of the CME 
phenotype (Figure 4.11 and Figure 4.12) but a full rescue of ADBE (Figure 4.13 and 
Figure 4.14). The overexpression of K152A PI4KIIα in cells expressing endogenous 
PI4KIIα also had no observable effect on the amount of dextran uptake in 
comparison to control (Figure 4.22), showing a lack of a dominant-negative action of 
kinase-dead PI4KIIα on ADBE unlike that seen on CME. 
The phospho-mimetic form of PI4KIIα was somehow incapacitated with regards to 
its role in ADBE. This indicates that GSK3 phosphorylation somehow inactivates 
PI4KIIα. As this effect is not tied in with the kinase or AP-3 binding properties of the 
protein, the theories of this mutation connected to altered AP-3 abundance and PI4P 
production are not relevant to ADBE. However, one property of QUAD-D PI4KIIα 
which could impact on its function in ADBE is its location. As discussed earlier, it is 
likely that QUAD-D PI4KIIα is more quickly and more efficiently bound by AP-3 
than its wild-type counterpart. If this is true it is more quickly and efficiently 
trafficked away from SVs. This would mean not only a decrease in PI4KIIα on SVs 
but also a decrease in PI4P production on SVs. However, as the kinase-dead form of 
PI4KIIα rescues ADBE it is unlikely that PI4P is the critical component for 
functional ADBE. It is possible that PI4KIIα must simply be present for the normal 
formation of bulk endosomes. This may mean that PI4KIIα is a marker for yet-to-be 
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identified ADBE-specific cargo or adaptor proteins to initiate invagination upon 
HFS. 
Overexpression of all forms of PI4KIIα had no effect on the incidence of ADBE as 
measured by dextran uptake. This would imply that, although a knockdown of 
PI4KIIα causes an inhibition of ADBE, overexpression of PI4KIIα has no effect on 
ADBE incidence. However, this conclusion has two caveats: firstly, the cell type 
used in these experiments may be prone to physiologically high PI4KIIα abundance 
due to its depolarised culture conditions and as such any effect of PI4KIIα on ADBE 
in control conditions may already be saturated. Performing these experiments in cell 
types cultured in a non-depolarising medium with a lower innate PI4KIIα abundance 
may reveal a bi-directional effect of PI4KIIα abundance. Secondly, dextran is not a 
measure of the amount of ADBE occurring in each nerve terminal but a measure of 
how many synapses in a given length of axon are undergoing ADBE. To measure the 
number of bulk endosomes per synapse the use of a lentiviral vector would again be 
needed to induce a culture-wide infection of relevant DNA. Once this was attained 
an HRP-uptake assay could be performed and imaged using electron microscopy. In 
lieu of a more accurate, live-cell assay this would be the most accurate method to 
quantify bulk endosome formation per synapse in CGNs with manipulated PI4KIIα 
expression. 
Much more work is needed to identify the specific nature of the role of PI4KIIα in 
ADBE. One area of focus should be the interaction of PI4KIIα with endocytic 
machinery and the effects of each of the mutations used here on those interactions. 
Interactions between PI4KIIα and many endocytic proteins such as endophilin, 
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SNX9, SNX18 and SGIP1 are inhibited via ubiquitination of PI4KIIα (Mössinger et 
al. 2012). Interestingly, the site of ubiquitination is within 10 residues of one site for 
GSK3 phosphorylation (Ser 5/9). As such it is a possibility that phosphorylation by 
GSK3 (or mutations such as QUAD-D) could also cause this block in normal 
interactions possibly inactivating PI4KIIα with regards to its role in endocytosis. 
Performing GST-pull downs on WT PI4KIIα alongside each of the available mutant 
forms may give a clearer picture as to the role of GSK phosphorylation in PI4KIIα 
function with regards to endocytosis. It may also offer an explanation as to the failure 
of QUAD-D to rescue both CME and ADBE phenotypes. 
In conclusion, a role for PI4KIIα has been revealed in both CME and ADBE in 
CGNs during HFS. I have also found that different properties of the PI4KIIα protein 
are responsible for its action in both of these although the precise nature of its 
method of action is still unidentified. Future work will focus on phosphoinositide 
effects through PI4KIIα manipulation. AP-3 abundance and localisation will also 
warrant further investigation as to roles in the recycling of synaptic vesicle proteins 
via CME. A detailed analysis of phospho-dependent interactions between PI4KIIα 
and presynaptic proteins may reveal important information about PI4KIIα function, 














5. A Variety of pHluorins Preferentially Report CME 
5.1 Introduction 
In the previous chapter the knock-down of PI4KIIα resulted in an inhibition of 
ADBE along with an acceleration of CME. These results raised questions as to the 
possible coupling between CME and ADBE. One hypothesis is that the absence of 
PI4KIIα was only directly affecting one of these endocytic modes and the other was 
merely compensating for that change. Therefore, it is possible that ADBE was 
decreased due to increased CME capacity or vice versa.  Further experimentation 
however seemed to show a functional separation of these two endocytic modes, with 
ADBE inhibition being rescued by mutant forms of the protein which did not rescue, 
and actually exacerbated, the accelerated CME phenotype (see Figure 4.11, Figure 
4.12, Figure 4.13 and Figure 4.14).  
In light of these results, further experiments were required to investigate the bi-
directionality of inhibition or facilitation of one endocytic mode due to an effect on 
the other. It is important to investigate this problem more precisely, manipulating 
those proteins directly involved with either CME or ADBE as it is possible that the 
expression of mutant PI4KIIα disturbed this natural coupling between endocytic 
modes. 
Previous work has examined the effect of manipulating CME-specific machinery 
such as Clathrin Heavy Chain (CHC) or adaptor-protein 2 (AP-2) on the recycling of 
synaptotagmin-pHluorin (Kononenko et al. 2014) and found a slowing in the 
retrieval of this SV protein only during mild stimulation. Work utilising the acute 
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relocation of a FKBP-tagged protein (re-routing) (M. S. Robinson et al. 2010), has 
shown a dependence on clathrin and stonin-2 for endocytosis of synaptophysin-
pHluorin (syp-pH) (Willox & Royle 2012). However, these experiments did not 
explore the effects on pHluorin recycling caused by manipulating of ADBE in 
isolation from CME. Therefore, a series of experiments were conducted to 
systematically approach the issue investigating the roles of both forms of endocytosis 
in the recycling of a variety of SV proteins. 
Effects of specifically blocking either CME or ADBE on the recycling of a variety of 
tagged SV proteins were investigated using a selection of genetic or pharmacological 
manipulation.  Genetically encoded versions of the most abundant SV proteins, 
tagged with pHluorin molecules, were used; synaptobrevin II-pHluorin (sybII-pH) 
and syp-pH, synaptotagmin 1-pHluorin (tagmin-pH) and vGLUT 1-pHluorin (vGlut-
pH).  
A further rationale for these experiments was to assess the role of ADBE in the 
recycling of these SV cargoes. It is currently unknown what role ADBE has in 
reclaiming SV cargo inserted into the PM upon exocytosis and whether it performs 
this role with any specificity. For example, does ADBE have its own adaptor proteins 
which specifically recognise SV cargo or does it simply invaginate SV cargo along 
with the large portion of membrane without selection? It was hoped that the 
individual manipulation of these endocytic routes could identify any proportion of 




5.2.1 Pharmacological Inhibition of ADBE has no Effect on the 
Recycling of Several pHluorins 
 CGNs Display no Significant Trafficking of Synaptophysin-
pHluorin via ADBE During HFS 
The rate of endocytosis can be revealed using pHluorins. After cessation of 
stimulation, exocytosis has stopped and the fluorescence of a transfected cell 
decreases as those pHluorin molecules which have been exposed to the extracellular 
space via exocytosis undergo endocytosis and their new vesicles/endosomes acidify. 
However, the rate of fluorescence decrease after stimulation is technically a function 
of the rate of both acidification and of endocytosis. The process of CME acidification 
using pHluorins similar to those used in this thesis was estimated as 4-5 seconds 
(Sankaranarayanan & Ryan 2000; Atluri & Ryan 2006). With acidification occurring 
so rapidly after endocytosis, one can use the kinetics and extent of the quenching of 
fluorescence of pHluorins to equate the rate and extent of CME. 
During mild stimulation the dominant form of endocytosis is CME (Granseth et al. 
2006; Zhu et al. 2009), therefore the observed endocytosis of pHluorin is due to 
internalisation via this endocytic mode. However, during HFS CME reaches its 
maximum capacity (Sankaranarayanan & Ryan 2000) and another form of membrane 
retrieval is required. During these stimulation conditions both CME and ADBE occur 
in the presynapse, with ADBE being the dominant mode of membrane retrieval 
under these conditions (Royle & Lagnado 2003; Wu et al. 2007; Clayton et al. 2008).  
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It is currently unknown what role ADBE plays in the specific retrieval of SV cargo 
and, by extension, what portion of the observed endocytosis of a population of 
pHluorin molecules can be attributed to ADBE.   
To isolate what, if any, fraction of pHluorin-tagged SV protein syp-pH is internalised 
via ADBE during HFS a stimulation protocol was designed wherein two sequential 
and identical stimulations “S1” and “S2” were delivered to a syp-pH transfected 
CGN in the presence of the GSK3 and Cdk5 inhibitors CT99021 (CT, 2 µM) and 
roscovitine (10 µM) respectively (Figure 5.2 A).  
CT and roscovitine do not interfere with ADBE during a priming HFS “S1” (400AP,  
40 Hz) as it does not affect dynamin I dephosphorylation by calcineurin (Clayton et 
al. 2010). However these drugs prevent GSK3 and Cdk5 from rephosphorylating 
dynamin I, an action which is required to allow ADBE in a second HFS “S2” 
(Clayton et al. 2010). The effect on ADBE via GSK3/Cdk5 inhibition can be 
visualised via the uptake of dextran during S2 with/without CT or roscovitine 
respectively (Figure 5.1). The mechanism of action for these compounds allows the 
comparison of an HFS-evoked syp-pH response with the contribution of ADBE 
during S1 to that in the absence of ADBE during S2 (Figure 5.2 A). 
Peak heights and endocytic time constants (tau – τ) were taken from time-lapse 
traces of pHluorin fluorescence of all conditions (see 2.2.5.1.4.1): control, CT, 
roscovitine and CT plus roscovitine (Figure 5.2 B, C, D and E respectively). Ratios 
of peak heights (S1/S2) and taus (S1/S2) (Figure 5.2 G) from individual syp- pH 
responses were compared between all conditions to visualise differences in response 
during S2 due to the removal of ADBE. 
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There were no significant differences observed either in the S1/S2 peak height ratio 
(Figure 5.2 F) or tau ratio (Figure 5.2 G) during inhibition of either GSK3 by CT or 
Cdk5 by roscovitine or by the two in combination when compared to control. This 
implies that inhibition of ADBE does not impact on either the amount of exocytosis 
or the kinetics of endocytosis (depicted by peak height and tau values respectively) 
meaning that ADBE may not play a significant role in the recycling of syp-pH during 
HFS. 
To assess if ADBE’s lack of contribution to SV cargo recycling is limited to syp-pH, 
a series of further experiments utilising other commonly used pHluorins were 
performed.  
Using the same “S1 S2” protocol the role of ADBE was assessed in the recycling of 
vGlut-pH, tagmin-pH and sybII-pH (Figure 5.3 A, Figure 5.4 A and Figure 5.5 A). 
Ratios of peak heights (S1/S2) and tau values (S1/S2) of the response of each 
pHluorin was compared between control and CT conditions (Figure 5.3, Figure 5.4 
and Figure 5.5 B and C respectively). No significant differences were seen with the 
inhibition of ADBE by CT either in peak height or tau ratio for any of these 
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Figure 5.1 CT and Roscovitine effectively Inhibit ADBE 
A) CGNs were repolarised in imaging buffer for 10 minutes prior to incubation with imaging 
buffer alone (Control) or supplemented with 2µM CT99021 (CT) or 10 µM Roscovitine for 
10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) (S1) and allowed to 
recover for 10 minutes. Cells were then stimulated with a second HFS train (S2) in the 
presence of 50 µM dextran. B) and C) Average dextran puncta per field + SEM for Control 
Vs. CT (B) or Control Vs, Roscovitine (C). Control n=4, CT n=5 (B). Control n=3, 




Figure 5.2 Pharmacological Inhibition of ADBE has no Effect on Synaptophysin-pHluorin 
Recycling. 
A) Protocol (top) and representative control trace (bottom) of experiment: Repolarised CGNs 
transfected with synaptophysin-pHluorin (syp-pH) were incubated with imaging buffer 
(control) supplemented with either 2 µM CT99021 (CT), 10 µM roscovitine or both 10 minutes 
and then continuously onwards. Cells were challenged with 2 sequential HFS trains (400 AP, 
40 Hz) (S1 and S2) 10 minutes apart and then challenged with 50 mM NH4Cl (shaded 
region). B-E) Average time course (ΔF/F0) + SEM of S1 overlaid with S2 for control, CT, 
roscovitine and CT plus roscovitine respectively. All stimulations were normalised to the 
evoked peak height. Black bars represent stimulation. F) Average ratios of peak height 
(ΔF/F0) S1/S2 + SEM G) Average ratios of tau values (s) S1/S2 + SEM. Control n=6, CT n=5, 
Roscovitine n=6, CT/Roscovitine n=4. n.s., one-way ANOVA with Bonferroni post-test. 
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Figure 5.3 Pharmacological Inhibition of ADBE does not Affect on vGlut-pHuorin Recycling 
A) “S1 S2” experiment. CGNs co-transfected with mCer and vGlut-pHluorin (vGlut-pH) were 
incubated with imaging buffer for 10 minutes before being incubated in imaging buffer alone 
(control) or supplemented with 2 µM CT99021 (CT) for 10 minutes prior to S1 and then 
continuously onwards. Cells were challenged with 2 sequential HFS trains (400 AP, 40 Hz) 
(S1 and S2) 10 minutes apart. B and C) Average time traces + SEM of S1 overlaid with S2 
for control and CT respectively. D) Average ratio value of peak height (F/F0) S1 over peak 




Figure 5.4 Pharmacological Inhibition of ADBE does not Affect Synaptotagmin-pHluorin 
Recycling 
A) Protocol of “S1 S2” experiment. CGNs co-transfected with mCer and synaptotagmin-
pHluorin (tagmin-pH) were incubated with imaging buffer for 10 min before being incubated 
in imaging buffer alone (control) or supplemented with 2 µM CT99021 (CT) for 10 minutes 
prior to S1 and then continuously onwards. Cells were challenged with 2 sequential HFS 
trains (400 AP, 40 Hz) (S1 and S2) 10 minutes apart. B and C) Average time traces + SEM 
of S1 overlaid with S2 for control and CT respectively. D) Average ratio value of peak 
height (F/F0) S1 over peak height S2 + SEM. E) Average ratio of tau (s) S1 over S2 + SEM. 




Figure 5.5 Pharmacological Inhibition of ADBE does not Affect Synaptobrevin II-pHluorin 
Recycling 
A) Protocol of “S1 S2” experiment. CGNs co-transfected with mCer and synaptobrevin II-
pHluorin (sybII-pH) were incubated in imaging buffer for 10 min before being incubated with 
imaging buffer alone (control) or supplemented with 2 µM CT99021 (CT) for 10 minutes prior 
to S1 and then continuously onwards. Cells were challenged with 2 sequential HFS trains 
(400 AP, 40 Hz) (S1 and S2) 10 minutes apart. B and C) Average time traces + SEM of S1 
overlaid with S2 for control and CT respectively. D) Average ratio of peak height (F/F0) S1 
over peak height S2 + SEM. E) Average ratio of tau (s) S1 over S2 + SEM. Control n=4, CT 
n=6. n.s., Student’s t-test.  
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pHluorins (Figure 5.3, Figure 5.4 and Figure 5.5 D and E respectively) indicating 
that ADBE does not significantly contribute to the recycling of vGlut-pH, tagmin-pH 
or sybII-pH during HFS. Taken together these results suggest that a wide range of 
commonly used pHluorins do not traffic via ADBE. 
 Hippocampal Neurons Display no Significant Trafficking of 
Synaptophysin-pHluorin via ADBE During HFS 
So far these experiments have indicated that in CGNs exogenously expressed SV 
proteins tagged with a pH-sensitive marker are trafficked independently of the 
dominant form of endocytosis, ADBE, during HFS. 
To assess if this finding is specific to CGNs or if it common to most neuronal 
subtypes, hippocampal neurons expressing syp-pH were utilised in an identical “S1 
S2” protocol, inhibiting ADBE only on the second stimulation (Figure 5.6 A-C). 
No significant difference was found in peak height ratio between control and CT 
conditions (Figure 5.6 D) showing that the inhibition of ADBE did not affect the 
amount of exocytosis occurring on S2. No significant difference was found between 
tau ratios of control or CT conditions (Figure 5.6 E) showing no effect of ADBE 
inhibition on the rate of endocytosis. However, in hippocampal neurons a slowing of 
endocytic kinetics on S2 was observed leading to a smaller ratio value. This was 
consistent across both control and CT conditions however and as such is not 
pertinent to the manipulation of ADBE.  
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Figure 5.6 Pharmacological Inhibition of ADBE Does Not Effect Synaptophysin-pHluorin 
Retrieval in Hippocampal Neurons During HFS 
A) Protocol of “S1 S2” experiment. Hippocampal neurons transfected with synaptophysin-
pHluorin (syp-pH) were incubated with hippocampal imaging buffer (control) or 
supplemented with 2 µM CT99021 (CT) for 10 minutes prior to S1 and then continuously 
onwards. Cells were challenged with 2 sequential HFS trains (400 AP, 40 Hz) (S1 and S2) 
10 minutes apart. B and C) Average time traces + SEM, S1 overlaid with S2 for control and 
CT respectively. D) Average ratio of peak height (F/F0) S1 over peak height S2 + SEM. E) 
Average ratio of tau (s) S1 over S2 + SEM. Control n=5, CT n=6. n.s., Student’s t-test. 
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5.2.2 Genetic Inhibition of ADBE has no Effect on the Recycling of 
Synaptophysin-pHluorin 
Previous experiments discussed here have shown that pHluorins are predominantly 
recycled via an alternative endocytic route to ADBE. Pharmacological approaches 
however can be troublesome due to non-specific effects as well as the possibility of 
their degradation during prolonged exposure to either light or temperature. To further 
strengthen my hypothesis, the same question was approached using a genetic 
manipulation. 
Syndapin I is an essential molecule for ADBE (Clayton et al. 2009). During HFS 
dynamin I is dephosphorylated on two serine residues (Ser774 and 778) facilitating 
an interaction with syndapin I (Clayton et al. 2009). This interaction is needed for 
ADBE as shown by phospho-null mutant forms of dynamin I resulting in a lack of 
ADBE in CGNs (Clayton et al. 2009). By knocking down syndapin I ADBE is also 
significantly inhibited (Clayton et al. 2009) as visualised by the inhibition of dextran 
uptake in syndapin I-depleted cells (Figure 5.7). This established syndapin I knock 
down system was utilised to visualise syp-pH recycling during a “Single HFS” 
experiment in comparison to a control condition.  
CGNs co-expressing syp-pH and either syndapin shRNA or an empty vector (pSuper 
neo) were stimulated with a train of 400 AP at 40 Hz (HFS) (Figure 5.8 A). 
Fluorescence was plotted over time and compared between conditions (Figure 5.8 B). 
No significant difference was found either in amount of exocytosis as evidenced by 
peak height (Figure 5.8 C) or the time constant of endocytosis (tau) (Figure 5.8 D).  
224 
Therefore, the genetic ablation of ADBE had no effect on syp-pH recycling, giving 
further evidence that syp-pH is not significantly recycled via ADBE during HFS. 
5.2.3 No Evidence of Synaptophysin-pHluorin Being Sequestered by 
ADBE During High Frequency Stimulation 
The rate of decrease in pHluorin fluorescence after an action potential train is a 
function of both vesicle/endosome acidification and endocytosis. When referring to 
CME, SV acidification occurs rapidly (4-5 sec) and as such the rate of decrease of 
pHluorin fluorescence after stimulation can be considered an approximation of the 
rate of endocytosis (Sankaranarayanan & Ryan 2000; Atluri & Ryan 2006).  
This issue becomes more complicated however when monitoring ADBE, as a bulk 
endosome has a larger internal volume than a SV (approximately 50 fold larger 
assuming an endosome of 150 nm diameter (Cheung & Cousin 2013)). This larger 
volume should mean a significantly longer period of time to acidify and therefore 
quench any pHluorin cargo fluorescence especially when one considers the 
availability of V-type ATPase responsible for vesicle acidification is extremely 
limited in nerve terminals (Takamori, Holt, Stenius, Edward A Lemke, et al. 2006) 
with only 1 or 2 copies per SV.  
It therefore follows that pHluorins internalised via ADBE would remain fluorescent 
for a significant time period after their uptake. To search for evidence of pHluorin 
molecules sequestered into a neutral environment away from the PM (a bulk 
endosome which is still acidifying) after a HFS, an experimental protocol to track 
endosome acidification was used.  
225 
  
Figure 5.7 Silencing Syndapin I Expression Effectively Inhibits ADBE 
A) CGNs transfected with empty vector pSuper neo or Syndapin I shRNA were repolarised 
in imaging buffer for 10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) in 
the presence of 50 µM dextran. B) Average number of dextran puncta per µm of axon 
expressed as a proportion of empty pSuper neo + SEM. pSuper n=33, Syndapin shRNA 
n=40.  ****=p<0.0001. Student’s t-test. 
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Figure 5.8 Genetic Inhibition of ADBE Does not Effect Synaptophysin-pHluorin Retrieval 
During HFS 
A) CGNs co-transfected with either mCer empty vector (pSuper neo) or syndapin shRNA 
(Syndapin KD) and synaptophysin-pHluorin (syp-pH) were incubated with imaging buffer for 
10 minutes prior to stimulation and then continuously onwards. Cells were stimulated with 
HFS train (400 AP, 40 Hz). B) Average time trace + SEM is displayed with stimulation 
indicated by black bar. C) Average peak heights of each condition (F/F0) + SEM. D) 
Average endocytosis kinetics (tau) + SEM. Syndapin KD n=8 Control n=5. n.s., Student’s t-
test. 
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An impermeant, weak acidic buffer was pulsed over syp-pH transfected cells before 
and after stimulation, comparing the “quenchable” portion of pHluorin molecules in 
a cell pre- and post-stimulation (Figure 5.9 A and B). Before stimulation this fraction 
represents those pHluorin molecules residing on the PM “the surface fraction”. The 
quenching of this fraction should mean all pHluorins are in an acidic environment 
and therefore non-fluorescent. 
Any difference between the quenchable portion of fluorescence pre- and post- 
stimulation could indicate pHluorin-tagged SV cargo having been sequestered into a 
neutral environment away from the membrane. A third acid pulse was also 
performed a minute later to assess, if pHluorin molecules were sequestered into a 
bulk endosome structure, at what rate that endosome was acidifying (Figure 5.9 A 
and B). 
No significant difference was seen between the “quenchable” portions of syp-pH 
fluorescence pre-stimulation or at either post-stimulation acid wash (Figure 5.9 C). 
This indicates that newly endocytosed syp-pH is either rapidly acidified and 
therefore is not being retrieved via ADBE or that bulk endosomes acidify at the same 
rate as SVs. Syp-pH response during HFS is unaffected by two independent methods 
of ADBE inhibition, this would therefore suggest that the former of these 
possibilities is correct.  
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Figure 5.9 There is no Evidence of Sequestered Synaptophysin-pHluorin After HFS 
A) Protocol of experiment: CGNs transfected with synaptophysin-pHluorin (syp-pH) were 
repolarised before a control acid wash (peach bars), isolating fluorescence of surface bound 
syp-pH. Cells were then stimulated with HFS train (400 AP, 40 Hz) and two more acid 
washes performed at 30 seconds (1st Post-Stim) and 90 seconds (2nd Post-stim) post-
stimulation. B) Average time trace F/F0 + SEM with stimulation indicated by black back bar, 
traces were normalised to stimulation peak height and difference between peak height and 
acid wash fluorescence calculated for control (black arrow), 1st Post-stim (blue arrow) and 2nd 
Post-stim (green arrow) washes (ΔF/F0), C) Average ΔF/F0 values + SEM. n=12. n.s. One-
way ANOVA with Bonferroni post-test. 
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5.2.4 Pharmacological Inhibition of CME Severely Disrupts 
Synaptophysin-pHluorin Retrieval 
The experiments thus far have indicated that many typical pHluorins are not recycled 
via ADBE. However, it has not yet been shown which endocytic mode is responsible 
for recovering SV cargo after HFS. The most obvious candidate for SV cargo 
recycling is CME. To test this hypothesis CME was inhibited in CGNs using the 
clathrin inhibitor Pitstop2-AM (Von Kleist et al. 2011).  
To be sure of a CME-specific effect of Pitstop-2 on endocytosis an experiment was 
performed, assessing any possible effect on ADBE. Pitstop-2 was used acutely just 
prior to a HFS in the presence of dextran in CGNs (Figure 5.10 A). No significant 
effect was seen on ADBE in the presence of Pistop-2 in CGNs in comparison to cells 
stimulated with HFS in the presence of dextran without Pitstop (Figure 5.10 B). 
CGNs transfected with syp-pH were stimulated using the same “S1 S2” protocol as 
described previously (5.2.1.1). Pitstop-2 was included just prior to S2 inhibit CME 
(Figure 5.11 A). Fluorescence was plotted over time for both conditions with S1 and 
S2 overlaid for both control and Pitstop-2 (Figure 5.11 B and C respectively). A 
significant difference was seen between S1 and S2 when average traces were 
compared which was not present between S1 and S2 of control.  
Efficiency of syp-pH retrieval was measured by comparing the fluorescence drop 
after stimulation as a percentage of fluorescence increase on stimulation, this is the 
proportion of pHluorin molecules retrieved post-stimulation as a percentage of those 
deposited into the PM on stimulation. 
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Figure 5.10 Acutely Inhibiting CME Does Not Inhibit ADBE 
A) CGNs were repolarised in imaging buffer for 10 minutes prior to incubation with imaging 
buffer with 50 µM dextran alone (Control) or supplemented with 15µM Pitstop-2 for 10 
seconds. Cells were stimulated with a HFS train (400 AP, 40 Hz). B) Average dextran 




Figure 5.11 Pharmacological Inhibition of CME Effectively Ablates Syp-pH Retrieval During 
HFS 
A) CGNs transfected with synaptophysin-pHluorin (syp-pH) were incubated with imaging 
buffer for 10 minutes prior to stimulation and then continuously onwards. Cells were 
challenged with 2 sequential action potential trains of 400 AP at 40 Hz separated by 10 
minutes. Cells were supplemented with 15 µM PItstop-2 8-12 seconds prior to S2 (Pitstop) or 
nothing (control). B) Average time course of control S1 overlaid with S2 C) Average time 
course of Pitstop S1 overlaid with S2. Each trace is normalised to baseline and peak 
fluorescence on stimulation. Black bars indicate location and duration of stimulation. D) 
Average value of peak height evoked on S2 as a proportion of S1 +SEM. E) Average value of 
endocytosis as a percentage of fluorescence decrease after increase on S2. Control n=5, 
Pitstop n=6. Error bars are equal to SEM. Time course: ****= p<0.0001 two-way ANOVA, Bar 
chart: ****= p<0.0001 Student’s t-test. 
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No significant effect was seen on exocytosis (Figure 5.11 D) however retrieval of 
syp-pH was inhibited by nearly 90% at a time point by which control cells had 
retrieved all exocytosed syp-pH (Figure 5.11 E). As ADBE is unaffected by this drug 
treatment (see Figure 5.10) this demonstrates that, even during a stimulation protocol 
in which CME is not the dominant form of endocytosis, SV cargo is being retrieved 
almost exclusively via CME. 
 Pitstop-2 does not Affect Acidification of SVs During the 
Experimental Timeframe. 
Previous work has suggested an impact of Pitstop-2 on vesicle acidification (Hua et 
al. 2013). As such it is possible that the lack of fluorescence drop seen with the 
application of pitstop-2 could be attributed to an off-target effect. To examine the 
effect of Pitstop-2 on vesicle pH during the time-frame of the previous experiment, a 
protocol was designed to track the baseline fluorescence of vesicles over time with 
and without the presence of pitstop-2 (Figure 5.12 A).  
Syp-pH transfected cells were imaged for a minute to acquire a baseline 
fluorescence; this is the fluorescence of surface-bound pHluorin molecules exposed 
to the neutral pH of the extracellular media. An ammonium chloride solution was 
then pulsed over the culture for a further minute; this has the effect of de-acidifying 
all synaptic vesicles thereby allowing the maximal fluorescence of all pHluorin 
molecules within the transfected cell. After these preliminary baseline measurements 
imaging buffer alone (control) or supplemented with Pitstop-2 was pulsed over the 
cultures. This solution was continuously perfused over the culture for a period 
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consistent with previous experiments using Pitstop-2. If Pitstop-2 had an effect on 
vesicle pH during this time period, it would be observable as an increase in baseline 
fluorescence over time. No significant difference in baseline fluorescence, and 
therefore the pH of the population of SVs between control and Pitstop-2-treated 
conditions was observed over this time-frame.  
However, when this solution was left on cultures for a further 5 minutes a significant 
increase in baseline fluorescence (corresponding to an increase in vesicle pH) was 
observed in Pitstop-2-treated cells when compared to controls (Figure 5.12 B).  
This indicates that Pitstop-2 does have off-target effects on SV pH over a longer 
period of time, however it does not affect the pH of vesicles within the time-frame of 
the experiments conducted here. This also means that the drastic inhibition of the 
syp-pH fluorescence decrease after stimulation in the presence of Pitstop-2 cannot be 
attributed to its effects on vesicle pH and must, therefore, be due to its effects on syp-
pH retrieval via the inhibition of CME. 
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Figure 5.12 Pitstop- 2 Does not Affect Vesicle Acidity During Experimental Time Frame 
A) CGNs transfected with synaptophysin-pHluorin (syp-pH) were incubated with imaging 
buffer for 10 minutes prior to an ammonium buffer (NH+- grey bands) for one minute before 
being replaced with imaging buffer (control) supplemented with 15 µM Pitstop-2. After 3 
minutes cells were given a second NH+ pulse and then washed with the relevant buffer. After 
5 minutes a third NH+ pulse was applied. B) Example time courses of control (above) and 
Pitstop-treated (below) conditions normalised to initial baseline and highest fluorescence (0 
and1 respectively). Pitstop n=3 Control n=3. 
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5.2.5 Genetic Inhibition of CME Severely Affects Synaptophysin-
pHluorin Retrieval 
 CGNs Exhibit Severe Inhibition of Synaptophysin-pHluorin 
Retrieval with Silenced CHC Expression 
5.2.5.1.1 Silencing of CHC Expression Causes Severe Inhibition of 
Synaptophysin-pHluorin Retrieval During Low Frequency Stimulation 
A genetic method was used to interfere with clathrin-coated vesicle formation and 
investigate any effects on syp-pH recycling due to the possibility of off-target effects 
inherent with the use of pharmacological interventions. A CHC shRNA vector, 
previously shown to significantly reduce the expression of CHC (Royle et al. 2005) 
was used. CHC levels were measured in CGNs expressing CHC shRNA or its 
scrambled control by overlaying images of transfected CGNs with CHC antibody 
staining. Fluorescence measurements were taken from both transfected and non-
transfected synapses (Figure 5.13 A and B) and compared. CHC shRNA transfected 
cells displayed a 75% decrease in CHC after 3 days when compared to non-
transfected cells in the same region (Figure 5.13 B and C). A scrambled vector 
showed no difference in CHC levels (Figure 5.13 A and C). This demonstrates the 
high efficacy of the CHC shRNA used. 
CGNs were co-transfected with syp-pH and either CHC shRNA or its scrambled 
vector. Cultures were then stimulated at a low frequency (10 Hz 30 sec, LFS) which 
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is known to activate CME but not ADBE (Granseth et al. 2006; Clayton et al. 2008; 
Clayton & Cousin 2009). 
Using this protocol (Figure 5.14 A) CGNs displayed a significant difference in syp-
pH retrieval (Figure 5.14 B and D). CHC-depleted cells retained over 50% of 
exocytosed syp-pH on the PM after a time point when control cells had re-
internalised all exocytosed syp-pH (Figure 5.14 D).  The amount of exocytosed syp-
pH (as measured by fluorescence increase on stimulation – peak height) was 
unaffected by this CHC-knockdown (Figure 5.14 C), therefore this CHC-dependent 
effect on syp-pH recycling was limited to endocytic and not exocytic mechanisms. 
5.2.5.1.2 Silencing of CHC Expression Causes Sever Inhibition of 
Synaptophysin-pHluorin Retrieval During High Frequency Stimulation 
This experiment was repeated using HFS to investigate whether inhibiting CME via 
CHC knockdown would affect syp-pH retrieval when CME is not the dominant form 
of endocytosis. CGNs transfected with the same CHC shRNA/ scrambled vector and 
syp-pH were stimulated using the same HFS protocol as previously described (40 Hz 




Figure 5.13 CHC shRNA Significantly Reduces CHC Levels in CGNs 
Images of CGNs transfected with A) Scrambled shRNA or B) CHC shRNA. The whole CGN culture was labelled with GFP Ab (left) and a CHC Ab 
(middle), when overlaid one can see that the synapses of the transfected cell (white arrows) do not exhibit CHC labelling in the presence of CHC 
shRNA. Average fluorescence of Scrambled shRNA or CHC shRNA transfected CGN synapses as a percentage of fluorescence nearby non-
transfected synapses of similar size + SEM. Scrambled shRNA n=12, CHC shRNA n=16. ****= p<0.0001. Student’s t-test. 
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Figure 5.14 Genetic Inhibition of CME Significantly Reduces Synaptophysin-pHluorin 
Retrieval During LFS in CGNs. 
A) CGNs co-transfected with either control scrambled shRNA vector (Scrambled shRNA) or 
CHC shRNA and synaptophysin-pHluorin (syp-pH) were incubated with imaging buffer for 10 
minutes prior to stimulation and then continuously onwards. Cells were stimulated with a LFS 
train (300 AP, 10 Hz). B) Average time trace + SEM is displayed with stimulation indicated by 
black bar. C) Average peak heights of each condition (F/F0) + SEM. D) Average extent of 
syp-pH retrieval (endocytosis) measured as a percentage of exocytosis F/F0 + SEM. 
Scrambled shRNA n=5, CHC shRNA n=8. Time trace: ****=P<0.0001, Two-way ANOVA, 
Bonferroni post-test. Bar charts: ***=p<0.001, Student’s    t-test. 
239 
  
Figure 5.15 Genetic Inhibition of CME Significantly Reduces Retrieval of Synaptophysin-
pHluorin During HFS in CGNs 
A) CGNs co-transfected with either control scrambled shRNA vector (Scrambled shRNA) or 
CHC shRNA and synaptophysin-pHluorin (syp-pH) were incubated with imaging buffer for 
10 minutes prior to stimulation and then continuously onwards. Cells were stimulated with a 
HFS train (400 AP, 40 Hz). B) Average time trace + SEM is displayed with stimulation 
indicated by black bar. C) Average peak heights of each condition (F/F0) + SEM. D) 
Average extent of syp-pH retrieval (endocytosis) measured as a percentage of exocytosis 
F/F0 + SEM. Scrambled shRNA n=7, CHC shRNA n=8. Time trace: ****=P<0.0001, Two-
way ANOVA. Bar charts: ****=p<0.0001, Student’s t-test. 
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A significant difference in the recycling of syp-pH was seen between control and 
CHC-depleted cells after HFS (Figure 5.15 B). CHC-depleted cells retained almost 
70% of exocytosed syp-pH on their PM at a time point where scrambled shRNA-
transfected cells had re-internalised all exocytosed syp-pH (Figure 5.15 D).  The 
amount of exocytosed syp-pH (peak height) was unaffected by CHC-depletion 
(Figure 5.15 C) showing that CHC knockdown affected only the retrieval of syp-pH 
and not SV fusion. 
Syp-pH uptake is inhibited via this genetic approach even during stimulation 
intensities when the dominant form of endocytosis is the clathrin-independent 
ADBE. This is further proof that this SV cargo is being primarily recycled via 
clathrin-dependent mechanisms i.e. CME, and not via ADBE. 
To investigate any effects of CHC knockdown on ADBE, CGNs transfected with 
CHC shRNA and its scrambled control were stimulated with a HFS train (400 AP, 40 
Hz) in the presence of dextran (50 µM) (Figure 5.16 A). CGNs transfected with CHC 
shRNA showed a significant inhibition ADBE as measured by dextran puncta/µm 
transfected axon in comparison to controls (Figure 5.16 B).  
As ADBE is thought to be clathrin-independent this was an unexpected result and as 
such this experimental paradigm was repeated in hippocampal neurons (Figure 5.16 
C). Interestingly, hippocampal neurons showed no effect on ADBE in the presence 
of CHC shRNA. 
CGNs and hippocampal neurons display nearly identical levels of CHC expression in 
the presence of CHC shRNA (CHC shRNA transfected cells displayed an 80 % 
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decrease in CHC after 7 days when compared to non-transfected cells in the same 
region –  Figure 5.17) and as such it is unclear as to why this difference in ADBE 
inhibition may occur. However, as hippocampal neurons display unaffected ADBE it 
was important to assess if the lack of syp-pH retrieval in CGNs is in any part due to 
the inhibition of ADBE by CHC knockdown. 
 Hippocampal Neurons Exhibit Severe Inhibition of 
Synaptophysin-pHluorin Retrieval with Silenced CHC Expression 
To ensure that this clathrin-dependent dominance of syp-pH trafficking was not 
specific to CGNs (in which ADBE was also inhibited), the experiments described 
previously were conducted in hippocampal cultures. Identical stimulation protocols 
to those on CGNs were performed on hippocampal cultures (Figure 5.18 A and 
Figure 5.19 A). 
Comparable inhibition of syp-pH retrieval was seen in hippocampal neurons as that 
which was seen in CGNs in CHC-depleted cells compared to scrambled controls 
(Figure 5.18 B and Figure 5.19 B). Peak height was unaffected by knockdown of 
CHC for both LFS and HFS (Figure 5.18 C and Figure 5.19 C). LFS and HFS 
resulted in similar percentages of stranded syp-pH after stimulation as that seen in 
CGNs (Figure 5.18 D and Figure 5.19 D), at a time point when control cells had 
entirely retrieved deposited syp-pH.  
This would indicate that the dominant contribution of CME in the retrieval of 
exocytosed syp-pH post-stimulation is true for both mild and intense stimulation in 
hippocampal neurons. The fact that the inhibition of ADBE in CGNs does not have  
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Figure 5.16 Chronic Inhibition of CME Affects ADBE in CGNs but not Hippocampal 
Neurons 
A and C) CGNs or Hippocampal neurons respectively transfected with either Scrambled 
shRNA or CHC shRNA. A only) were repolarised in imaging buffer for 10 minutes. A and C) 
Cells were stimulated with a HFS train (400 AP, 40 Hz) in the presence of 50 µM dextran. B 
and D) Average puncta per µm + SEM of transfected axon of CGN or hippocampal cells 
respectively. CGNs: Scrambled shRNA n=28, CHC shRNA n=30. Hippocampal neurons: 
Scrambled shRNA n=20, CHC shRNA n=17. **=p<0.01. Student’s t-test 
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Figure 5.17 CHC shRNA Significantly Reduces CHC Levels in Hippocampal Neurons 
Images of Hippocampal neurons transfected with A) Scrambled shRNA or B) CHC shRNA. The whole hippocampal cell culture was labelled with GFP 
Ab (left) and a CHC Ab (middle), when overlaid one can see that the synapses of the transfected cell (white arrows) do not exhibit CHC labelling in the 
presence of CHC shRNA. Average fluorescence of Scrambled shRNA or CHC shRNA transfected Hippocampal synapses as a percentage of 
fluorescence nearby non-transfected synapses of similar size.+ SEM. Scrambled shRNA n=16, CHC shRNA n=15. ****= p<0.0001. Student’s t-test. 
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Figure 5.18 Genetic Inhibition of CME Significantly Reduces Synaptophysin Retrieval in 
Hippocampal Neurons During LFS 
A) Hippocampal neurons co-transfected with either control scrambled shRNA vector 
(Scrambled shRNA) or CHC shRNA and synaptophysin-pHluorin (syp-pH) were incubated 
with hippocampal imaging buffer continuously. Cells were stimulated with a LFS train (300 
AP, 10 Hz). B) Average time trace + SEM is displayed with stimulation indicated by black bar. 
C) Average peak heights of each condition (F/F0) + SEM. D) Average extent of syp-pH 
retrieval (endocytosis) measured as a percentage of exocytosis F/F0 + SEM. Scrambled 
shRNA n=5, CHC shRNA n=5. Time trace: *=P<0.05, Two-way ANOVA. Bar charts: 
**=p<0.01, Student’s t-test. 
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Figure 5.19 Genetic Inhibition of CME Significantly Reduces Synaptophysin-pHluorin 
Retrieval in Hippocampal Neurons During HFS 
A) Hippocampal neurons co-transfected with either control scrambled shRNA vector 
(Scrambled shRNA) or CHC shRNA and synaptophysin-pHluorin (syp-pH) were incubated 
with hippocampal imaging buffer continuously. Cells were stimulated with a HFS train (400 
AP, 40 Hz). B) Average time trace + SEM is displayed with stimulation indicated by black 
bar. C) Average peak heights of each condition (F/F0) + SEM. D) Average extent of syp-pH 
retrieval (endocytosis) measured as a percentage of exocytosis F/F0 + SEM. Scrambled 
shRNA n=9, CHC shRNA n=6. Time trace: ****=P<0.0001, Two-way ANOVA. Bar charts: 
****=p<0.0001, Student’s t-test. 
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an additive effect on the inhibition of syp-pH retrieval is further evidence that ADBE 
does not contribute to the retrieval of syp-pH during HFS. 
5.2.5.2.1 Genetic Inhibition of CME Severely Inhibits 
Synaptotagmin I-pHluorin Retrieval after Intense Stimulation 
To address the possibility that the dominance of clathrin-dependent trafficking of SV 
cargo across stimulations is unique to syp-pH, the pHluorin tagged SV protein 
Synaptotagmin I-pHluorin (tagmin-pH) was used.  
It has previously been claimed that CHC knockdown has an effect on retrieval of 
pHluorin tagged SV cargo only during mild stimulation and that this effect is absent 
at higher frequencies (Kononenko et al. 2014). As this is direct contradiction to the 
results compiled so far the stimulation protocol used in this publication was 
replicated (40 Hz 5 sec) as opposed to the standard HFS (40 Hz 10 sec) 
predominantly used for this work, to assess the possibility that this inconsistency 
could cause the discrepancies between both findings (Figure 5.20 A). 
Despite this however, a significant difference was seen between CHC shRNA 
transfected and scrambled controls in the retrieval of tagmin-pH (Figure 5.20 B) with 
an average of 45% of exocytosed tagmin-pH remaining stranded on the PM at a time 
point when control cells had successfully retrieved all previously deposited reporter 
(Figure 5.20 D). In other words, a robust inhibition of tagmin-pH was seen using 
identical stimulation conditions to the previous study, suggesting CME does retrieve 
SV cargo during HFS. 
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One additional difference is the method of shRNA delivery, with the other group 
using a lentiviral vector. Since lentivirus preferentially infects excitatory neurones 
(Nathanson et al. 2009), a silencing of CHC expression may reduce glutamatergic 
transmission, while keeping GABAergic transmission intact. This may lead to 
decreased spontaneous activity, effectively silencing the culture. 
To test if this effect could be causing the differences between this work and that 
reported in Kononenko et al 2014 tetrodotoxin (TTX) (100 nM) was applied for 48 
hours to hippocampal cultures co-transfected with CHC shRNA and syp-pH before 
conducting a single HFS experiment (Figure 5.21 A). The removal of spontaneous 
activity during culture via TTX did not affect the ability of CHC knockdown to 
inhibit syp-pH retrieval during HFS (Figure 5.21 B-D). As such the causes of the 
differences between the results here and in other work is undetermined.  
Together this data clearly demonstrates that a variety of common SV cargoes (syp-
pH, vGlut-pH, tagmin-pH and sybII-pH) are not being significantly trafficked via 
ADBE. Instead, it has been revealed that these pHluorins are being largely retrieved 
via a clathrin-dependent process during stimulation intensities in which ADBE is 
dominant in both CGNs and hippocampal cells. 
5.2.6 Clathrin Has a Role in Recycling at Physiological Temperatures 
Recently questions have been raised as to which endocytic modes are active at 
physiological temperatures as opposed to room temperature, at which many studies 
characterising these endocytic routes have been performed (Watanabe et al. 2014). 
To date all of the studies in this thesis have been performed at room temperature  
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Figure 5.20 Genetic Inhibition of CME Significantly Reduces Synaptotagmin-pHluorin 
Retrieval in Hippocampal Neurons During HFS 
A) Hippocampal neurons co-transfected with either control scrambled shRNA vector 
(Scrambled shRNA) or CHC shRNA and synaptotagmin-pHluorin (tagmin-pH) were incubated 
with hippocampal imaging buffer continuously. Cells were stimulated with a HFS train (400 
AP, 40 Hz). B) Average time trace + SEM is displayed with stimulation indicated by black bar. 
C) Average peak heights of each condition (F/F0) + SEM. D) Average extent of tagmin-pH 
retrieval (endocytosis) measured as a percentage of exocytosis F/F0 + SEM. Scrambled 
shRNA n=10, CHC shRNA n=9. Time trace: ****=P<0.0001, Two-way ANOVA Bonferroni 
post-test. Bar charts: ****=p<0.0001, Student’s  t-test. 
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Figure 5.21 Silencing Network Activity Does Not Ameliorate Effect of CHC Knock Down on 
Synaptophysin-pHluorin Retrieval 
A) Hippocampal neurons co-transfected with either control scrambled shRNA vector 
(Scrambled shRNA) or CHC shRNA and synaptophysin-pHluorin    (syp-pH) had incubation 
medium supplemented with 100 nM TTX for 48 hr previous to experiment. Hippocampal 
imaging buffer was perfused continuously throughout experiment. Cells were stimulated with 
a HFS train (400 AP, 40 Hz). B) Average time trace + SEM with stimulation indicated by 
black bar. C) Average peak heights of each condition (F/F0) + SEM. D) Average extent of 
syp-pH retrieval (endocytosis) measured as a percentage of exocytosis F/F0 + SEM. 
Scrambled shRNA n=5, CHC shRNA n=4. Time trace: ****=P<0.0001, Two-way ANOVA 
Bonferroni post-test. Bar charts: **=p<0.01, Student’s t-test 
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where CME is dominant at low frequencies and ADBE is dominant at high 
frequencies. 
To investigate how physiological temperatures impact on the trafficking of SV cargo 
via CME, clathrin-cage formation during a HFS at 37 ºC was inhibited using Pitstop-
2. CGNs transfected with syp-pH were perfused with imaging buffer heated to a 
constant temperature of 37 ºC, which was supplemented with or without Pitstop-2 8-
12 seconds before stimulation (Figure 5.22 A).  
Pitstop-2 exposure resulted in an average of 33% of exocytosed syp-pH remaining in 
a neutral environment at a time point where control cells had fully retrieved all 
exocytosed syp-pH (Figure 5.22 B and D). This results shows a clathrin-dependent 
mechanism in the recycling of syp-pH even at physiological temperatures. 
To further test the role of clathrin in syp-pH recycling at physiological temperatures 
a CHC shRNA vector was used. Hippocampal cells were chosen for this experiment 
as it has been noted that CHC knockdown in CGNs, but not hippocampal neurons, 
causes an inhibition of ADBE (see Figure 5.16). Hippocampal neurons co-
transfected with syp-pH and either CHC shRNA or its scrambled control were then 
perfused with hippocampal imaging buffer at a constant temperature of 37 ºC and an 
otherwise standard “single HFS” experiment was performed (Figure 5.23 A). 
Clathrin-depleted cells showed a significantly different fluorescent response to HFS 
when compared to scrambled controls (Figure 5.23 B). The presence of CHC shRNA 
resulted in 70% of all exocytosed syp-pH remaining in a neutral environment (Figure 
5.23 D) at a time point when scrambled control had fully retrieved all exocytosed 
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syp-pH. These results together show an integral role for clathrin in the recycling of 
syp-pH at physiological temperatures at levels comparable to those seen at room 
temperature. This shows that clathrin-independent ADBE does not acquire a role in 






Figure 5.22 Pharmacological Inhibition Shows a Role for Clathrin in CGNs at Physiological 
Temperatures 
A) CGNs transfected with synaptophysin-pHluorin (syp-pH) were incubated with imaging 
buffer for 10 minutes prior to stimulation and perfused with imaging buffer heated 
continuously to 37 ºC onwards (control) supplemented with Pitstop-2 8-12 seconds before 
stimulation (Pitstop-2). Cells were stimulated with a HFS train (400 AP, 40 Hz). B) Average 
time trace + SEM is displayed with stimulation indicated by black bar. C) Average peak 
heights of each condition (F/F0) + SEM. D) Average extent of syp-pH retrieval (endocytosis) 
measured as a percentage of exocytosis F/F0 + SEM. Control n=7, Pitstop-2 n=8. Time 
trace: ****=P<0.0001, Two-way ANOVA. Bar charts: ****=p<0.0001, Student’s t-test. 
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Figure 5.23 Genetic Inhibition Shows a Role for Clathrin in Hippocampal Neurons at 
Physiological Temperatures 
A) Hippocampal neurons co-transfected a control scrambled shRNA (Scrambled shRNA) or 
CHC shRNA and synaptophysin-pHluorin (syp-pH) were perfused with hippocampal 
imaging buffer heated continuously to 37 ºC. Cells were stimulated with a HFS train (400 
AP, 40 Hz). B) Average time trace + SEM is displayed with stimulation indicated by black 
bar. C) Average peak heights of each condition (F/F0) + SEM. D) Average extent of syp-pH 
retrieval (endocytosis) measured as a percentage of exocytosis F/F0 + SEM. Scrambled 
shRNA n=5, CHC shRNA n=4. Time trace: ***=p<0.001, Two-way ANOVA. Bar charts: 
**=p<0.01, Student’s t-test. 
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5.3 Discussion 
The maintenance of neurotransmission is reliant on the specific and efficient retrieval 
of deposited SV cargo with the correct stoichiometry, forming fusion-competent SVs 
for future rounds of exo- and endocytosis. This is performed via a complex set of 
relationships between adaptor proteins and their cargo, recruiting and sorting the 
correct constituents from the active zone. These presynaptic adaptor-cargo 
relationships have so far been specifically identified in the context of CME. There is 
currently very little known about the specificity of ADBE in retrieving SV cargo 
during HFS.  
It has been proposed that cargo sorting onto SVs occurs predominantly on the 
endosome after scission (Clayton & Cousin 2009). This is due to the rapid nature of 
ADBE as well as the requirement for both AP-1 and AP-3 at the budding stage. The 
need for adaptor proteins may suggest that SV protein uptake is fairly non-selective 
during ADBE itself and that cargo sorting predominantly occurs on the endosome 
during this process (Cheung & Cousin 2012). 
Using several approaches, it has been shown here that pHluorin-tagged versions of 
many SV proteins, currently widely used to investigate the recycling of their 
endogenous counterparts, are not being recycled via ADBE after HFS.  
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5.3.1 Inhibition of ADBE Does Not Result in Altered Trafficking of a 
Variety of pHluorins in Different Cell Types 
The effect of acute inhibition of ADBE on the recycling of syp-pH during HFS was 
assessed utilising the necessity for the rephosphorylation of dynamin I for 
consecutive rounds of ADBE (Tan et al. 2003). CT99021 and roscovitine inhibit this 
rephosphorylation, causing inhibition of ADBE on a second HFS (Clayton et al. 
2010).  
Effects on the priming stimulus as a result of drug exposure were noted, the 
application of CT caused a decreased syp-pH peak height to the S1 (control: 0.41 + 
0.06, CT: 0.24 + 0.04), this reduction was consistent across both stimulations (S2 – 
control: 0.41 + 0.07, CT 0.26 + 0.02). The lack of difference in peak height between 
S1 and S2 implies that this difference is not associated with an effect of CT on 
ADBE and is due to off-target effects. The resultant ratio of peak heights was 
consistent with all other conditions (Figure 5.2 F). This effect was not seen with 
other pHluorins used. 
Our results would suggest that ADBE has no significant contribution to the recycling 
of syp-pH, sybII-pH, tagmin-pH and vGlut-pH. As these pHluorins utilise the same 
adaptor proteins as their endogenously expressed counterparts it could therefore be 
concluded that the same is true for the endogenous SV proteins.  
The knockdown of syndapin I and chronic inhibition of ADBE had no effect on 
either release or retrieval of syp-pH during HFS. Further implying that ADBE does 
not play a role in the retrieval of synaptophysin-pHluorin during HFS.  
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Another approach to this study would be through the use of a syndapin I 
“knocksideways” experiment. Rapamycin is used to form a heterodimer between an 
exogenously expressed protein of interest tagged with an FKBP domain and a 
mitochondrial marker containing a complimentary FRB domain, rapidly re-routing 
the protein of interest. If this is done in a cell which has also been depleted of its 
endogenous protein of interest this is termed “knocksideways” (Robinson et al. 2010) 
and allows one to visualise the effect of an almost instantaneous knockdown. This 
has advantages over the procedures used here as it precludes the possibility of any 
confounding off-target drug effects cause by pharmacological intervention or 
compensatory mechanisms caused by a chronic knockdown. However, an FKBP-
tagged protein which is re-routed may also carry with it any proteins with which it is 
bound. Therefore, any functional effect seen upon rapamycin exposure may also be 
due to a re-routing of these binding partners. 
However, I achieved consistent results between acute pharmacological and chronic 
knockdown inhibition of ADBE and the knockdown used here did not result in a 
phenotype that would suggest injury to transfected cells. As such, I am confident in 
these results. 
5.3.2 No disparity is Seen Between Acid-Accessible pHluorin Pre- and 
Post-Stimulation 
The rate of CME as measured by quenching of fluorescence of internalised pHluorin 
has been measured as being rapid (4-5 sec) (Sankaranarayanan & Ryan 2000; Atluri 
& Ryan 2006). Although it has been suggested a slower acidification rate of 15 
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seconds (Egashira et al. 2015), this was only detectable utilising SV proteins tagged 
to mOrange.  
The probes mOrange and pHluorin differ in pKa (the pH at which half of the probes 
molecules are protonated), with values of 6.5 (Shaner et al. 2008) and 7.1 
(Sankaranarayanan & Ryan 2000) respectively. This means that mOrange is a more 
accurate tool to measure the later stages of vesicle acidification. However, mOrange 
is not entirely quenched inside a fully acidified vesicle SV, meaning it would not be 
an appropriate tool for some of the experiments here such as the acid-wash assays.  
It is known that the fluorescence of pHluorins used in this thesis are rapidly 
quenched when internalised via CME. As pHluorin is used for each experiment 
discussed in this thesis, and an attempt to infer information as to the time taken until 
full acidification of a structure after endocytosis was not made, it is a suitable tool for 
these experiments. 
Using acidic washes and HFS I found no evidence of syp-pH retrieving via any 
structure which it is not immediately acidified. These results are in concordance with 
previous data acquired at lower frequencies (Sankaranarayanan & Ryan 2000) in 
which conditions ADBE is not active. 
The lack of evidence for sequestered syp-pH after HFS would indicate no role for 
ADBE in the retrieval of syp-pH in conditions when it is the dominant form of 
endocytosis. 
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5.3.3 Inhibition of CME Results in Massive Deficits in syp-pH 
Retrieval 
The effects of inhibiting CME was investigated through different means. Firstly via 
Pitstop-2 which inhibits the interaction between clathrin and adaptor protein-2 (AP-
2) (Von Kleist et al. 2011) effectively inhibiting the formation of a clathrin-coated pit 
leading to inhibition of CME.  
Inhibiting CME pharmacologically resulted in a dramatic inhibition of syp-pH 
retrieval during a stimulation protocol in which CME is not the dominant form of 
endocytosis. 
In a recent paper it was suggested that pHluorins should not be utilised in 
conjunction with pitstop-2 due to an undefined effect on vesicle acidity (Hua et al. 
2013). However, I have shown that this caution was not relevant here; the innate 
fluorescence of a pHluorin-transfected cell does increase after exposure to pitstop-2, 
but only after the period of time in which the other experiments using this drug were 
completed. 
Another concern with the use of pitstop-2 is due to its “non-specificity” (Willox et al. 
2014). It has been noted that the inhibition of CME caused by exposure to pitstop-2 
is not purely a result of its action on the N-terminal domain of clathrin heavy-chain 
as was previously believed. As such, no assumptions should be drawn about this 
domain from experiments with pitstop-2. However, as pitstop-2 is a potent inhibitor 
of CME and as I was not probing for functions of specific domains within the 
clathrin complex, pitstop-2 is a suitable tool for these purposes. 
259 
A knockdown of CHC was also utilised to investigate the effects of inhibiting CME 
on pHluorin retrieval. Using the same shRNA and scrambled controls a knockdown 
of 75% (CGNs) or 80% (hippocampal neurons) of CHC was seen in comparison to 
non-transfected controls. Using this shRNA, a significant inhibition of syp-pH 
retrieval was seen in both CGNs and hippocampal cells for LFS (300 AP, 10 Hz) and 
HFS (400 AP, 40 Hz) showing that whether CME is the dominant form of 
endocytosis or not, it has a major role in the trafficking of syp-pH across different 
cell types. 
An unusual finding within this dataset was that the knockdown of CHC causes an 
inhibition of ADBE as measured by dextran in CGNs but not hippocampal neurons. 
Although it is not certain why this may be, one possibility is that it is due to the 
different culture conditions of the two cell types. CGNs are unusual in that they are 
cultured in permanently depolarising conditions (Burgoyne & Cambray-Deakin 
1988). This means ADBE is active throughout the period of culture for CGNs, 
whereas it is not in hippocampal neurons. Since CHC is also necessary for the 
budding of SVs from bulk endosomes (Heerssen et al. 2008; Kasprowicz et al. 2008; 
Kononenko et al. 2014) it is possible that with a knockdown of CHC in CGNs there 
is a build-up of un-budded endosomes. Any proteins essential for ADBE may remain 
sequestered on these endosomes, leading to an inability to form new endosomes from 
the PM upon stimulation. In support of this theory, the inhibition of CME acutely via 
pitstop-2 does not cause an inhibition of ADBE in CGNs as measured by dextran 
uptake. 
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Previous work focussing on the role of clathrin or CME in pHluorin retrieval have 
yielded varied results. Granseth et al. used CHC siRNA to reveal the role for CME in 
syp-pH retrieval. Their group found significant inhibition in syp-pH retrieval in a 
CHC-depleted cell in comparable levels to work shown here with both 4 and 40 AP 
at 20 Hz stimulation (Granseth et al. 2006). This is in agreement with my findings. 
However, another study using CHC shRNA showed an effect of CHC-depletion on 
tagmin-pH retrieval only during mild stimulation (200 AP, 5 Hz ) and a lack of any 
inhibition on the retrieval of tagmin-pH during a high frequency stimulus train (200 
AP, 40 Hz) (Kononenko et al. 2014). To address this anomalous result these 
experiments were recreated here, using tagmin-pH as opposed to syp-pH and the 
slightly different stimulation protocol used by Kononenko et al. of 200 AP, 40 Hz. In 
these experiments, a significant inhibition in tagmin-pH was seen using this 
experimental paradigm. 
The reasons for the conflicting findings in this area are undetermined. The cell type 
and stimulation profile used is identical, although the buffers utilised for imaging are 
different. The resultant levels of CHC after knockdown were also comparable, 
although the method of shRNA delivery was different. Kononenko et al. utilised a 
lentiviral vector which preferentially infects excitatory neurons (Nathanson et al. 
2009). It is possible that a culture-wide infection of excitatory neurons with CHC 
shRNA would reduce glutamatergic transmission, leading to a decrease in 
spontaneous activity within the culture. To control for this possible discrepancy, 
hippocampal neurons co-transfected with CHC shRNA or its scrambled control and 
syp-pH were exposed to tetrodotoxin for 48 hours, silencing the culture prior to the 
261 
same stimulation. Using this protocol, a comparable level of inhibition in syp-pH 
retrieval was seen to that in previous experiments with CHC shRNA, contradicting 
those seen by Kononenko et al.. 
Further work could be done to identify the causes for these inconsistent results. A 
recent paper has noted a large variability of CHC knockdown efficacy even within 
cells exposed to the same shRNA (López-Murcia et al. 2014). This could be an 
explanation as to inconsistent results found between different laboratories. This work 
also found a correlation between resultant level of CHC after knockdown and its 
functional effect in autaptic synapses.  
Other CME-essential machinery has been examined in previous studies as to their 
role in SV protein retrieval. Knockdowns of subunits of AP-2 have shown marked 
effects on the kinetics of endocytosis of a multitude of pHluorin-tagged SV proteins 
during mild stimulation (Kim & Ryan 2009; Kononenko et al. 2014). Effects on 
retrieval during HFS has been less intensively examined. One study observed an 
effect of AP-2 knockdown on tagmin-pH retrieval at low frequencies which was lost 
at high frequencies (Kononenko et al. 2014). However, another found endocytic 
slowing of vGlut-pH retrieval at higher frequencies (Foss et al. 2013). 
Knockdowns are not an ideal system to test for the role of a protein. This is due to 
the possibility of compensatory effects or, in the case of CHC, injury to the cells 
especially after a 7-day transfection such as is utilised for hippocampal neurons. A 
loss of CHC over a prolonged period may affect the health of a neuron due to the loss 
of spontaneous activity.  
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An observably unhealthy cell or nerve terminal would usually be excluded from a 
data-set. This is accomplished due to its characteristic lack of pHluorin retrieval after 
stimulation. Any nerve terminals exhibiting these traces are routinely screened out 
during data analysis. However, as this characteristic is the resultant phenotype of 
CHC knockdown, the same screening protocols could not be conducted on both 
conditions in these experiments. To ensure there was no bias in the analysis of these 
results a separate analysis was performed including all nerve terminals which 
responded to stimulation with an increase in fluorescence. This was performed in 
both conditions, regardless of whether this fluorescence then decreased. The results 
were consistent. Although the control condition average traces no longer appeared to 
retrieve as quickly or efficiently due to the inclusion of these “unhealthy” traces, 
there was still a significant difference between fluorescent traces from control and 
CHC knockdown neurons, in which syp-pH retrieval was severely impaired after 
HFS (data not shown). 
Unhealthy cells are symptomatic of a chronic removal of an essential protein. 
However, due to the high level of reproducibility between cell types, stimulation 
intensities and means of CME intervention (both chronic and acute), as well as 
corroborative results from another, independent team I am confident that the 
inhibition seen here with the knockdown of CHC is due to a real effect on the 
retrieval of pHluorins caused by the inhibition of CME during HFS.  
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5.3.4 ADBE Does Not Gain New Roles in pHluorin Recycling at 
Physiological Temperatures  
Recent work using the extremely rapid “flash and freeze” fixation process has shown 
that single AP stimulation elicits an entirely different endocytic mode exclusively at 
physiological temperatures (34-37 ºC): ultrafast endocytosis. 
Ultrafast endocytosis forms large vesicles (60-80 nm diameter) from the PM by 
means of actin polymerisation which can be seen fully formed in the synapse as little 
as 50 ms after a single action potential (Watanabe, Rost, et al. 2013). Although 
ultrafast endocytosis is clathrin-independent, the large endocytic vesicles created bud 
into SVs via a clathrin-dependent mechanism after around 3 seconds (Watanabe et al. 
2014).  
The molecular physiology of a large endocytic vesicle formed via ultrafast 
endocytosis has not been studied and as such it is not known which, if any, SV cargo 
proteins are retrieved via this mechanism. Although, since it appears that CME does 
not occur during these stimulation conditions (Watanabe et al. 2014) one would 
assume that ultrafast endocytosis would be responsible for recycling deposited SV 
proteins. However, studies have not yet investigated whether action potential trains 
would evoke ultrafast endocytosis at physiological temperatures or if CME activation 
would then be required for the retrieval of SV cargo. 
To assess the function of clathrin at physiological temperatures pitstop-2 was used. It 
was found that the inhibition of syp-pH retrieval in the presence of pitstop-2 was not 
as pronounced at physiological temperatures as at room temperature. One reason for 
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this could be the pitstop-2 itself; it is stable at room temperature for a period of hours 
but it is not known what happens to the compound when heated to 37 ºC. It is 
possible that in these conditions the drug has started to degrade by the time it reaches 
the culture leading to a lower efficiency, as such these results should be treated with 
caution.  
It is also possible that at physiological temperature, syp-pH retrieval is less reliant on 
CME as another, high capacity form of clathrin-independent endocytosis has been 
activated: ultrafast endocytosis. 
However, experiments utilising the same CHC shRNA as previously conducted at 
this new temperature resulted in a comparable inhibition of syp-pH retrieval as that 
seen at room temperature. This implies that the muted effect on syp-pH retrieval seen 
at physiological temperatures using pitstop-2 is more likely due to a deactivation of 
the compound due to its heating prior to exposure to the cell.  
The inhibition of clathrin function in these conditions, either through 
pharmacological intervention or through CHC knockdown, will cause not only the 
inhibition of CME from the PM but also the budding of SVs from any large ultrafast 
vesicles. Both of these processes would occur within the timeframe of the 
experiments described. As it is unknown whether ultrafast large vesicles acidify 
before or after budding it should be remembered that what is being visualised here in 
the retrieval of syp-pH is the role of clathrin and not specifically of CME. However, 
the differences in diameter between these two structures would mean an acidification 
time around twice as long for an ultrafast vesicle as a SV.  
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In summary, I have shown through various manipulations of both CME and ADBE 
that a variety of SV cargoes are predominantly retrieved via clathrin-dependent 
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6. VAMP4 is a Specific and Necessary Cargo for ADBE 
6.1 Introduction 
The formation of functional, fusion-competent SVs requires the incorporation of the 
correct protein cargo with the appropriate stoichiometry (Ashby et al. 2006). CME 
efficiently retrieves SV cargo deposited into the PM during exocytosis via a clathrin 
coat and a series of different adaptor proteins (Rao et al. 2012; Kelly & Owen 2011).  
Bulk endosome formation is a rapid, high capacity means of retrieving membrane 
during intense stimulation (Clayton et al. 2008). However, results acquired and 
detailed in the previous chapter would suggest that ADBE does not retrieve a 
substantial proportion of many SV cargoes.  
ADBE is thought to be clathrin-independent as inactivation or knockdown of clathrin 
does not affect the formation of bulk endosomes as measured by FM-dye uptake 
(Heerssen et al. 2008; Kasprowicz et al. 2008) or electron microscopy (Kononenko et 
al. 2014) (but see Figure 5.16) in neurons. It is unknown if any adaptor proteins or 
SV cargo are involved with specificity for ADBE or ultrafast endocytosis at the PM.  
SVs formed via ADBE repopulate the reserve pool, a population of SVs which are 
only mobilised during intense stimulation and after the synchronous release of the 
RRP (Richards et al. 2003; Cheung et al. 2010). This would imply that they possess a 
specific molecular identity allowing them to be recognised and shuttled to the 
appropriate pool. This also implies that SVs formed from bulk endosomes gain the 
necessary cargo proteins to be fusion-competent. However, as was shown in the 
previous chapter, this does not occur via retrieval from the PM. One possibility is 
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that these SVs are shuttled through an endosomal intermediate, equipping them with 
the SV proteins required to allow future exocytosis. 
I aimed to determine if any cargo proteins were retrieved from the PM via ADBE. If 
so, I also aimed to identify any adaptor proteins which may facilitate this retrieval. 
The existence of such would allow ADBE-derived SVs a specific protein 
composition, allowing their recognition and appropriate shuttling to vesicle pools or 
endosomal intermediates. 
To examine this possibility, a candidate ADBE-retrieved SV protein was needed. 
The SV protein VAMP4 was chosen as VAMP4-pHluorin (VAMP4-pH) exhibits an 
unusual fluorescence change upon stimulation at higher frequencies in hippocampal 
cells (Raingo et al. 2012). On such HFS VAMP4-pH reports an activity-dependent 
decrease in fluorescence. This is the opposite to the majority of pHluorins which 
show a dramatic increase in fluorescence during such stimuli. It is possible that this 
activity-dependent decrease in fluorescence could denote a retrieval of VAMP4-pH 
via ADBE. 
It is possible ADBE is responsible for generating SVs that mediate asynchronous 
release making VAMP4 of particular interest as a potential ADBE cargo due to its 
role in mediating asynchronous neurotransmitter release (Raingo et al. 2012). Up- or 
downregulation of VAMP4 expression in mouse hippocampal cells caused a 
correlative effect on the amount of asynchronous release. AP-3b2 knock out mice 
have a decreased capacity for asynchronous release (Evstratova et al. 2014) and AP-3 
is known to be essential for the budding of SVs from a bulk endosome (Cheung & 
Cousin 2012).  
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It has been proposed that the ratio of synaptobrevin II to VAMP4 dictates in which 
pool an SV resides (Raingo et al. 2012). The model proposed is thus: SVs containing 
a high abundance of synaptobrevin II and a lower abundance of VAMP4 are directed 
for synchronous release, whereas SVs with a higher abundance of VAMP4 compared 
to synaptobrevin II are utilised to sustain asynchronous release. As bulk endosomes 
show a de-enrichment of synaptobrevin II (Nicholson-Fish et al. 2015) it is possible 
that uptake of VAMP4 via ADBE forms SVs with a distinct molecular signature, 
directing them to maintain a SV pool responsible for mediating asynchronous 
release.  
I aimed to investigate the possibility that SVs with a higher proportion of VAMP4 
molecules are formed via ADBE. The retrieval of the pHluorin-tagged VAMP4 




6.2.1 The VAMP4-pHluorin Response Differs Between High and Low 
Frequency Stimulation 
VAMP4-pH has been identified as a potential reporter of ADBE due to its unusual 
fluorescence change upon HFS (Raingo et al. 2012). However, in this study the 
response of VAMP4-pH to milder stimulation was not examined. This is important 
as ADBE does not occur during mild stimulation and any differences observed in the 
response of VAMP4-pH between high and low frequency stimulation could reveal 
differential trafficking that should be characteristic of an ADBE cargo protein.  
Firstly, VAMP4-pH retrieval in CGNs at different stimulation intensities was 
investigated. Co-transfection of mCer with VAMP4-pH allowed identification of 
transfected neurites as VAMP4-pH has a low basal fluorescence. The VAMP4-pH 
fluorescence of transfected cells was recorded as they were stimulated with a train of 
300 AP at 10 Hz (LFS) to selectively stimulate CME, or 400 AP at 40 Hz (HFS) to 
initiate both CME and ADBE (Figure 6.1 A).  
The fluorescence of individual nerve terminals expressing VAMP4-pH was plotted 
over time (Figure 6.1 B and C). After a LFS, nerve terminals predominantly 
displayed an increase in fluorescence after stimulation (Figure 6.1 B). This resulted 
in an average trace which has a small but steady increase in fluorescence over time. 
This is in agreement with Raingo et al. as this is potentially the reporting of 
asynchronous release of SVs containing VAMP4-pH. These responses have been 
termed “upstrokes” as they continue to increase after stimulation terminates.  
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After HFS, a large proportion of synapses exhibited a decrease in fluorescence below 
baseline after stimulation terminated (termed “downstrokes”) as well as a smaller 
proportion still exhibiting upstrokes. This results in an average trace which remains 
relatively stable during and after stimulation (Figure 6.1 C). When proportions of 
synapses exhibiting either upstrokes or downstrokes are compared between LFS and 
HFS, there are significantly more nerve terminals exhibiting downstrokes in 
fluorescence during HFS (Figure 6.1 D). This suggests that during HFS VAMP4-pH 
is being internalised through an endocytic mode which does not occur during or after 
LFS. It is possible that these slow downstrokes represent a slowly acidifying 
endosome. 
To determine whether this activity-dependent response profile was specific to CGNs 
or common across multiple cell types, the same experiments were conducted in 
hippocampal neurons (Figure 6.2 A). After LFS, VAMP4-pH transfected 
hippocampal cells displayed an average fluorescence trace which increased over time 
(Figure 6.2 B) in concordance with VAMP4-pH response in CGNs. 
Hippocampal cells exposed to HFS, unlike CGNs, exhibited an immediate decrease 
in fluorescence. The rapid nature of this downstroke may suggest something other 
than bulk endosome acidification and may be due to an increased rate of CME during 
HFS. This immediate decrease was then followed by either slow increases or 
decreases in fluorescence after stimulation, in a similar manner and magnitude to that 
observed in CGNs (Figure 6.2 C). These slower changes are defined as upstrokes and 
downstrokes for hippocampal neurons. When comparing the proportions of synapses 
exhibiting upstrokes versus downstrokes in fluorescence, there is a significant 
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increase in the proportion of downstrokes in cells during HFS compared to LFS 
(Figure 6.2 D).  
The initial decrease followed by either an upstroke or downstroke in fluorescence 
described can also be directly observed when viewing time-lapse images. Focussing 
on individual nerve terminals one can see that, upon stimulation, the fluorescence of 
a responsive nerve terminal sharply decreases, followed by a bidirectional change in 
fluorescence over a longer period of time (Figure 6.3). 
Hippocampal neurons and CGNs both display a significant increase in the number of 
nerve terminals displaying downstrokes in fluorescence after HFS. CGNs show an 
average proportion of around 60% of synapses displaying downstrokes. In 
agreement, previous work has identified that only a subpopulation of CGN nerve 
terminals undergo ADBE during intense stimulation as measured by dextran uptake 
(Clayton & Cousin 2009). This was also the case with hippocampal nerve terminals, 
however this subpopulation was found to be smaller than present in CGNs (Wenzel 
et al. 2012). In agreement, the experiments conducted here revealed that the 
proportion of hippocampal cell nerve terminals displaying downstrokes was smaller 
than in CGNs, around 40%.  
The different response profiles between HFS and LFS in both hippocampal neurons 
and CGNs would suggest that this pHluorin is being trafficked via different 
endocytic modes in an activity-dependent manner. ADBE is the dominant form of 
endocytosis during HFS. As such, it is possible that the downstrokes in VAMP4-pH 
fluorescence observed almost entirely during HFS are in fact nerve terminals in 
which VAMP4-pH has been internalised via ADBE. The slow decrease in 
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fluorescence that persists after HFS could therefore be an indicator of the slow 
acidification kinetics of a bulk endosome. 
In addition to the hypothesis presented above, there are other potential explanations 
for the appearance of VAMP4-pH downstrokes during HFS. One possibility is that 
the decrease in fluorescence is not due to an acidification, but due to relocation of 
VAMP4-pH from the area of the allocated ROI used to measure fluorescence 
intensity. To test this, a dataset from a previous experiment using hippocampal 
neurons transfected with VAMP4-pH (Figure 6.4 A) was re-analysed. Firstly, 
standard 3x3 pixel ROIs were placed over synapses (Figure 6.4 B) and fluorescence 
within these ROIs was monitored over time. These ROIs were then increased in 
diameter to form 6x6 pixel ROIs (Figure 6.4 C) and again fluorescence within these 
ROIs was measured over time. 
When traces from both ROI sets were averaged and overlaid there was no difference 
observed (Figure 6.4 D) and the same characteristics were seen; an immediate 
downstroke followed by a diversity of upstrokes or downstrokes. This shows the 
immediate decrease and any changes after this were not due to an escape of VAMP4-
pH from the nerve terminal. 
6.2.2 Pharmacological Inhibition of ADBE Inhibits VAMP4-pHluorin 
Downstrokes 
So far experiments using VAMP4-pH in both hippocampal neurons and CGNs have 
indicated a difference in its fluorescent response between HFS and LFS, with a large 
population of synapses exhibiting a slow decrease in fluorescence after HFS only. 
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Figure 6.1 VAMP4-pHluorin Responds Differently between Stimulation Intensities in CGNs 
A) CGNs co-transfected empty mCer vector and VAMP4-pHluorin (VAMP-pH) were 
incubated in imaging buffer for 10 mins prior to stimulation and then continuously onwards. 
Cells were stimulated with a LFS or HFS train (300 AP, 10 Hz or 400 AP, 40 Hz 
respectively). B and C) Representative averages (grey) LFS and HFS time trace 
respectively with separated populations of increasing (Up, red) and decreasing (Down, 
blue) fluorescence + SEM with stimulation indicated by black bar. D) Average proportions 
of synapses within a transfected cell increasing (Up) or decreasing (Down) in VAMP4-pH 
fluorescence after stimulation + SEM. 10 Hz 30 sec n=5, 40 Hz 10  n=7. ***=p<0.001. 
Student’s t-test between conditions. 
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Figure 6.2 VAMP4-pHluorin Responds Differently between Stimulation Intensities in 
Hippocampal Neurons 
A) Hippocampal neurons co-transfected empty mCer vector and VAMP4-pHluorin (VAMP-
pH) were perfused with continuously. Cells were stimulated with a LFS or HFS train (300 AP, 
10 Hz or 400 AP, 40 Hz respectively). B and C) Representative averages (grey) LFS and 
HFS time trace respectively with separated populations of increasing (Up, red) and 
decreasing (Down, blue) fluorescence + SEM with stimulation indicated by black bar. D) 
Average proportions of synapses within a transfected cell increasing (Up) or decreasing 
(Down) in VAMP4-pH fluorescence after stimulation + SEM. 10 Hz 30 sec n=3, 40 Hz 10  
n=4. *=p<0.05. Student’s t-test between conditions. 
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Figure 6.3 Bi-Directional Changes in VAMP4-pH Fluorescence are Directly Visible During 
Image Acquisition 
Hippocampal neurons transfected with VAMP4-pH before (left) during (middle) and after 
(right) HFS (400 AP, 40 Hz). All arrows indicate responsive synapses, which decrease in 
fluorescence during stimulation. After stimulation has cease, each responsive synapse 
continues to either increase in fluorescence (“upstrokes”, white arrows) or decrease in 




Figure 6.4 Evoked Decrease in VAMP4-pH Fluorescence is not due to its Escape from the 
Nerve Terminal 
A) Hippocampal neurons transfected with VAMP4-pH were perfused continuously with 
hippocampal imaging buffer. Cells were stimulated with a HFS train (400 AP, 40 Hz). B) 
3x3 pixel ROIs were placed over synapses as revealed by an ammonia imaging buffer 
pulse and fluorescence monitored over time. C) These ROIs were then increased in 
diameter to 6x6 pixels and fluorescence monitored over time. D) Time traces of VAMP-pH 
fluorescence + SEM from 3x3 pixel ROIs (black) and 6x6 pixel ROIs (grey) overlaid. 
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I next tested the hypothesis that observed downstrokes in VAMP4-pH fluorescence 
during HFS represent VAMP4-pH internalised in a slowly acidifying bulk endosome. 
This was done via the pharmacological inhibition of ADBE. CGNs co-transfected 
with VAMP4-pH and an empty mCer vector were stimulated with 2 HFS trains 10 
minutes apart, with or without the GSK3 inhibitor CT99021 (CT, 10 µM) (Figure 6.5 
A) in an identical “S1 S2” protocol to that performed previously on cells expressing 
syp-pH, vGlut-pH, tagmin-pH and sybII-pH (see Figure 5.2, Figure 5.3, Figure 5.4 
and Figure 5.5 respectively). This protocol allows visualisation of effects on 
VAMP4-pH trafficking during an acute inhibition of ADBE at S2. 
For control conditions, both S1 and S2 exhibited the same proportion of each type of 
response as seen with a single HFS (Figure 6.5 B), however there was little 
uniformity of response per nerve terminal between S1 and S2 i.e. a typical nerve 
terminal exhibiting an upstroke during S1 could exhibit either an up- or downstroke 
during S2 and vice versa (Figure 6.6). The resultant diversity of responses led to four 
classifications of responsive nerve terminals: 
 S1 Upstroke, S2 Upstroke 
 S1 Upstroke, S2 Downstroke 
 S1 Downstroke, S2 Upstroke 
 S1 Downstroke, S2 Downstroke 
These were then grouped based on the response of a nerve terminal per stimulation 
e.g. the “S1 Up” group included nerve terminals that exhibited an upstroke after S1 
regardless of which response occurred on S2 (Table 6.1).  
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Table 6.1 Grouping of VAMP4-pH transfected Synapses by Fluorescence Response 
after Stimulation 
Control cells showed the same proportion of upstrokes and downstrokes over both S1 
and S2. In the presence of CT, the same proportions of upstrokes and downstrokes 
were seen during the S1 as in control cells (Figure 6.5 C), this indicates there is no 
effect of CT exposure on the retrieval of VAMP4-pH during the priming stimulus. 
However, in the presence of CT there was a significant reduction in the proportion of 
synapses exhibiting a downstroke after S2 (in which ADBE had been inhibited) 
(Figure 6.5 C). 
These results support the hypothesis that the slow downstrokes in VAMP4-pH 
fluorescence after HFS represent VAMP4-pH molecules that have been retrieved via 
ADBE and are contained within a slowly acidifying bulk endosome. 
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Figure 6.5  Pharmacological Inhibition of ADBE Inhibits VAMP4-pHluorin Downstrokes 
A) CGNs co-transfected empty mCer vector and VAMP4-pHluorin (VAMP-pH) were 
incubated in imaging buffer for 10 mins before being incubated in imaging buffer alone 
(control) or supplemented with 2 µM CT99021 (CT) for 10 minutes prior to S1 and then 
continuously onwards. Cells were challenged with 2 sequential HFS trains (400 AP, 40 Hz) 
(S1 and S2) 10 minutes apart. B) Representative control time course depicting decay 
corrected responses of all responding synapses on one transfected cell normalised to NH+ 
pulse (grey band). C) Average proportions of synapses within a transfected cell increasing 
(Up) or decreasing (Down) in VAMP4-pH fluorescence after S1 and S2 + SEM. Control 
n=5, CT n=7. **=p<0.01. Student’s t-test Control Vs CT S1 and S2. 
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Figure 6.6 Example of Diversity of Responses Within VAMP4-pH "S1 S2" Experiment 
Representative VAMP4-pH fluorescence traces from individual nerve terminals of one 
transfected CGN. Each of the four classifications of responses is represented: S1 “Down” 
S2 “Down” (top left), S1 “Down” S2 “Up” (top right), S1 “Up” S2 “Down” (bottom left), S1 
“Up” S2 “Up” (bottom right). Black bars represent stimulation. 
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Interestingly, the proportions of upstrokes and downstrokes were consistent across 
S1 and S2 for control cells even though the identity of those nerve terminals 
displaying a downstroke differs between the two stimulations. Thus transfected cells 
display a consistent proportion of nerve terminals undergoing ADBE across 
sequential stimuli, even though the subpopulation of nerve terminals undergoing 
ADBE is altered between stimulations (Figure 6.6). 
6.2.3 Genetic Inhibition of ADBE Inhibits Downstrokes of VAMP4-
pHluorin After HFS 
VAMP4-pH is unique amongst the SV proteins tested here in that the inhibition of 
ADBE has a pronounced effect on its retrieval profile when compared to a control 
stimulus.   
A separate manoeuvre was used to confirm that VAMP4-pH fluorescence 
downstrokes represent the quenching of pHluorin molecules which have been 
internalised by ADBE. Syndapin I shRNA was utilised to inhibit ADBE in an 
identical protocol as used previously with syp-pH (see 5.2.2). 
CGNs co-expressing VAMP4-pH and either an empty mCer-pSuper vector or mCer-
pSuper vector expressing syndapin shRNA were subjected to a single HFS (Figure 
6.7 A).  
CGNs expressing the control pSuper vector exhibited the same, stable average 
fluorescence trace as seen previously, appearing relatively flat due to individual 
boutons exhibiting either an increase or decrease in fluorescence. In contrast, the 
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average response of CGNs expressing syndapin I shRNA noticeably increased in 
fluorescence after stimulation (Figure 6.7 B). This suggests an alteration in the 
number of nerve terminals displaying slow downstrokes. When the number of nerve 
terminals displaying upstrokes and downstrokes was quantified and compared, it was 
apparent that CGNs expressing the control pSuper vector showed consistent 
proportions of upstrokes and downstrokes as observed in previous CGN HFS 
experiments. This is in contrast to CGNs expressing syndapin I shRNA which 
exhibited a dramatic reduction in the proportion of nerve terminals exhibiting 
downstrokes (Figure 6.7 C). This results in the overall increase in fluorescence over 
time when compared to controls. 
These results show that VAMP4-pH retrieval is significantly affected by the 
inhibition of ADBE, whether it be via pharmacological or genetic means. This adds 
weight to the hypothesis that slow downstrokes could represent the quenching of 
VAMP4-pH fluorescence in acidifying bulk endosomes. This is an effect not seen 
with any other pHluorins tested here and as such it appears that VAMP4-pH alone 
amongst said other pHluorins is recycled via ADBE. 
6.2.4 VAMP4-pHluorin is Sequestered into a Slowly Acidifying 
Environment After High but not Low Frequency Stimulation. 
The absence of downstrokes in VAMP4-pHluorin fluorescence after LFS as well as 
after HFS with the inhibition of ADBE, collectively suggests that VAMP4-pH is 
being recovered via ADBE. If this is the case, a proportion of VAMP4-pH should be 
retrieved into a slowly acidifying compartment, with its fluorescent response  
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Figure 6.7 Genetic Inhibition of ADBE Inhibits VAMP4-pHluorin Downstrokes 
A) CGNs co-transfected with empty mCer-tagged pSuper vector (pSuper neo) or syndapin 
shRNA and VAMP4-pHluorin (VAMP4-pH) were incubated in imaging buffer for 10 mins prior 
to stimulation and then continuously onwards. Cells were stimulated with a HFS train (400 
AP, 40 Hz respectively). B) Average time traces of fluorescence + SEM with stimulation 
indicated by black bar. C) Average proportions of synapses within a transfected cell 
increasing (Up) or decreasing (Down) in VAMP4-pH fluorescence after stimulation + SEM. 
pSuper neo n=5, Syndapin shRNA n=7. *=p<0.05. Student’s t-test between conditions. 
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protected from application of an impermeant weak acid to the exterior of the cell. To 
test this hypothesis, a protocol was employed very similar to that previously designed 
to determine if syp-pH was sequestered into a slowly acidifying compartment after 
HFS (see Figure 5.9).  
CGNs co-expressing VAMP4-pH and an empty mCer vector were pulsed with 
impermeant acidic imaging buffer to evaluate the surface or “quenchable” fraction of 
the VAMP4-pH fluorescence at rest. This fraction was then compared to the 
“quenchable” portion after a LFS (300 AP, 10 Hz) or HFS (400 AP, 40 Hz) when the 
cells were quickly subjected to a second acidic imaging buffer pulse (Figure 6.8 A). 
Any difference observed between the quenchable portions of VAMP4-pH acquired 
pre- and post-stimulation could indicate molecules which have been taken up via 
ADBE and are therefore still in a neutral pH environment. One would not expect to 
identify any difference after a LFS as ADBE does not occur during these stimulation 
conditions. 
When stimulated with a LFS, the quenchable portion of VAMP4-pH fluorescence 
post-stimulation was almost identical to that before stimulation (Figure 6.8 B). When 
measured as a percentage of the pre-stimulation portion, 95% of VAMP4-pH 
previously quenched by an acid wash was still accessible to acid (Figure 6.8 C). 
Therefore, in CGNs there is no evidence of any sequestered VAMP4-pH after LFS. 
This is in agreement with the absence of ADBE during this stimulation protocol.  
When stimulated with a HFS the quenchable portion of VAMP4-pH is noticeably 
different post-stimulation to that seen with a LFS (Figure 6.8 B). Around 42% of 
VAMP4-pH that was quenchable pre-stimulation was inaccessible to acid after HFS 
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(Figure 6.8 C). This indicates that this subpopulation of pHluorin molecules has been 
internalised into a neutral pH, for example a bulk endosome. 
To determine whether this result was common to other neuronal cell types, the same 
experimental protocols were repeated in cultured hippocampal neurons (Figure 6.9 
A). As seen with CGNs, VAMP4-pH showed no evidence of sequestered pHluorin in 
an environment of neutral pH after a LFS (Figure 6.9 B and C). This is in contrast to 
the results found with HFS, where approximately 32% of previously surface-bound 
pHluorin has been sequestered away from the membrane into a slowly acidifying 
compartment after stimulation (Figure 6.9 C).  
These results further indicate that both CGNs and hippocampal neurons retrieve 
VAMP4-pH differently in response to either LFS or HFS. During LFS, VAMP4-pH 
would appear either to not be retrieved or is being retrieved via an endocytic mode 
that undergoes rapid acidification after scission from the membrane such as CME. 
During HFS, a large portion of VAMP4-pH appears to be internalised via a structure 
which takes a significantly longer period of time to acidify, such as a bulk endosome 
formed via ADBE. 
6.2.5 Pharmacological Inhibition of CME does not Alter VAMP4-
pHluorin Retrieval 
Now that it is apparent that VAMP4-pH is recovered via ADBE, it is important to 
assess what role, if any, CME plays in the retrieval of VAMP4-pH. This was firstly 
addressed using the clathrin-cage inhibitor pitstop-2 which inhibits clathrin – AP-2 
interactions (Von Kleist et al. 2011).  
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Figure 6.8 VAMP4-pHluorin is Sequestered after HFS but not LFS in CGNs 
A) CGNs co-transfected with VAMP4-pHluorin (VAMP4-pH) and mCer were repolarised 
before a control acid wash (peach bars), isolating fluorescence of surface bound VAMP4-pH. 
Cells were then stimulated with a LFS/HFS train (300 AP. 10 Hz or 400 AP, 40 Hz 
respectively) and one more acid wash performed immediately post-stimulation. B) Average 
time trace F/F0 + SEM, traces were normalised to basal fluorescence (0) and the lowest point 
of the pre-stimulation acid wash (-1). The black bar indicates location of 40 Hz 10 sec 
stimulation. C) The average difference in fluorescence drop of the post-stimulation acid wash 
as a percentage of the pre-stimulation acid wash (ΔF/F0) for 10 Hz 30 sec (grey) and 40 Hz 
10 sec (black) + SEM. 10 Hz n=5, 40 Hz n=3. ***= p<0.001. Student’s t-test. 
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Figure 6.9 VAMP4-pHluorin is Sequestered after HFS but not LFS in Hippocampal Neurons 
A) Hippocampal neurons co-transfected with VAMP4-pHluorin (VAMP4-pH) and mCer were 
given a control acid wash (peach bars), isolating fluorescence of surface bound VAMP4-
pH. Cells were then stimulated with a LFS/HFS train (300 AP. 10 Hz or 400 AP, 40 Hz 
respectively) and one more acid wash performed immediately post-stimulation. B) Average 
time trace F/F0 + SEM, traces were normalised to basal fluorescence (0) and the lowest 
point of the pre-stimulation acid wash (-1). The black bar indicates location of 40 Hz 10 sec 
stimulation. C) The average difference in fluorescence drop of the post-stimulation acid 
wash as a percentage of the pre-stimulation acid wash (ΔF/F0) for 10 Hz 30 sec (grey) and 
40 Hz 10 sec (black) + SEM. 10 Hz n=3, 40 Hz n=4 **= p<0.01. Student’s t-test. 
290 
The role of CME during LFS was assessed using a single LFS train. CGNs 
transfected with VAMP4-pH and an empty mCer vector were subjected to a stimulus 
train of 300 AP at 10 Hz. For control conditions, imaging buffer was perfused over 
the culture continuously. For pitstop-2 conditions, this imaging buffer was 
supplemented with 15 µM pitstop-2 8-12 seconds before stimulation (Figure 6.10 A). 
A significant difference was seen during stimulation when comparing fluorescence 
traces for both conditions (Figure 6.10 B). Controls cells exhibited a comparable 
response to those CGNs previously transfected with VAMP4-pH and subjected to a 
LFS train; the average trace remains fairly stable during stimulation and then exhibits 
a slow and steady increase after stimulation cessation. CGNs exposed to pitstop-2 
however exhibited an increase in fluorescence upon stimulation not usually seen in 
control cells. This significance disappears after stimulation as control cells continue 
to increase in fluorescence to a comparable level seen during stimulation in pitstop-
2-treated cells. This would imply that CME has a role in the retrieval of VAMP4-pH 
into SVs during LFS. 
The role of CME during HFS was assessed using a “S1 S2” protocol. In this protocol 
CGNs co-expressing VAMP4-pH and an empty mCer vector were subjected to 2 
HFS trains separated by 10 minutes. The second stimulation (S2) was performed in 
the presence of pitstop-2 (15 µM) (Figure 6.11 A).  
The HFS train at S1 evoked a typical VAMP4-pH response, with the average trace 
displaying little deviation from the baseline. In the absence of CME at S2, the 
VAMP4-pH fluorescence time course exhibits an initial, small but significant peak in 
fluorescence. After cessation of stimulation this significant difference is lost as a 
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slow decrease is seen across all nerve terminals (Figure 6.11 B). The decrease in 
fluorescence was exhibited in all nerve terminals as opposed to a subpopulation 
within each cell, resulting in a further significant deviation from the control 
stimulation fluorescence trace after stimulation.  
These results indicate that during both LFS and HFS, CME does have a role in the 
retrieval of VAMP4-pH. However, the characteristic slow retrieval of VAMP4-pH 
from the PM after HFS is not clathrin-dependent as this is preserved and even 
accentuated with the inhibition of CME. 
The fluorescent response of VAMP4-pH in hippocampal neurons has a very different 
profile than that seen in CGNs during HFS (see Figure 6.1 C and Figure 6.2 C). 
CGNs display no fluorescence change upon stimulation followed by either an 
upstroke or downstroke in fluorescence, whereas hippocampal neurons display an 
immediate and sharp decrease in fluorescence (shown not to be due to relocation of 
VAMP4-pH – see Figure 6.4), which is then followed by either an upstroke or 
downstroke. To assess if any of these characteristics could be attributed to CME, a 
single HFS protocol was used in VAMP4-pH-expressing hippocampal neurons with 
or without 15 µM pitstop-2 (Figure 6.12 A). 
Control hippocampal neurons displayed a fluorescence trace comparable to previous 
control conditions when subjected to HFS. However, in the presence of pitstop-2 and 
therefore in the absence of CME, the immediate drop in fluorescence seen upon 
stimulation has been significantly attenuated (Figure 6.12 B). This significant 
difference disappears after stimulation ends.  
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Figure 6.10 Pharmacological Inhibition of CME Does Not Affect VAMP4-pH Response After 
Stimulation 
A) CGNs co-transfected empty mCer vector and VAMP4-pHluorin (VAMP4-pH) were 
incubated in imaging buffer for 10 mins prior to stimulation and then continuously onwards. 
Cells were challenged with a LFS trains (300 AP, 10 Hz) with or without Pistop-2 
supplemented to the imaging buffer 8-12 seconds before stimulation. B) Average time traces 
of control (black) overlaid withPistop-2 (blue) + SEM with stimulation depicted by black bar. 




Figure 6.11 Pharmacological Inhibition of CME Does Not Arrest VAMP4-pHluorin Retrieval 
After HFS in CGNs 
A) CGNs co-transfected with empty mCer vector and VAMP4-pHluorin (VAMP4-pH) were 
incubated in imaging buffer for 10 mins prior to S1 and then continuously onwards. Cells 
were challenged with 2 sequential HFS trains (400 AP, 40 Hz) (S1 and S2) 10 minutes apart. 
Pitstop-2 was supplemented to the imaging buffer 8-12 seconds before S2. B) Average time 
traces of S1 (control, black) overlaid with S2 (Ptistop-2, blue) + SEM with stimulation depicted 
by black bar. n=3. **=p<0.01. Two-way ANOVA with Bonferroni post-test. 
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Figure 6.12 Pharmacological Inhibition of CME Does Not Arrest VAMP4-pHluorin Retrieval 
During HFS in Hippocampal Neurons 
A) Hippocampal Neurons co-transfected with empty mCer vector and VAMP4-pHluorin 
(VAMP4-pH) perfused with hippocampal imaging buffer continuously. Cells were challenged 
with a HFS trains (400 AP, 40 Hz) with or without Pitstop-2 supplemented to the imaging 
buffer 8-12 seconds before stimulation. B) Average time traces of control (black) overlaid 
with Pitstop-2 (blue) + SEM with stimulation depicted by black bar. Control n=5, Pitstop n=3. 




These results indicate that CME plays a role in the retrieval of VAMP4-pH during 
both LFS and HFS. However, it would appear that this role does not extend far 
beyond the timeframe of stimulation, as control and pistop-2-treated conditions re-
converge and significant difference is lost after this. It would also appear that the 
slow decreases that are seen after HFS are not an artefact of internalisation of 
VAMP4-pH by any clathrin-mediated form of endocytosis. 
6.2.6 Genetic Inhibition of CME does not Affect VAMP4-pHluorin 
Downstrokes 
To confirm the lack of a role for CME in the slow downstrokes of VAMP4-pH, CME 
was inhibited by expressing CHC shRNA (as used previously, see 5.2.5). To address 
this problem entirely it was decided that both LFS and HFS protocols should be 
conducted, thus allowing the visualisation of the role of CME in VAMP4-pH 
retrieval during LFS, when it is the dominant form of endocytosis, as well as during 
HFS when ADBE becomes dominant but CME is still active. 
CGNs co-expressing VAMP4-pH and CHC shRNA, or its scrambled shRNA control 
were challenged with a LFS and fluorescence was monitored over time (Figure 6.13 
A). No significant difference was observed between the average fluorescence traces 
after LFS between CHC shRNA or scrambled shRNA (Figure 6.13 B). There was 
also no alteration in the proportion of synapses exhibiting upstrokes or downstrokes 
(Figure 6.13 C). These results suggest that although CME may play a small role in 
the recycling of VAMP4-pH in CGNs (as seen when inhibited acutely, see Figure 
6.11), its absence can be compensated for when inhibited chronically.  
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It is also possible that CHC shRNA is not as effective a method of inhibiting CME at 
LFS as pitstop-2. During LFS, less clathrin is required to compensate for the 
membrane inserted via SV exocytosis. It is possible that the 20% of CHC still 
expressed in the KD system is sufficient to perform CME at a sufficient rate to allow 
the continued internalisation of a small proportion of VAMP4-pH via CME.  
To investigate the contribution of CME to VAMP4-pH retrieval during HFS (when 
ADBE is dominant), CGNs co-transfected with VAMP4-pH and CHC shRNA or a 
scrambled control were challenged with a single HFS (Figure 6.14 A). 
CGNs expressing CHC shRNA exhibit the same, small peak in VAMP4-pH 
fluorescence as observed with pitstop-2 treatment. However, in this experiment the 
characteristic slow decrease after this peak was not observed (Figure 6.14 B). This 
fluorescent phenotype was caused by a significant decrease in the proportion of 
nerve terminals displaying a downstroke in fluorescence after stimulation (Figure 
6.14 C). This might suggest that, in this system, CHC knockdown is causing an 
inhibition of ADBE. In agreement, CHC shRNA does significantly inhibit dextran 
uptake in CGNs as noted previously (Figure 5.16 B). Thus, it is difficult to interpret 
the impact of CHC depletion on the VAMP4-pH response during HFS in CGNs, 
since there is also a confounding effect of this manoeuvre on ADBE. 
Silencing CHC expression in hippocampal neurons does not have this inhibitory 
effect on ADBE (Figure 5.16 C). This cell type therefore is a more suitable model to 
test the role of a CME on the recycling of a pHluorin which seems to traffic through 
both ADBE and CME. 
297 
  
Figure 6.13 Silencing CHC Expression does not Affect the VAMP4-pHluorin Response 
After LFS.  
A) CGNs co-transfected empty mCer vector and VAMP4-pHluorin (VAMP4-pH) were 
incubated in imaging buffer for 10 mins prior to stimulation and then continuously onwards. 
Cells were stimulated with a LFS train (300 AP, 10 Hz). B) Average time traces of 
scrambled shRNA (black) and CHC shRNA (red) + SEM with stimulation depicted by black 
bar. C) Average proportions of synapses within a transfected cell increasing (Up) or 
decreasing (Down) in VAMP4-pH fluorescence after stimulation + SEM. Scrambled sRNA 
n=5, CHC shRNA n=6. n.s. Student’s t-test between conditions. 
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Figure 6.14 Silencing CHC Expression Affects VAMP4-pHluorin Retrieval During HFS. 
A) CGNs co-transfected with a scrambled shRNA vector (black) or CHC shRNA (red) and 
VAMP4-pHluorin (VAMP4-pH) were incubated in imaging buffer for 10 mins prior to 
stimulation and then continuously onwards. Cells were stimulated with a HFS train (400 AP, 
40 Hz). B) Average time traces of fluorescence + SEM with stimulation indicated by black 
bar. C) Average proportions of synapses within a transfected cell increasing (Up) or 
decreasing (Down) in VAMP4-pH fluorescence after stimulation + SEM Scrambled shRNA 
n=7, CHC shRNA n=6. *=p<0.05. Two-way ANOVA, Bonferroni post-test. Bar chart: 
****=p<0.0001, Student’s t-test between conditions 
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Figure 6.15 Silencing CHC Expression Does Not Affect VAMP4-pHluorin Retrieval or ADBE 
in Hippocampal Neurons 
A) Hippocampal neurons were co-transfected with a scrambled shRNA vector (black) or 
CHC shRNA (red) and VAMP4-pHluorin (VAMP-pH). Cells were then stimulated with a 
HFS train (400 AP, 40 Hz) and perfused continuously with hippocampal imaging buffer. B) 
Average time traces of fluorescence + SEM with stimulation indicated by black bar. C) 
Average proportions of synapses within a transfected cell increasing (Up) or decreasing 
(Down) in VAMP4-pH fluorescence after stimulation + SEM Scrambled shRNA n=5, CHC 
shRNA n=4.Time trace: ****=p<0.0001. Two-way ANOVA, Bonferroni post-test. Bar chart: 
n.s. Student’s t-test between conditions. 
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Hippocampal neurons were co-transfected with VAMP4-pH and either CHC shRNA 
or its scrambled control and challenged with a single HFS (Figure 6.15 A). 
Hippocampal neurons transfected with the control shRNA exhibited a typical 
average fluorescence trace: an immediate decrease on stimulation followed by a 
diversity of upstrokes or downstrokes, in comparable proportions to those seen with 
control conditions in previous HFS experiments (Figure 6.15 B and C).  In the 
absence of CHC in hippocampal cells, VAMP4-pH displayed a similar fluorescence 
trace to that seen when CME is inhibited acutely with pitstop-2 in CGNs (Figure 6.15 
B, see Figure 6.11): upon stimulation VAMP4-pH exhibits a small peak followed by 
a slow decrease in fluorescence. The proportion of nerve terminal displaying a 
downstroke in fluorescence after HFS was not affected by the silencing of CHC 
expression (Figure 6.15 C). 
These results indicate that when CME is inhibited in a system in which ADBE is 
unaffected, VAMP4-pH is still efficiently retrieved. Therefore, the slow downstrokes 
in VAMP4-pH fluorescence are not clathrin-dependent. VAMP4-pH is selectively 
retrieved via ADBE and is the first identified genetically-encoded reporter of ADBE.  
6.2.7 Silencing VAMP4 expression Affects ADBE but not CME 
The work discussed so far has shown that VAMP4-pH is being internalised via 
ADBE during HFS.  The question remains as to whether this uptake is selective or 
whether this uptake is due to the location and abundance of VAMP4-pH (and 
endogenous VAMP4) on the PM. 
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To test for function of VAMP4 on both forms of endocytosis, VAMP4 shRNA was 
used to silence endogenous VAMP4 expression in CGNs. This shRNA was 
successful in reducing VAMP4 to less than 40% of its endogenous levels (Figure 
6.16). 
To investigate any role of VAMP4 in CME, a single HFS protocol utilising syp-pH 
was conducted. The rationale for this was that it has been established that, even 
during HFS, syp-pH is predominantly retrieved via CME. As such, investigations 
performed utilising syp-pH will only report alterations in CME and not ADBE. 
CGNs co-expressing syp-pH with VAMP4 shRNA and its scrambled control were 
subjected to a standard single HFS (400 AP, 40 Hz) (Figure 6.17 A) with their 
fluorescence monitored over time (Figure 6.17 B). 
CGNs expressing control scrambled shRNA, exhibited an evoked fluorescence 
increase and tau values consistent with the control conditions of previous CGN 
experiments. CGNs expressing VAMP4 shRNA, showed no significant difference in 
fluorescence increase upon stimulation (Figure 6.17 C), showing no effect on the 
exocytosis of SVs labelled with syp-pH. There was also no significant effect on 
endocytosis kinetics after stimulation (Figure 6.17 D). As syp-pH is being 
predominantly recycled via CME even during HFS, it can be concluded from this 
result that the depletion of VAMP4 has no effect on CME. 
As I had ascertained that VAMP4 depletion has no effect on either SV exocytosis or 
CME, I now aimed to determine the effect of this knockdown on ADBE. In this 
protocol, CGNs expressing VAMP4 shRNA or its scrambled control were subjected 
to HFS in the presence of dextran (50 µM) (Figure 6.18 A). The comparative number 
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of synapses undergoing ADBE was estimated by calculating the number of dextran 
puncta/ length of axon. 
CGNs expressing the scrambled shRNA vector exhibited a similar number of 
puncta/µm of axon to previous control conditions, whereas the silencing of VAMP4 
expression resulted in a significantly reduced amount of dextran uptake per µm of 
axon (Figure 6.18 B). This indicates a significant inhibition of ADBE in neurons 
where VAMP4 is depleted. 
These results would indicate that, although VAMP4 does not appear to have a role in 
the process of CME, its retrieval via ADBE is not a passive occurrence as its 
presence is essential for the function of ADBE. 
Although no significant effect was seen on syp-pH trafficking when VAMP4-
expression was silenced, the essential requirement for VAMP4 for ADBE provides 
an opportunity to investigate the effects of ablating this endocytic mode on 
presynaptic function during a train of intense and sustained activity. One would 
expect that the removal of ADBE from a synapse would have effects on SV turnover. 
It is possible that these effects would become apparent over a series of high 
frequency stimuli, revealing the role for ADBE-derived SVs in presynaptic 
performance during sustained HFS. 
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Figure 6.16 VAMP4 shRNA Effectively Reduces VAMP4 Expression in CGNs 
Images of CGNs transfected with A) Scrambled shRNA or B) VAMP4 shRNA. The culture was labelled with GFP Ab (left) and VAMP4 Ab (middle). 
These images were overlaid (right) to visualise intensity of VAMP4 Ab labelling in the nerve terminals of the transfected cell (white arrows). Average 
fluorescence of VAMP4 Ab for Scrambled shRNA or VAMP4 shRNA transfected CGN synapses as a percentage of fluorescence nearby non-
transfected synapses of similar size + SEM. Scrambled shRNA n=12, VAMP4 shRNA n=16. ****= p<0.0001. Student’s t-test. 
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Figure 6.17 Silencing VAMP4 Expression Does not Affect Synaptophysin-pHluorin 
Retrieval During HFS 
A) CGNs co-transfected a control scrambled shRNA or VAMP4 shRNA and 
synaptophysin-pHluorin (syp-pH) were perfused with repolarised for 10 minutes in imaging 
buffer and then continuously onwards. Cells were stimulated with a HFS train (400 AP, 40 
Hz). B) Average time trace + SEM is displayed with stimulation indicated by black bar. C) 
Average peak eights of each condition (F/F0) + SEM. D) Average endocytic kinetics (tau) 




Figure 6.18 Silencing VAMP4 Expression Inhibits ADBE During HFS  
A) CGNs transfected with either Scrambled shRNA or VAMP4 shRNA were repolarised in 
imaging buffer for 10 minutes. Cells were stimulated with a HFS train (400 AP, 40 Hz) in the 
presence of 50 µM dextran. B) Average puncta per µm of transfected axon + SEM 
expressed as a percentage of Scrambled shRNA condition Scrambled shRNA n=28, CHC 
shRNA n=30. Hippocampal cells: Scrambled shRNA n=49, VAMP4 shRNA n=53. 
****=p<0.0001. Student’s t-test 
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An experimental protocol was designed to probe for the possible effects of ADBE 
inhibition on presynaptic performance during repeated trains of HFS. In this protocol 
hippocampal neurons were transfected with syp-pH and either VAMP4 shRNA or its 
scrambled control and challenged with four HFS trains each separated by 10 minutes 
(Figure 6.19 A) 
In control cells, bulk endosomes formed on the first stimulation should have budded 
and donated SVs to the recycling pool within the time frame of the experiment 
(Cheung et al. 2010). It is possible that the lack of SVs donated via budding from 
bulk endosomes would cause a depletion of releasable vesicles over time. 
The syp-pH response of hippocampal neurons expressing the control scrambled 
shRNA was highly reproducible. Neurons responded to each HFS with a progressive 
reduction in evoked peak fluorescence with each consecutive stimulation, with the 
second stimulation 62% of the first followed by 40% and 32% for the third and 
fourth stimulations respectively (Figure 6.19 C). There was a significant difference 
between control and VAMP4-depleted cells in syp-pH fluorescence over time from 
the second stimulation onwards (Figure 6.19 B). 
VAMP4-depleted cells exhibited an exaggerated decrease in peak fluorescence.  A 
peak height of 47% was seen on the second stimulation when compared to the first, 
followed by 25% and 17% for the third and fourth stimulations respectively. A 
significant difference between these values is seen from the third stimulation 
onwards (Figure 6.19 C). The endocytic rate (tau) however does not exhibit any 
significant differences between control and VAMP4-depleted neurons (Figure 6.19 
D) showing that the decreased peak height is not due to modulated CME. 
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Figure 6.19 Silencing VAMP4 Expression Affects Presynaptic Performance during Sustained HFS 
A) Hippocampal neurons co-transfected with either scrambled shRNA or VAMP4 shRNA and syp-pH were perfused continuously with hippocampal 
imaging buffer and stimulated with 4 HFS trains each separated by 10 minutes. B) Average time trace of fluorescence (ΔF/F0) + SEM normalised to the 
first stimulation peak. C) Average Peak heights S2 onwards + SEM as a percentage of S1. D) Average tau of S2 onwards (seconds) + SEM. Time trace: 
**=p<0.01, Two-way ANOVA, Bonferroni post-test. Bar charts: *=p<0.05, Student’s t-test per stimulation between conditions. 
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These results indicate that the removal of ADBE leads to a depleted stock of fusion-
ready SVs. This effect is only revealed over several HFS, suggesting ADBE-derived 
SVs contribute to synaptic transmission during times of intense neuronal activity.  
6.2.8 A Di-leucine Motif on VAMP4 is Essential for ADBE 
I next investigated which protein interaction mediates the necessity for VAMP4 in 
ADBE. VAMP4 contains a di-leucine motif at residues 25 and 26 in its cytoplasmic 
N-terminal domain which facilitates interactions with AP-1 (Peden et al. 2001) 
(Figure 6.20 A). To assess if the essential role of VAMP4 in ADBE is mediated via 
its interaction with AP-1, a VAMP4-pH with the first leucine residue of the di-
leucine motif mutated to an alanine (VAMP4-pH L25A) (Figure 6.20 B) was used. 
This mutation inhibits AP-1 binding (Peden et al. 2001), thereby allowing one to 
visualise the importance of this interaction in the trafficking of VAMP4-pH. 
 Retrieval of VAMP4-pH is Disrupted with the Mutation of an 
Adaptor-Binding Di-leucine Motif  
To determine the importance of AP-1 interaction in the integral role of VAMP4 
during ADBE, CGNs co-transfected with either wild-type VAMP4-pH (VAMP4-pH 
WT) or mutant VAMP4-pH (VAMP4-pH L25A) and an empty mCer vector were 
stimulated with HFS (400 AP, 40 Hz) (Figure 6.21 A). 
Nerve terminals expressing VAMP4-pH L25A exhibited a significantly different 
fluorescence trace than those expressing VAMP4-pH WT (Figure 6.21 B). CGNs 
expressing VAMP4-pH WT produced the typical stable average fluorescence during 
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and after HFS caused by its component upstrokes and downstrokes. However, nerve 
terminals expressing VAMP4-pH L25A exhibit an average fluorescence which 
increases quickly upon stimulation and then remains constant in fluorescence with 
very few of the downstrokes below baseline characteristic of WT VAMP4-pH 
(Figure 6.21 C). 
The fluorescence trace produced by these neurons exhibits similar characteristics to 
that of CGNs whose expression of syndapin I has been silenced, inhibiting ADBE 
(see Figure 6.7). 
The same protocol was repeated in hippocampal neurons (Figure 6.22 A) and a very 
similar average fluorescence profile was seen for the L25A mutant, with an 
immediate upstroke on stimulation followed by a small and steady increase over time 
(Figure 6.22 B). Again, very few downstrokes below baseline were observed after 
stimulation for this VAMP4 mutant (Figure 6.22 C). 
These results indicate that the adaptor protein binding site (residing at Leu 25 and 
Leu 26) is required for the internalisation of VAMP4 via ADBE as the characteristic 
downstrokes, seen in synapses in which ADBE is operating normally, are 
significantly reduced when adaptor binding has been abolished. It would also imply 
that the immediate internalisation of VAMP4-pH, which is normally apparent in 





Figure 6.20 VAMP4-pH with Mutated Adaptor Protein Binding Site  
A) WT VAMP4 contains a di-leucine motif in it cytoplasmic domain (blue and white) at 
residues Leu 25 and Leu 26 (red letters). This motif was mutated at residue Leu 25 
(underlined). B) WT VAMP4 fused to pHluorin on its luminal domain (green circle) was used 
in previous experiments. This WT VAMP4 was mutated at Leu 25 to an alanine (Ala25), 
forming L25A (red segment) to create VAMP4-pHluorin L25A 
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Figure 6.21 VAMP4-pH L25A Does not Display Characteristic Slow Retrieval in CGNs 
A) CGNs co-transfected with either Wild-type VAMP4-pHluorin (VAMP4-pH WT) or mutated 
L25A VAMP4-pHluorin (VAMP4-pH L25A) were incubated with imaging buffer for 10 minutes 
before stimulation and then continuously onwards. Cells were stimulated with a HFS train 
(400 AP, 40 Hz). B) Average time trace + SEM is displayed with stimulation indicated by 
black bar. C) Average proportions of synapses within a transfected cell increasing (Up) or 
decreasing (Down) in VAMP4-pH fluorescence after stimulation + SEM. VAMP4-pH WT n=5, 
VAMP4-pH L25A n=5. Time trace: **=P<0.01, Two-way ANOVA Bonferroni post-test. Bar 
chart: ***=p<0.001, Student’s t-test between conditions. 
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  Figure 6.22 VAMP4-pH L25A Does not Display Characteristic Slow Retrieval in 
Hippocampal Neurons 
A) Hippocampal neurons co-transfected with either Wild-type VAMP4-pHluorin (VAMP4-pH 
WT) or mutated L25A VAMP4-pHluorin (VAMP4-pH L25A) were incubated with 
hippocampal imaging buffer continuously. Cells were stimulated with a HFS train (400 AP, 
40 Hz). B) Average time trace + SEM is displayed with stimulation indicated by black bar. 
C) Average proportions of synapses within a transfected cell increasing (Up) or decreasing 
(Down) in VAMP4-pH fluorescence after stimulation + SEM. VAMP4-pH WT n=6, VAMP4-
pH L25A n=7. Time trace: ***=P<0.001, Two-way ANOVA, Bonferroni post-test. Bar chart: 
**=p<0.01, Student’s t-test between conditions. 
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 VAMP4 Overexpression Does Not Affect ADBE 
I have concluded, based on the lack of downstrokes seen when tracking VAMP4-pH 
L25A after HFS, that VAMP4 uptake into bulk endosomes is mediated via its 
interaction with adaptor proteins. It is possible however, that the lack of downstrokes 
seen when expressing VAMP4-pH L25A is due to a dominant negative effect on 
ADBE caused by the overexpression of a mutant VAMP4 protein.  
To assess this possibility, the following protocol was designed; overexpressing either 
VAMP4-pH WT or the mutant VAMP4-pH L25A in CGNs and evaluating any effect 
on ADBE in comparison to a GFP empty vector (to control for the expression of the 
modified GFP molecule - pHluorin). This experiment would also reveal any effect of 
overexpression VAMP4-pH WT on prevalence of ADBE. This is important as, to 
date, VAMP4-pH is the only pHluorin seen to be trafficking via ADBE. As its now 
apparent that VAMP4 is essential for ADBE, the possibility that overexpressing a 
pHluorin-tagged VAMP4 protein increases the occurrence of ADBE needs to be 
addressed.  
CGNs triple-transfected with mCer empty vector, scrambled shRNA and either 
VAMP4-pH WT, VAMP4-pH L25A or an empty GFP vector were challenged with a 
HFS (400AP, 40 Hz) in the presence of dextran (50 µM) (Figure 6.23 A).  
Overexpressing VAMP4-pH WT caused no increase in the number of synapses 
undergoing ADBE as measured by number of puncta/µm of axon when compared to 
the GFP control (Figure 6.23 B). This is an important result as it shows that the 
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VAMP4-pH assay used throughout this project is not enhancing the ability of the 
presynapse to undergo ADBE. 
The overexpression of VAMP4-pH L25A similarly had no significant effect on the 
number of synapses undergoing ADBE (Figure 6.23 B). From this it can be 
concluded that the decreased number of downstrokes seen in VAMP4-pH L25A 
trafficking is not due to a decreased incidence of ADBE, but instead due to an 
inability of this mutant L25A VAMP4 to be recruited into bulk endosomes. This 
would indicate a requirement for adaptor proteins in VAMP4 recruitment into bulk 
endosomes during HFS and further highlights that the retrieval of VAMP4 via 
ADBE is a specific process and not merely due to its location or abundance. 
 Inhibition of ADBE via VAMP4 Knockdown is not Rescued by 
Mutated VAMP4 Which is Incapable of Binding Adaptor 
Proteins 
VAMP4 is essential for ADBE (see Figure 6.18), and its interaction with adaptor 
proteins is essential for its retrieval during ADBE (see Figure 6.21 and Figure 6.22). 
However, it has not been determined whether the interaction of VAMP4 with adaptor 
proteins is in itself essential for ADBE to proceed. To determine this, the ability of 
both VAMP4-pH WT and the mutant VAMP4-pH L25A (both shRNA-resistant) to 
rescue ADBE was tested with the simultaneous knockdown of endogenous VAMP4 
via shRNA. 
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CGNs co-transfected with VAMP4 shRNA and either VAMP4-pH WT, VAMP4-pH 
L25A or an empty GFP vector were challenged with a HFS train (400AP, 40 Hz) in 
the presence of dextran (50 µM) (Figure 6.23 A). Puncta per µm of axon were 
quantified and compared against control cells co-transfected with scrambled shRNA 
plus a GFP empty vector. 
The expression of VAMP4-pH WT resulted in a full rescue of ADBE back to control 
levels (Figure 6.23 B, Figure 6.24), showing that the effect on ADBE caused by 
silencing endogenous VAMP4 expression is fully reversible by replacing it with a 
functional exogenous form of the protein. Again this is important, since it confirms 
that the inhibition of ADBE was due to VAMP4 depletion and not off targets effects 
of the shRNA  
When endogenous VAMP4 is replaced with the L25A mutant form, ADBE is not 
restored (Figure 6.23 B, Figure 6.24). These results confirm that VAMP4 is essential 
for ADBE and that its interaction with adaptor proteins is an essential step in the 






Figure 6.23 ADBE is not Rescued by Expression of Mutated AP-1 Binding-Deficient VAMP4  
A) CGNs co-transfected with either VAMP4 shRNA or its scrambled control and either 
VAMP4 WT pHluorin, VAMP4 L25A pHluorin or an empty GFP-tagged vector were 
incubated with imaging buffer for 10 minutes prior to stimulation with a HFS train (400 AP, 
40 Hz) in the presence of 50 µM dextran. B) Average puncta per µm of axon + SEM for each 
condition as a percentage of the control condition (Scrambled shRNA + GFP). Scrambled 
shRNA + GFP n=23, Scrambled shRNA + VAMP4-pH WT n=24, Scrambled shRNA + 
VAMP4-pH L25A n=25, VAMP shRNA + GFP n=21, VAMP4 shRNA + VAMP4-pH WT n=23, 
VAMP4 shRNA + VAMP4-pH L25A n=26. ***=P<0.001, One-way ANOVA comparison to 
Control (Scrambled shRNA + GFP). 
317 
  
Figure 6.24 VAMP4 with Mutated Protein with Interrupted Adaptor Protein Binging Does not 
Rescue ADBE 
CGNs transfected with an mCer empty vector, VAMP4 shRNA and either a GFP empty 
vector, WT VAMP4-pH or L25A VAMP4-pH. Cells were repolarised for 10 minutes in 
imaging buffer and then exposed to HFS (400 AP, 40 Hz) in the presence of 50 µM 
dextran. Images were acquired of mCer (left) and dextran (middle) and then overlaid (right) 
to identify dextran puncta localised within transfected neurons (white arrows).  
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6.3 Discussion 
During intense neuronal activity, exocytosis causes a transient accumulation of SV 
cargo as well as membrane in the PM of central nerve terminals. Under these 
conditions, ADBE becomes the dominant form of endocytosis.  
It is known that this endocytic mode has a high capacity, as it retrieves much larger 
sections of membrane than a single SV. However, the capacity of this mode for the 
retrieval of SV cargo from the PM is unknown. Clathrin and adaptor proteins have 
both been shown to be necessary for the formation of functional SVs from bulk 
endosomes (Heerssen et al. 2008; Kasprowicz et al. 2008; Cheung & Cousin 2012; 
Kononenko et al. 2014), but are not required for the formation and scission of 
endosomes from the PM (Heerssen et al. 2008; Kasprowicz et al. 2008; Cheung & 
Cousin 2012; Kononenko et al. 2014), suggesting a lack of SV cargo sorting into 
these invaginating structures. Work discussed in the previous chapter also indicates a 
lack of retrieval of a variety of SV cargoes via ADBE. 
I investigated another, less commonly used pHluorin molecule; VAMP4-pH with a 
hope to understand its unique response to more intense stimuli. Using several 
approaches, I have shown here that VAMP4-pH is selectively retrieved via ADBE 
unlike other pHluorins examined. I have also found a necessity for VAMP4 for 
ADBE and isolated the location of its functional binding site. 
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6.3.1 VAMP4-pH Responds Differently Between LFS and HFS 
Our experiments revealed that mild and intense stimulation elicited a differential 
effect on the fluorescent response of VAMP4-pH. During HFS both CGNs and 
hippocampal cells exhibited a subpopulation of nerve terminals in which the 
fluorescence of VAMP4-pH would undergo a slow decrease in fluorescence over 
time. Inhibiting ADBE in CGNs via pharmacological and genetic means showed that 
this endocytic mode was essential for the presence of these downstrokes.  
Independent manipulations of both CME and ADBE revealed that these downstrokes 
were indicative of an invaginated bulk endosome slowly acidifying over time. All 
manipulations were conducted using either pharmacological interventions or 
knockdown systems, both of which have potential pitfalls. One such pitfall was 
demonstrated in the knockdown of clathrin heavy chain (CHC) in CGNs. 
Knockdown of this protein caused differential effects between hippocampal cells and 
CGNs and actually resulted in an inhibition of ADBE, a process for which CHC is 
not an essential molecule. However, the juxtaposition of VAMP4-pH response 
between the two cell types actually strengthened my existing hypothesis; when one 
considers that in a system in which CHC knockdown causes an inhibition of both 
CME and ADBE (CGNs see Figure 6.14) there is no slow retrieval after HFS, it can 
be concluded that the downstrokes seen after HFS in another CHC knockdown 
system in which ADBE is not inhibited are in fact reporting the uptake and 
acidification of VAMP4-pH within bulk endosomes. 
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To ensure that no other side effects of the manipulations discussed here have gone 
unnoticed, further experiments could be conducted using alternative technologies 
such as the acute relocation via knocksideways of a protein-of-interest such as 
syndapin I to achieve acute inhibition of ADBE.  
6.3.2 VAMP4-pH is Retrieved Differently Between CGNs and 
Hippocampal Cells 
 A Higher Proportion of CGN Versus Hippocampal Cell Nerve 
Terminals Undergo ADBE 
When quantified, it became clear that VAMP4-pH transfected CGNs contained a 
larger proportion of nerve terminals displaying downstrokes than hippocampal cells. 
Previous studies utilising dextran found that only 35% of CGN nerve terminals 
exhibited uptake of dextran when exposed to high potassium (Clayton & Cousin 
2009), compared to a maximum of 20% of nerve terminals in hippocampal cultures 
with high frequency stimulations (Wenzel et al. 2012). Interestingly, this disparity in 
participating nerve terminals between cell types in conserved between the two 
measures of ADBE. This observation is further supported by the greater percentage 
of sequestered VAMP4-pH in CGNs than in hippocampal cells after HFS (see Figure 
6.8 and Figure 6.9).  
However, the information gathered utilising VAMP4-pH would suggest higher 
proportions of nerve terminals undergoing ADBE in both cell types (60-65% of CGN 
versus 40% of hippocampal cell nerve terminals). These results could indicate that 
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VAMP4-pH is a more sensitive reporter of ADBE than dextran uptake. This is 
possibly due to the non-directed manner of fluid phase marker uptake, making it 
possible that all not all nerve terminals undergoing ADBE actually accumulate 
dextran.  
Another conclusion that could be drawn from this information is that certain nerve 
terminals are not capable of undergoing ADBE. This hypothesis appears incorrect 
however as during two HFS, even though the proportions of nerve terminals 
undergoing ADBE between stimulations are equivalent in percentage, it is not the 
same populations of nerve terminals undergoing ADBE between stimulations. This is 
evidenced by the existence of traces displaying a downstroke after one stimulus but 
not after the other. 
To assess the proportion of nerve terminals which undergo ADBE during at least one 
of the two rounds of intense stimuli, existing data from CGN “S1 S2” experiments 
were re-analysed. Each nerve terminal was grouped based on the criterion of whether 
the response it exhibited after at least one stimulation was a downstroke. This 
identifies all nerve terminals which underwent ADBE in response to either stimulus 
during the experiment (this includes all nerve terminals included under the titles: S1 
Up S2 Down, S1 Down S2 Down and S1 Down S2 Up). This analysis showed that 
90% of all CGN nerve terminals will undergo ADBE during two rounds of HFS 
(data not shown).  
This finding bears significance in two ways; firstly, it appears that nearly all if not all 
CGN nerve terminals retain the capacity to undergo ADBE during HFS. Secondly, 
this endocytic mode is not uniformly triggered during every intense stimulation in 
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nerve terminals. Although the reasons for non-uniformity of ADBE initiation are not 
yet determined, these are never-the-less important observations as they demonstrate 
the ability of each nerve terminal to produce VAMP4-positive SVs which go on to 
mediate asynchronous release, independent of whether a specific nerve terminal is 
undergoing ADBE during any one stimulation.  
The difference in incidence of ADBE between hippocampal cells and CGNs is 
interesting in itself. The reason for this is unknown, however it has been observed n 
other studies (Clayton & Cousin 2009; Wenzel et al. 2012). One possibility is that 
CGNs are “hardwired” to undergo ADBE. CGNs can experience unusually high 
frequency, firing via mossy fibre input in vivo of up to 300 Hz (Linne & Jalonen 
2003) and cultures must be incubated in elevated K+ to avoid apoptosis (Burgoyne & 
Cambray-Deakin 1988). This environment may lead to a specialisation of CGNs to 
more efficiently activate ADBE under HFS. 
Another possibility is that the heterogeneity of hippocampal cultures causes a 
confounding of results. CGNs can be cultured to greater than 95% homogeneity 
(Burgoyne & Cambray-Deakin 1988) whereas hippocampal cultures contain around 
35:65% of GABAergic : non-GABAergic boutons (Wenzel et al. 2012).  GABAergic 
boutons belong to inhibitory interneurons, a cell type which is characterised by high 
rates of activity (Bartos et al. 2007) and which are more prone to ADBE as measured 
by dextran uptake (Wenzel et al. 2012). This increase in incidence of ADBE in the 
cell type accustomed to higher frequency firing is in agreement with the hypothesis 
that CGNs are more prone to ADBE due to their high firing rate in vivo. The majority 
of hippocampal cultures are non-GABAergic and less prone to ADBE, possibly 
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resulting in the lower incidence of ADBE in hippocampal cultures than in CGN 
cultures. 
Future investigations should be focussed on why a nerve terminal will undergo 
ADBE during one HFS and not the next, or vice versa. It is possible that the 
initiation of ADBE is affected by previous experienced stimulation, SV pool size or 
input from post-synaptic partners. Manipulation of these factors may offer insight 
into the factors increasing or decreasing likelihood of ADBE in a nerve terminal 
during a given stimulation. For example, sequential stimulation experiments in 
hippocampal cells or CGNs expressing VAMP4-pH may reveal a change in 
probability of ADBE events based on the number or frequency of previous 
stimulations.  
It is also possible that each nerve terminal may undergo both asynchronous release 
and ADBE during each stimulation but to different extents. As these two processes 
would result in a slow increase or decrease in VAMP4-pH fluorescence respectively, 
it is possible that the observed VAMP4-pH response in any given nerve terminal is a 
report of the balance of both of these processes. i.e. in a nerve terminal undergoing a 
higher incidence of bulk endosome formation, the net effect on VAMP4-pH 
fluorescence would be a downstroke, as it is effectively cancelling out and 
overshadowing the effect of asynchronous release on the overall fluorescence of 
VAMP4-pH in that specific nerve terminal. It is very possible that all nerve terminals 
undergo asynchronous release after HFS, however this is only observable in nerve 
terminals undergoing little or no ADBE during that stimulus. This hypothesis is 
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supported by the almost uniform increase in VAMP4-pH during HFS with inhibition 
of ADBE through silencing syndapin I expression (see Figure 6.7). 
 Hippocampal Cell Nerve Terminals Exhibit an Acute Response 
to Stimulation Not Seen in CGNs  
Another interesting difference between CGNs and hippocampal cells is the 
immediate response of VAMP4-pH to a HFS. CGNs exhibit no obvious response 
upon stimulation, with changes in fluorescence occurring slowly and only after 
cessation of stimulation. Hippocampal cells exhibit a distinct and dramatic decrease 
of fluorescence during the HFS itself. The most obvious possible cause for this effect 
was examined first; an artefact of the restrictive size of the acquisition area. 
However, upon doubling the size of said area to include neighbouring axonal 
regions, this characteristic drop in fluorescence was still observed.  
A logical explanation for this activity-dependent drop in fluorescence is the 
internalisation of VAMP4-pH upon HFS into a rapidly-acidifying environment. This 
is unlikely to be a bulk endosome as one would expect to see a much slower 
quenching of pHluorin internalised via this route, in line with its rate of acidification. 
It is possible that VAMP4-pH is retrieved via endocytosis and the structure in which 
it is contained then immediately fuses with an acidified endosome (possibly a bulk 
endosome formed via a previous stimulation). However, if this is the case it is 
unknown why this would be more prevalent in hippocampal cells than in CGNs. 
This immediate drop observed in VAMP4-pH in hippocampal cells appears to be 
dependent upon clathrin and may, therefore, be reporting VAMP4-pH internalised 
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via CME. When clathrin cage assembly is inhibited by pitstop-2 application, there is 
a significant slowing of the fluorescence drop (Figure 6.12) and knockdown of 
clathrin heavy-chain completely abolishes it, instead there is a peak in fluorescence 
upon stimulation (see Figure 6.15). The different results between these two 
interventions could be explained by relative efficiency of these methods to inhibit 
CME. It is possible, as pitstop-2 prevents the formation of a clathrin coat, that any 
pre-formed coat residing at the clathrin-coated pit is sufficient to allow some CME to 
occur. 
When CME is inhibited via pitstop-2 in CGNs, VAMP4-pH exhibits a peak in 
fluorescence followed by a decrease below baseline (see Figure 6.11). The reason 
this occurs in CGNs and not hippocampal cells is not clear. Interestingly, when the 
endocytic kinetic (tau) is calculated for the post-stimulation decrease in VAMP4-pH 
fluorescence in the presence of pitstop-2 a value of 31 + 2 seconds is achieved. This 
is almost identical to the time constant of the post-stimulation decrease in VAMP4-
pH after stimulation in CGNs in the presence of pitstop-2, which is 32 seconds + 2. 
This would imply that, although the two traces have differing characteristics, the 
same process is being reported. It is also of note that this time course is an order of 
magnitude slower than that of SV acidification (Atluri & Ryan 2006; Egashira et al. 
2015) and is consistent with the acidification rate of the larger internal volume of a 
bulk endosome. This is extremely indicative that, in the absence of CME, VAMP4-
pH is retrieved predominantly via ADBE in both CGNs and hippocampal cells.  
CGNs recapitulate this peak in VAMP4-pH fluorescence upon stimulation in neurons 
where CHC has been knocked down (see Figure 6.14). This supports the hypothesis 
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that some VAMP4-pH is being endocytosed via CME in both CGNs and 
hippocampal cells. If this is true, it is possible that the activity-dependent drop in 
fluorescence seen in hippocampal cells (see Figure 6.2) is due to more VAMP4-pH 
being internalised via this route in hippocampal cells, possibly due to the lower 
incidence of ADBE in this cell type. 
Another possible explanation for the dramatic differences in VAMP4-pH response 
during HFS between CGNs and hippocampal cells, is a difference in the amount of 
VAMP4-pH on readily-releasable vesicles. If SVs residing in the RRP of a CGN 
nerve terminal contain a greater copy number of VAMP4-pH molecules than 
hippocampal cells, CGNs would exhibit a higher evoked fluorescence increase of 
VAMP4-pH on stimulation than hippocampal cells. If the fluorescence change 
initiated via internalisation of VAMP4-pH via CME and externalisation of VAMP4-
pH (via exocytosis) are equal in magnitude in CGNs but not hippocampal cells, this 
could account for the lack of a net fluorescence change upon stimulation in CGNs in 
comparison to the dramatic drop in VAMP4-pH seen in hippocampal cells. i.e. the 
amount of VAMP4-pH retrieved via CME is around equal to the amount being 
exocytosed upon stimulation in CGNs, whereas in hippocampal cells far more is 
being retrieved during stimulation than released. 
This explanation would also account for the effect of pitstop-2 on VAMP4-pH in 
CGNs and not hippocampal cells (see Figure 6.12 and Figure 6.11 respectively). 
Inhibiting CME results in an evoked increase in fluorescence which is otherwise 
unseen. This would suggest that VAMP4-pH is normally retrieved via CME in 
CGNs, however this is usually masked by that being externalised. Pitstop-2 does not 
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have as marked an effect on VAMP4-pH fluorescence upon HFS in hippocampal 
cells as there is not as large a fluorescence increase to reveal by removing 
confounding fluorescence decrease (VAMP4-pH internalisation via CME). 
 VAMP4 is Essential for ADBE and its Internalisation is 
Dependent on Adaptor Proteins  
VAMP4 does not appear to bind with AP-2, instead its sorting is dependent on AP-1 
(Hinners et al. 2003) and as such it should not be clustered at the active zone in the 
same fashion as other SV proteins. Clustering of SV proteins may force VAMP4 into 
the peri-active zone, the site of ADBE. If this is true it could be argued that the 
uptake of VAMP4 into bulk endosomes is purely due to its relative abundance and 
location on the presynaptic membrane. This would not appear to be the case 
however. Experiments performed using acidic imaging buffer for this project indicate 
a surface-bound fraction of VAMP4-pH of 23 + 4% in resting CGNs, or 36 + 7% in 
resting hippocampal nerve terminals. Other published work has found comparable 
surface-bound fractions of tagmin-pH and sybII-pH to be 26.5 + 3 and 19.7 + 2.6 
respectively (Pan et al. 2015) in hippocampal synapses. Despite this, these pHluorins 
do not show evidence of retrieval via ADBE (see Figure 5.4 and Figure 5.5). 
Therefore, a high abundance on the PM does not seem to be a deciding factor in 
retrieval via this endocytic mode. 
Further evidence against this argument for non-specific uptake was provided by 
demonstrating the necessity for normal VAMP4 expression for the function of 
328 
ADBE in CGNs. A knockdown of VAMP4 showed a significant inhibition in ADBE 
as measured by dextran uptake.  
The need for VAMP4 (and by logical extension ADBE) in the maintenance of 
neurotransmission over sequential HFS was also demonstrated. The inhibition of 
ADBE via VAMP4 knockdown resulted in a significant decrease in evoked 
fluorescence peak height of syp-pH over a series of four HFS compared to control. 
Further work could be done to determine if this run-down effect is in fact due to a 
run-down of vesicles caused by a lack of SVs formed from bulk endosomes as my 
hypothesis states. A recapitulation of these results when inhibiting ADBE via other 
mechanisms such as sustained CT92001 incubation or syndapin I knockdown would 
give confirmation. As would the visualisation of the RRP in transfected nerve 
terminals after stimulation.  
I have also elucidated a mechanism of the action of VAMP4 in ADBE using VAMP4 
L25A. This form of VAMP4 has been mutated to eliminate binding with adaptor 
protein partners, specifically AP-1 (Peden et al. 2001). The loss of this binding site 
renders the protein incapable of rescuing the inhibition of ADBE caused by VAMP4 
knockdown, unlike its wild-type counterpart. This shows a necessity for interaction 
of VAMP4 with adaptor proteins for normal functioning ADBE. VAMP4-pH L25A 
also showed an almost complete lack of slow downstrokes after stimulation, 
indicating that it is not internalised via ADBE. This is not due to a dominant negative 
effect of VAMP4-pH L25A on the occurrence of ADBE as demonstrated through 
dextran uptake assays. This would imply that this adaptor protein binding site is 
essential for the internalisation of VAMP4 via ADBE. It would be interesting to 
329 
express this VAMP4 mutant into a knockdown background and repeat the sequential 
HFS experiment discussed above. This experiment would re-introduce a VAMP4 
protein which is incapable of rescuing ADBE but is otherwise unaltered. This would 
allow the observer to test the requirement of VAMP4 versus the necessity for 
functioning ADBE in the maintenance of neurotransmission over sequential HFS. 
The internalisation of VAMP4 upon stimulation also appears to be dependent on 
binding with adaptor proteins. The immediate response of VAMP4-pH L25A is very 
different to VAMP4-pH WT in both CGNs and hippocampal cells. Upon stimulation, 
an immediate peak is seen in both CGNs and hippocampal cells, the lack of an 
immediate downstroke in hippocampal shows that this rapid internalisation usually 
observed is adaptor protein-dependent. It should be noted that the average 
fluorescence trace acquired using VAMP4-pH L25A greatly resembles that of 
wildtype VAMP4-pH expressed in CGNs depleted of syndapin I, inhibiting ADBE. 
This could also imply that this immediate drop is in somehow linked with ADBE. 
Further work is needed to investigate the provenance of this immediate fluorescence 
drop in hippocampal cells; performing the same syndapin I knockdown with wild-
type VAMP4-pH could answer the question of whether the internalisation of 
VAMP4-pH observed upon stimulation is facilitated via CME or ADBE. 
The L25A mutation disrupts binding of AP-1 (Peden et al. 2001) and no evidence has 
been found for the interaction of VAMP4 with AP-2 and AP-3.  Further experiments, 
such as looking at effects of VAMP4-pH response with the knockdown of AP-1, are 
needed to prove which adaptor-protein interaction is in fact responsible for VAMP4 
uptake in ADBE.  
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AP-3 plays a joint role with AP-1 in SV formation from bulk endosomes (Cheung & 
Cousin 2012) and the inhibition of this budding in AP-3 KO mice has shown a 
reduction in vesicles supporting asynchronous release (Evstratova et al. 2014) 
thought to be derived from bulk endosomes.  
The information compiled here could indicate that VAMP4 is the initial marker for 
AP-1 binding, causing the invagination of a bulk endosome. AP-3 is then responsible 
for the budding of VAMP4-rich SVs which are directed to fill the pool of SVs 
responsible for asynchronous release. However, previous work has shown no 
requirement for the AP-1γ subunit in ADBE (Cheung & Cousin 2012) although this 
study utilised dextran uptake as a measure of ADBE. This protocol is an indicator of 
how many nerve terminals have experienced ADBE and not the amount of ADBE 
within each nerve terminal. This AP-1 knockdown did result in a decrease in reserve 
pool size, a phenotype which could be caused by either a decrease in the number of 
invaginated bulk endosomes or of SV budding and as such, a role for AP-1 in the 
formation of bulk endosomes may warrant further investigation. 
6.3.3 VAMP4 is Enriched in Endosomal Membranes 
All work described so far has been utilising exogenous versions of endogenous SV 
proteins. To investigate the validity of my observations with regards to endogenous 
SV proteins, experiments were performed within the laboratory utilising an 
optimised fractionation protocol; CGNs were stimulated with high KCl, lysed via 
mechanical disruption and then fractionated utilising a non-ionic density gradient 
medium (Nycodenz) (Barysch et al. 2010). Lysates from the SV and bulk endosome 
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fraction were submitted to Western blotting (Nicholson-Fish et al. 2015). The 
abundance of proteins was converted into an endosome/SV ratio. vGlut1 and 
synaptobrevin-II were both found to be highly enriched in SVs when compared to 
endosomes with ratios of less than 0.5. Synaptotagmin and synaptophysin had ratios 
of between 1 and 1.5. As ADBE is the dominant form of endocytosis during intense 
stimulation, the bulk endosome fraction would contain far more membrane. As such 
a value of 1-1.5 could be considered to show less uptake via ADBE than CME. 
VAMP4 was found to be significantly enriched in the endosome fraction, with a 
resultant endosome/SV ratio of over 2 (Nicholson-Fish et al. 2015).  
This data could suggest that other endogenous SV cargo investigated in the previous 
chapter is being retrieved via ADBE (although not in a proportionate manner to 
CME). Unfortunately, the nature of this experiment makes controlling for amount of 
membrane difficult. Another interpretation of this data would be that, as I have 
shown that there is a lack of uptake via ADBE of these SV proteins, their presence in 
endosomes is due to the fusion of SVs formed via CME which are rich with these 
proteins having fused with endosomes post-invagination. However, it is apparent that 
VAMP4 is being retrieved more selectively via ADBE.  
In conclusion, I have identified an SV protein which is unique in that it is selectively 
and preferentially retrieved via ADBE. I have also determined a necessity for this SV 
protein, including its functional domain to allow ADBE to proceed.  This discovery 
should allow the advancement of investigations of both the initiation and progression 















7. Final Discussion 
The efficient recycling of SVs is essential to maintain synaptic transmission. This 
system is tightly regulated and involves cascades of protein-protein and -lipid 
interactions, facilitated by a plethora of kinases and phosphatases, which together 
ensure the temporal and spatial co-ordination of exo- and endocytosis. There are two 
main forms of endocytosis; CME, which forms individual SVs and is dominant 
during mild stimulation and ADBE, a higher capacitance mode which retrieves larger 
surfaces of membrane to be formed into SVs later.  The work contained in this thesis 
has focussed on the essential components of ADBE.  
7.1 PI3K Activity and Localised Calcium Concentration are Essential 
Akt/GSK3 Phosphorylation  
During HFS a signalling cascade is initiated, causing phosphorylation and activation 
of Akt. Akt then phosphorylates GSK3, causing inhibition of its kinase activity. This 
cascade is essential for the continuation of ADBE (Clayton et al. 2010). Dynamin I 
dephosphorylation is essential for ADBE to occur, active GSK3 rephosphorylates 
dynamin I after stimulation, thereby allowing it to be used for further rounds of 
ADBE. The inactivation of GSK3 by phosphorylation during HFS allows maximal 
dephosphorylation of dynamin I during stimulation. The essential factors responsible 
for the initiation of this signalling cascade were not defined.  
The activity-dependent nature of this signalling cascade implied a role for calcium 
and my initial experiments focussed on the manipulation of intracellular Ca2+. 
Allowing entry of Ca2+ independent of stimulation caused both Akt and GSK3 
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phosphorylation and showed that Ca2+ entry was sufficient for Akt/GSK3 
phosphorylation (Figure 3.2). The buffering of intracellular Ca2+ during HFS showed 
that Ca2+ was also necessary. The use of Ca2+ buffers with differing abilities to 
deplete microdomain of Ca2+ at the active zone during stimulation also showed that a 
microdomain of Ca2+ was required to allow activation of the cascade, whereas 
buffering cytosolic Ca2+ had no effect on Akt/GSK3 phosphorylation (Figure 3.5). 
The use of a VGCC inhibitor demonstrated that entry via these Ca2+ channels is 
required for the phosphorylation of both Akt and GSK3 (Figure 3.4). 
Our investigations as to the upstream components of this cascade brought me to 
examine PI3K, a known component of BDNF-stimulated Akt/GSK3 phosphorylation 
(Smillie et al. 2013). The presence of two different inhibitors of PI3K caused an 
ablation of Akt/GSK3 phosphorylation during HFS (Figure 3.6) showing a role for 
this kinase upstream of Akt activation.  
In the search for the Ca2+-sensitive initiator of this cascade I examined the PI3K-
activator calmodulin. Although calmodulin did appear to play a role in Ca2+-
activated Akt/GSK3 phosphorylation independent of stimulation, its inhibition did 
not show any effect on the signalling cascade during HFS (Figure 3.7) and therefore 
it is not an upstream component of this activity-dependent signalling cascade.  
The identity of this upstream catalyst is of importance, as its discovery offers another 
avenue for the manipulation of ADBE in central nerve terminals. Several Ca2+-
sensitive possibilities, such as Ras-GRF and PI3K-C2α, have the potential to be 
involved in the initiation of this cascade, but neither fit the current data optimally. 
Ras-GRF is thought to be activated via calmodulin (Farnsworth et al. 1995; Bähler & 
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Rhoads 2002) the inhibition of which did not affect Akt/GSK3 phosphorylation. 
Also, the effect seen on the cascade via PI3K inhibition with both wortmannin and 
LY294002 would eliminate PI3K-C2α as it is insensitive to both drugs at the levels 
used here. Further candidates suffer similar contradictions (see 3.3) and more work is 
required to identify the activator of PI3K within this signalling cascade. 
One possibility is that the Akt/GSK3 phosphorylation is caused purely due to a 
secretion of BDNF in neurons during HFS (Matsuda et al. 2009), which has already 
been shown to act through PI3K (Smillie et al. 2013). This would mean that 
Akt/GSK3 phosphorylation is an indirect result of local Ca2+ increases. PI3K can 
activate PDK1 or the mTORC2 complex via growth factor receptors (Oh & Jacinto 
2011) and inhibition of these may lead to further insight as to the progression of 
PI3K activation through to Akt/GSK3 phosphorylation and provide a clue as to the 
activator of PI3K. If BDNF excretion is in fact the initial activator of PI3K during 
HFS, then those manipulations resulting in inhibited Akt/GSK3 phosphorylation 
should exhibit a concurrent decrease in BDNF secretion during HFS. BDNF 
sequestering agents could also be applied to cultures during HFS to investigate any 
effect on Akt and GSK3 phosphorylation and this is one area that would be of great 
interest for further work.  
It is possible that PI3K not only has a role in the formation, but that it also plays a 
role in the budding of bulk endosomes. PI3K is responsible for the production of 
PI(3,4,5)P3 (Hao et al. 1997) as well as PI(3)P (Patki et al. 1997) which bind the 
budding-essential adaptor protein, AP-3 and early endosome antigen 1 (EEA1) 
respectively. Early endosome fusion is dependent on PI3K activity (Jones & Clague 
337 
1995) and treatment with wortmannin results in an inhibition of the recycling of FM-
dye taken up via ADBE (Richards et al. 2004). These factors together may lead one 
to the view that PI3K has a primary function in the fusion of a bulk endosome, or an 
intermediate, fusing with an early endosome via a PI3K-dependent mechanism. PI3K 
inhibition after stimulation via LY294002 or wortmannin in conjunction with either 
the FM unloading protocol or the HRP budding assay (see 1.3.2.3.4) could reveal any 
effect on the budding of bulk endosomes in the absence of its activity.  
7.2 PI4KIIα is an Essential Protein for ADBE 
PI4KIIα is enriched in synapses, being responsible for all PI4K activity on SVs (Guo 
et al. 2003), and is also regulated by GSK3 activity. Phosphorylation by GSK3 
causes the translocation and degradation of PI4KIIα (Robinson et al. 2014). In 
conjunction, these facts made PI4KIIα an interesting candidate for a possible role in 
SV recycling or, more specifically, in ADBE.  
The knockdown of PI4KIIα caused two concomitant phenotypes across the two 
major endocytic routes. Firstly, PI4KIIα -depleted CGNs showed an increased rate in 
the retrieval of syp-pH (an indicator of endocytic rate) (Figure 4.3). Secondly, 
PI4KIIα -depleted cells displayed a significant inhibition in dextran uptake (an 
indicator of successful ADBE) (Figure 4.4). Together these phenotypes were 
suggestive of a compensatory mechanism, although the question remained as to 
whether decreased PI4KIIα caused an increased rate of CME which in turn caused an 
inhibition of ADBE or vice versa. 
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GSK3 phosphorylates PI4KIIα on two serine residues which is thought to cause a 
conformational shift of the protein, allowing access of AP-3 to a di-leucine binding 
site (Robinson et al. 2014) and allowing transport of PI4KIIα for degradation.  
Mutations of these phosphorylation sites revealed their necessity in the role of 
PI4KIIα in SV recycling; a mutant which mimics GSK3 phosphorylation of PI4KIIα 
was unable to rescue either CME kinetics or ADBE inhibition during knockdown of 
the endogenous protein (Figure 4.9 and 4.10), whereas a phospho-null mutant 
exacerbated the accelerated syp-pH retrieval rate but successfully rescued ADBE 
Figure 4.11 and 4.13). This trend was mimicked by a mutant version of the protein 
with a mutated di-leucine motif which does not interact with AP-3 (Figure 4.12 and 
4.14).  
This separation of phenotypes by the two latter mutants suggested that the endocytic 
effects seen with a PI4KIIα knockdown were not causally linked as previously 
thought and that PI4KIIα actually plays distinct roles in either mode of retrieval. A 
mutant version of the PI4KIIα, which did not possess the kinase activity of its wild-
type counterpart, was successful in rescuing ADBE showing that the kinase function 
of the enzyme is not essential for its role in this endocytic mode (Figure 4.16). The 
kinase-dead mutant did partially rescue the accelerated syp-pH retrieval (Figure 4.15) 
but also displayed a dominant-negative effect on syp-pH retrieval in CGNs 
expressing endogenous PI4KIIα (Figure 4.21). This indicates that the kinase activity 
of PI4KIIα is important in its function in CME. 
Further work is required to determine the implications of the differential effects of 
each of these mutant forms of PI4KIIα. The execution of GST-pull downs using each 
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mutated form of PI4KIIα could reveal a difference in binding partners in line with 
the phosphorylation status of these particular sites, as well as any effects of binding 
in the presence or absence of the kinase activity of the protein. Any modifications of 
interactions with CME- or ADBE-specific proteins could reveal a mechanism for the 
role of PI4KIIα in each endocytic mode.  
It is still unknown if the phosphorylation status of PI4KIIα is changed within a HFS. 
GSK3 undergoes rapid inactivation under such conditions which may mean that 
PI4KIIα is dephosphorylated within a similar time period. Western blot analysis 
using existing phospho-specific antibodies (Robinson et al. 2014) could be 
performed on cell lysates before, immediately after or at set intervals after HFS. This 
would allow visualisation of the time course of PI4KIIα dephosphorylation, as well 
as its rephosphorylation and may allow further insight into its function in ADBE 
during HFS. 
The role of GSK3 in the stability of PI4KIIα could imply a chronic activity-
dependent regulation for PI4KIIα in cell types such as CGNs which experience long 
periods of intense stimulation. In these conditions there would be less degradation of 
PI4KIIα when compared to cells which experience milder stimulation, possibly 
facilitating a higher occurrence of ADBE. If so, this should also be true for the 
cultured hippocampal cells and CGNs, as their incubation media mimic these 
conditions. A comparison of the levels of PI4KIIα between both chronically 
depolarised CGNs and hippocampal cells may lend insight into this hypothesis. A 
comparison could also be made between CGNs direct from high K+ medium and 
CGNs which have been placed into a basic sodium solution and allowed to 
340 
repolarise. This could be performed as a time course experiment, allowing the 
observer to determine if GSK3 is able to affect a clearance of PI4KIIα in a relatively 
fast manner. 
The use of an HRP uptake assay in conjunction with a lentiviral infection of different 
PI4KIIα constructs resulting in their overexpression could also reveal, with more 
fidelity, whether the level of PI4KIIα expression affects ADBE in two directions. 
The dextran experiments performed here are only a measure of how many synapses 
performed ADBE and not how many endosomes were being formed. If 
overexpression of PI4KIIα does in fact cause a larger number of endosomes formed 
per HFS, this could be useful information with regards to the aim to find methods of 
modulating ADBE. 
Although the knockdown of PI4KIIα results in a decrease of the phosphoinositide 
PI4P (Mössinger et al. 2012) (especially on SVs), the effects on the levels of other 
PIs may be more complicated. It is possible that the depletion of one PI is not the 
only cause of phenotypes seen, but actually the result in the shift of a ratio of one or 
more different PIs. In order to investigate if it is in fact a disturbance in the creation 
of the phosphoinositides causing the physiological effects of PI4KIIα there are a 
number of further experiments which could be conducted utilising overexpression or 
knockdown of other kinases such as phosphaditylinositol-4-phosphate 5 kinase 
(PI5K), PIKfyve.  
Proportions of PI4P to PI(4,5)P2 and PI(3,4,5)P3 are regulated not only by PI3Ks and 
PI5Ks but also by phosphatases like synaptojanins I and II (Cremona et al. 1999; 
Berman et al. 2008; Chang-Ileto et al. 2011; McPherson et al. 1996; Woscholski et 
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al. 1998) or oculocerebrorenal syndrome of Lowe (OCRL) (Attree et al. 1992) by 
their removal of phosphate groups on the D5 position of PI(4,5)P2 and PI(3,4,5)P3 
(see Figure 1.5).  
Previous work has shown an increase in PI(4,5)P2 levels along with a decrease in 
PI4P and PI levels in synaptojanin I deficient mice (Cremona et al. 1999). Work with 
this mouse model or other forms of synaptojanin I manipulation with those CME and 
ADBE-monitoring protocols available may reveal more information as to the 
importance of the proportions of these phosphoinositides in the presynapse for 
normal endocytosis. 
7.3 Most pHluorin-tagged Synaptic Vesicle Proteins Are Not 
Recycled via ADBE 
My initial theory explaining the effects of PI4KIIα knockdown included a coupling 
mechanism between the two major forms of endocytosis, allowing compensation of 
one mode when the other is altered. This was disproved when the two phenotypes 
were separated in one experiment. ADBE was rescued by one mutant form of the 
protein but the rate of retrieval of syp-pH was further accelerated. This raised 
questions as to the ability of ADBE to retrieve SV proteins. If ADBE function is 
restored, how is more SV protein still being retrieved via CME? What is the normal 
proportion of SV protein retrieved via ADBE compared to CME? To answer these 
questions a series of experiments were designed and performed; using syp-pH and an 
acid wash protocol the proportion of syp-pH which had been internalised into a 
neutral compartment such as an endosome was revealed to be insignificant. The 
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pharmacological inhibition of ADBE resulted in no change in the kinetics or 
efficiency of syp-pH, vGlut-pH, tagmin-pH or sybII-pH compared to a control 
stimulus. These results would all indicate that a wide selection of pHluorin-tagged 
SV proteins, are not significantly retrieved via ADBE.  
To determine what form of endocytosis is responsible for the internalisation of these 
probes, a series of experiments were performed manipulating the well-defined cargo-
specific mode of CME. Inhibitions, both genetic and pharmacological, of CME 
showed a near ablation of syp-pH retrieval after HFS showing that this is the primary 
route for syp-pH internalisation, even when this is not the dominant form of PM 
retrieval. This remained true even when CME was inhibited at physiological 
temperatures. This showed that ADBE does not gain function in the retrieval of 
cargo at physiological temperatures. It also demonstrated that, although it would 
appear from recent work that other forms of endocytosis are present in a nerve 
terminal at physiological temperatures, these are not the dominant method for SV 
cargo retrieval during HFS.  
Combined, this data suggests that the variety of pHluorin-tagged SV proteins which 
are used widely in research to monitor changes in endocytosis, are in fact 
predominantly retrieved via (and therefore reporting) CME and not ADBE. 
Further work is needed to guarantee the effects on pHluorin retrieval after inhibition 
of CME is not a side effect of an unhealthy cell due to a prolonged knockdown of an 
essential protein. Although the effect on syp-pH retrieval was also seen using 
pharmacological methods, there is always a question of non-specific action or, 
specifically for pitstop-2, an effect on the acidification of vesicles (although this 
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particular issue was addressed. See Figure 5.12). One acute and specific method of 
CME inhibition would be to utilise a re-routing of clathrin from the PM and monitor 
the effect on pHluorin retrieval in comparison to a control stimulus (Willox & Royle 
2012). This experiment does have its own shortcomings in that clathrin will not be 
rerouted in isolation, but will be connected to many of its binding partners which 
form the machinery for CME. However, as these interactions will largely be specific 
for CME, the experiment should still have the desired CME-specific effect in relation 
to SV cargo retrieval from the PM. 
Other questions still remain as to the discrepancies between the results obtained from 
my work and those published by other groups, in which a clathrin depleted cell 
showed inhibition of pHluorin-tagged SV protein retrieval only during mild and not 
more intense stimulation. A method of identifying the level of knockdown of clathrin 
in each cell used for live cell retrieval experiments could allow insight into the 
hypothesis that individual cells within one population exposed to the same siRNA 
can have a large disparity in the efficacy of clathrin knockdown. It is possible that 
this variation is of vital importance in the severity of the phenotype observed (López-
Murcia et al. 2014).  
7.4 VAMP4 is Specifically Trafficked via and is Essential for ADBE 
Work with a battery of pHluorin-tagged SV proteins showed that very little, if any, 
of their population was being retrieved via ADBE during HFS. If this was the case, 
and one believes the abundant evidence that SVs formed via ADBE are recycled 
differently than those formed via CME (Richards et al. 2000; Sara et al. 2002; 
Richards et al. 2004; Clayton & Cousin 2009; Cheung et al. 2010), one must ask the 
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question of how these SVs are recognised by their shuttling machinery. I determined 
that it was likely that there was a specific SV protein which marks these SVs to allow 
correct trafficking.  
Previous work with VAMP4-pHluorin showed a distinct fluorescence change upon 
intense stimulation over mild stimulation in that the fluorescence of a synapse 
actually decreases (Raingo et al. 2012). This is highly unusual for a pHluorin-tagged 
SV protein and indicative of a mass internalisation which seemingly only occurs 
during intense stimulation. These results led me to believe that VAMP4 may be 
significantly internalised via ADBE. 
To test this hypothesis, experiments were performed in two cell types in which cells 
transfected with VAMP4-pHluorin were exposed to both LFS and HFS. I discovered 
that individual fluorescence traces from transfected synaptic boutons could be 
separated into two populations with regards to their net change in fluorescence over 
time. In the case of CGNs, HFS led to a population of boutons which exhibited a 
slow increase in fluorescence and another exhibiting a slow decrease. The proportion 
of synapses displaying a decrease in fluorescence was significantly increased after 
HFS compared to LFS. 
Further analysis revealed that hippocampal cells also exhibited these differential 
responses after HFS and that the proportion of downwards traces was dramatically 
decreased during LFS. These results led me to hypothesise that VAMP4-pHluorin 
was indeed being internalised by ADBE, but only by a subset of synapses within 
each cell. This hypothesis correlated with the finding that only a subset of synapses 
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in both CGN and hippocampal cultures internalise dextran upon HFS (Clayton & 
Cousin 2009; Wenzel et al. 2012).  
To investigate the effects of inhibiting ADBE on the retrieval of VAMP4-pH a two-
stimulation protocol was used in which ADBE is inhibited upon a second stimulus, 
but not the first. Using this protocol it was observed that there were significantly 
fewer downwards traces upon inhibition of ADBE. This was seen in comparison to 
both a second stimulation when compared to control cells and when compared to the 
internal control. Blocking ADBE via syndapin knockdown also caused a near 
ablation of downwards traces. This further strengthened the hypothesis that 
downwards traces were indicative of VAMP4-pHluorin which has been internalised 
via ADBE into an endosome which is undergoing slow acidification.  
One further experiment which would solidify the theory of synapses exhibiting 
downwards traces being equivalent to synapses undergoing (more) ADBE, would be 
via a combined dextran uptake/VAMP4-pHluorin experiment. This experiment could 
give very useful information providing the fluorescence of the dextran used does not 
overlap with that of VAMP4-pH and a system of dextran application and removal 
was devised that did not interfere with the live imaging of VAMP4-pH. One would 
be looking to see if those synapses which displayed downwards traces after HFS 
corresponded significantly with those which internalised dextran on the same 
stimulation. 
The cause of the upwards fluorescence is also a matter of interest. VAMP4 
specifically labels asynchronous pool SVs and it has also been shown that an 
overexpression of VAMP4 leads to a significant increase in asynchronous fusion 
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(Raingo et al. 2012). It is possible that the slow increase in fluorescence is due to the 
(enhanced) asynchronous release of vesicles labelled with VAMP4-pH. The 
inhibition of asynchronous release could reveal if this is the case. This could be 
achieved via application of the calcium chelator EGTA (Raingo et al. 2012). 
However, as EGTA application also causes an inhibition of ADBE (Morton et al. 
2015), this would only be a useful stratagem during LFS. 
The acid wash protocol previously used to show a lack of sequestered pHluorin after 
HFS when tagged to synaptophysin, was successful in revealing a significant 
proportion of sequestered VAMP4-pHluorin after HFS but not LFS in both 
hippocampal cells and CGNs. 
Pharmacological and genetic methods to inhibit CME were utilised to observe any 
effects on the trafficking of VAMP4-pHluorin during HFS. The retrieval of VAMP4-
pHluorin after HFS via the slowly acidifying route was not inhibited when used in a 
protocol which did not affect the incidence of ADBE. However, when used in 
conjunction with a knockdown of CHC in CGNs, which was individual in that it had 
an inhibitory effect on ADBE, a significantly reduced retrieval was observed. These 
observations also agreed with my theory that the slow decreases in VAMP4-pHluorin 
were indicative of ADBE. 
As it appeared that VAMP4 was unusual in its uptake via ADBE I investigated any 
role that it may play in ADBE itself. Knocking down VAMP4 in CGNs resulted in 
an inhibition of ADBE as measured by dextran uptake but no effect of the retrieval of 
syp-pH via CME, revealing a particular requirement for VAMP4 in the normal 
function of ADBE but not CME.  
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To investigate the effects of ablating ADBE on exocytosis and CME, I next 
conducted a four-HFS experiment, monitoring the release and retrieval of syp-pH 
over each stimulation in comparison to the first stimulation (which is unaffected by 
VAMP4 knockdown - Figure 6.17). Interestingly, VAMP4 knockdown resulted in a 
steady and significant decrease of peak height upon stimulation across all 
stimulations from the second onwards. This was not due to an increased rate of CME 
and so was attributed to the reduction in fusion ready SVs due to the elimination of 
ADBE-derived SVs as a supplement to the RP and RRP during HFS. 
This theory could be investigated using an HRP budding assay in conjunction with a 
culture wide infection using a lentiviral vector. If it was true that SV stocks are 
depleted due to a lack of ADBE, this should be apparent due to a lack of HRP-
labelled SVs after a number of stimulations. The results using syp-pH would imply 
that this difference could be visible even after the first stimulation.  
I next attempted to identify the protein interaction responsible for the uptake of 
VAMP4 into bulk endosomes. A VAMP4-pH containing a mutated di-leucine motif 
known to be essential for adaptor protein binding was used, and its retrieval during 
HFS was examined in hippocampal cells and CGNs. Both cell types exhibited a 
significant reduction of retrieval compared to wild-type VAMP4-pH. This was 
deemed not to be a dominant-negative effect of mutant VAMP4 expression, as 
overexpression of this mutant VAMP4 did not inhibit dextran uptake. This adaptor 
binding mutant was also incapable of rescuing ADBE inhibition as caused by 
VAMP4 knock down. This data together demonstrates a necessity for adaptor 
binding in both the role of VAMP4 in ADBE and its retrieval by this mode. 
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Hippocampal cultures consist of around 65% excitatory and 35% inhibitory synapses 
and inhibitory synapses are more likely to undergo ADBE (Wenzel et al. 2012). It is 
possible therefore that inhibitory synapses would exhibit a higher proportion of 
downstrokes. However, as hippocampal cells experience a much higher rate of 
transfection than CGNs, it is nearly impossible to study individual transfected cells in 
these cultures. As such it is possible that any difference in responses between 
inhibitory and excitatory neurons was not detected.  
The vesicular GABA transporter (vGAT) is only expressed in inhibitory neurons and 
therefore the use of a fluorescently-labelled antibody for vGAT (vGAT-oyster488) 
(Wenzel et al. 2012) could make this comparison possible. This antibody recognises 
the luminal domain of vGAT and can be used during live cell imaging. Comparing 
the fluorescent responses of hippocampal cells transfected with both VAMP4-pH and 
mCer in the presence of vGAT-oyster488 would allow one to distinguish which 
synapses belonged to inhibitory neurons and compare the two populations for 
differences in their VAMP4-pH retrieval. This would only be possible if the 
pHluorin molecule tagged to VAMP4 was modified to mOrange to allow 




The results accumulated within this thesis have allowed for the creation of a model 
of some of the essential components and cellular factors which must be present for 
the normal progression of ADBE during HFS (Figure 7.1). 
HFS leads to a rapid and localised increase in Ca2+ concentration via voltage-gated 
calcium channels which are enriched at the active zone. This Ca2+ increase initiates a 
PI3K-mediated cascade, leading to activation of the kinase Akt via its 
phosphorylation. Akt then phosphorylates and de-activates GSK3, allowing the 
efficient dephosphorylation of the ADBE essential molecule dynamin I and 
potentially other ADBE substrates such as PI4KIIα. Inhibition of GSK3 has 
previously been shown to inhibit ADBE over sequential stimuli. GSK3 deactivation 
therefore plays an acute role in ADBE, which is mediated via a rapid change in the 
presynaptic environment in response to an intense stimulation.  
PI4KIIα is essential for ADBE and its phosphorylation by GSK3 inhibits its function 
in the capacity. Therefore, GSK3 activity may also have a longer term role in the 
modulation of PI4KIIα levels in the synapse. The active form of GSK3 
phosphorylates PI4KIIα, marking it for degradation via AP-3-mediated trafficking to 
the lysosome. This would be predicted to occur during low neuronal activity. This 
increased clearance of PI4KIIα may cause an inhibition of ADBE. Conversely, it is 
possible that GSK3 inhibition via intense activity results in more PI4KIIα at the 
synapse, possibly allowing a higher incidence of ADBE to compensate for the high 
rate of SV fusion, which would be another consequence of high activity in the 
synapse. Thus GSK3 phosphorylation may perform a dual role to ensure optimal 
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coupling of neuronal activity to ADBE. In addition, PI4KIIα plays discrete role in 
the regulation of CME potentially via its enzymatic activity. 
SV proteins are predominantly recycled via CME and do not form a representative 
proportion of the cargo composition of bulk endosomes. VAMP4 is unusual in that it 
is retrieved in the majority by ADBE. VAMP4 is essential for ADBE, as is the 
presence of an adaptor-protein-specific binding site on the protein. As such, it is my 
theory that formation of a bulk endosome involves the use of specific adaptor 
proteins (potentially AP-1) which recognise VAMP4 to initiate ADBE. This leads to 
a distinct protein signature of SVs formed via ADBE and CME which may allow for 
their differential sorting to vesicle pools. It is still unknown how SVs from bulk 
endosomes become fusion-competent as they possess a much lower copy number of 
essential fusion proteins but it is possible that they are shuttled through another 
endosome to be equipped with this machinery after budding from the bulk endosome. 
In conclusion, the work completed for this thesis has identified several new potential 
avenues for the continued research of ADBE. VAMP4-pH was designed to be the 
first specific, live-cell capable method of tracking ADBE. A potential adaptor protein 
interaction was identified for the initiation of ADBE. In addition, novel regulatory 
roles for PI4KIIα have been revealed for both CME and ADBE, with different 
aspects of the kinase serving different functions for both. The work here, taken 
together, should allow significant scope for the manipulation of ADBE and will 
allow simpler observation of the effects of cellular manipulations on ABDE in future 
experiments. 
351 
ADBE is of particular interest because of its role in synaptic exhaustion which takes 
place with high incidence of ADBE. In this instance ADBE sequesters large sections 
of plasma membrane and possibly SV cargo or adaptors, causing a run down in 
synaptic activity until SVs are formed from bulk endosomes. Synaptic exhaustion, if 
manipulated via the facilitation of ADBE, could allow the control of epileptic 
seizures. The identification of the active regions within these two, newly discovered 
ADBE-specific proteins may allow for this. Synthetic peptides which mimic these 
functional regions could be utilised and these tools are becoming an increasingly 
relevant tool for clinical use (Groß et al. 2015). Conversely, synaptic exhaustion 
could be ablated through the inhibition of ADBE, allowing a larger number of ready-
made, readily-releasable SVs. This could be a useful tact for the treatment of 












Figure 7.1 Model of Phosphorylation Cascades Relevant to ADBE and SV protein retrieval and Recycling 
During HFS, increased calcium concentration in the presynapse causes simultaneous activation of calcineurin (by cytoplasmic increase) (A), leading 
to dephosphorylation as well as the activation of a signalling cascade which leads to the phosphorylation and de-activation of GSK3 via Akt and 
PI3K (by active zone increase) (B). This de-activation allows maximal dephosphorylation of dynamin during HFS and binding to syndapin (C). GSK3 
de-activation also prevents the phosphorylation of PI4KIIα (D). This phosphorylation would normally lead to a removal of PI4KIIα from the 
presynapse via AP-3 binding (E). PI4KIIα is essential for ADBE and plays a distinct role in the modulation of CME (F). VAMP4 is specifically 
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